covariate_id,covariate_name,covariate_analysis_id
1901,Charlson index - Romano adaptation,901
1902,Diabetes Comorbidity Severity Index (DCSI),902
1903,CHADS2,903
1904,CHADS2VASc,904
2007,index month: 2,7
3007,index month: 3,7
5003,age group: 25-29,3
7003,age group: 35-39,3
8003,age group: 40-44,3
9003,age group: 45-49,3
10003,age group: 50-54,3
11003,age group: 55-59,3
12003,age group: 60-64,3
13003,age group: 65-69,3
14003,age group: 70-74,3
15003,age group: 75-79,3
16003,age group: 80-84,3
17003,age group: 85-89,3
2020006,index year: 2020,6
8507001,gender = MALE,1
8532001,gender = FEMALE,1
23220210,condition_era group during day -365 through 0 days relative to index: Chronic tonsillitis,210
23220212,condition_era group during day -30 through 0 days relative to index: Chronic tonsillitis,212
23798210,condition_era group during day -365 through 0 days relative to index: Acute laryngopharyngitis,210
24609210,condition_era group during day -365 through 0 days relative to index: Hypoglycemia,210
24969210,condition_era group during day -365 through 0 days relative to index: Laryngitis,210
25297210,condition_era group during day -365 through 0 days relative to index: Acute pharyngitis,210
26638210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of esophagus,210
26638212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of esophagus,212
26711210,condition_era group during day -365 through 0 days relative to index: Chronic pharyngitis,210
26711212,condition_era group during day -30 through 0 days relative to index: Chronic pharyngitis,212
27587210,condition_era group during day -365 through 0 days relative to index: Disturbance of salivary secretion,210
27587212,condition_era group during day -30 through 0 days relative to index: Disturbance of salivary secretion,212
30133210,condition_era group during day -365 through 0 days relative to index: Acute laryngitis,210
30361210,condition_era group during day -365 through 0 days relative to index: Hypoglycemic disorder,210
30437210,condition_era group during day -365 through 0 days relative to index: Gastro-esophageal reflux disease with esophagitis,210
30753210,condition_era group during day -365 through 0 days relative to index: Esophagitis,210
72712210,condition_era group during day -365 through 0 days relative to index: Synovial cyst,210
72712212,condition_era group during day -30 through 0 days relative to index: Synovial cyst,212
73153210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of lateral wall of urinary bladder,210
73153212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of lateral wall of urinary bladder,212
73553210,condition_era group during day -365 through 0 days relative to index: Arthropathy,210
73553212,condition_era group during day -30 through 0 days relative to index: Arthropathy,212
73925210,condition_era group during day -365 through 0 days relative to index: Burn of upper limb,210
73925212,condition_era group during day -30 through 0 days relative to index: Burn of upper limb,212
75053210,condition_era group during day -365 through 0 days relative to index: Fracture of bone,210
75053212,condition_era group during day -30 through 0 days relative to index: Fracture of bone,212
75650210,condition_era group during day -365 through 0 days relative to index: Proteinuria,210
75650212,condition_era group during day -30 through 0 days relative to index: Proteinuria,212
75860210,condition_era group during day -365 through 0 days relative to index: Constipation,210
76349210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of urinary system,210
76685210,condition_era group during day -365 through 0 days relative to index: Myasthenia gravis,210
77079210,condition_era group during day -365 through 0 days relative to index: Spinal stenosis,210
77079212,condition_era group during day -30 through 0 days relative to index: Spinal stenosis,212
77234210,condition_era group during day -365 through 0 days relative to index: Benign neoplasm of colon,210
77670210,condition_era group during day -365 through 0 days relative to index: Chest pain,210
77670212,condition_era group during day -30 through 0 days relative to index: Chest pain,212
78200210,condition_era group during day -365 through 0 days relative to index: Benign mammary dysplasia,210
78786210,condition_era group during day -365 through 0 days relative to index: Pleurisy,210
78786212,condition_era group during day -30 through 0 days relative to index: Pleurisy,212
78804210,condition_era group during day -365 through 0 days relative to index: Fibrocystic disease of breast,210
79768210,condition_era group during day -365 through 0 days relative to index: Neoplasm of urinary system,210
79768212,condition_era group during day -30 through 0 days relative to index: Neoplasm of urinary system,212
79864210,condition_era group during day -365 through 0 days relative to index: Hematuria syndrome,210
79864212,condition_era group during day -30 through 0 days relative to index: Hematuria syndrome,212
80180210,condition_era group during day -365 through 0 days relative to index: Osteoarthritis,210
80180212,condition_era group during day -30 through 0 days relative to index: Osteoarthritis,212
80502210,condition_era group during day -365 through 0 days relative to index: Osteoporosis,210
80502212,condition_era group during day -30 through 0 days relative to index: Osteoporosis,212
80767210,condition_era group during day -365 through 0 days relative to index: Breast lump,210
80951210,condition_era group during day -365 through 0 days relative to index: Candidiasis of urogenital site,210
81902210,condition_era group during day -365 through 0 days relative to index: Urinary tract infectious disease,210
81902212,condition_era group during day -30 through 0 days relative to index: Urinary tract infectious disease,212
132344210,condition_era group during day -365 through 0 days relative to index: Gingival and periodontal disease,210
132797210,condition_era group during day -365 through 0 days relative to index: Sepsis,210
133729210,condition_era group during day -365 through 0 days relative to index: Hyperparathyroidism,210
134398210,condition_era group during day -365 through 0 days relative to index: Periodontal disease,210
134452210,condition_era group during day -365 through 0 days relative to index: Olecranon bursitis,210
134452212,condition_era group during day -30 through 0 days relative to index: Olecranon bursitis,212
134453210,condition_era group during day -365 through 0 days relative to index: Bursitis,210
134453212,condition_era group during day -30 through 0 days relative to index: Bursitis,212
134736210,condition_era group during day -365 through 0 days relative to index: Backache,210
135618210,condition_era group during day -365 through 0 days relative to index: Pruritic rash,210
136184210,condition_era group during day -365 through 0 days relative to index: Pruritus of skin,210
136773210,condition_era group during day -365 through 0 days relative to index: Rosacea,210
136773212,condition_era group during day -30 through 0 days relative to index: Rosacea,212
136788210,condition_era group during day -365 through 0 days relative to index: Spinal stenosis of lumbar region,210
136788212,condition_era group during day -30 through 0 days relative to index: Spinal stenosis of lumbar region,212
136937210,condition_era group during day -365 through 0 days relative to index: Benign neoplasm of endocrine gland,210
136937212,condition_era group during day -30 through 0 days relative to index: Benign neoplasm of endocrine gland,212
137053210,condition_era group during day -365 through 0 days relative to index: Seborrheic dermatitis,210
138102210,condition_era group during day -365 through 0 days relative to index: Benign neoplasm of skin,210
138102212,condition_era group during day -30 through 0 days relative to index: Benign neoplasm of skin,212
138148210,condition_era group during day -365 through 0 days relative to index: Plantar nerve lesion,210
138148212,condition_era group during day -30 through 0 days relative to index: Plantar nerve lesion,212
138388210,condition_era group during day -365 through 0 days relative to index: Secondary hyperparathyroidism,210
138525210,condition_era group during day -365 through 0 days relative to index: Pain in limb,210
138525212,condition_era group during day -30 through 0 days relative to index: Pain in limb,212
138790210,condition_era group during day -365 through 0 days relative to index: Chronic periodontitis,210
139099210,condition_era group during day -365 through 0 days relative to index: Ingrowing nail,210
139099212,condition_era group during day -30 through 0 days relative to index: Ingrowing nail,212
140214210,condition_era group during day -365 through 0 days relative to index: Eruption,210
140214212,condition_era group during day -30 through 0 days relative to index: Eruption,212
140673210,condition_era group during day -365 through 0 days relative to index: Hypothyroidism,210
141608210,condition_era group during day -365 through 0 days relative to index: Periodontitis,210
192279210,condition_era group during day -365 through 0 days relative to index: Kidney disorder due to diabetes mellitus,210
192279212,condition_era group during day -30 through 0 days relative to index: Kidney disorder due to diabetes mellitus,212
192359210,condition_era group during day -365 through 0 days relative to index: Renal failure syndrome,210
192359212,condition_era group during day -30 through 0 days relative to index: Renal failure syndrome,212
192438210,condition_era group during day -365 through 0 days relative to index: Abdominal mass,210
192438212,condition_era group during day -30 through 0 days relative to index: Abdominal mass,212
192568210,condition_era group during day -365 through 0 days relative to index: Secondary malignant neoplasm of intra-abdominal lymph nodes,210
192568212,condition_era group during day -30 through 0 days relative to index: Secondary malignant neoplasm of intra-abdominal lymph nodes,212
192671210,condition_era group during day -365 through 0 days relative to index: Gastrointestinal hemorrhage,210
192671212,condition_era group during day -30 through 0 days relative to index: Gastrointestinal hemorrhage,212
193253210,condition_era group during day -365 through 0 days relative to index: Nephritis,210
193253212,condition_era group during day -30 through 0 days relative to index: Nephritis,212
193431210,condition_era group during day -365 through 0 days relative to index: Benign tumor of digestive organ,210
193519210,condition_era group during day -365 through 0 days relative to index: Impaired renal function disorder,210
193519212,condition_era group during day -30 through 0 days relative to index: Impaired renal function disorder,212
193688210,condition_era group during day -365 through 0 days relative to index: Clostridioides difficile infection,210
193782210,condition_era group during day -365 through 0 days relative to index: End-stage renal disease,210
193782212,condition_era group during day -30 through 0 days relative to index: End-stage renal disease,212
194087210,condition_era group during day -365 through 0 days relative to index: Hepatitis due to infection,210
194087212,condition_era group during day -30 through 0 days relative to index: Hepatitis due to infection,212
194133210,condition_era group during day -365 through 0 days relative to index: Low back pain,210
194589210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of biliary tract,210
194589212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of biliary tract,212
194990210,condition_era group during day -365 through 0 days relative to index: Inflammatory disease of liver,210
194990212,condition_era group during day -30 through 0 days relative to index: Inflammatory disease of liver,212
195002210,condition_era group during day -365 through 0 days relative to index: Ulceration of intestine,210
195482210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of intestinal tract,210
195482212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of intestinal tract,212
195500210,condition_era group during day -365 through 0 days relative to index: Benign neoplasm of uterus,210
195867210,condition_era group during day -365 through 0 days relative to index: Noninflammatory disorder of the vagina,210
196360210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of bladder,210
196931210,condition_era group during day -365 through 0 days relative to index: Neoplasm of digestive tract,210
196931212,condition_era group during day -30 through 0 days relative to index: Neoplasm of digestive tract,212
197032210,condition_era group during day -365 through 0 days relative to index: Hyperplasia of prostate,210
197032212,condition_era group during day -30 through 0 days relative to index: Hyperplasia of prostate,212
197236210,condition_era group during day -365 through 0 days relative to index: Uterine leiomyoma,210
197320210,condition_era group during day -365 through 0 days relative to index: Acute renal failure syndrome,210
197320212,condition_era group during day -30 through 0 days relative to index: Acute renal failure syndrome,212
197500210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of colon,210
197500212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of colon,212
197506210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of abdomen,210
197506212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of abdomen,212
197508210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of urinary bladder,210
197508212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of urinary bladder,212
197804210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of intra-abdominal organs,210
197804212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of intra-abdominal organs,212
198091210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of retroperitoneum,210
198091212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of retroperitoneum,212
198124210,condition_era group during day -365 through 0 days relative to index: Kidney disease,210
198124212,condition_era group during day -30 through 0 days relative to index: Kidney disease,212
198678210,condition_era group during day -365 through 0 days relative to index: Intestinal infectious disease,210
198988210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of pelvis,210
199754210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of pancreas,210
199754212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of pancreas,212
199837210,condition_era group during day -365 through 0 days relative to index: Portal vein thrombosis,210
199837212,condition_era group during day -30 through 0 days relative to index: Portal vein thrombosis,212
199866210,condition_era group during day -365 through 0 days relative to index: Acute gastritis,210
199866212,condition_era group during day -30 through 0 days relative to index: Acute gastritis,212
200680210,condition_era group during day -365 through 0 days relative to index: Neoplasm of bladder,210
200680212,condition_era group during day -30 through 0 days relative to index: Neoplasm of bladder,212
201131210,condition_era group during day -365 through 0 days relative to index: Pelvic mass,210
201131212,condition_era group during day -30 through 0 days relative to index: Pelvic mass,212
201313210,condition_era group during day -365 through 0 days relative to index: Hypertensive renal disease,210
201340210,condition_era group during day -365 through 0 days relative to index: Gastritis,210
201340212,condition_era group during day -30 through 0 days relative to index: Gastritis,212
201817210,condition_era group during day -365 through 0 days relative to index: Benign neoplasm of female genital organ,210
201820210,condition_era group during day -365 through 0 days relative to index: Diabetes mellitus,210
201820212,condition_era group during day -30 through 0 days relative to index: Diabetes mellitus,212
201826210,condition_era group during day -365 through 0 days relative to index: Type 2 diabetes mellitus,210
201826212,condition_era group during day -30 through 0 days relative to index: Type 2 diabetes mellitus,212
252280210,condition_era group during day -365 through 0 days relative to index: Neoplasm of respiratory tract,210
252280212,condition_era group during day -30 through 0 days relative to index: Neoplasm of respiratory tract,212
252662210,condition_era group during day -365 through 0 days relative to index: Tracheobronchial disorder,210
252662212,condition_era group during day -30 through 0 days relative to index: Tracheobronchial disorder,212
253506210,condition_era group during day -365 through 0 days relative to index: Pneumonitis,210
253506212,condition_era group during day -30 through 0 days relative to index: Pneumonitis,212
254061210,condition_era group during day -365 through 0 days relative to index: Pleural effusion,210
254443210,condition_era group during day -365 through 0 days relative to index: Sjögren's syndrome,210
254443212,condition_era group during day -30 through 0 days relative to index: Sjögren's syndrome,212
254761210,condition_era group during day -365 through 0 days relative to index: Cough,210
254761212,condition_era group during day -30 through 0 days relative to index: Cough,212
255334210,condition_era group during day -365 through 0 days relative to index: Collagen disease,210
255334212,condition_era group during day -30 through 0 days relative to index: Collagen disease,212
255348210,condition_era group during day -365 through 0 days relative to index: Polymyalgia rheumatica,210
255348212,condition_era group during day -30 through 0 days relative to index: Polymyalgia rheumatica,212
255573210,condition_era group during day -365 through 0 days relative to index: Chronic obstructive lung disease,210
255573212,condition_era group during day -30 through 0 days relative to index: Chronic obstructive lung disease,212
255848210,condition_era group during day -365 through 0 days relative to index: Pneumonia,210
255848212,condition_era group during day -30 through 0 days relative to index: Pneumonia,212
256449210,condition_era group during day -365 through 0 days relative to index: Bronchiectasis,210
256449212,condition_era group during day -30 through 0 days relative to index: Bronchiectasis,212
256451210,condition_era group during day -365 through 0 days relative to index: Bronchitis,210
256451212,condition_era group during day -30 through 0 days relative to index: Bronchitis,212
256722210,condition_era group during day -365 through 0 days relative to index: Bronchopneumonia,210
257004210,condition_era group during day -365 through 0 days relative to index: Acute exacerbation of chronic obstructive airways disease,210
257004212,condition_era group during day -30 through 0 days relative to index: Acute exacerbation of chronic obstructive airways disease,212
257007210,condition_era group during day -365 through 0 days relative to index: Allergic rhinitis,210
257007212,condition_era group during day -30 through 0 days relative to index: Allergic rhinitis,212
257011210,condition_era group during day -365 through 0 days relative to index: Acute upper respiratory infection,210
257011212,condition_era group during day -30 through 0 days relative to index: Acute upper respiratory infection,212
257315210,condition_era group during day -365 through 0 days relative to index: Bacterial pneumonia,210
260125210,condition_era group during day -365 through 0 days relative to index: Acute bronchiolitis,210
260125212,condition_era group during day -30 through 0 days relative to index: Acute bronchiolitis,212
260139210,condition_era group during day -365 through 0 days relative to index: Acute bronchitis,210
260139212,condition_era group during day -30 through 0 days relative to index: Acute bronchitis,212
260427210,condition_era group during day -365 through 0 days relative to index: Common cold,210
260427212,condition_era group during day -30 through 0 days relative to index: Common cold,212
312327210,condition_era group during day -365 through 0 days relative to index: Acute myocardial infarction,210
312327212,condition_era group during day -30 through 0 days relative to index: Acute myocardial infarction,212
312339210,condition_era group during day -365 through 0 days relative to index: Arterial embolism,210
312339212,condition_era group during day -30 through 0 days relative to index: Arterial embolism,212
312437210,condition_era group during day -365 through 0 days relative to index: Dyspnea,210
312437212,condition_era group during day -30 through 0 days relative to index: Dyspnea,212
313217210,condition_era group during day -365 through 0 days relative to index: Atrial fibrillation,210
313217212,condition_era group during day -30 through 0 days relative to index: Atrial fibrillation,212
314378210,condition_era group during day -365 through 0 days relative to index: Hypertensive heart disease with congestive heart failure,210
314378212,condition_era group during day -30 through 0 days relative to index: Hypertensive heart disease with congestive heart failure,212
315085210,condition_era group during day -365 through 0 days relative to index: Lymphadenopathy,210
315085212,condition_era group during day -30 through 0 days relative to index: Lymphadenopathy,212
315286210,condition_era group during day -365 through 0 days relative to index: Chronic ischemic heart disease,210
315286212,condition_era group during day -30 through 0 days relative to index: Chronic ischemic heart disease,212
315296210,condition_era group during day -365 through 0 days relative to index: Preinfarction syndrome,210
315296212,condition_era group during day -30 through 0 days relative to index: Preinfarction syndrome,212
315558210,condition_era group during day -365 through 0 days relative to index: Atherosclerosis of arteries of the extremities,210
315558212,condition_era group during day -30 through 0 days relative to index: Atherosclerosis of arteries of the extremities,212
316139210,condition_era group during day -365 through 0 days relative to index: Heart failure,210
316139212,condition_era group during day -30 through 0 days relative to index: Heart failure,212
316501210,condition_era group during day -365 through 0 days relative to index: Vascular disease of the skin,210
316501212,condition_era group during day -30 through 0 days relative to index: Vascular disease of the skin,212
316866210,condition_era group during day -365 through 0 days relative to index: Hypertensive disorder,210
316866212,condition_era group during day -30 through 0 days relative to index: Hypertensive disorder,212
317002210,condition_era group during day -365 through 0 days relative to index: Low blood pressure,210
317009210,condition_era group during day -365 through 0 days relative to index: Asthma,210
317302210,condition_era group during day -365 through 0 days relative to index: Sinus node dysfunction,210
318096210,condition_era group during day -365 through 0 days relative to index: Secondary malignant neoplasm of lymph node,210
318096212,condition_era group during day -30 through 0 days relative to index: Secondary malignant neoplasm of lymph node,212
318443210,condition_era group during day -365 through 0 days relative to index: Arteriosclerotic vascular disease,210
318443212,condition_era group during day -30 through 0 days relative to index: Arteriosclerotic vascular disease,212
318459210,condition_era group during day -365 through 0 days relative to index: Respiratory insufficiency,210
318459212,condition_era group during day -30 through 0 days relative to index: Respiratory insufficiency,212
318800210,condition_era group during day -365 through 0 days relative to index: Gastroesophageal reflux disease,210
318800212,condition_era group during day -30 through 0 days relative to index: Gastroesophageal reflux disease,212
319041210,condition_era group during day -365 through 0 days relative to index: Orthostatic hypotension,210
319049210,condition_era group during day -365 through 0 days relative to index: Acute respiratory failure,210
319049212,condition_era group during day -30 through 0 days relative to index: Acute respiratory failure,212
319826210,condition_era group during day -365 through 0 days relative to index: Secondary hypertension,210
319826212,condition_era group during day -30 through 0 days relative to index: Secondary hypertension,212
319835210,condition_era group during day -365 through 0 days relative to index: Congestive heart failure,210
319835212,condition_era group during day -30 through 0 days relative to index: Congestive heart failure,212
319843210,condition_era group during day -365 through 0 days relative to index: Mitral valve disorder,210
319843212,condition_era group during day -30 through 0 days relative to index: Mitral valve disorder,212
319844210,condition_era group during day -365 through 0 days relative to index: Acute ischemic heart disease,210
319844212,condition_era group during day -30 through 0 days relative to index: Acute ischemic heart disease,212
320128210,condition_era group during day -365 through 0 days relative to index: Essential hypertension,210
320128212,condition_era group during day -30 through 0 days relative to index: Essential hypertension,212
321052210,condition_era group during day -365 through 0 days relative to index: Peripheral vascular disease,210
321318210,condition_era group during day -365 through 0 days relative to index: Angina pectoris,210
321318212,condition_era group during day -30 through 0 days relative to index: Angina pectoris,212
321588210,condition_era group during day -365 through 0 days relative to index: Heart disease,210
321588212,condition_era group during day -30 through 0 days relative to index: Heart disease,212
372324210,condition_era group during day -365 through 0 days relative to index: Eustachian tube disorder,210
372328210,condition_era group during day -365 through 0 days relative to index: Otitis media,210
372652210,condition_era group during day -365 through 0 days relative to index: Chronic tympanitis,210
372929210,condition_era group during day -365 through 0 days relative to index: Chronic eustachian tube salpingitis,210
373432210,condition_era group during day -365 through 0 days relative to index: Benign neoplasm of nervous system,210
373432212,condition_era group during day -30 through 0 days relative to index: Benign neoplasm of nervous system,212
373724210,condition_era group during day -365 through 0 days relative to index: Neoplasm of brain,210
373724212,condition_era group during day -30 through 0 days relative to index: Neoplasm of brain,212
373995210,condition_era group during day -365 through 0 days relative to index: Delirium,210
373995212,condition_era group during day -30 through 0 days relative to index: Delirium,212
374009210,condition_era group during day -365 through 0 days relative to index: Organic mental disorder,210
374009212,condition_era group during day -30 through 0 days relative to index: Organic mental disorder,212
374375210,condition_era group during day -365 through 0 days relative to index: Impacted cerumen,210
374886210,condition_era group during day -365 through 0 days relative to index: Benign neoplasm of ear,210
374886212,condition_era group during day -30 through 0 days relative to index: Benign neoplasm of ear,212
374905210,condition_era group during day -365 through 0 days relative to index: Non-organic sleep disorder,210
375239210,condition_era group during day -365 through 0 days relative to index: Degenerative brain disorder,210
375239212,condition_era group during day -30 through 0 days relative to index: Degenerative brain disorder,212
375290210,condition_era group during day -365 through 0 days relative to index: Chronic tubotympanic suppurative otitis media,210
375545210,condition_era group during day -365 through 0 days relative to index: Cataract,210
375545212,condition_era group during day -30 through 0 days relative to index: Cataract,212
375807210,condition_era group during day -365 through 0 days relative to index: Degenerative disorder of eye,210
375807212,condition_era group during day -30 through 0 days relative to index: Degenerative disorder of eye,212
376065210,condition_era group during day -365 through 0 days relative to index: Neurological disorder with type 2 diabetes mellitus,210
376065212,condition_era group during day -30 through 0 days relative to index: Neurological disorder with type 2 diabetes mellitus,212
376112210,condition_era group during day -365 through 0 days relative to index: Diabetic polyneuropathy,210
376112212,condition_era group during day -30 through 0 days relative to index: Diabetic polyneuropathy,212
376686210,condition_era group during day -365 through 0 days relative to index: Polyneuropathy associated with another disorder,210
376686212,condition_era group during day -30 through 0 days relative to index: Polyneuropathy associated with another disorder,212
376712210,condition_era group during day -365 through 0 days relative to index: Purulent otitis media,210
376713210,condition_era group during day -365 through 0 days relative to index: Cerebral hemorrhage,210
376979210,condition_era group during day -365 through 0 days relative to index: Cataract due to diabetes mellitus,210
376979212,condition_era group during day -30 through 0 days relative to index: Cataract due to diabetes mellitus,212
377091210,condition_era group during day -365 through 0 days relative to index: Seizure,210
377263210,condition_era group during day -365 through 0 days relative to index: Myoneural disorder,210
377575210,condition_era group during day -365 through 0 days relative to index: Tinnitus,210
377884210,condition_era group during day -365 through 0 days relative to index: Eustachian tube salpingitis,210
377886210,condition_era group during day -365 through 0 days relative to index: Chronic purulent otitis media,210
377889210,condition_era group during day -365 through 0 days relative to index: Hearing loss,210
378253210,condition_era group during day -365 through 0 days relative to index: Headache,210
378253212,condition_era group during day -30 through 0 days relative to index: Headache,212
378416210,condition_era group during day -365 through 0 days relative to index: Retinal disorder,210
378416212,condition_era group during day -30 through 0 days relative to index: Retinal disorder,212
378419210,condition_era group during day -365 through 0 days relative to index: Alzheimer's disease,210
378419212,condition_era group during day -30 through 0 days relative to index: Alzheimer's disease,212
378425210,condition_era group during day -365 through 0 days relative to index: Blepharitis,210
378425212,condition_era group during day -30 through 0 days relative to index: Blepharitis,212
378444210,condition_era group during day -365 through 0 days relative to index: Hearing disorder,210
378756210,condition_era group during day -365 through 0 days relative to index: Conjunctival hemorrhage,210
378756212,condition_era group during day -30 through 0 days relative to index: Conjunctival hemorrhage,212
379019210,condition_era group during day -365 through 0 days relative to index: Conjunctivitis,210
379019212,condition_era group during day -30 through 0 days relative to index: Conjunctivitis,212
379769210,condition_era group during day -365 through 0 days relative to index: Benign neoplasm of brain,210
379769212,condition_era group during day -30 through 0 days relative to index: Benign neoplasm of brain,212
380096210,condition_era group during day -365 through 0 days relative to index: Proliferative retinopathy with diabetes mellitus,210
380096212,condition_era group during day -30 through 0 days relative to index: Proliferative retinopathy with diabetes mellitus,212
381035210,condition_era group during day -365 through 0 days relative to index: Vertigo of central origin,210
381273210,condition_era group during day -365 through 0 days relative to index: Confusional state,210
381273212,condition_era group during day -30 through 0 days relative to index: Confusional state,212
381295210,condition_era group during day -365 through 0 days relative to index: Senile cataract,210
381316210,condition_era group during day -365 through 0 days relative to index: Cerebrovascular accident,210
381572210,condition_era group during day -365 through 0 days relative to index: Abducens nerve palsy,210
381591210,condition_era group during day -365 through 0 days relative to index: Cerebrovascular disease,210
432251210,condition_era group during day -365 through 0 days relative to index: Disease caused by parasite,210
432251212,condition_era group during day -30 through 0 days relative to index: Disease caused by parasite,212
432347210,condition_era group during day -365 through 0 days relative to index: Chronic disease of tonsils AND/OR adenoids,210
432347212,condition_era group during day -30 through 0 days relative to index: Chronic disease of tonsils AND/OR adenoids,212
432545210,condition_era group during day -365 through 0 days relative to index: Bacterial infectious disease,210
432661210,condition_era group during day -365 through 0 days relative to index: Inflammatory disease of mucous membrane,210
432661212,condition_era group during day -30 through 0 days relative to index: Inflammatory disease of mucous membrane,212
432851210,condition_era group during day -365 through 0 days relative to index: Secondary malignant neoplastic disease,210
432851212,condition_era group during day -30 through 0 days relative to index: Secondary malignant neoplastic disease,212
432867210,condition_era group during day -365 through 0 days relative to index: Hyperlipidemia,210
432867212,condition_era group during day -30 through 0 days relative to index: Hyperlipidemia,212
433243210,condition_era group during day -365 through 0 days relative to index: Anomaly of tooth position,210
433316210,condition_era group during day -365 through 0 days relative to index: Dizziness and giddiness,210
433456210,condition_era group during day -365 through 0 days relative to index: Acute pain,210
433595210,condition_era group during day -365 through 0 days relative to index: Edema,210
433595212,condition_era group during day -30 through 0 days relative to index: Edema,212
433701210,condition_era group during day -365 through 0 days relative to index: Mycosis,210
433740210,condition_era group during day -365 through 0 days relative to index: Immunodeficiency disorder,210
433740212,condition_era group during day -30 through 0 days relative to index: Immunodeficiency disorder,212
433778210,condition_era group during day -365 through 0 days relative to index: Orbital hemorrhage,210
433778212,condition_era group during day -30 through 0 days relative to index: Orbital hemorrhage,212
433968210,condition_era group during day -365 through 0 days relative to index: Candidiasis,210
434008210,condition_era group during day -365 through 0 days relative to index: White blood cell disorder,210
434008212,condition_era group during day -30 through 0 days relative to index: White blood cell disorder,212
434610210,condition_era group during day -365 through 0 days relative to index: Hyperkalemia,210
434610212,condition_era group during day -30 through 0 days relative to index: Hyperkalemia,212
434621210,condition_era group during day -365 through 0 days relative to index: Autoimmune disease,210
434621212,condition_era group during day -30 through 0 days relative to index: Autoimmune disease,212
434821210,condition_era group during day -365 through 0 days relative to index: Systemic inflammatory response syndrome,210
434821212,condition_era group during day -30 through 0 days relative to index: Systemic inflammatory response syndrome,212
435463210,condition_era group during day -365 through 0 days relative to index: Herpesvirus infection,210
435463212,condition_era group during day -30 through 0 days relative to index: Herpesvirus infection,212
435506210,condition_era group during day -365 through 0 days relative to index: Benign neoplastic disease,210
435506212,condition_era group during day -30 through 0 days relative to index: Benign neoplastic disease,212
435508210,condition_era group during day -365 through 0 days relative to index: Adrenal cortical hypofunction,210
435657210,condition_era group during day -365 through 0 days relative to index: Dyssomnia,210
435726210,condition_era group during day -365 through 0 days relative to index: Mechanical complication of device,210
435742210,condition_era group during day -365 through 0 days relative to index: Disease due to Gram-negative bacteria,210
436096210,condition_era group during day -365 through 0 days relative to index: Chronic pain,210
436096212,condition_era group during day -30 through 0 days relative to index: Chronic pain,212
436398210,condition_era group during day -365 through 0 days relative to index: Glaucoma associated with ocular disorder,210
436635210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of sigmoid colon,210
436635212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of sigmoid colon,212
436642210,condition_era group during day -365 through 0 days relative to index: Behcet's syndrome,210
436642212,condition_era group during day -30 through 0 days relative to index: Behcet's syndrome,212
436962210,condition_era group during day -365 through 0 days relative to index: Insomnia,210
437233210,condition_era group during day -365 through 0 days relative to index: Multiple myeloma,210
437233212,condition_era group during day -30 through 0 days relative to index: Multiple myeloma,212
437247210,condition_era group during day -365 through 0 days relative to index: Anemia of chronic disease,210
437247212,condition_era group during day -30 through 0 days relative to index: Anemia of chronic disease,212
437312210,condition_era group during day -365 through 0 days relative to index: Bleeding,210
437312212,condition_era group during day -30 through 0 days relative to index: Bleeding,212
437390210,condition_era group during day -365 through 0 days relative to index: Hypoxemia,210
437390212,condition_era group during day -30 through 0 days relative to index: Hypoxemia,212
437541210,condition_era group during day -365 through 0 days relative to index: Glaucoma,210
437663210,condition_era group during day -365 through 0 days relative to index: Fever,210
437663212,condition_era group during day -30 through 0 days relative to index: Fever,212
437677210,condition_era group during day -365 through 0 days relative to index: Abnormal findings on diagnostic imaging of lung,210
437827210,condition_era group during day -365 through 0 days relative to index: Pure hypercholesterolemia,210
437827212,condition_era group during day -30 through 0 days relative to index: Pure hypercholesterolemia,212
438067210,condition_era group during day -365 through 0 days relative to index: Malaria,210
438067212,condition_era group during day -30 through 0 days relative to index: Malaria,212
438112210,condition_era group during day -365 through 0 days relative to index: Neoplastic disease,210
438112212,condition_era group during day -30 through 0 days relative to index: Neoplastic disease,212
438297210,"condition_era group during day -365 through 0 days relative to index: Mechanical complication of cardiac device, implant AND/OR graft",210
438343210,condition_era group during day -365 through 0 days relative to index: Falciparum malaria,210
438343212,condition_era group during day -30 through 0 days relative to index: Falciparum malaria,212
438485210,condition_era group during day -365 through 0 days relative to index: Postoperative state,210
438878210,condition_era group during day -365 through 0 days relative to index: Liver function tests abnormal,210
438878212,condition_era group during day -30 through 0 days relative to index: Liver function tests abnormal,212
439383210,condition_era group during day -365 through 0 days relative to index: Vertigo,210
439392210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm,210
439392212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm,212
439418210,condition_era group during day -365 through 0 days relative to index: Indigestion,210
439418212,condition_era group during day -30 through 0 days relative to index: Indigestion,212
439674210,condition_era group during day -365 through 0 days relative to index: Chronic viral hepatitis B without delta-agent,210
439674212,condition_era group during day -30 through 0 days relative to index: Chronic viral hepatitis B without delta-agent,212
439676210,condition_era group during day -365 through 0 days relative to index: Coronavirus infection,210
439676212,condition_era group during day -30 through 0 days relative to index: Coronavirus infection,212
439708210,condition_era group during day -365 through 0 days relative to index: Disorders of initiating and maintaining sleep,210
439777210,condition_era group during day -365 through 0 days relative to index: Anemia,210
439777212,condition_era group during day -30 through 0 days relative to index: Anemia,212
439846210,condition_era group during day -365 through 0 days relative to index: Left heart failure,210
439846212,condition_era group during day -30 through 0 days relative to index: Left heart failure,212
439847210,condition_era group during day -365 through 0 days relative to index: Intracranial hemorrhage,210
440029210,condition_era group during day -365 through 0 days relative to index: Viral disease,210
440029212,condition_era group during day -30 through 0 days relative to index: Viral disease,212
440417210,condition_era group during day -365 through 0 days relative to index: Pulmonary embolism,210
440417212,condition_era group during day -30 through 0 days relative to index: Pulmonary embolism,212
440674210,condition_era group during day -365 through 0 days relative to index: Gout,210
440674212,condition_era group during day -30 through 0 days relative to index: Gout,212
440689210,condition_era group during day -365 through 0 days relative to index: Agranulocytosis,210
440689212,condition_era group during day -30 through 0 days relative to index: Agranulocytosis,212
440921210,condition_era group during day -365 through 0 days relative to index: Traumatic injury,210
440921212,condition_era group during day -30 through 0 days relative to index: Traumatic injury,212
441177210,condition_era group during day -365 through 0 days relative to index: Partial thickness burn of upper limb,210
441177212,condition_era group during day -30 through 0 days relative to index: Partial thickness burn of upper limb,212
441523210,condition_era group during day -365 through 0 days relative to index: Immunoproliferative neoplasm,210
441523212,condition_era group during day -30 through 0 days relative to index: Immunoproliferative neoplasm,212
441848210,condition_era group during day -365 through 0 days relative to index: Cranial nerve disorder,210
441969210,condition_era group during day -365 through 0 days relative to index: Radiology result abnormal,210
442013210,condition_era group during day -365 through 0 days relative to index: Burn,210
442013212,condition_era group during day -30 through 0 days relative to index: Burn,212
442099210,condition_era group during day -365 through 0 days relative to index: Benign neoplasm of large intestine,210
442103210,condition_era group during day -365 through 0 days relative to index: Benign neoplasm of intestinal tract,210
442105210,condition_era group during day -365 through 0 days relative to index: Benign neoplasm of soft tissue,210
442105212,condition_era group during day -30 through 0 days relative to index: Benign neoplasm of soft tissue,212
442176210,condition_era group during day -365 through 0 days relative to index: Protozoan infection,210
442176212,condition_era group during day -30 through 0 days relative to index: Protozoan infection,212
442604210,condition_era group during day -365 through 0 days relative to index: Hypertensive heart disease,210
442604212,condition_era group during day -30 through 0 days relative to index: Hypertensive heart disease,212
442752210,condition_era group during day -365 through 0 days relative to index: Muscle pain,210
442793210,condition_era group during day -365 through 0 days relative to index: Diabetic complication,210
442793212,condition_era group during day -30 through 0 days relative to index: Diabetic complication,212
443258210,condition_era group during day -365 through 0 days relative to index: Mass in head or neck,210
443258212,condition_era group during day -30 through 0 days relative to index: Mass in head or neck,212
443381210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of sigmoid colon,210
443381212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of sigmoid colon,212
443392210,condition_era group during day -365 through 0 days relative to index: Malignant neoplastic disease,210
443392212,condition_era group during day -30 through 0 days relative to index: Malignant neoplastic disease,212
443396210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of large intestine,210
443396212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of large intestine,212
443398210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of intestine,210
443398212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of intestine,212
443410210,condition_era group during day -365 through 0 days relative to index: Infective pneumonia,210
443454210,condition_era group during day -365 through 0 days relative to index: Cerebral infarction,210
443454212,condition_era group during day -30 through 0 days relative to index: Cerebral infarction,212
443568210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of gastrointestinal tract,210
443568212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of gastrointestinal tract,212
443597210,condition_era group during day -365 through 0 days relative to index: Chronic kidney disease stage 3,210
443597212,condition_era group during day -30 through 0 days relative to index: Chronic kidney disease stage 3,212
443611210,condition_era group during day -365 through 0 days relative to index: Chronic kidney disease stage 5,210
443611212,condition_era group during day -30 through 0 days relative to index: Chronic kidney disease stage 5,212
443612210,condition_era group during day -365 through 0 days relative to index: Chronic kidney disease stage 4,210
443612212,condition_era group during day -30 through 0 days relative to index: Chronic kidney disease stage 4,212
443730210,condition_era group during day -365 through 0 days relative to index: Nervous system disorder due to diabetes mellitus,210
443730212,condition_era group during day -30 through 0 days relative to index: Nervous system disorder due to diabetes mellitus,212
443731210,condition_era group during day -365 through 0 days relative to index: Renal disorder due to type 2 diabetes mellitus,210
443732210,condition_era group during day -365 through 0 days relative to index: Disorder due to type 2 diabetes mellitus,210
443732212,condition_era group during day -30 through 0 days relative to index: Disorder due to type 2 diabetes mellitus,212
443743210,condition_era group during day -365 through 0 days relative to index: Plasma cell neoplasm,210
443743212,condition_era group during day -30 through 0 days relative to index: Plasma cell neoplasm,212
443771210,condition_era group during day -365 through 0 days relative to index: Renal hypertension,210
443771212,condition_era group during day -30 through 0 days relative to index: Renal hypertension,212
443784210,condition_era group during day -365 through 0 days relative to index: Vascular disorder,210
443784212,condition_era group during day -30 through 0 days relative to index: Vascular disorder,212
443919210,condition_era group during day -365 through 0 days relative to index: Hypertensive renal failure,210
443962210,condition_era group during day -365 through 0 days relative to index: Mitral valve regurgitation,210
443962212,condition_era group during day -30 through 0 days relative to index: Mitral valve regurgitation,212
444101210,condition_era group during day -365 through 0 days relative to index: Hypertensive heart failure,210
444101212,condition_era group during day -30 through 0 days relative to index: Hypertensive heart failure,212
444108210,condition_era group during day -365 through 0 days relative to index: Finding related to sleep,210
444187210,condition_era group during day -365 through 0 days relative to index: Open wound,210
444200210,condition_era group during day -365 through 0 days relative to index: Neoplasm of nervous system,210
444200212,condition_era group during day -30 through 0 days relative to index: Neoplasm of nervous system,212
444207210,condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of the eye,210
444207212,condition_era group during day -30 through 0 days relative to index: Inflammatory disorder of the eye,212
444208210,condition_era group during day -365 through 0 days relative to index: Chronic inflammatory disorder,210
444208212,condition_era group during day -30 through 0 days relative to index: Chronic inflammatory disorder,212
444209210,condition_era group during day -365 through 0 days relative to index: Neoplasm of skin,210
444209212,condition_era group during day -30 through 0 days relative to index: Neoplasm of skin,212
444247210,condition_era group during day -365 through 0 days relative to index: Venous thrombosis,210
444247212,condition_era group during day -30 through 0 days relative to index: Venous thrombosis,212
444429210,condition_era group during day -365 through 0 days relative to index: Herpes simplex,210
444429212,condition_era group during day -30 through 0 days relative to index: Herpes simplex,212
702774410,drug_era group during day -365 through 0 days relative to index: Mepivacaine,410
702774412,drug_era group during day -30 through 0 days relative to index: Mepivacaine,412
706163702,measurement during day -365 through 0 days relative to index: SARS coronavirus 2 RNA [Presence] in Respiratory specimen by NAA with probe detection,702
706163704,measurement during day -30 through 0 days relative to index: SARS coronavirus 2 RNA [Presence] in Respiratory specimen by NAA with probe detection,704
708298410,drug_era group during day -365 through 0 days relative to index: Midazolam,410
708298412,drug_era group during day -30 through 0 days relative to index: Midazolam,412
708298413,drug_era group during day 0 through 0 days relative to index: Midazolam,413
711584410,drug_era group during day -365 through 0 days relative to index: Levetiracetam,410
713823410,drug_era group during day -365 through 0 days relative to index: ropinirole,410
713823412,drug_era group during day -30 through 0 days relative to index: ropinirole,412
713823413,drug_era group during day 0 through 0 days relative to index: ropinirole,413
715259410,drug_era group during day -365 through 0 days relative to index: duloxetine,410
715259412,drug_era group during day -30 through 0 days relative to index: duloxetine,412
715997410,drug_era group during day -365 through 0 days relative to index: donepezil,410
715997412,drug_era group during day -30 through 0 days relative to index: donepezil,412
715997413,drug_era group during day 0 through 0 days relative to index: donepezil,413
732893410,drug_era group during day -365 through 0 days relative to index: Bupivacaine,410
734354410,drug_era group during day -365 through 0 days relative to index: pregabalin,410
734354412,drug_era group during day -30 through 0 days relative to index: pregabalin,412
734354413,drug_era group during day 0 through 0 days relative to index: pregabalin,413
744740410,drug_era group during day -365 through 0 days relative to index: zolpidem,410
753626410,drug_era group during day -365 through 0 days relative to index: Propofol,410
759740410,drug_era group during day -365 through 0 days relative to index: Pyridostigmine,410
762446210,condition_era group during day -365 through 0 days relative to index: Arthropathy of multiple joints,210
762446212,condition_era group during day -30 through 0 days relative to index: Arthropathy of multiple joints,212
766529410,drug_era group during day -365 through 0 days relative to index: Haloperidol,410
766814410,drug_era group during day -365 through 0 days relative to index: quetiapine,410
777221410,drug_era group during day -365 through 0 days relative to index: Hydroxyzine,410
777221412,drug_era group during day -30 through 0 days relative to index: Hydroxyzine,412
785788410,drug_era group during day -365 through 0 days relative to index: olanzapine,410
787787410,drug_era group during day -365 through 0 days relative to index: hyaluronate,410
787787412,drug_era group during day -30 through 0 days relative to index: hyaluronate,412
791967410,drug_era group during day -365 through 0 days relative to index: Lorazepam,410
794852410,drug_era group during day -365 through 0 days relative to index: Chlorpromazine,410
797399410,drug_era group during day -365 through 0 days relative to index: gabapentin,410
797399412,drug_era group during day -30 through 0 days relative to index: gabapentin,412
797399413,drug_era group during day 0 through 0 days relative to index: gabapentin,413
901318410,drug_era group during day -365 through 0 days relative to index: Sodium Ascorbate,410
901318412,drug_era group during day -30 through 0 days relative to index: Sodium Ascorbate,412
902427410,drug_era group during day -365 through 0 days relative to index: Timolol,410
903963410,drug_era group during day -365 through 0 days relative to index: Triamcinolone,410
904453410,drug_era group during day -365 through 0 days relative to index: Esomeprazole,410
904453412,drug_era group during day -30 through 0 days relative to index: Esomeprazole,412
904453413,drug_era group during day 0 through 0 days relative to index: Esomeprazole,413
906072410,drug_era group during day -365 through 0 days relative to index: Tropicamide,410
906072412,drug_era group during day -30 through 0 days relative to index: Tropicamide,412
906780410,drug_era group during day -365 through 0 days relative to index: Metoclopramide,410
906780412,drug_era group during day -30 through 0 days relative to index: Metoclopramide,412
906780413,drug_era group during day 0 through 0 days relative to index: Metoclopramide,413
911354410,drug_era group during day -365 through 0 days relative to index: palonosetron,410
911486410,drug_era group during day -365 through 0 days relative to index: Glutamate,410
912362410,drug_era group during day -365 through 0 days relative to index: Ammonium Chloride,410
912362412,drug_era group during day -30 through 0 days relative to index: Ammonium Chloride,412
912362413,drug_era group during day 0 through 0 days relative to index: Ammonium Chloride,413
914335410,drug_era group during day -365 through 0 days relative to index: Atropine,410
914335412,drug_era group during day -30 through 0 days relative to index: Atropine,412
914335413,drug_era group during day 0 through 0 days relative to index: Atropine,413
915542410,drug_era group during day -365 through 0 days relative to index: brimonidine,410
915855410,drug_era group during day -365 through 0 days relative to index: olopatadine,410
916005410,drug_era group during day -365 through 0 days relative to index: Solifenacin,410
917205410,drug_era group during day -365 through 0 days relative to index: Desonide,410
919839410,drug_era group during day -365 through 0 days relative to index: Arnica extract,410
919839412,drug_era group during day -30 through 0 days relative to index: Arnica extract,412
919839413,drug_era group during day 0 through 0 days relative to index: Arnica extract,413
923081410,drug_era group during day -365 through 0 days relative to index: Ofloxacin,410
923081412,drug_era group during day -30 through 0 days relative to index: Ofloxacin,412
923645410,drug_era group during day -365 through 0 days relative to index: Omeprazole,410
923645412,drug_era group during day -30 through 0 days relative to index: Omeprazole,412
923645413,drug_era group during day 0 through 0 days relative to index: Omeprazole,413
924939410,drug_era group during day -365 through 0 days relative to index: Bisacodyl,410
926487410,drug_era group during day -365 through 0 days relative to index: Pancreatin,410
926487412,drug_era group during day -30 through 0 days relative to index: Pancreatin,412
926487413,drug_era group during day 0 through 0 days relative to index: Pancreatin,413
928110410,drug_era group during day -365 through 0 days relative to index: prednicarbate,410
928744410,drug_era group during day -365 through 0 days relative to index: Dimenhydrinate,410
930021410,drug_era group during day -365 through 0 days relative to index: alfuzosin,410
930021412,drug_era group during day -30 through 0 days relative to index: alfuzosin,412
934075410,drug_era group during day -365 through 0 days relative to index: azelastine,410
939134410,drug_era group during day -365 through 0 days relative to index: sertaconazole,410
939506410,drug_era group during day -365 through 0 days relative to index: Sodium Bicarbonate,410
939506412,drug_era group during day -30 through 0 days relative to index: Sodium Bicarbonate,412
939506413,drug_era group during day 0 through 0 days relative to index: Sodium Bicarbonate,413
939976410,drug_era group during day -365 through 0 days relative to index: sodium sulfate,410
939976412,drug_era group during day -30 through 0 days relative to index: sodium sulfate,412
940426410,drug_era group during day -365 through 0 days relative to index: calcium polycarbophil,410
941258410,drug_era group during day -365 through 0 days relative to index: Docusate,410
941258412,drug_era group during day -30 through 0 days relative to index: Docusate,412
941258413,drug_era group during day 0 through 0 days relative to index: Docusate,413
941577410,drug_era group during day -365 through 0 days relative to index: tetrahydrozoline,410
942350410,drug_era group during day -365 through 0 days relative to index: torsemide,410
942350412,drug_era group during day -30 through 0 days relative to index: torsemide,412
942350413,drug_era group during day 0 through 0 days relative to index: torsemide,413
948078410,drug_era group during day -365 through 0 days relative to index: pantoprazole,410
948078412,drug_era group during day -30 through 0 days relative to index: pantoprazole,412
948078413,drug_era group during day 0 through 0 days relative to index: pantoprazole,413
951469410,drug_era group during day -365 through 0 days relative to index: calcium acetate,410
951469412,drug_era group during day -30 through 0 days relative to index: calcium acetate,412
951469413,drug_era group during day 0 through 0 days relative to index: calcium acetate,413
951511410,drug_era group during day -365 through 0 days relative to index: Mupirocin,410
951511412,drug_era group during day -30 through 0 days relative to index: Mupirocin,412
952004410,drug_era group during day -365 through 0 days relative to index: sevelamer,410
952004412,drug_era group during day -30 through 0 days relative to index: sevelamer,412
952004413,drug_era group during day 0 through 0 days relative to index: sevelamer,413
953076410,drug_era group during day -365 through 0 days relative to index: Famotidine,410
953076412,drug_era group during day -30 through 0 days relative to index: Famotidine,412
953076413,drug_era group during day 0 through 0 days relative to index: Famotidine,413
955583410,drug_era group during day -365 through 0 days relative to index: Fluorometholone,410
955583412,drug_era group during day -30 through 0 days relative to index: Fluorometholone,412
956874410,drug_era group during day -365 through 0 days relative to index: Furosemide,410
956874412,drug_era group during day -30 through 0 days relative to index: Furosemide,412
956874413,drug_era group during day 0 through 0 days relative to index: Furosemide,413
959196410,drug_era group during day -365 through 0 days relative to index: Witch Hazel,410
959196412,drug_era group during day -30 through 0 days relative to index: Witch Hazel,412
959196413,drug_era group during day 0 through 0 days relative to index: Witch Hazel,413
961047410,drug_era group during day -365 through 0 days relative to index: Ranitidine,410
966991410,drug_era group during day -365 through 0 days relative to index: Simethicone,410
967823410,drug_era group during day -365 through 0 days relative to index: Sodium Chloride,410
967823412,drug_era group during day -30 through 0 days relative to index: Sodium Chloride,412
967823413,drug_era group during day 0 through 0 days relative to index: Sodium Chloride,413
970011410,drug_era group during day -365 through 0 days relative to index: Sorbitol,410
970011412,drug_era group during day -30 through 0 days relative to index: Sorbitol,412
970011413,drug_era group during day 0 through 0 days relative to index: Sorbitol,413
974166410,drug_era group during day -365 through 0 days relative to index: Hydrochlorothiazide,410
975125410,drug_era group during day -365 through 0 days relative to index: Hydrocortisone,410
981709410,drug_era group during day -365 through 0 days relative to index: dorzolamide,410
985247410,drug_era group during day -365 through 0 days relative to index: Aluminum Hydroxide,410
985247412,drug_era group during day -30 through 0 days relative to index: Aluminum Hydroxide,412
985247413,drug_era group during day 0 through 0 days relative to index: Aluminum Hydroxide,413
986117410,drug_era group during day -365 through 0 days relative to index: Ketotifen,410
986417410,drug_era group during day -365 through 0 days relative to index: POLYETHYLENE GLYCOL 3350,410
986417412,drug_era group during day -30 through 0 days relative to index: POLYETHYLENE GLYCOL 3350,412
986517410,drug_era group during day -365 through 0 days relative to index: Cellulose,410
987245410,drug_era group during day -365 through 0 days relative to index: Lactulose,410
987245412,drug_era group during day -30 through 0 days relative to index: Lactulose,412
987245413,drug_era group during day 0 through 0 days relative to index: Lactulose,413
988095410,drug_era group during day -365 through 0 days relative to index: Ursodeoxycholate,410
988095412,drug_era group during day -30 through 0 days relative to index: Ursodeoxycholate,412
988095413,drug_era group during day 0 through 0 days relative to index: Ursodeoxycholate,413
988294410,drug_era group during day -365 through 0 days relative to index: dexpanthenol,410
989482410,drug_era group during day -365 through 0 days relative to index: Dutasteride,410
989482412,drug_era group during day -30 through 0 days relative to index: Dutasteride,412
989878410,drug_era group during day -365 through 0 days relative to index: Lidocaine,410
991876410,drug_era group during day -365 through 0 days relative to index: Loperamide,410
992956410,drug_era group during day -365 through 0 days relative to index: Magnesium Hydroxide,410
994058410,drug_era group during day -365 through 0 days relative to index: Mannitol,410
1000560410,drug_era group during day -365 through 0 days relative to index: Ondansetron,410
1000772410,drug_era group during day -365 through 0 days relative to index: Granisetron,410
1000772412,drug_era group during day -30 through 0 days relative to index: Granisetron,412
1000772413,drug_era group during day 0 through 0 days relative to index: Granisetron,413
1036228410,drug_era group during day -365 through 0 days relative to index: Sucralfate,410
1101554410,drug_era group during day -365 through 0 days relative to index: Colchicine,410
1101554412,drug_era group during day -30 through 0 days relative to index: Colchicine,412
1101554413,drug_era group during day 0 through 0 days relative to index: Colchicine,413
1103314410,drug_era group during day -365 through 0 days relative to index: Tramadol,410
1103314412,drug_era group during day -30 through 0 days relative to index: Tramadol,412
1103314413,drug_era group during day 0 through 0 days relative to index: Tramadol,413
1106776410,drug_era group during day -365 through 0 days relative to index: tiotropium,410
1110410410,drug_era group during day -365 through 0 days relative to index: Morphine,410
1110410412,drug_era group during day -30 through 0 days relative to index: Morphine,412
1110410413,drug_era group during day 0 through 0 days relative to index: Morphine,413
1112807410,drug_era group during day -365 through 0 days relative to index: Aspirin,410
1112807412,drug_era group during day -30 through 0 days relative to index: Aspirin,412
1112807413,drug_era group during day 0 through 0 days relative to index: Aspirin,413
1114220410,drug_era group during day -365 through 0 days relative to index: Naloxone,410
1114220412,drug_era group during day -30 through 0 days relative to index: Naloxone,412
1114220413,drug_era group during day 0 through 0 days relative to index: Naloxone,413
1115008410,drug_era group during day -365 through 0 days relative to index: Naproxen,410
1115008412,drug_era group during day -30 through 0 days relative to index: Naproxen,412
1115008413,drug_era group during day 0 through 0 days relative to index: Naproxen,413
1115572410,drug_era group during day -365 through 0 days relative to index: Beclomethasone,410
1116109410,drug_era group during day -365 through 0 days relative to index: Belladonna Alkaloids,410
1116109412,drug_era group during day -30 through 0 days relative to index: Belladonna Alkaloids,412
1116109413,drug_era group during day 0 through 0 days relative to index: Belladonna Alkaloids,413
1118084410,drug_era group during day -365 through 0 days relative to index: celecoxib,410
1124300410,drug_era group during day -365 through 0 days relative to index: Diclofenac,410
1124300412,drug_era group during day -30 through 0 days relative to index: Diclofenac,412
1124957410,drug_era group during day -365 through 0 days relative to index: Oxycodone,410
1124957412,drug_era group during day -30 through 0 days relative to index: Oxycodone,412
1124957413,drug_era group during day 0 through 0 days relative to index: Oxycodone,413
1125315410,drug_era group during day -365 through 0 days relative to index: Acetaminophen,410
1125315412,drug_era group during day -30 through 0 days relative to index: Acetaminophen,412
1125315413,drug_era group during day 0 through 0 days relative to index: Acetaminophen,413
1133201410,drug_era group during day -365 through 0 days relative to index: Buprenorphine,410
1135766410,drug_era group during day -365 through 0 days relative to index: Phenylephrine,410
1135766412,drug_era group during day -30 through 0 days relative to index: Phenylephrine,412
1136422410,drug_era group during day -365 through 0 days relative to index: levocetirizine,410
1136422412,drug_era group during day -30 through 0 days relative to index: levocetirizine,412
1136422413,drug_era group during day 0 through 0 days relative to index: levocetirizine,413
1136487410,drug_era group during day -365 through 0 days relative to index: ropivacaine,410
1136980410,drug_era group during day -365 through 0 days relative to index: Ketorolac,410
1136980412,drug_era group during day -30 through 0 days relative to index: Ketorolac,412
1139042410,drug_era group during day -365 through 0 days relative to index: Acetylcysteine,410
1139042412,drug_era group during day -30 through 0 days relative to index: Acetylcysteine,412
1139042413,drug_era group during day 0 through 0 days relative to index: Acetylcysteine,413
1143374410,drug_era group during day -365 through 0 days relative to index: Ephedrine,410
1149380410,drug_era group during day -365 through 0 days relative to index: fluticasone,410
1153428410,drug_era group during day -365 through 0 days relative to index: fexofenadine,410
1153428412,drug_era group during day -30 through 0 days relative to index: fexofenadine,412
1153428413,drug_era group during day 0 through 0 days relative to index: fexofenadine,413
1154029410,drug_era group during day -365 through 0 days relative to index: Fentanyl,410
1154029412,drug_era group during day -30 through 0 days relative to index: Fentanyl,412
1154029413,drug_era group during day 0 through 0 days relative to index: Fentanyl,413
1154161410,drug_era group during day -365 through 0 days relative to index: montelukast,410
1154161412,drug_era group during day -30 through 0 days relative to index: montelukast,412
1154161413,drug_era group during day 0 through 0 days relative to index: montelukast,413
1154332410,drug_era group during day -365 through 0 days relative to index: Pseudoephedrine,410
1154332412,drug_era group during day -30 through 0 days relative to index: Pseudoephedrine,412
1154332413,drug_era group during day 0 through 0 days relative to index: Pseudoephedrine,413
1154343410,drug_era group during day -365 through 0 days relative to index: Albuterol,410
1154343412,drug_era group during day -30 through 0 days relative to index: Albuterol,412
1154343413,drug_era group during day 0 through 0 days relative to index: Albuterol,413
1177480410,drug_era group during day -365 through 0 days relative to index: Ibuprofen,410
1189596410,drug_era group during day -365 through 0 days relative to index: dihydrocodeine,410
1189596412,drug_era group during day -30 through 0 days relative to index: dihydrocodeine,412
1189596413,drug_era group during day 0 through 0 days relative to index: dihydrocodeine,413
1192710410,drug_era group during day -365 through 0 days relative to index: Chlorpheniramine,410
1192710412,drug_era group during day -30 through 0 days relative to index: Chlorpheniramine,412
1192710413,drug_era group during day 0 through 0 days relative to index: Chlorpheniramine,413
1195334410,drug_era group during day -365 through 0 days relative to index: Choline,410
1195334412,drug_era group during day -30 through 0 days relative to index: Choline,412
1195334413,drug_era group during day 0 through 0 days relative to index: Choline,413
1196677410,drug_era group during day -365 through 0 days relative to index: formoterol,410
1201620410,drug_era group during day -365 through 0 days relative to index: Codeine,410
1201620412,drug_era group during day -30 through 0 days relative to index: Codeine,412
1201620413,drug_era group during day 0 through 0 days relative to index: Codeine,413
1300673410,drug_era group during day -365 through 0 days relative to index: Thrombin,410
1300978410,drug_era group during day -365 through 0 days relative to index: Megestrol,410
1300978412,drug_era group during day -30 through 0 days relative to index: Megestrol,412
1300978413,drug_era group during day 0 through 0 days relative to index: Megestrol,413
1301025410,drug_era group during day -365 through 0 days relative to index: Enoxaparin,410
1303425410,drug_era group during day -365 through 0 days relative to index: Tranexamic Acid,410
1304643410,drug_era group during day -365 through 0 days relative to index: darbepoetin alfa,410
1304643412,drug_era group during day -30 through 0 days relative to index: darbepoetin alfa,412
1304643413,drug_era group during day 0 through 0 days relative to index: darbepoetin alfa,413
1305058410,drug_era group during day -365 through 0 days relative to index: Methotrexate,410
1305058412,drug_era group during day -30 through 0 days relative to index: Methotrexate,412
1305058413,drug_era group during day 0 through 0 days relative to index: Methotrexate,413
1307515410,drug_era group during day -365 through 0 days relative to index: Urokinase,410
1307863410,drug_era group during day -365 through 0 days relative to index: Verapamil,410
1308368410,drug_era group during day -365 through 0 days relative to index: Midodrine,410
1308368412,drug_era group during day -30 through 0 days relative to index: Midodrine,412
1308368413,drug_era group during day 0 through 0 days relative to index: Midodrine,413
1308842410,drug_era group during day -365 through 0 days relative to index: valsartan,410
1308842412,drug_era group during day -30 through 0 days relative to index: valsartan,412
1308842413,drug_era group during day 0 through 0 days relative to index: valsartan,413
1309944410,drug_era group during day -365 through 0 days relative to index: Amiodarone,410
1310149410,drug_era group during day -365 through 0 days relative to index: Warfarin,410
1314924410,drug_era group during day -365 through 0 days relative to index: gemcitabine,410
1316262410,drug_era group during day -365 through 0 days relative to index: sildenafil,410
1317640410,drug_era group during day -365 through 0 days relative to index: telmisartan,410
1317640412,drug_era group during day -30 through 0 days relative to index: telmisartan,412
1317640413,drug_era group during day 0 through 0 days relative to index: telmisartan,413
1318137410,drug_era group during day -365 through 0 days relative to index: Nicardipine,410
1318853410,drug_era group during day -365 through 0 days relative to index: Nifedipine,410
1318853412,drug_era group during day -30 through 0 days relative to index: Nifedipine,412
1318853413,drug_era group during day 0 through 0 days relative to index: Nifedipine,413
1319880410,drug_era group during day -365 through 0 days relative to index: Nisoldipine,410
1321341410,drug_era group during day -365 through 0 days relative to index: Norepinephrine,410
1321341412,drug_era group during day -30 through 0 days relative to index: Norepinephrine,412
1321341413,drug_era group during day 0 through 0 days relative to index: Norepinephrine,413
1322184410,drug_era group during day -365 through 0 days relative to index: clopidogrel,410
1322184412,drug_era group during day -30 through 0 days relative to index: clopidogrel,412
1322184413,drug_era group during day 0 through 0 days relative to index: clopidogrel,413
1325363410,drug_era group during day -365 through 0 days relative to index: erlotinib,410
1326303410,drug_era group during day -365 through 0 days relative to index: Digoxin,410
1326303412,drug_era group during day -30 through 0 days relative to index: Digoxin,412
1326303413,drug_era group during day 0 through 0 days relative to index: Digoxin,413
1328165410,drug_era group during day -365 through 0 days relative to index: Diltiazem,410
1328165412,drug_era group during day -30 through 0 days relative to index: Diltiazem,412
1328165413,drug_era group during day 0 through 0 days relative to index: Diltiazem,413
1332418410,drug_era group during day -365 through 0 days relative to index: Amlodipine,410
1332418412,drug_era group during day -30 through 0 days relative to index: Amlodipine,412
1332418413,drug_era group during day 0 through 0 days relative to index: Amlodipine,413
1334456410,drug_era group during day -365 through 0 days relative to index: Ramipril,410
1334456412,drug_era group during day -30 through 0 days relative to index: Ramipril,412
1334456413,drug_era group during day 0 through 0 days relative to index: Ramipril,413
1337860410,drug_era group during day -365 through 0 days relative to index: Dopamine,410
1338005410,drug_era group during day -365 through 0 days relative to index: Bisoprolol,410
1338005412,drug_era group during day -30 through 0 days relative to index: Bisoprolol,412
1338005413,drug_era group during day 0 through 0 days relative to index: Bisoprolol,413
1343916410,drug_era group during day -365 through 0 days relative to index: Epinephrine,410
1343916412,drug_era group during day -30 through 0 days relative to index: Epinephrine,412
1344143410,"drug_era group during day -365 through 0 days relative to index: Albumin Human, USP",410
1344905410,drug_era group during day -365 through 0 days relative to index: Carboplatin,410
1346823410,drug_era group during day -365 through 0 days relative to index: carvedilol,410
1346823412,drug_era group during day -30 through 0 days relative to index: carvedilol,412
1346823413,drug_era group during day 0 through 0 days relative to index: carvedilol,413
1350504410,drug_era group during day -365 through 0 days relative to index: Etoposide,410
1353766410,drug_era group during day -365 through 0 days relative to index: Propranolol,410
1353766412,drug_era group during day -30 through 0 days relative to index: Propranolol,412
1361711410,drug_era group during day -365 through 0 days relative to index: Nitroglycerin,410
1361711412,drug_era group during day -30 through 0 days relative to index: Nitroglycerin,412
1361711413,drug_era group during day 0 through 0 days relative to index: Nitroglycerin,413
1367571410,drug_era group during day -365 through 0 days relative to index: heparin,410
1367571412,drug_era group during day -30 through 0 days relative to index: heparin,412
1367571413,drug_era group during day 0 through 0 days relative to index: heparin,413
1373225410,drug_era group during day -365 through 0 days relative to index: Perindopril,410
1373225412,drug_era group during day -30 through 0 days relative to index: Perindopril,412
1373225413,drug_era group during day 0 through 0 days relative to index: Perindopril,413
1373928410,drug_era group during day -365 through 0 days relative to index: Hydralazine,410
1373928412,drug_era group during day -30 through 0 days relative to index: Hydralazine,412
1373928413,drug_era group during day 0 through 0 days relative to index: Hydralazine,413
1381504410,drug_era group during day -365 through 0 days relative to index: Alprostadil,410
1381504412,drug_era group during day -30 through 0 days relative to index: Alprostadil,412
1383925410,drug_era group during day -365 through 0 days relative to index: Isosorbide Dinitrate,410
1383925412,drug_era group during day -30 through 0 days relative to index: Isosorbide Dinitrate,412
1383925413,drug_era group during day 0 through 0 days relative to index: Isosorbide Dinitrate,413
1386957410,drug_era group during day -365 through 0 days relative to index: Labetalol,410
1389036410,drug_era group during day -365 through 0 days relative to index: Mitomycin,410
1395773410,drug_era group during day -365 through 0 days relative to index: iron sucrose,410
1395773412,drug_era group during day -30 through 0 days relative to index: iron sucrose,412
1396131410,drug_era group during day -365 through 0 days relative to index: ferrous sulfate,410
1396131412,drug_era group during day -30 through 0 days relative to index: ferrous sulfate,412
1396131413,drug_era group during day 0 through 0 days relative to index: ferrous sulfate,413
1397599410,drug_era group during day -365 through 0 days relative to index: Cisplatin,410
1398677410,drug_era group during day -365 through 0 days relative to index: Echinacea angustifolia root extract,410
1398677412,drug_era group during day -30 through 0 days relative to index: Echinacea angustifolia root extract,412
1398677413,drug_era group during day 0 through 0 days relative to index: Echinacea angustifolia root extract,413
1398816410,drug_era group during day -365 through 0 days relative to index: Echinacea purpurea root extract,410
1398816412,drug_era group during day -30 through 0 days relative to index: Echinacea purpurea root extract,412
1398816413,drug_era group during day 0 through 0 days relative to index: Echinacea purpurea root extract,413
1436169410,drug_era group during day -365 through 0 days relative to index: Antithrombin III,410
1506270410,drug_era group during day -365 through 0 days relative to index: Methylprednisolone,410
1506270412,drug_era group during day -30 through 0 days relative to index: Methylprednisolone,412
1506270413,drug_era group during day 0 through 0 days relative to index: Methylprednisolone,413
1510813410,drug_era group during day -365 through 0 days relative to index: rosuvastatin,410
1510813412,drug_era group during day -30 through 0 days relative to index: rosuvastatin,412
1510813413,drug_era group during day 0 through 0 days relative to index: rosuvastatin,413
1516766410,drug_era group during day -365 through 0 days relative to index: repaglinide,410
1518254410,drug_era group during day -365 through 0 days relative to index: Dexamethasone,410
1525215410,drug_era group during day -365 through 0 days relative to index: pioglitazone,410
1525215412,drug_era group during day -30 through 0 days relative to index: pioglitazone,412
1525215413,drug_era group during day 0 through 0 days relative to index: pioglitazone,413
1526475410,drug_era group during day -365 through 0 days relative to index: ezetimibe,410
1545958410,drug_era group during day -365 through 0 days relative to index: atorvastatin,410
1545958412,drug_era group during day -30 through 0 days relative to index: atorvastatin,412
1545958413,drug_era group during day 0 through 0 days relative to index: atorvastatin,413
1548111410,drug_era group during day -365 through 0 days relative to index: cinacalcet,410
1550023410,drug_era group during day -365 through 0 days relative to index: Insulin Lispro,410
1550557410,drug_era group during day -365 through 0 days relative to index: prednisolone,410
1550557412,drug_era group during day -30 through 0 days relative to index: prednisolone,412
1550557413,drug_era group during day 0 through 0 days relative to index: prednisolone,413
1551860410,drug_era group during day -365 through 0 days relative to index: Pravastatin,410
1551860412,drug_era group during day -30 through 0 days relative to index: Pravastatin,412
1551860413,drug_era group during day 0 through 0 days relative to index: Pravastatin,413
1555120410,drug_era group during day -365 through 0 days relative to index: Fludrocortisone,410
1555120412,drug_era group during day -30 through 0 days relative to index: Fludrocortisone,412
1555120413,drug_era group during day 0 through 0 days relative to index: Fludrocortisone,413
1560305410,drug_era group during day -365 through 0 days relative to index: Omega-3 Acid Ethyl Esters (USP),410
1560305412,drug_era group during day -30 through 0 days relative to index: Omega-3 Acid Ethyl Esters (USP),412
1560524410,drug_era group during day -365 through 0 days relative to index: Glucose,410
1560524412,drug_era group during day -30 through 0 days relative to index: Glucose,412
1560524413,drug_era group during day 0 through 0 days relative to index: Glucose,413
1580747410,drug_era group during day -365 through 0 days relative to index: sitagliptin,410
1596977410,"drug_era group during day -365 through 0 days relative to index: Regular Insulin, Human",410
1703687410,drug_era group during day -365 through 0 days relative to index: Acyclovir,410
1703687412,drug_era group during day -30 through 0 days relative to index: Acyclovir,412
1707164410,drug_era group during day -365 through 0 days relative to index: Metronidazole,410
1707164412,drug_era group during day -30 through 0 days relative to index: Metronidazole,412
1707687410,drug_era group during day -365 through 0 days relative to index: Vancomycin,410
1707687412,drug_era group during day -30 through 0 days relative to index: Vancomycin,412
1707687413,drug_era group during day 0 through 0 days relative to index: Vancomycin,413
1709170410,drug_era group during day -365 through 0 days relative to index: meropenem,410
1710281410,drug_era group during day -365 through 0 days relative to index: tenofovir disoproxil,410
1710281412,drug_era group during day -30 through 0 days relative to index: tenofovir disoproxil,412
1710281413,drug_era group during day 0 through 0 days relative to index: tenofovir disoproxil,413
1713332410,drug_era group during day -365 through 0 days relative to index: Amoxicillin,410
1713332412,drug_era group during day -30 through 0 days relative to index: Amoxicillin,412
1713332413,drug_era group during day 0 through 0 days relative to index: Amoxicillin,413
1716903410,drug_era group during day -365 through 0 days relative to index: moxifloxacin,410
1717704410,drug_era group during day -365 through 0 days relative to index: valacyclovir,410
1717704412,drug_era group during day -30 through 0 days relative to index: valacyclovir,412
1734104410,drug_era group during day -365 through 0 days relative to index: Azithromycin,410
1734104412,drug_era group during day -30 through 0 days relative to index: Azithromycin,412
1734104413,drug_era group during day 0 through 0 days relative to index: Azithromycin,413
1738170410,drug_era group during day -365 through 0 days relative to index: lopinavir,410
1738170412,drug_era group during day -30 through 0 days relative to index: lopinavir,412
1738170413,drug_era group during day 0 through 0 days relative to index: lopinavir,413
1738521410,drug_era group during day -365 through 0 days relative to index: Doxycycline,410
1741122410,drug_era group during day -365 through 0 days relative to index: tazobactam,410
1741122412,drug_era group during day -30 through 0 days relative to index: tazobactam,412
1741122413,drug_era group during day 0 through 0 days relative to index: tazobactam,413
1742253410,drug_era group during day -365 through 0 days relative to index: Levofloxacin,410
1742253412,drug_era group during day -30 through 0 days relative to index: Levofloxacin,412
1742253413,drug_era group during day 0 through 0 days relative to index: Levofloxacin,413
1746114410,drug_era group during day -365 through 0 days relative to index: Piperacillin,410
1746114412,drug_era group during day -30 through 0 days relative to index: Piperacillin,412
1746114413,drug_era group during day 0 through 0 days relative to index: Piperacillin,413
1747005410,drug_era group during day -365 through 0 days relative to index: cefditoren,410
1747005412,drug_era group during day -30 through 0 days relative to index: cefditoren,412
1747005413,drug_era group during day 0 through 0 days relative to index: cefditoren,413
1748921410,drug_era group during day -365 through 0 days relative to index: Ritonavir,410
1748921412,drug_era group during day -30 through 0 days relative to index: Ritonavir,412
1748921413,drug_era group during day 0 through 0 days relative to index: Ritonavir,413
1748975410,drug_era group during day -365 through 0 days relative to index: cefepime,410
1754994410,drug_era group during day -365 through 0 days relative to index: Fluconazole,410
1759842410,drug_era group during day -365 through 0 days relative to index: Clavulanate,410
1759842412,drug_era group during day -30 through 0 days relative to index: Clavulanate,412
1759842413,drug_era group during day 0 through 0 days relative to index: Clavulanate,413
1763204410,drug_era group during day -365 through 0 days relative to index: Rifampin,410
1763204412,drug_era group during day -30 through 0 days relative to index: Rifampin,412
1763204413,drug_era group during day 0 through 0 days relative to index: Rifampin,413
1768849410,drug_era group during day -365 through 0 days relative to index: Cefaclor,410
1769535410,drug_era group during day -365 through 0 days relative to index: Cefadroxil,410
1769535412,drug_era group during day -30 through 0 days relative to index: Cefadroxil,412
1771162410,drug_era group during day -365 through 0 days relative to index: Cefazolin,410
1771162412,drug_era group during day -30 through 0 days relative to index: Cefazolin,412
1771162413,drug_era group during day 0 through 0 days relative to index: Cefazolin,413
1774932410,drug_era group during day -365 through 0 days relative to index: Cefotetan,410
1774932412,drug_era group during day -30 through 0 days relative to index: Cefotetan,412
1774932413,drug_era group during day 0 through 0 days relative to index: Cefotetan,413
1777087410,drug_era group during day -365 through 0 days relative to index: Hydroxychloroquine,410
1777087412,drug_era group during day -30 through 0 days relative to index: Hydroxychloroquine,412
1777087413,drug_era group during day 0 through 0 days relative to index: Hydroxychloroquine,413
1777806410,drug_era group during day -365 through 0 days relative to index: Ceftriaxone,410
1777806412,drug_era group during day -30 through 0 days relative to index: Ceftriaxone,412
1777806413,drug_era group during day 0 through 0 days relative to index: Ceftriaxone,413
1782521410,drug_era group during day -365 through 0 days relative to index: isoniazid,410
1782521412,drug_era group during day -30 through 0 days relative to index: isoniazid,412
1782521413,drug_era group during day 0 through 0 days relative to index: isoniazid,413
1786621410,drug_era group during day -365 through 0 days relative to index: Cephalexin,410
1790812410,drug_era group during day -365 through 0 days relative to index: Chlorhexidine,410
1790812412,drug_era group during day -30 through 0 days relative to index: Chlorhexidine,412
1790812413,drug_era group during day 0 through 0 days relative to index: Chlorhexidine,413
1796435410,drug_era group during day -365 through 0 days relative to index: Cefixime,410
1797513410,drug_era group during day -365 through 0 days relative to index: Ciprofloxacin,410
1797513412,drug_era group during day -30 through 0 days relative to index: Ciprofloxacin,412
1797513413,drug_era group during day 0 through 0 days relative to index: Ciprofloxacin,413
2006975502,"procedure_occurrence during day -365 through 0 days relative to index: Diagnostic interview, consultation, and evaluation",502
2006975504,"procedure_occurrence during day -30 through 0 days relative to index: Diagnostic interview, consultation, and evaluation",504
2007914502,procedure_occurrence during day -365 through 0 days relative to index: Insertion of other (naso-)gastric tube,502
2007914504,procedure_occurrence during day -30 through 0 days relative to index: Insertion of other (naso-)gastric tube,504
2109729502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2109740502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2109747502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2111197502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2211755502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2211794502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2211794504,procedure_occurrence during day -30 through 0 days relative to index: Unknown concept,504
2212964502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2213560502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2213560504,procedure_occurrence during day -30 through 0 days relative to index: Unknown concept,504
2314004502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2314004504,procedure_occurrence during day -30 through 0 days relative to index: Unknown concept,504
2314049502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2314049504,procedure_occurrence during day -30 through 0 days relative to index: Unknown concept,504
2514438502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2514438504,procedure_occurrence during day -30 through 0 days relative to index: Unknown concept,504
2614772602,"device_exposure during day -365 through 0 days relative to index: Indwelling catheter, foley type, two-way, all silicone, each",602
2614772604,"device_exposure during day -30 through 0 days relative to index: Indwelling catheter, foley type, two-way, all silicone, each",604
2614773602,"device_exposure during day -365 through 0 days relative to index: Indwelling catheter; foley type, three way for continuous irrigation, each",602
2614875602,"device_exposure during day -365 through 0 days relative to index: Surgical stockings thigh length, each",602
2614875604,"device_exposure during day -30 through 0 days relative to index: Surgical stockings thigh length, each",604
2615756602,"device_exposure during day -365 through 0 days relative to index: Catheter, drainage",602
2615771602,"device_exposure during day -365 through 0 days relative to index: Closure device, vascular (implantable/insertable)",602
2615775602,device_exposure during day -365 through 0 days relative to index: Adhesion barrier,602
2616633602,device_exposure during day -365 through 0 days relative to index: Chest wrap,602
2725227502,"procedure_occurrence during day -365 through 0 days relative to index: Bypass Coronary Artery, Two Arteries from Aorta with Autologous Venous Tissue, Open Approach",502
3000034702,measurement during day -365 through 0 days relative to index: Microalbumin [Mass/volume] in Urine,702
3000034704,measurement during day -30 through 0 days relative to index: Microalbumin [Mass/volume] in Urine,704
3000067702,measurement during day -365 through 0 days relative to index: Parathyrin.intact [Mass/volume] in Serum or Plasma,702
3000067704,measurement during day -30 through 0 days relative to index: Parathyrin.intact [Mass/volume] in Serum or Plasma,704
3000185702,measurement during day -365 through 0 days relative to index: Iron saturation [Mass Fraction] in Serum or Plasma,702
3000185704,measurement during day -30 through 0 days relative to index: Iron saturation [Mass Fraction] in Serum or Plasma,704
3000259702,measurement during day -365 through 0 days relative to index: Yeast [Presence] in Urine sediment by Light microscopy,702
3000348702,measurement during day -365 through 0 days relative to index: Leukocyte esterase [Presence] in Urine by Test strip,702
3000348704,measurement during day -30 through 0 days relative to index: Leukocyte esterase [Presence] in Urine by Test strip,704
3000515702,measurement during day -365 through 0 days relative to index: Antithrombin actual/normal in Platelet poor plasma by Chromogenic method,702
3000515704,measurement during day -30 through 0 days relative to index: Antithrombin actual/normal in Platelet poor plasma by Chromogenic method,704
3000593702,measurement during day -365 through 0 days relative to index: Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,702
3000593704,measurement during day -30 through 0 days relative to index: Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,704
3000600702,measurement during day -365 through 0 days relative to index: Renal tubular casts [#/area] in Urine by Light microscopy,702
3000600704,measurement during day -30 through 0 days relative to index: Renal tubular casts [#/area] in Urine by Light microscopy,704
3000620702,measurement during day -365 through 0 days relative to index: Complement C3 [Mass/volume] in Serum or Plasma,702
3000620704,measurement during day -30 through 0 days relative to index: Complement C3 [Mass/volume] in Serum or Plasma,704
3000636702,measurement during day -365 through 0 days relative to index: Histone Ab [Presence] in Serum,702
3000740702,measurement during day -365 through 0 days relative to index: Common Reed IgE Ab RAST class [Presence] in Serum,702
3000809702,measurement during day -365 through 0 days relative to index: Color of Pleural fluid,702
3001079702,measurement during day -365 through 0 days relative to index: Blood group antibody screen [Presence] in Serum or Plasma,702
3001079704,measurement during day -30 through 0 days relative to index: Blood group antibody screen [Presence] in Serum or Plasma,704
3001081702,measurement during day -365 through 0 days relative to index: Peach IgE Ab RAST class [Presence] in Serum,702
3001123702,measurement during day -365 through 0 days relative to index: Platelet mean volume [Entitic volume] in Blood,702
3001137702,measurement during day -365 through 0 days relative to index: Triple phosphate crystals [Presence] in Urine sediment by Light microscopy,702
3001357702,measurement during day -365 through 0 days relative to index: Hazelnut IgE Ab RAST class [Presence] in Serum,702
3001363702,measurement during day -365 through 0 days relative to index: Cryptococcus sp Ag [Presence] in Cerebral spinal fluid,702
3001363704,measurement during day -30 through 0 days relative to index: Cryptococcus sp Ag [Presence] in Cerebral spinal fluid,704
3001420702,measurement during day -365 through 0 days relative to index: Magnesium [Mass/volume] in Serum or Plasma,702
3001420704,measurement during day -30 through 0 days relative to index: Magnesium [Mass/volume] in Serum or Plasma,704
3001539702,measurement during day -365 through 0 days relative to index: Cat dander IgE Ab RAST class [Presence] in Serum,702
3001721702,measurement during day -365 through 0 days relative to index: Guinea pig epithelium IgE Ab RAST class [Presence] in Serum,702
3001775702,measurement during day -365 through 0 days relative to index: Smith extractable nuclear Ab [Presence] in Serum by Immunoassay,702
3001802702,measurement during day -365 through 0 days relative to index: Microalbumin/Creatinine [Mass Ratio] in Urine,702
3001873702,measurement during day -365 through 0 days relative to index: Granular casts [Presence] in Urine sediment by Light microscopy,702
3001873704,measurement during day -30 through 0 days relative to index: Granular casts [Presence] in Urine sediment by Light microscopy,704
3002030702,measurement during day -365 through 0 days relative to index: Lymphocytes/100 leukocytes in Blood,702
3002030704,measurement during day -30 through 0 days relative to index: Lymphocytes/100 leukocytes in Blood,704
3002035702,measurement during day -365 through 0 days relative to index: Myeloperoxidase Ab [Presence] in Serum by Immunoassay,702
3002035704,measurement during day -30 through 0 days relative to index: Myeloperoxidase Ab [Presence] in Serum by Immunoassay,704
3002058702,measurement during day -365 through 0 days relative to index: Cow milk IgE Ab RAST class [Presence] in Serum,702
3002079702,measurement during day -365 through 0 days relative to index: Sodium [Moles/time] in 24 hour Urine,702
3002079704,measurement during day -30 through 0 days relative to index: Sodium [Moles/time] in 24 hour Urine,704
3002237702,measurement during day -365 through 0 days relative to index: Japanese Cedar IgE Ab RAST class [Presence] in Serum,702
3002240702,measurement during day -365 through 0 days relative to index: Glucose [Mass/volume] in Peritoneal fluid,702
3002331702,measurement during day -365 through 0 days relative to index: Protein [Mass/volume] in Peritoneal fluid,702
3002400702,measurement during day -365 through 0 days relative to index: Iron [Mass/volume] in Serum or Plasma,702
3002400704,measurement during day -30 through 0 days relative to index: Iron [Mass/volume] in Serum or Plasma,704
3002460702,measurement during day -365 through 0 days relative to index: Hamster epithelium IgE Ab RAST class [Presence] in Serum,702
3002529702,measurement during day -365 through 0 days relative to index: ABO group [Type] in Blood,702
3002529704,measurement during day -30 through 0 days relative to index: ABO group [Type] in Blood,704
3002582702,measurement during day -365 through 0 days relative to index: Erythrocytes [#/volume] in Urine,702
3002582704,measurement during day -30 through 0 days relative to index: Erythrocytes [#/volume] in Urine,704
3002651702,measurement during day -365 through 0 days relative to index: Cholesterol [Mass/volume] in Peritoneal fluid,702
3002720702,measurement during day -365 through 0 days relative to index: Acarus siro IgE Ab RAST class [Presence] in Serum,702
3002852702,measurement during day -365 through 0 days relative to index: Dog epithelium IgE Ab RAST class [Presence] in Serum,702
3003181702,measurement during day -365 through 0 days relative to index: Sodium [Moles/volume] in Urine,702
3003181704,measurement during day -30 through 0 days relative to index: Sodium [Moles/volume] in Urine,704
3003327702,measurement during day -365 through 0 days relative to index: Ova and parasites identified in Stool by Light microscopy,702
3003327704,measurement during day -30 through 0 days relative to index: Ova and parasites identified in Stool by Light microscopy,704
3003338702,measurement during day -365 through 0 days relative to index: MCHC [Mass/volume],702
3003338704,measurement during day -30 through 0 days relative to index: MCHC [Mass/volume],704
3003396702,measurement during day -365 through 0 days relative to index: Base excess in Arterial blood by calculation,702
3003396704,measurement during day -30 through 0 days relative to index: Base excess in Arterial blood by calculation,704
3003403702,measurement during day -365 through 0 days relative to index: Glucose [Mass/volume] in Pleural fluid,702
3003434702,measurement during day -365 through 0 days relative to index: Protein [Mass/volume] in Pleural fluid,702
3003467702,measurement during day -365 through 0 days relative to index: Lymphocytes [#/volume] in Body fluid,702
3003526702,measurement during day -365 through 0 days relative to index: Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma by Immunoassay,702
3003733702,measurement during day -365 through 0 days relative to index: Legionella pneumophila Ag [Presence] in Unspecified specimen,702
3003733704,measurement during day -30 through 0 days relative to index: Legionella pneumophila Ag [Presence] in Unspecified specimen,704
3004077702,measurement during day -365 through 0 days relative to index: Glucose [Mass/volume] in Capillary blood,702
3004077704,measurement during day -30 through 0 days relative to index: Glucose [Mass/volume] in Capillary blood,704
3004239702,measurement during day -365 through 0 days relative to index: Creatinine [Mass/time] in 24 hour Urine,702
3004239704,measurement during day -30 through 0 days relative to index: Creatinine [Mass/time] in 24 hour Urine,704
3004249702,measurement during day -365 through 0 days relative to index: Systolic blood pressure,702
3004249704,measurement during day -30 through 0 days relative to index: Systolic blood pressure,704
3004410702,measurement during day -365 through 0 days relative to index: Hemoglobin A1c/Hemoglobin.total in Blood,702
3004410704,measurement during day -30 through 0 days relative to index: Hemoglobin A1c/Hemoglobin.total in Blood,704
3004448702,measurement during day -365 through 0 days relative to index: Specific gravity of Pleural fluid by Refractometry,702
3004501702,measurement during day -365 through 0 days relative to index: Glucose [Mass/volume] in Serum or Plasma,702
3004501704,measurement during day -30 through 0 days relative to index: Glucose [Mass/volume] in Serum or Plasma,704
3004562702,measurement during day -365 through 0 days relative to index: Bacteria [Presence] in Urine sediment by Light microscopy,702
3004562704,measurement during day -30 through 0 days relative to index: Bacteria [Presence] in Urine sediment by Light microscopy,704
3004789702,measurement during day -365 through 0 days relative to index: Transferrin [Mass/volume] in Serum or Plasma,702
3004789704,measurement during day -30 through 0 days relative to index: Transferrin [Mass/volume] in Serum or Plasma,704
3004809702,measurement during day -365 through 0 days relative to index: Band form neutrophils/100 leukocytes in Blood,702
3004809704,measurement during day -30 through 0 days relative to index: Band form neutrophils/100 leukocytes in Blood,704
3004905702,measurement during day -365 through 0 days relative to index: Lipase [Enzymatic activity/volume] in Serum or Plasma,702
3004905704,measurement during day -30 through 0 days relative to index: Lipase [Enzymatic activity/volume] in Serum or Plasma,704
3005307702,measurement during day -365 through 0 days relative to index: Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoassay,702
3005322702,measurement during day -365 through 0 days relative to index: IgE [Units/volume] in Serum or Plasma,702
3005322704,measurement during day -30 through 0 days relative to index: IgE [Units/volume] in Serum or Plasma,704
3005356702,measurement during day -365 through 0 days relative to index: Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay,702
3005543702,measurement during day -365 through 0 days relative to index: Specific gravity of Peritoneal fluid by Refractometry,702
3005719702,measurement during day -365 through 0 days relative to index: IgG [Mass/volume] in Serum or Plasma,702
3005719704,measurement during day -30 through 0 days relative to index: IgG [Mass/volume] in Serum or Plasma,704
3005770702,measurement during day -365 through 0 days relative to index: Creatinine renal clearance in 24 hour Urine and Serum or Plasma,702
3005770704,measurement during day -30 through 0 days relative to index: Creatinine renal clearance in 24 hour Urine and Serum or Plasma,704
3005785702,measurement during day -365 through 0 days relative to index: Creatine kinase.MB [Mass/volume] in Serum or Plasma,702
3005785704,measurement during day -30 through 0 days relative to index: Creatine kinase.MB [Mass/volume] in Serum or Plasma,704
3005895702,measurement during day -365 through 0 days relative to index: Myoglobin [Mass/volume] in Serum or Plasma,702
3006504702,measurement during day -365 through 0 days relative to index: Eosinophils/100 leukocytes in Blood,702
3006504704,measurement during day -30 through 0 days relative to index: Eosinophils/100 leukocytes in Blood,704
3006567702,measurement during day -365 through 0 days relative to index: Chloride [Moles/time] in 24 hour Urine,702
3006567704,measurement during day -30 through 0 days relative to index: Chloride [Moles/time] in 24 hour Urine,704
3006594702,measurement during day -365 through 0 days relative to index: Cockroach IgE Ab RAST class [Presence] in Serum,702
3006661702,measurement during day -365 through 0 days relative to index: Calcium [Mass/volume] in Urine,702
3006661704,measurement during day -30 through 0 days relative to index: Calcium [Mass/volume] in Urine,704
3006906702,measurement during day -365 through 0 days relative to index: Calcium [Mass/volume] in Serum or Plasma,702
3006906704,measurement during day -30 through 0 days relative to index: Calcium [Mass/volume] in Serum or Plasma,704
3006923702,measurement during day -365 through 0 days relative to index: Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,702
3006923704,measurement during day -30 through 0 days relative to index: Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,704
3007070702,measurement during day -365 through 0 days relative to index: Cholesterol in HDL [Mass/volume] in Serum or Plasma,702
3007070704,measurement during day -30 through 0 days relative to index: Cholesterol in HDL [Mass/volume] in Serum or Plasma,704
3007087702,measurement during day -365 through 0 days relative to index: Corn IgE Ab RAST class [Presence] in Serum,702
3007124702,measurement during day -365 through 0 days relative to index: Reticulocytes/100 erythrocytes in Blood by Automated count,702
3007124704,measurement during day -30 through 0 days relative to index: Reticulocytes/100 erythrocytes in Blood by Automated count,704
3007164702,measurement during day -365 through 0 days relative to index: IgA [Mass/volume] in Serum or Plasma,702
3007164704,measurement during day -30 through 0 days relative to index: IgA [Mass/volume] in Serum or Plasma,704
3007220702,measurement during day -365 through 0 days relative to index: Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,702
3007220704,measurement during day -30 through 0 days relative to index: Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,704
3007461702,measurement during day -365 through 0 days relative to index: Platelets [#/volume] in Blood,702
3007461704,measurement during day -30 through 0 days relative to index: Platelets [#/volume] in Blood,704
3007490702,measurement during day -365 through 0 days relative to index: White Oak IgE Ab RAST class [Presence] in Serum,702
3007687702,measurement during day -365 through 0 days relative to index: Calcium [Mass/time] in 24 hour Urine,702
3007687704,measurement during day -30 through 0 days relative to index: Calcium [Mass/time] in 24 hour Urine,704
3007733702,measurement during day -365 through 0 days relative to index: Chloride [Moles/volume] in Urine,702
3007733704,measurement during day -30 through 0 days relative to index: Chloride [Moles/volume] in Urine,704
3007980702,measurement during day -365 through 0 days relative to index: Soybean IgE Ab RAST class [Presence] in Serum,702
3008152702,measurement during day -365 through 0 days relative to index: Bicarbonate [Moles/volume] in Arterial blood,702
3008152704,measurement during day -30 through 0 days relative to index: Bicarbonate [Moles/volume] in Arterial blood,704
3008295702,measurement during day -365 through 0 days relative to index: Osmolality of Serum or Plasma,702
3008295704,measurement during day -30 through 0 days relative to index: Osmolality of Serum or Plasma,704
3008364702,measurement during day -365 through 0 days relative to index: Apolipoprotein A-I [Mass/volume] in Serum or Plasma,702
3008364704,measurement during day -30 through 0 days relative to index: Apolipoprotein A-I [Mass/volume] in Serum or Plasma,704
3008392702,measurement during day -365 through 0 days relative to index: Creatinine/Protein [Mass Ratio] in Urine,702
3008392704,measurement during day -30 through 0 days relative to index: Creatinine/Protein [Mass Ratio] in Urine,704
3008691702,measurement during day -365 through 0 days relative to index: Amylase [Enzymatic activity/volume] in Peritoneal fluid,702
3008882702,measurement during day -365 through 0 days relative to index: English plantain IgE Ab RAST class [Presence] in Serum,702
3009201702,measurement during day -365 through 0 days relative to index: Thyrotropin [Units/volume] in Serum or Plasma,702
3009201704,measurement during day -30 through 0 days relative to index: Thyrotropin [Units/volume] in Serum or Plasma,704
3009220702,measurement during day -365 through 0 days relative to index: Epithelial cells.squamous [#/volume] in Urine sediment,702
3009268702,measurement during day -365 through 0 days relative to index: Sheep epithelium IgE Ab RAST class [Presence] in Serum,702
3009471702,measurement during day -365 through 0 days relative to index: Fatty acids.nonesterified [Moles/volume] in Serum or Plasma,702
3009471704,measurement during day -30 through 0 days relative to index: Fatty acids.nonesterified [Moles/volume] in Serum or Plasma,704
3009537702,measurement during day -365 through 0 days relative to index: Aspergillus fumigatus IgE Ab RAST class [Presence] in Serum,702
3009609702,"measurement during day -365 through 0 days relative to index: Carbon dioxide, total [Moles/volume] in Arterial blood",702
3009609704,"measurement during day -30 through 0 days relative to index: Carbon dioxide, total [Moles/volume] in Arterial blood",704
3009613702,measurement during day -365 through 0 days relative to index: Erythrocytes [#/volume] in Peritoneal fluid,702
3009682702,measurement during day -365 through 0 days relative to index: Cortisol [Mass/volume] in Serum or Plasma,702
3009745702,measurement during day -365 through 0 days relative to index: Common Ragweed IgE Ab RAST class [Presence] in Serum,702
3009804702,measurement during day -365 through 0 days relative to index: Carcinoembryonic Ag [Mass/volume] in Pleural fluid,702
3009944702,measurement during day -365 through 0 days relative to index: Mycobacterium tuberculosis DNA [Presence] in Pleural fluid by NAA with probe detection,702
3010020702,measurement during day -365 through 0 days relative to index: Ox-eye daisy IgE Ab RAST class [Presence] in Serum,702
3010084702,measurement during day -365 through 0 days relative to index: C peptide [Mass/volume] in Serum or Plasma,702
3010084704,measurement during day -30 through 0 days relative to index: C peptide [Mass/volume] in Serum or Plasma,704
3010101702,measurement during day -365 through 0 days relative to index: Cocksfoot IgE Ab RAST class [Presence] in Serum,702
3010156702,measurement during day -365 through 0 days relative to index: C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,702
3010156704,measurement during day -30 through 0 days relative to index: C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,704
3010234702,measurement during day -365 through 0 days relative to index: Bromelin IgE Ab RAST class [Presence] in Serum,702
3010375702,measurement during day -365 through 0 days relative to index: cycloSPORINE [Mass/volume] in Blood,702
3010521702,measurement during day -365 through 0 days relative to index: Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay,702
3010521704,measurement during day -30 through 0 days relative to index: Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay,704
3010702702,measurement during day -365 through 0 days relative to index: American house dust mite IgE Ab RAST class [Presence] in Serum,702
3010761702,measurement during day -365 through 0 days relative to index: Herpes simplex virus IgM Ab [Presence] in Serum,702
3010761704,measurement during day -30 through 0 days relative to index: Herpes simplex virus IgM Ab [Presence] in Serum,704
3010813702,measurement during day -365 through 0 days relative to index: Leukocytes [#/volume] in Blood,702
3010813704,measurement during day -30 through 0 days relative to index: Leukocytes [#/volume] in Blood,704
3010910702,measurement during day -365 through 0 days relative to index: Erythrocytes [#/volume] in Body fluid,702
3011066702,measurement during day -365 through 0 days relative to index: Myoglobin [Mass/volume] in Urine,702
3011066704,measurement during day -30 through 0 days relative to index: Myoglobin [Mass/volume] in Urine,704
3011177702,measurement during day -365 through 0 days relative to index: Bermuda grass IgE Ab RAST class [Presence] in Serum,702
3011325702,measurement during day -365 through 0 days relative to index: HIV 1+2 Ab [Presence] in Serum,702
3011325704,measurement during day -30 through 0 days relative to index: HIV 1+2 Ab [Presence] in Serum,704
3011337702,measurement during day -365 through 0 days relative to index: Aldosterone [Mass/volume] in Serum or Plasma,702
3011363702,measurement during day -365 through 0 days relative to index: Streptococcus pneumoniae Ag [Presence] in Urine,702
3011363704,measurement during day -30 through 0 days relative to index: Streptococcus pneumoniae Ag [Presence] in Urine,704
3011422702,measurement during day -365 through 0 days relative to index: Epithelial cells [Presence] in Urine sediment by Light microscopy,702
3011422704,measurement during day -30 through 0 days relative to index: Epithelial cells [Presence] in Urine sediment by Light microscopy,704
3011904702,measurement during day -365 through 0 days relative to index: Phosphate [Mass/volume] in Serum or Plasma,702
3011904704,measurement during day -30 through 0 days relative to index: Phosphate [Mass/volume] in Serum or Plasma,704
3011958702,measurement during day -365 through 0 days relative to index: Ammonia [Moles/volume] in Plasma,702
3011958704,measurement during day -30 through 0 days relative to index: Ammonia [Moles/volume] in Plasma,704
3011965702,measurement during day -365 through 0 days relative to index: Urea nitrogen [Mass/volume] in Urine,702
3011965704,measurement during day -30 through 0 days relative to index: Urea nitrogen [Mass/volume] in Urine,704
3012471702,measurement during day -365 through 0 days relative to index: Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay,702
3012471704,measurement during day -30 through 0 days relative to index: Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay,704
3012565702,measurement during day -365 through 0 days relative to index: Volume of 24 hour Urine,702
3012565704,measurement during day -30 through 0 days relative to index: Volume of 24 hour Urine,704
3012636702,measurement during day -365 through 0 days relative to index: Phosphate [Mass/time] in 24 hour Urine,702
3012636704,measurement during day -30 through 0 days relative to index: Phosphate [Mass/time] in 24 hour Urine,704
3012764702,measurement during day -365 through 0 days relative to index: Erythrocyte morphology finding [Identifier] in Blood,702
3012764704,measurement during day -30 through 0 days relative to index: Erythrocyte morphology finding [Identifier] in Blood,704
3012888702,measurement during day -365 through 0 days relative to index: Diastolic blood pressure,702
3012888704,measurement during day -30 through 0 days relative to index: Diastolic blood pressure,704
3013043702,measurement during day -365 through 0 days relative to index: Timothy IgE Ab RAST class [Presence] in Serum,702
3013115702,measurement during day -365 through 0 days relative to index: Eosinophils [#/volume] in Blood,702
3013199702,measurement during day -365 through 0 days relative to index: Leukocytes [#/volume] in Stool,702
3013199704,measurement during day -30 through 0 days relative to index: Leukocytes [#/volume] in Stool,704
3013273702,measurement during day -365 through 0 days relative to index: Insulin-like growth factor-I [Mass/volume] in Serum or Plasma,702
3013498702,measurement during day -365 through 0 days relative to index: Variant lymphocytes/100 leukocytes in Blood,702
3013498704,measurement during day -30 through 0 days relative to index: Variant lymphocytes/100 leukocytes in Blood,704
3013650702,measurement during day -365 through 0 days relative to index: Neutrophils [#/volume] in Blood by Automated count,702
3013650704,measurement during day -30 through 0 days relative to index: Neutrophils [#/volume] in Blood by Automated count,704
3013682702,measurement during day -365 through 0 days relative to index: Urea nitrogen [Mass/volume] in Serum or Plasma,702
3013682704,measurement during day -30 through 0 days relative to index: Urea nitrogen [Mass/volume] in Serum or Plasma,704
3013721702,measurement during day -365 through 0 days relative to index: Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,702
3013721704,measurement during day -30 through 0 days relative to index: Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,704
3013861702,measurement during day -365 through 0 days relative to index: Lipoprotein a [Mass/volume] in Serum or Plasma,702
3013861704,measurement during day -30 through 0 days relative to index: Lipoprotein a [Mass/volume] in Serum or Plasma,704
3014218702,measurement during day -365 through 0 days relative to index: Bicarbonate [Moles/volume] standard in Arterial blood,702
3014218704,measurement during day -30 through 0 days relative to index: Bicarbonate [Moles/volume] standard in Arterial blood,704
3014576702,measurement during day -365 through 0 days relative to index: Chloride [Moles/volume] in Serum or Plasma,702
3014576704,measurement during day -30 through 0 days relative to index: Chloride [Moles/volume] in Serum or Plasma,704
3014791702,measurement during day -365 through 0 days relative to index: Apolipoprotein B [Mass/volume] in Serum or Plasma,702
3014791704,measurement during day -30 through 0 days relative to index: Apolipoprotein B [Mass/volume] in Serum or Plasma,704
3014825702,measurement during day -365 through 0 days relative to index: Centromere Ab [Presence] in Serum,702
3014952702,measurement during day -365 through 0 days relative to index: Taenia solium larva IgG Ab [Presence] in Serum,702
3015056702,measurement during day -365 through 0 days relative to index: Horse epithelium IgE Ab RAST class [Presence] in Serum,702
3015183702,measurement during day -365 through 0 days relative to index: Erythrocyte sedimentation rate,702
3015183704,measurement during day -30 through 0 days relative to index: Erythrocyte sedimentation rate,704
3015242702,measurement during day -365 through 0 days relative to index: Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,702
3015242704,measurement during day -30 through 0 days relative to index: Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,704
3015579702,measurement during day -365 through 0 days relative to index: Color of Body fluid,702
3015632702,"measurement during day -365 through 0 days relative to index: Carbon dioxide, total [Moles/volume] in Serum or Plasma",702
3015632704,"measurement during day -30 through 0 days relative to index: Carbon dioxide, total [Moles/volume] in Serum or Plasma",704
3015704702,measurement during day -365 through 0 days relative to index: Mugwort IgE Ab RAST class [Presence] in Serum,702
3015942702,measurement during day -365 through 0 days relative to index: Alternaria alternata IgE Ab RAST class [Presence] in Serum,702
3016038702,measurement during day -365 through 0 days relative to index: Potassium [Moles/volume] in Urine,702
3016038704,measurement during day -30 through 0 days relative to index: Potassium [Moles/volume] in Urine,704
3016135702,measurement during day -365 through 0 days relative to index: IgD [Mass/volume] in Serum,702
3016135704,measurement during day -30 through 0 days relative to index: IgD [Mass/volume] in Serum,704
3016244702,measurement during day -365 through 0 days relative to index: Insulin [Units/volume] in Serum or Plasma,702
3016244704,measurement during day -30 through 0 days relative to index: Insulin [Units/volume] in Serum or Plasma,704
3016258702,measurement during day -365 through 0 days relative to index: Waist Circumference at umbilicus by Tape measure,702
3016258704,measurement during day -30 through 0 days relative to index: Waist Circumference at umbilicus by Tape measure,704
3016330702,measurement during day -365 through 0 days relative to index: Potassium [Moles/time] in 24 hour Urine,702
3016330704,measurement during day -30 through 0 days relative to index: Potassium [Moles/time] in 24 hour Urine,704
3016407702,measurement during day -365 through 0 days relative to index: Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay,702
3016407704,measurement during day -30 through 0 days relative to index: Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay,704
3016502702,measurement during day -365 through 0 days relative to index: Oxygen saturation in Arterial blood,702
3016502704,measurement during day -30 through 0 days relative to index: Oxygen saturation in Arterial blood,704
3016723702,measurement during day -365 through 0 days relative to index: Creatinine [Mass/volume] in Serum or Plasma,702
3016723704,measurement during day -30 through 0 days relative to index: Creatinine [Mass/volume] in Serum or Plasma,704
3016724702,measurement during day -365 through 0 days relative to index: Homocysteine [Moles/volume] in Serum or Plasma,702
3016724704,measurement during day -30 through 0 days relative to index: Homocysteine [Moles/volume] in Serum or Plasma,704
3016771702,measurement during day -365 through 0 days relative to index: Amylase [Enzymatic activity/volume] in Serum or Plasma,702
3016771704,measurement during day -30 through 0 days relative to index: Amylase [Enzymatic activity/volume] in Serum or Plasma,704
3016835702,measurement during day -365 through 0 days relative to index: Common Pigweed IgE Ab RAST class [Presence] in Serum,702
3016980702,measurement during day -365 through 0 days relative to index: House dust IgE Ab RAST class [Presence] in Serum,702
3017044702,measurement during day -365 through 0 days relative to index: Thyrotropin receptor Ab [Units/volume] in Serum,702
3017143702,measurement during day -365 through 0 days relative to index: Hepatitis C virus Ab [Presence] in Serum,702
3017143704,measurement during day -30 through 0 days relative to index: Hepatitis C virus Ab [Presence] in Serum,704
3017250702,measurement during day -365 through 0 days relative to index: Creatinine [Mass/volume] in Urine,702
3017250704,measurement during day -30 through 0 days relative to index: Creatinine [Mass/volume] in Urine,704
3017354702,measurement during day -365 through 0 days relative to index: Segmented neutrophils/100 leukocytes in Blood,702
3017354704,measurement during day -30 through 0 days relative to index: Segmented neutrophils/100 leukocytes in Blood,704
3017457702,measurement during day -365 through 0 days relative to index: Urea nitrogen [Mass/time] in 24 hour Urine,702
3017457704,measurement during day -30 through 0 days relative to index: Urea nitrogen [Mass/time] in 24 hour Urine,704
3017504702,measurement during day -365 through 0 days relative to index: Pine IgE Ab RAST class [Presence] in Serum,702
3017766702,measurement during day -365 through 0 days relative to index: Complement C4 [Mass/volume] in Serum or Plasma,702
3017766704,measurement during day -30 through 0 days relative to index: Complement C4 [Mass/volume] in Serum or Plasma,704
3017925702,measurement during day -365 through 0 days relative to index: Prealbumin [Mass/volume] in Serum or Plasma by Immunoassay,702
3017925704,measurement during day -30 through 0 days relative to index: Prealbumin [Mass/volume] in Serum or Plasma by Immunoassay,704
3018095702,measurement during day -365 through 0 days relative to index: Leukocytes [#/volume] in Urine,702
3018095704,measurement during day -30 through 0 days relative to index: Leukocytes [#/volume] in Urine,704
3018339702,measurement during day -365 through 0 days relative to index: Honey bee IgE Ab RAST class [Presence] in Serum,702
3018645702,measurement during day -365 through 0 days relative to index: Cladosporium herbarum IgE Ab RAST class [Presence] in Serum,702
3018672702,measurement during day -365 through 0 days relative to index: pH of Body fluid,702
3018677702,measurement during day -365 through 0 days relative to index: aPTT in Platelet poor plasma by Coagulation assay,702
3018677704,measurement during day -30 through 0 days relative to index: aPTT in Platelet poor plasma by Coagulation assay,704
3018737702,measurement during day -365 through 0 days relative to index: Fibrin D-dimer [Units/volume] in Platelet poor plasma by Immunoassay,702
3018737704,measurement during day -30 through 0 days relative to index: Fibrin D-dimer [Units/volume] in Platelet poor plasma by Immunoassay,704
3018760702,measurement during day -365 through 0 days relative to index: Blood smear finding [Identifier] in Blood by Light microscopy,702
3018760704,measurement during day -30 through 0 days relative to index: Blood smear finding [Identifier] in Blood by Light microscopy,704
3018910702,measurement during day -365 through 0 days relative to index: Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma,702
3018910704,measurement during day -30 through 0 days relative to index: Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma,704
3018970702,measurement during day -365 through 0 days relative to index: Chocolate IgE Ab RAST class [Presence] in Serum,702
3019069702,measurement during day -365 through 0 days relative to index: Monocytes/100 leukocytes in Blood,702
3019069704,measurement during day -30 through 0 days relative to index: Monocytes/100 leukocytes in Blood,704
3019284702,measurement during day -365 through 0 days relative to index: Hepatitis B virus surface Ag [Presence] in Serum,702
3019284704,measurement during day -30 through 0 days relative to index: Hepatitis B virus surface Ag [Presence] in Serum,704
3019428702,measurement during day -365 through 0 days relative to index: Reagin Ab [Presence] in Serum by VDRL,702
3019428704,measurement during day -30 through 0 days relative to index: Reagin Ab [Presence] in Serum by VDRL,704
3019550702,measurement during day -365 through 0 days relative to index: Sodium [Moles/volume] in Serum or Plasma,702
3019550704,measurement during day -30 through 0 days relative to index: Sodium [Moles/volume] in Serum or Plasma,704
3019633702,measurement during day -365 through 0 days relative to index: Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoassay,702
3019889702,measurement during day -365 through 0 days relative to index: Broad casts [Presence] in Urine sediment by Light microscopy,702
3019889704,measurement during day -30 through 0 days relative to index: Broad casts [Presence] in Urine sediment by Light microscopy,704
3019897702,measurement during day -365 through 0 days relative to index: Erythrocyte distribution width [Ratio] by Automated count,702
3019942702,measurement during day -365 through 0 days relative to index: Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoassay,702
3019977702,measurement during day -365 through 0 days relative to index: pH of Arterial blood,702
3019977704,measurement during day -30 through 0 days relative to index: pH of Arterial blood,704
3020134702,measurement during day -365 through 0 days relative to index: Herpes simplex virus IgG Ab [Presence] in Serum,702
3020134704,measurement during day -30 through 0 days relative to index: Herpes simplex virus IgG Ab [Presence] in Serum,704
3020184702,measurement during day -365 through 0 days relative to index: Dandelion IgE Ab RAST class [Presence] in Serum,702
3020389702,measurement during day -365 through 0 days relative to index: Ova and parasites identified in Stool by Concentration,702
3020389704,measurement during day -30 through 0 days relative to index: Ova and parasites identified in Stool by Concentration,704
3020460702,measurement during day -365 through 0 days relative to index: C reactive protein [Mass/volume] in Serum or Plasma,702
3020460704,measurement during day -30 through 0 days relative to index: C reactive protein [Mass/volume] in Serum or Plasma,704
3020467702,measurement during day -365 through 0 days relative to index: Red top grass IgE Ab RAST class [Presence] in Serum,702
3020515702,measurement during day -365 through 0 days relative to index: Wattle IgE Ab RAST class [Presence] in Serum,702
3020630702,measurement during day -365 through 0 days relative to index: Protein [Mass/volume] in Serum or Plasma,702
3020630704,measurement during day -30 through 0 days relative to index: Protein [Mass/volume] in Serum or Plasma,704
3020695702,measurement during day -365 through 0 days relative to index: Perennial rye grass IgE Ab RAST class [Presence] in Serum,702
3020825702,measurement during day -365 through 0 days relative to index: European house dust mite IgE Ab RAST class [Presence] in Serum,702
3020891702,measurement during day -365 through 0 days relative to index: Body temperature,702
3020891704,measurement during day -30 through 0 days relative to index: Body temperature,704
3021044702,measurement during day -365 through 0 days relative to index: Iron binding capacity [Mass/volume] in Serum or Plasma,702
3021044704,measurement during day -30 through 0 days relative to index: Iron binding capacity [Mass/volume] in Serum or Plasma,704
3021236702,measurement during day -365 through 0 days relative to index: Streptolysin O Ab [Units/volume] in Serum or Plasma,702
3021322702,measurement during day -365 through 0 days relative to index: Cryoglobulin [Presence] in Serum,702
3021347702,measurement during day -365 through 0 days relative to index: Calcium.ionized [Moles/volume] in Serum or Plasma,702
3021347704,measurement during day -30 through 0 days relative to index: Calcium.ionized [Moles/volume] in Serum or Plasma,704
3021354702,measurement during day -365 through 0 days relative to index: Sweet Vernal grass IgE Ab RAST class [Presence] in Serum,702
3021601702,measurement during day -365 through 0 days relative to index: Nitrite [Presence] in Urine by Test strip,702
3021601704,measurement during day -30 through 0 days relative to index: Nitrite [Presence] in Urine by Test strip,704
3021614702,measurement during day -365 through 0 days relative to index: Rheumatoid factor [Units/volume] in Serum or Plasma,702
3021614704,measurement during day -30 through 0 days relative to index: Rheumatoid factor [Units/volume] in Serum or Plasma,704
3021644702,measurement during day -365 through 0 days relative to index: Mackerel IgE Ab RAST class [Presence] in Serum,702
3021660702,measurement during day -365 through 0 days relative to index: Color of Peritoneal fluid,702
3021737702,measurement during day -365 through 0 days relative to index: Glucose [Mass/volume] in Serum or Plasma --2 hours post meal,702
3021835702,measurement during day -365 through 0 days relative to index: Urate [Mass/time] in 24 hour Urine,702
3021835704,measurement during day -30 through 0 days relative to index: Urate [Mass/time] in 24 hour Urine,704
3022096702,measurement during day -365 through 0 days relative to index: Basophils/100 leukocytes in Blood,702
3022096704,measurement during day -30 through 0 days relative to index: Basophils/100 leukocytes in Blood,704
3022174702,measurement during day -365 through 0 days relative to index: Leukocytes [#/volume] in Body fluid,702
3022192702,measurement during day -365 through 0 days relative to index: Triglyceride [Mass/volume] in Serum or Plasma,702
3022192704,measurement during day -30 through 0 days relative to index: Triglyceride [Mass/volume] in Serum or Plasma,704
3022217702,measurement during day -365 through 0 days relative to index: INR in Platelet poor plasma by Coagulation assay,702
3022217704,measurement during day -30 through 0 days relative to index: INR in Platelet poor plasma by Coagulation assay,704
3022250702,measurement during day -365 through 0 days relative to index: Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction,702
3022250704,measurement during day -30 through 0 days relative to index: Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction,704
3022379702,measurement during day -365 through 0 days relative to index: Silver Birch IgG Ab RAST class [Presence] in Serum,702
3023037702,measurement during day -365 through 0 days relative to index: pH of Peritoneal fluid,702
3023103702,measurement during day -365 through 0 days relative to index: Potassium [Moles/volume] in Serum or Plasma,702
3023103704,measurement during day -30 through 0 days relative to index: Potassium [Moles/volume] in Serum or Plasma,704
3023174702,measurement during day -365 through 0 days relative to index: Cryptococcus sp Ag [Presence] in Serum,702
3023174704,measurement during day -30 through 0 days relative to index: Cryptococcus sp Ag [Presence] in Serum,704
3023199702,measurement during day -365 through 0 days relative to index: Leukocytes [#/volume] in Pleural fluid,702
3023230702,measurement during day -365 through 0 days relative to index: Hematocrit [Volume Fraction] of Arterial blood,702
3023314702,measurement during day -365 through 0 days relative to index: Hematocrit [Volume Fraction] of Blood by Automated count,702
3023314704,measurement during day -30 through 0 days relative to index: Hematocrit [Volume Fraction] of Blood by Automated count,704
3023386702,measurement during day -365 through 0 days relative to index: Triglyceride [Mass/volume] in Peritoneal fluid,702
3023421702,measurement during day -365 through 0 days relative to index: Hepatitis B virus surface Ab [Units/volume] in Serum,702
3023421704,measurement during day -30 through 0 days relative to index: Hepatitis B virus surface Ab [Units/volume] in Serum,704
3023487702,measurement during day -365 through 0 days relative to index: Leukocytes [#/volume] in Peritoneal fluid,702
3023646702,measurement during day -365 through 0 days relative to index: Shrimp IgE Ab RAST class [Presence] in Serum,702
3023671702,measurement during day -365 through 0 days relative to index: Herpes simplex virus 1 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection,702
3023671704,measurement during day -30 through 0 days relative to index: Herpes simplex virus 1 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection,704
3023709702,measurement during day -365 through 0 days relative to index: Somatotropin [Mass/volume] in Serum or Plasma,702
3023830702,measurement during day -365 through 0 days relative to index: Crab IgE Ab RAST class [Presence] in Serum,702
3023914702,measurement during day -365 through 0 days relative to index: Latex IgE Ab RAST class [Presence] in Serum,702
3024128702,measurement during day -365 through 0 days relative to index: Bilirubin.total [Mass/volume] in Serum or Plasma,702
3024128704,measurement during day -30 through 0 days relative to index: Bilirubin.total [Mass/volume] in Serum or Plasma,704
3024171702,measurement during day -365 through 0 days relative to index: Respiratory rate,702
3024171704,measurement during day -30 through 0 days relative to index: Respiratory rate,704
3024172702,measurement during day -365 through 0 days relative to index: Erythropoietin (EPO) [Units/volume] in Serum or Plasma,702
3024172704,measurement during day -30 through 0 days relative to index: Erythropoietin (EPO) [Units/volume] in Serum or Plasma,704
3024311702,measurement during day -365 through 0 days relative to index: White Poplar IgE Ab RAST class [Presence] in Serum,702
3024561702,measurement during day -365 through 0 days relative to index: Albumin [Mass/volume] in Serum or Plasma,702
3024561704,measurement during day -30 through 0 days relative to index: Albumin [Mass/volume] in Serum or Plasma,704
3024731702,measurement during day -365 through 0 days relative to index: MCV [Entitic volume],702
3024731704,measurement during day -30 through 0 days relative to index: MCV [Entitic volume],704
3024980702,measurement during day -365 through 0 days relative to index: IgG subclass 4 [Mass/volume] in Serum,702
3025005702,measurement during day -365 through 0 days relative to index: Willow IgE Ab RAST class [Presence] in Serum,702
3025287702,measurement during day -365 through 0 days relative to index: Rabbit epithelium IgE Ab RAST class [Presence] in Serum,702
3025313702,measurement during day -365 through 0 days relative to index: Albumin [Mass/volume] in Body fluid,702
3025315702,measurement during day -365 through 0 days relative to index: Body weight,702
3025315704,measurement during day -30 through 0 days relative to index: Body weight,704
3025987702,measurement during day -365 through 0 days relative to index: Albumin [Presence] in Urine,702
3025987704,measurement during day -30 through 0 days relative to index: Albumin [Presence] in Urine,704
3026361702,measurement during day -365 through 0 days relative to index: Erythrocytes [#/volume] in Blood,702
3026361704,measurement during day -30 through 0 days relative to index: Erythrocytes [#/volume] in Blood,704
3026692702,measurement during day -365 through 0 days relative to index: Albumin [Mass/volume] in Peritoneal fluid,702
3026729702,measurement during day -365 through 0 days relative to index: Phosphate [Mass/volume] in Urine,702
3026729704,measurement during day -30 through 0 days relative to index: Phosphate [Mass/volume] in Urine,704
3026780702,measurement during day -365 through 0 days relative to index: Yellow Jacket IgE Ab RAST class [Presence] in Serum,702
3026782702,measurement during day -365 through 0 days relative to index: Osmolality of Urine,702
3026782704,measurement during day -30 through 0 days relative to index: Osmolality of Urine,704
3026910702,measurement during day -365 through 0 days relative to index: Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,702
3026910704,measurement during day -30 through 0 days relative to index: Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,704
3026925702,measurement during day -365 through 0 days relative to index: Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,702
3026925704,measurement during day -30 through 0 days relative to index: Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,704
3027018702,measurement during day -365 through 0 days relative to index: Heart rate,702
3027018704,measurement during day -30 through 0 days relative to index: Heart rate,704
3027114702,measurement during day -365 through 0 days relative to index: Cholesterol [Mass/volume] in Serum or Plasma,702
3027114704,measurement during day -30 through 0 days relative to index: Cholesterol [Mass/volume] in Serum or Plasma,704
3027117702,measurement during day -365 through 0 days relative to index: Goldenrod IgE Ab RAST class [Presence] in Serum,702
3027271702,measurement during day -365 through 0 days relative to index: Potato IgE Ab RAST class [Presence] in Serum,702
3027484702,measurement during day -365 through 0 days relative to index: Hemoglobin [Mass/volume] in Blood by calculation,702
3027484704,measurement during day -30 through 0 days relative to index: Hemoglobin [Mass/volume] in Blood by calculation,704
3027597702,measurement during day -365 through 0 days relative to index: Bilirubin.direct [Mass/volume] in Serum or Plasma,702
3027597704,measurement during day -30 through 0 days relative to index: Bilirubin.direct [Mass/volume] in Serum or Plasma,704
3027658702,measurement during day -365 through 0 days relative to index: Sesame Seed IgE Ab RAST class [Presence] in Serum,702
3027801702,measurement during day -365 through 0 days relative to index: Oxygen [Partial pressure] in Arterial blood,702
3027801704,measurement during day -30 through 0 days relative to index: Oxygen [Partial pressure] in Arterial blood,704
3027813702,measurement during day -365 through 0 days relative to index: Mycobacterium tuberculosis DNA [Presence] in Sputum by NAA with probe detection,702
3027813704,measurement during day -30 through 0 days relative to index: Mycobacterium tuberculosis DNA [Presence] in Sputum by NAA with probe detection,704
3027946702,measurement during day -365 through 0 days relative to index: Carbon dioxide [Partial pressure] in Arterial blood,702
3027946704,measurement during day -30 through 0 days relative to index: Carbon dioxide [Partial pressure] in Arterial blood,704
3028026702,measurement during day -365 through 0 days relative to index: IgM [Mass/volume] in Serum or Plasma,702
3028026704,measurement during day -30 through 0 days relative to index: IgM [Mass/volume] in Serum or Plasma,704
3028164702,measurement during day -365 through 0 days relative to index: Complement total hemolytic [Units/volume] in Blood,702
3028164704,measurement during day -30 through 0 days relative to index: Complement total hemolytic [Units/volume] in Blood,704
3028308702,measurement during day -365 through 0 days relative to index: Erythrocytes [#/volume] in Pleural fluid,702
3028437702,measurement during day -365 through 0 days relative to index: Cholesterol in LDL [Mass/volume] in Serum or Plasma,702
3028437704,measurement during day -30 through 0 days relative to index: Cholesterol in LDL [Mass/volume] in Serum or Plasma,704
3028475702,measurement during day -365 through 0 days relative to index: Transitional cells [Presence] in Urine sediment by Light microscopy,702
3028475704,measurement during day -30 through 0 days relative to index: Transitional cells [Presence] in Urine sediment by Light microscopy,704
3028772702,measurement during day -365 through 0 days relative to index: Osteocalcin [Mass/volume] in Serum or Plasma,702
3028772704,measurement during day -30 through 0 days relative to index: Osteocalcin [Mass/volume] in Serum or Plasma,704
3028856702,measurement during day -365 through 0 days relative to index: Paragonimus sp Ab [Presence] in Serum by Immunoblot,702
3029103702,measurement during day -365 through 0 days relative to index: Nuclear Ab [Presence] in Serum by Immunofluorescence,702
3029103704,measurement during day -30 through 0 days relative to index: Nuclear Ab [Presence] in Serum by Immunofluorescence,704
3029187702,measurement during day -365 through 0 days relative to index: Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma,702
3029187704,measurement during day -30 through 0 days relative to index: Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma,704
3029305702,measurement during day -365 through 0 days relative to index: pH of Urine by Automated test strip,702
3029305704,measurement during day -30 through 0 days relative to index: pH of Urine by Automated test strip,704
3029483702,measurement during day -365 through 0 days relative to index: DNA double strand Ab [Units/volume] in Serum by Immunoassay,702
3029634702,measurement during day -365 through 0 days relative to index: Reagin Ab [Titer] in Serum by VDRL,702
3029759702,measurement during day -365 through 0 days relative to index: Cold agglutinin [Presence] in Serum or Plasma,702
3029759704,measurement during day -30 through 0 days relative to index: Cold agglutinin [Presence] in Serum or Plasma,704
3029925702,measurement during day -365 through 0 days relative to index: Color of Urine by Auto,702
3029925704,measurement during day -30 through 0 days relative to index: Color of Urine by Auto,704
3030260702,measurement during day -365 through 0 days relative to index: Glucose [Presence] in Urine by Automated test strip,702
3030260704,measurement during day -30 through 0 days relative to index: Glucose [Presence] in Urine by Automated test strip,704
3030366702,measurement during day -365 through 0 days relative to index: Cystatin C [Mass/volume] in Serum or Plasma,702
3030366704,measurement during day -30 through 0 days relative to index: Cystatin C [Mass/volume] in Serum or Plasma,704
3030477702,measurement during day -365 through 0 days relative to index: Bilirubin.total [Presence] in Urine by Automated test strip,702
3030477704,measurement during day -30 through 0 days relative to index: Bilirubin.total [Presence] in Urine by Automated test strip,704
3030603702,measurement during day -365 through 0 days relative to index: Waxy casts [Presence] in Urine sediment by Light microscopy,702
3030603704,measurement during day -30 through 0 days relative to index: Waxy casts [Presence] in Urine sediment by Light microscopy,704
3030833702,measurement during day -365 through 0 days relative to index: Lymphocytes [#/volume] in Peritoneal fluid,702
3030845702,measurement during day -365 through 0 days relative to index: Lymphocytes [#/volume] in Pleural fluid,702
3030872702,measurement during day -365 through 0 days relative to index: Polymorphonuclear cells [#/volume] in Pleural fluid,702
3030894702,measurement during day -365 through 0 days relative to index: Polymorphonuclear cells [#/volume] in Body fluid,702
3031154702,measurement during day -365 through 0 days relative to index: Polymorphonuclear cells [#/volume] in Peritoneal fluid,702
3033308702,measurement during day -365 through 0 days relative to index: Hyaline casts [Presence] in Urine sediment by Light microscopy,702
3033308704,measurement during day -30 through 0 days relative to index: Hyaline casts [Presence] in Urine sediment by Light microscopy,704
3033335702,measurement during day -365 through 0 days relative to index: Egg white IgE Ab RAST class [Presence] in Serum,702
3033515702,measurement during day -365 through 0 days relative to index: Saltwort IgE Ab RAST class [Presence] in Serum,702
3033526702,measurement during day -365 through 0 days relative to index: Urate [Mass/volume] in Urine,702
3033526704,measurement during day -30 through 0 days relative to index: Urate [Mass/volume] in Urine,704
3033658702,measurement during day -365 through 0 days relative to index: Prothrombin time (PT) actual/Normal,702
3033658704,measurement during day -30 through 0 days relative to index: Prothrombin time (PT) actual/Normal,704
3034426702,measurement during day -365 through 0 days relative to index: Prothrombin time (PT),702
3034426704,measurement during day -30 through 0 days relative to index: Prothrombin time (PT),704
3034639702,measurement during day -365 through 0 days relative to index: Hemoglobin A1c [Mass/volume] in Blood,702
3034639704,measurement during day -30 through 0 days relative to index: Hemoglobin A1c [Mass/volume] in Blood,704
3034708702,measurement during day -365 through 0 days relative to index: Nucleated erythrocytes/100 leukocytes [Ratio] in Blood,702
3034708704,measurement during day -30 through 0 days relative to index: Nucleated erythrocytes/100 leukocytes [Ratio] in Blood,704
3034860702,measurement during day -365 through 0 days relative to index: Kappa light chains.free [Mass/volume] in Serum,702
3034860704,measurement during day -30 through 0 days relative to index: Kappa light chains.free [Mass/volume] in Serum,704
3035162702,measurement during day -365 through 0 days relative to index: Adenovirus Ag [Presence] in Nasopharynx,702
3035162704,measurement during day -30 through 0 days relative to index: Adenovirus Ag [Presence] in Nasopharynx,704
3035355702,measurement during day -365 through 0 days relative to index: Turbidity [Presence] of Urine Qualitative,702
3035355704,measurement during day -30 through 0 days relative to index: Turbidity [Presence] of Urine Qualitative,704
3035637702,measurement during day -365 through 0 days relative to index: Corticotropin [Mass/volume] in Plasma,702
3035706702,measurement during day -365 through 0 days relative to index: Apple IgE Ab RAST class [Presence] in Serum,702
3035769702,measurement during day -365 through 0 days relative to index: Cytomegalovirus Ag [Presence] in Urine,702
3035880702,measurement during day -365 through 0 days relative to index: pH of Pleural fluid,702
3035941702,measurement during day -365 through 0 days relative to index: MCH [Entitic mass],702
3035941704,measurement during day -30 through 0 days relative to index: MCH [Entitic mass],704
3035995702,measurement during day -365 through 0 days relative to index: Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,702
3035995704,measurement during day -30 through 0 days relative to index: Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,704
3036277702,measurement during day -365 through 0 days relative to index: Body height,702
3036277704,measurement during day -30 through 0 days relative to index: Body height,704
3036574702,measurement during day -365 through 0 days relative to index: Grey Alder IgE Ab RAST class [Presence] in Serum,702
3036671702,measurement during day -365 through 0 days relative to index: Fasting glucose [Mass/volume] in Capillary blood,702
3036671704,measurement during day -30 through 0 days relative to index: Fasting glucose [Mass/volume] in Capillary blood,704
3036857702,measurement during day -365 through 0 days relative to index: White Ash IgE Ab RAST class [Presence] in Serum,702
3036987702,measurement during day -365 through 0 days relative to index: Folate [Mass/volume] in Serum or Plasma,702
3036987704,measurement during day -30 through 0 days relative to index: Folate [Mass/volume] in Serum or Plasma,704
3037110702,measurement during day -365 through 0 days relative to index: Fasting glucose [Mass/volume] in Serum or Plasma,702
3037121702,measurement during day -365 through 0 days relative to index: Protein [Mass/volume] in Urine,702
3037121704,measurement during day -30 through 0 days relative to index: Protein [Mass/volume] in Urine,704
3037235702,measurement during day -365 through 0 days relative to index: Penicillium notatum IgE Ab RAST class [Presence] in Serum,702
3037310702,measurement during day -365 through 0 days relative to index: Renin [Mass/volume] in Plasma,702
3037437702,measurement during day -365 through 0 days relative to index: Adenosine deaminase [Enzymatic activity/volume] in Body fluid,702
3037556702,measurement during day -365 through 0 days relative to index: Urate [Mass/volume] in Serum or Plasma,702
3037556704,measurement during day -30 through 0 days relative to index: Urate [Mass/volume] in Serum or Plasma,704
3038066702,measurement during day -365 through 0 days relative to index: American Sycamore IgE Ab RAST class [Presence] in Serum,702
3038106702,measurement during day -365 through 0 days relative to index: Epithelial casts [Presence] in Urine sediment by Light microscopy,702
3038106704,measurement during day -30 through 0 days relative to index: Epithelial casts [Presence] in Urine sediment by Light microscopy,704
3038308702,measurement during day -365 through 0 days relative to index: Chloride [Moles/volume] in Pleural fluid,702
3038466702,measurement during day -365 through 0 days relative to index: Reticulocytes.high light scatter [#/volume] in Blood,702
3038466704,measurement during day -30 through 0 days relative to index: Reticulocytes.high light scatter [#/volume] in Blood,704
3038553702,measurement during day -365 through 0 days relative to index: Body mass index (BMI) [Ratio],702
3038553704,measurement during day -30 through 0 days relative to index: Body mass index (BMI) [Ratio],704
3038705702,measurement during day -365 through 0 days relative to index: Toxocara canis IgG Ab [Presence] in Serum by Immunoassay,702
3039312702,measurement during day -365 through 0 days relative to index: Plateletocrit [Volume Fraction] in Blood,702
3039385702,measurement during day -365 through 0 days relative to index: Mean sphered cell volume [Entitic volume] in Red Blood Cells,702
3039385704,measurement during day -30 through 0 days relative to index: Mean sphered cell volume [Entitic volume] in Red Blood Cells,704
3039417702,measurement during day -365 through 0 days relative to index: Platelet distribution width [Ratio] in Blood,702
3039686702,measurement during day -365 through 0 days relative to index: IgE Ab [Presence] in Serum or Plasma,702
3039919702,measurement during day -365 through 0 days relative to index: Specific gravity of Urine by Automated test strip,702
3039919704,measurement during day -30 through 0 days relative to index: Specific gravity of Urine by Automated test strip,704
3041096702,measurement during day -365 through 0 days relative to index: Erythrocytes [Presence] in Urine by Automated,702
3041096704,measurement during day -30 through 0 days relative to index: Erythrocytes [Presence] in Urine by Automated,704
3041426702,measurement during day -365 through 0 days relative to index: Ketones [Moles/volume] in Blood,702
3041426704,measurement during day -30 through 0 days relative to index: Ketones [Moles/volume] in Blood,704
3041942702,measurement during day -365 through 0 days relative to index: Cyclic citrullinated peptide Ab [Units/volume] in Serum,702
3041942704,measurement during day -30 through 0 days relative to index: Cyclic citrullinated peptide Ab [Units/volume] in Serum,704
3042038702,measurement during day -365 through 0 days relative to index: Carcinoembryonic Ag [Mass/volume] in Peritoneal fluid,702
3042702702,measurement during day -365 through 0 days relative to index: Immunoglobulin light chains [Mass/time] in 24 hour Urine,702
3042702704,measurement during day -30 through 0 days relative to index: Immunoglobulin light chains [Mass/time] in 24 hour Urine,704
3043133702,measurement during day -365 through 0 days relative to index: Erythrocytes.dysmorphic [#/volume] in Urine by Light microscopy,702
3043156702,measurement during day -365 through 0 days relative to index: Chloride [Moles/volume] in Peritoneal fluid,702
3043409702,measurement during day -365 through 0 days relative to index: Potassium [Moles/volume] in Arterial blood,702
3043644702,measurement during day -365 through 0 days relative to index: Calcium oxalate dihydrate crystals [Presence] in Urine sediment,702
3043706702,measurement during day -365 through 0 days relative to index: Sodium [Moles/volume] in Arterial blood,702
3043714702,measurement during day -365 through 0 days relative to index: Erythrocytes [Presence] in Stool,702
3043714704,measurement during day -30 through 0 days relative to index: Erythrocytes [Presence] in Stool,704
3044141702,measurement during day -365 through 0 days relative to index: Influenza virus A Ag [Presence] in Nasopharynx,702
3044141704,measurement during day -30 through 0 days relative to index: Influenza virus A Ag [Presence] in Nasopharynx,704
3044242702,measurement during day -365 through 0 days relative to index: Glucose [Moles/volume] in Arterial blood,702
3044331702,measurement during day -365 through 0 days relative to index: Calcium.ionized [Moles/volume] in Arterial blood,702
3044936702,measurement during day -365 through 0 days relative to index: Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay,702
3044936704,measurement during day -30 through 0 days relative to index: Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay,704
3045068702,measurement during day -365 through 0 days relative to index: Mycoplasma pneumoniae IgG Ab [Presence] in Serum by Immunoassay,702
3045068704,measurement during day -30 through 0 days relative to index: Mycoplasma pneumoniae IgG Ab [Presence] in Serum by Immunoassay,704
3045628702,measurement during day -365 through 0 days relative to index: Bordetella pertussis Ag [Presence] in Nasopharynx,702
3045628704,measurement during day -30 through 0 days relative to index: Bordetella pertussis Ag [Presence] in Nasopharynx,704
3045769702,measurement during day -365 through 0 days relative to index: Mixed cellular casts [Presence] in Urine sediment by Light microscopy,702
3045769704,measurement during day -30 through 0 days relative to index: Mixed cellular casts [Presence] in Urine sediment by Light microscopy,704
3045831702,measurement during day -365 through 0 days relative to index: Influenza virus B Ag [Presence] in Nasopharynx,702
3045831704,measurement during day -30 through 0 days relative to index: Influenza virus B Ag [Presence] in Nasopharynx,704
3045996702,measurement during day -365 through 0 days relative to index: Lipase [Enzymatic activity/volume] in Peritoneal fluid,702
3046000702,measurement during day -365 through 0 days relative to index: Immature reticulocytes/Reticulocytes.total in Blood,702
3046000704,measurement during day -30 through 0 days relative to index: Immature reticulocytes/Reticulocytes.total in Blood,704
3046326702,measurement during day -365 through 0 days relative to index: RBC casts [Presence] in Urine sediment by Light microscopy,702
3046326704,measurement during day -30 through 0 days relative to index: RBC casts [Presence] in Urine sediment by Light microscopy,704
3046619702,measurement during day -365 through 0 days relative to index: Specific gravity of Unspecified specimen,702
3046806702,measurement during day -365 through 0 days relative to index: Japanese hop IgE Ab RAST class [Presence] in Serum,702
3046861702,measurement during day -365 through 0 days relative to index: Legionella sp Ag [Presence] in Urine,702
3046861704,measurement during day -30 through 0 days relative to index: Legionella sp Ag [Presence] in Urine,704
3047117702,measurement during day -365 through 0 days relative to index: Bordetella pertussis DNA [Presence] in Nasopharynx by NAA with probe detection,702
3047117704,measurement during day -30 through 0 days relative to index: Bordetella pertussis DNA [Presence] in Nasopharynx by NAA with probe detection,704
3047169702,measurement during day -365 through 0 days relative to index: Lambda light chains.free [Mass/volume] in Serum or Plasma,702
3047169704,measurement during day -30 through 0 days relative to index: Lambda light chains.free [Mass/volume] in Serum or Plasma,704
3047181702,measurement during day -365 through 0 days relative to index: Lactate [Moles/volume] in Blood,702
3047181704,measurement during day -30 through 0 days relative to index: Lactate [Moles/volume] in Blood,704
3049858702,measurement during day -365 through 0 days relative to index: Reticulocyte mean volume [Entitic volume] in Reticulocytes,702
3049858704,measurement during day -30 through 0 days relative to index: Reticulocyte mean volume [Entitic volume] in Reticulocytes,704
3051825702,measurement during day -365 through 0 days relative to index: Creatinine [Mass/volume] in Blood,702
3051825704,measurement during day -30 through 0 days relative to index: Creatinine [Mass/volume] in Blood,704
4000938210,condition_era group during day -365 through 0 days relative to index: Bacterial sepsis,210
4003834210,condition_era group during day -365 through 0 days relative to index: Malignant immunoproliferative disease,210
4003834212,condition_era group during day -30 through 0 days relative to index: Malignant immunoproliferative disease,212
4004352210,condition_era group during day -365 through 0 days relative to index: Irritant contact dermatitis,210
4006788502,procedure_occurrence during day -365 through 0 days relative to index: Percutaneous transluminal coronary angioplasty,502
4006969210,condition_era group during day -365 through 0 days relative to index: Acute respiratory disease,210
4006969212,condition_era group during day -30 through 0 days relative to index: Acute respiratory disease,212
4008576210,condition_era group during day -365 through 0 days relative to index: Diabetes mellitus without complication,210
4008576212,condition_era group during day -30 through 0 days relative to index: Diabetes mellitus without complication,212
4008955602,device_exposure during day -365 through 0 days relative to index: Surgical saw,602
4009573210,condition_era group during day -365 through 0 days relative to index: Uninhibited neurogenic bladder,210
4012809502,procedure_occurrence during day -365 through 0 days relative to index: Dementia test,502
4013074210,condition_era group during day -365 through 0 days relative to index: Hemoglobin low,210
4013074212,condition_era group during day -30 through 0 days relative to index: Hemoglobin low,212
4013354502,procedure_occurrence during day -365 through 0 days relative to index: Insertion of endotracheal tube,502
4013354504,procedure_occurrence during day -30 through 0 days relative to index: Insertion of endotracheal tube,504
4013518210,condition_era group during day -365 through 0 days relative to index: RBC count abnormal,210
4013518212,condition_era group during day -30 through 0 days relative to index: RBC count abnormal,212
4013643210,condition_era group during day -365 through 0 days relative to index: Pulmonary arterial hypertension,210
4013643212,condition_era group during day -30 through 0 days relative to index: Pulmonary arterial hypertension,212
4013842210,condition_era group during day -365 through 0 days relative to index: RBC count low,210
4013842212,condition_era group during day -30 through 0 days relative to index: RBC count low,212
4018852210,condition_era group during day -365 through 0 days relative to index: Acute genitourinary disorder,210
4018852212,condition_era group during day -30 through 0 days relative to index: Acute genitourinary disorder,212
4022812210,condition_era group during day -365 through 0 days relative to index: Disease due to Plasmodiidae,210
4022812212,condition_era group during day -30 through 0 days relative to index: Disease due to Plasmodiidae,212
4023314210,condition_era group during day -365 through 0 days relative to index: Quantitative abnormality of granulocytes,210
4023314212,condition_era group during day -30 through 0 days relative to index: Quantitative abnormality of granulocytes,212
4023557602,device_exposure during day -365 through 0 days relative to index: Filter,602
4023986210,condition_era group during day -365 through 0 days relative to index: Organic mental disorder of unknown etiology,210
4023986212,condition_era group during day -30 through 0 days relative to index: Organic mental disorder of unknown etiology,212
4024561210,condition_era group during day -365 through 0 days relative to index: Pain in lower limb,210
4024561212,condition_era group during day -30 through 0 days relative to index: Pain in lower limb,212
4025327210,condition_era group during day -365 through 0 days relative to index: Chronic periodontitis complex,210
4027255210,condition_era group during day -365 through 0 days relative to index: Structural disorder of heart,210
4027255212,condition_era group during day -30 through 0 days relative to index: Structural disorder of heart,212
4027369210,condition_era group during day -365 through 0 days relative to index: Vascular disease of abdomen,210
4027369212,condition_era group during day -30 through 0 days relative to index: Vascular disease of abdomen,212
4027537210,condition_era group during day -365 through 0 days relative to index: Neuromuscular junction disorder,210
4027663210,condition_era group during day -365 through 0 days relative to index: Peptic ulcer,210
4028062210,condition_era group during day -365 through 0 days relative to index: Infectious disease of abdomen,210
4028062212,condition_era group during day -30 through 0 days relative to index: Infectious disease of abdomen,212
4028241210,condition_era group during day -365 through 0 days relative to index: Chronic disease of teeth AND/OR supporting structures,210
4028242210,condition_era group during day -365 through 0 days relative to index: Chronic duodenal ulcer,210
4028244210,condition_era group during day -365 through 0 days relative to index: Chronic disease of cardiovascular system,210
4028244212,condition_era group during day -30 through 0 days relative to index: Chronic disease of cardiovascular system,212
4028253210,condition_era group during day -365 through 0 days relative to index: Neoplasm of digestive system,210
4028253212,condition_era group during day -30 through 0 days relative to index: Neoplasm of digestive system,212
4028367210,condition_era group during day -365 through 0 days relative to index: Acute disease of cardiovascular system,210
4028367212,condition_era group during day -30 through 0 days relative to index: Acute disease of cardiovascular system,212
4028389210,condition_era group during day -365 through 0 days relative to index: Infectious disease of lung,210
4028876210,condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of lower respiratory tract,210
4028876212,condition_era group during day -30 through 0 days relative to index: Inflammatory disorder of lower respiratory tract,212
4028982502,procedure_occurrence during day -365 through 0 days relative to index: Transanal enema,502
4029305210,condition_era group during day -365 through 0 days relative to index: Hypercholesterolemia,210
4029305212,condition_era group during day -30 through 0 days relative to index: Hypercholesterolemia,212
4029423210,condition_era group during day -365 through 0 days relative to index: Hypoglycemic state due to diabetes mellitus,210
4029490210,condition_era group during day -365 through 0 days relative to index: Abnormal presence of protein,210
4029490212,condition_era group during day -30 through 0 days relative to index: Abnormal presence of protein,212
4029816210,condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of the cardiovascular system,210
4029816212,condition_era group during day -30 through 0 days relative to index: Inflammatory disorder of the cardiovascular system,212
4030518210,condition_era group during day -365 through 0 days relative to index: Renal impairment,210
4030518212,condition_era group during day -30 through 0 days relative to index: Renal impairment,212
4031211502,procedure_occurrence during day -365 through 0 days relative to index: Angiography of arteriovenous shunt,502
4032466210,condition_era group during day -365 through 0 days relative to index: Myringitis,210
4033864210,condition_era group during day -365 through 0 days relative to index: Livedoid vasculitis,210
4033864212,condition_era group during day -30 through 0 days relative to index: Livedoid vasculitis,212
4034964210,condition_era group during day -365 through 0 days relative to index: Abnormal metabolic state in diabetes mellitus,210
4034987210,condition_era group during day -365 through 0 days relative to index: Hypothalamic mass,210
4034987212,condition_era group during day -30 through 0 days relative to index: Hypothalamic mass,212
4035127210,condition_era group during day -365 through 0 days relative to index: Hypoadrenalism,210
4037672502,procedure_occurrence during day -365 through 0 days relative to index: Ultrasonography,502
4037760502,"procedure_occurrence during day -365 through 0 days relative to index: Laboratory procedure, review by pathologist",502
4037760504,"procedure_occurrence during day -30 through 0 days relative to index: Laboratory procedure, review by pathologist",504
4037780502,procedure_occurrence during day -365 through 0 days relative to index: Autotransfusion of red cells,502
4039956602,device_exposure during day -365 through 0 days relative to index: Electrode,602
4039956604,device_exposure during day -30 through 0 days relative to index: Electrode,604
4040556502,procedure_occurrence during day -365 through 0 days relative to index: Procedure on tooth,502
4041541210,condition_era group during day -365 through 0 days relative to index: Blood urate abnormal,210
4041541212,condition_era group during day -30 through 0 days relative to index: Blood urate abnormal,212
4041554210,condition_era group during day -365 through 0 days relative to index: Serum cholesterol raised,210
4041554212,condition_era group during day -30 through 0 days relative to index: Serum cholesterol raised,212
4041664210,condition_era group during day -365 through 0 days relative to index: Difficulty breathing,210
4041664212,condition_era group during day -30 through 0 days relative to index: Difficulty breathing,212
4042056210,condition_era group during day -365 through 0 days relative to index: Lipids abnormal,210
4042056212,condition_era group during day -30 through 0 days relative to index: Lipids abnormal,212
4042074210,condition_era group during day -365 through 0 days relative to index: Blood drug level high,210
4042074212,condition_era group during day -30 through 0 days relative to index: Blood drug level high,212
4042584210,condition_era group during day -365 through 0 days relative to index: Serum lipids high,210
4042584212,condition_era group during day -30 through 0 days relative to index: Serum lipids high,212
4043371210,condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of digestive tract,210
4043371212,condition_era group during day -30 through 0 days relative to index: Inflammatory disorder of digestive tract,212
4043671210,condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of upper respiratory tract,210
4043671212,condition_era group during day -30 through 0 days relative to index: Inflammatory disorder of upper respiratory tract,212
4044013210,condition_era group during day -365 through 0 days relative to index: Hematologic neoplasm,210
4044013212,condition_era group during day -30 through 0 days relative to index: Hematologic neoplasm,212
4044391210,condition_era group during day -365 through 0 days relative to index: Diabetic neuropathy,210
4044391212,condition_era group during day -30 through 0 days relative to index: Diabetic neuropathy,212
4044878210,condition_era group during day -365 through 0 days relative to index: Infection of ear,210
4046776602,device_exposure during day -365 through 0 days relative to index: Sterile absorbent dressing pad,602
4046776604,device_exposure during day -30 through 0 days relative to index: Sterile absorbent dressing pad,604
4047791210,condition_era group during day -365 through 0 days relative to index: Abnormal body temperature,210
4047791212,condition_era group during day -30 through 0 days relative to index: Abnormal body temperature,212
4048027210,condition_era group during day -365 through 0 days relative to index: Neuropathy associated with endocrine disorder,210
4048027212,condition_era group during day -30 through 0 days relative to index: Neuropathy associated with endocrine disorder,212
4048532602,device_exposure during day -365 through 0 days relative to index: Silk suture,602
4048532604,device_exposure during day -30 through 0 days relative to index: Silk suture,604
4048694502,procedure_occurrence during day -365 through 0 days relative to index: Electronic analysis of internal pacemaker system,502
4049402502,procedure_occurrence during day -365 through 0 days relative to index: Transthoracic cardiac pacing procedure,502
4049659210,condition_era group during day -365 through 0 days relative to index: Subcortical hemorrhage,210
4050747210,condition_era group during day -365 through 0 days relative to index: Fracture of upper limb,210
4050747212,condition_era group during day -30 through 0 days relative to index: Fracture of upper limb,212
4050863502,procedure_occurrence during day -365 through 0 days relative to index: Continuous hemodialysis,502
4051221210,condition_era group during day -365 through 0 days relative to index: Increased lipid,210
4051221212,condition_era group during day -30 through 0 days relative to index: Increased lipid,212
4051329502,procedure_occurrence during day -365 through 0 days relative to index: Continuous venovenous hemodialysis,502
4052079210,condition_era group during day -365 through 0 days relative to index: Chronic otitis media,210
4053584210,condition_era group during day -365 through 0 days relative to index: Superficial injury,210
4054405210,condition_era group during day -365 through 0 days relative to index: Neoplasm of skin of ear,210
4054405212,condition_era group during day -30 through 0 days relative to index: Neoplasm of skin of ear,212
4054501210,condition_era group during day -365 through 0 days relative to index: Neoplasm of trunk,210
4054501212,condition_era group during day -30 through 0 days relative to index: Neoplasm of trunk,212
4054503210,condition_era group during day -365 through 0 days relative to index: Neoplasm of intra-abdominal organs,210
4054503212,condition_era group during day -30 through 0 days relative to index: Neoplasm of intra-abdominal organs,212
4054835210,condition_era group during day -365 through 0 days relative to index: Neoplasm of head,210
4054835212,condition_era group during day -30 through 0 days relative to index: Neoplasm of head,212
4054839210,condition_era group during day -365 through 0 days relative to index: Neoplasm of pelvis,210
4054839212,condition_era group during day -30 through 0 days relative to index: Neoplasm of pelvis,212
4055620210,condition_era group during day -365 through 0 days relative to index: Impacted third molar tooth,210
4056478210,condition_era group during day -365 through 0 days relative to index: Chronic nephritic syndrome,210
4056478212,condition_era group during day -30 through 0 days relative to index: Chronic nephritic syndrome,212
4058165502,procedure_occurrence during day -365 through 0 days relative to index: Abdominal aortogram,502
4058335502,procedure_occurrence during day -365 through 0 days relative to index: CT of chest,502
4058335504,procedure_occurrence during day -30 through 0 days relative to index: CT of chest,504
4058388210,condition_era group during day -365 through 0 days relative to index: Hypertrophic scar,210
4058494210,condition_era group during day -365 through 0 days relative to index: Superficial injuries involving multiple body regions,210
4059290210,condition_era group during day -365 through 0 days relative to index: Steatosis of liver,210
4059452210,condition_era group during day -365 through 0 days relative to index: Glomerular disease,210
4059452212,condition_era group during day -30 through 0 days relative to index: Glomerular disease,212
4060499502,procedure_occurrence during day -365 through 0 days relative to index: CT of neck,502
4061009502,procedure_occurrence during day -365 through 0 days relative to index: CT of abdomen,502
4061009504,procedure_occurrence during day -30 through 0 days relative to index: CT of abdomen,504
4061010502,procedure_occurrence during day -365 through 0 days relative to index: Computerized diagnostic radiology,502
4061010504,procedure_occurrence during day -30 through 0 days relative to index: Computerized diagnostic radiology,504
4063381210,condition_era group during day -365 through 0 days relative to index: Chronic disease of respiratory system,210
4063381212,condition_era group during day -30 through 0 days relative to index: Chronic disease of respiratory system,212
4063911502,procedure_occurrence during day -365 through 0 days relative to index: Ocular fundus photography,502
4063911504,procedure_occurrence during day -30 through 0 days relative to index: Ocular fundus photography,504
4064036210,condition_era group during day -365 through 0 days relative to index: Generalized skin eruption caused by drug and medicament,210
4064077502,procedure_occurrence during day -365 through 0 days relative to index: Ocular muscle balance testing,502
4064377502,procedure_occurrence during day -365 through 0 days relative to index: Depression screening,502
4065263502,procedure_occurrence during day -365 through 0 days relative to index: Ambulatory blood pressure recording,502
4065263504,procedure_occurrence during day -30 through 0 days relative to index: Ambulatory blood pressure recording,504
4066819210,condition_era group during day -365 through 0 days relative to index: Localized skin eruption caused by drug and medicament,210
4066819212,condition_era group during day -30 through 0 days relative to index: Localized skin eruption caused by drug and medicament,212
4068155210,condition_era group during day -365 through 0 days relative to index: Atrial arrhythmia,210
4068155212,condition_era group during day -30 through 0 days relative to index: Atrial arrhythmia,212
4068261210,condition_era group during day -365 through 0 days relative to index: Bile duct proliferation,210
4068261212,condition_era group during day -30 through 0 days relative to index: Bile duct proliferation,212
4069340502,procedure_occurrence during day -365 through 0 days relative to index: T tube cholangiogram,502
4071011502,procedure_occurrence during day -365 through 0 days relative to index: Scaling of tooth,502
4071354502,procedure_occurrence during day -365 through 0 days relative to index: Open reduction of fracture with internal fixation,502
4073287210,condition_era group during day -365 through 0 days relative to index: Chronic infectious disease,210
4074035802,observation during day -365 through 0 days relative to index: Current drinker,802
4074035804,observation during day -30 through 0 days relative to index: Current drinker,804
4074176602,device_exposure during day -365 through 0 days relative to index: Abdominal binder,602
4075249210,condition_era group during day -365 through 0 days relative to index: Potassium disorder,210
4075249212,condition_era group during day -30 through 0 days relative to index: Potassium disorder,212
4075951502,procedure_occurrence during day -365 through 0 days relative to index: Intermittent urethral catheterization,502
4076762502,procedure_occurrence during day -365 through 0 days relative to index: Insertion of indwelling urethral catheter,502
4076762504,procedure_occurrence during day -30 through 0 days relative to index: Insertion of indwelling urethral catheter,504
4078199502,procedure_occurrence during day -365 through 0 days relative to index: Epidural anesthesia,502
4078925210,condition_era group during day -365 through 0 days relative to index: Pulmonary edema,210
4079147210,condition_era group during day -365 through 0 days relative to index: Lymphoproliferative disorder,210
4079147212,condition_era group during day -30 through 0 days relative to index: Lymphoproliferative disorder,212
4079750210,condition_era group during day -365 through 0 days relative to index: Osteoarthritis of knee,210
4079750212,condition_era group during day -30 through 0 days relative to index: Osteoarthritis of knee,212
4080011210,condition_era group during day -365 through 0 days relative to index: Organ dysfunction syndrome,210
4080146210,condition_era group during day -365 through 0 days relative to index: Autonomic neuropathy,210
4080169502,procedure_occurrence during day -365 through 0 days relative to index: Continuous ambulatory peritoneal dialysis,502
4080499502,procedure_occurrence during day -365 through 0 days relative to index: Dressing of wound,502
4080499504,procedure_occurrence during day -30 through 0 days relative to index: Dressing of wound,504
4080549502,procedure_occurrence during day -365 through 0 days relative to index: Lumbar puncture,502
4080549504,procedure_occurrence during day -30 through 0 days relative to index: Lumbar puncture,504
4080965502,procedure_occurrence during day -365 through 0 days relative to index: Extracorporeal circulation procedure,502
4081560502,procedure_occurrence during day -365 through 0 days relative to index: Plain X-ray of femur,502
4082346210,condition_era group during day -365 through 0 days relative to index: Soft tissue disorder due to diabetes mellitus,210
4082346212,condition_era group during day -30 through 0 days relative to index: Soft tissue disorder due to diabetes mellitus,212
4082696502,procedure_occurrence during day -365 through 0 days relative to index: CT of lower limb,502
4082870502,procedure_occurrence during day -365 through 0 days relative to index: US scan of prostate,502
4083666210,condition_era group during day -365 through 0 days relative to index: Inflamed tonsils,210
4083666212,condition_era group during day -30 through 0 days relative to index: Inflamed tonsils,212
4083787210,condition_era group during day -365 through 0 days relative to index: Skin or mucosa lesion,210
4083787212,condition_era group during day -30 through 0 days relative to index: Skin or mucosa lesion,212
4083964210,condition_era group during day -365 through 0 days relative to index: Soft tissue injury,210
4083964212,condition_era group during day -30 through 0 days relative to index: Soft tissue injury,212
4084229210,condition_era group during day -365 through 0 days relative to index: Primary gout,210
4084229212,condition_era group during day -30 through 0 days relative to index: Primary gout,212
4084966210,condition_era group during day -365 through 0 days relative to index: Candida infection of genital region,210
4085100210,condition_era group during day -365 through 0 days relative to index: Viral upper respiratory tract infection,210
4085100212,condition_era group during day -30 through 0 days relative to index: Viral upper respiratory tract infection,212
4085429502,procedure_occurrence during day -365 through 0 days relative to index: Cystoscopy,502
4086254502,procedure_occurrence during day -365 through 0 days relative to index: CT of upper limb,502
4086254504,procedure_occurrence during day -30 through 0 days relative to index: CT of upper limb,504
4086687210,condition_era group during day -365 through 0 days relative to index: Lump on extremities,210
4086687212,condition_era group during day -30 through 0 days relative to index: Lump on extremities,212
4087571502,procedure_occurrence during day -365 through 0 days relative to index: Injection of soft tissue,502
4087882502,procedure_occurrence during day -365 through 0 days relative to index: Provision of image intensifier,502
4088889502,procedure_occurrence during day -365 through 0 days relative to index: Individual psychotherapy,502
4089897210,condition_era group during day -365 through 0 days relative to index: Vascular degeneration,210
4089897212,condition_era group during day -30 through 0 days relative to index: Vascular degeneration,212
4090425210,condition_era group during day -365 through 0 days relative to index: Altered sensation of skin,210
4092747210,condition_era group during day -365 through 0 days relative to index: Cerebral degeneration presenting primarily with dementia,210
4092747212,condition_era group during day -30 through 0 days relative to index: Cerebral degeneration presenting primarily with dementia,212
4093950210,"condition_era group during day -365 through 0 days relative to index: Benign neoplasm of brain, supratentorial",210
4093950212,"condition_era group during day -30 through 0 days relative to index: Benign neoplasm of brain, supratentorial",212
4094061210,condition_era group during day -365 through 0 days relative to index: Infection by Ascomycetes,210
4094202210,condition_era group during day -365 through 0 days relative to index: Space-occupying lesion of nervous system,210
4094202212,condition_era group during day -30 through 0 days relative to index: Space-occupying lesion of nervous system,212
4098108602,device_exposure during day -365 through 0 days relative to index: Bone plate,602
4098508502,procedure_occurrence during day -365 through 0 days relative to index: 24 Hour ECG,502
4098611210,condition_era group during day -365 through 0 days relative to index: Hyperuricemia without signs of inflammatory arthritis and tophaceous disease,210
4098611212,condition_era group during day -30 through 0 days relative to index: Hyperuricemia without signs of inflammatory arthritis and tophaceous disease,212
4098784502,procedure_occurrence during day -365 through 0 days relative to index: Repetitive nerve stimulation,502
4098810502,procedure_occurrence during day -365 through 0 days relative to index: Prism cover test,502
4098814502,procedure_occurrence during day -365 through 0 days relative to index: Refraction assessment,502
4099350210,condition_era group during day -365 through 0 days relative to index: Infectious disease of genitourinary system,210
4099350212,condition_era group during day -30 through 0 days relative to index: Infectious disease of genitourinary system,212
4099373502,procedure_occurrence during day -365 through 0 days relative to index: Intraocular pressure test,502
4099373504,procedure_occurrence during day -30 through 0 days relative to index: Intraocular pressure test,504
4099521502,procedure_occurrence during day -365 through 0 days relative to index: Sensory nerve conduction study,502
4099539502,procedure_occurrence during day -365 through 0 days relative to index: Posterior segment fluorescein angiography,502
4099547502,procedure_occurrence during day -365 through 0 days relative to index: Binocular vision test,502
4100065210,condition_era group during day -365 through 0 days relative to index: Disease due to Coronaviridae,210
4100065212,condition_era group during day -30 through 0 days relative to index: Disease due to Coronaviridae,212
4101053210,condition_era group during day -365 through 0 days relative to index: Lesion of external ear,210
4101053212,condition_era group during day -30 through 0 days relative to index: Lesion of external ear,212
4101227210,condition_era group during day -365 through 0 days relative to index: Liver mass,210
4101343210,condition_era group during day -365 through 0 days relative to index: Functional finding of gastrointestinal tract,210
4101343212,condition_era group during day -30 through 0 days relative to index: Functional finding of gastrointestinal tract,212
4101918210,condition_era group during day -365 through 0 days relative to index: Noninflammatory disorder of the female genital organs,210
4102082502,procedure_occurrence during day -365 through 0 days relative to index: Motor nerve conduction studies,502
4102112210,condition_era group during day -365 through 0 days relative to index: Mass of ear structure,210
4102112212,condition_era group during day -30 through 0 days relative to index: Mass of ear structure,212
4102631210,condition_era group during day -365 through 0 days relative to index: Acute interstitial nephritis,210
4102631212,condition_era group during day -30 through 0 days relative to index: Acute interstitial nephritis,212
4102985210,condition_era group during day -365 through 0 days relative to index: Nonorganic insomnia,210
4103192210,condition_era group during day -365 through 0 days relative to index: Myocardial lesion,210
4103192212,condition_era group during day -30 through 0 days relative to index: Myocardial lesion,212
4103380502,procedure_occurrence during day -365 through 0 days relative to index: Endoscopic polypectomy of large intestine,502
4103380504,procedure_occurrence during day -30 through 0 days relative to index: Endoscopic polypectomy of large intestine,504
4103523502,procedure_occurrence during day -365 through 0 days relative to index: Laryngoscopy,502
4103523504,procedure_occurrence during day -30 through 0 days relative to index: Laryngoscopy,504
4103988210,condition_era group during day -365 through 0 days relative to index: Esophageal mass,210
4103988212,condition_era group during day -30 through 0 days relative to index: Esophageal mass,212
4103992210,condition_era group during day -365 through 0 days relative to index: Mass of stomach,210
4103992212,condition_era group during day -30 through 0 days relative to index: Mass of stomach,212
4104000210,condition_era group during day -365 through 0 days relative to index: Lesion of liver,210
4104155210,condition_era group during day -365 through 0 days relative to index: Lesion of bladder,210
4104155212,condition_era group during day -30 through 0 days relative to index: Lesion of bladder,212
4105206602,device_exposure during day -365 through 0 days relative to index: K-wire,602
4105219602,device_exposure during day -365 through 0 days relative to index: Locking screw,602
4105229602,device_exposure during day -365 through 0 days relative to index: Polypropylene suture,602
4105229604,device_exposure during day -30 through 0 days relative to index: Polypropylene suture,604
4105230602,device_exposure during day -365 through 0 days relative to index: Polyester suture,602
4105239602,device_exposure during day -365 through 0 days relative to index: Breathing circuit,602
4106141602,device_exposure during day -365 through 0 days relative to index: Oxygenator,602
4106158602,device_exposure during day -365 through 0 days relative to index: Self-expanding stent,602
4106203210,condition_era group during day -365 through 0 days relative to index: Gastrointestinal and digestive injury,210
4106220502,procedure_occurrence during day -365 through 0 days relative to index: Radiography of shoulder,502
4106220504,procedure_occurrence during day -30 through 0 days relative to index: Radiography of shoulder,504
4108467210,condition_era group during day -365 through 0 days relative to index: Burn of skin,210
4108467212,condition_era group during day -30 through 0 days relative to index: Burn of skin,212
4108838502,procedure_occurrence during day -365 through 0 days relative to index: Insertion of chronic ambulatory peritoneal dialysis catheter,502
4110480210,condition_era group during day -365 through 0 days relative to index: Pharyngolaryngitis,210
4110858210,"condition_era group during day -365 through 0 days relative to index: Tumor of soft tissue of head, face and neck",210
4110858212,"condition_era group during day -30 through 0 days relative to index: Tumor of soft tissue of head, face and neck",212
4111017210,condition_era group during day -365 through 0 days relative to index: Neoplasm of head and neck,210
4111017212,condition_era group during day -30 through 0 days relative to index: Neoplasm of head and neck,212
4111798210,condition_era group during day -365 through 0 days relative to index: Neoplasm of digestive organ,210
4111798212,condition_era group during day -30 through 0 days relative to index: Neoplasm of digestive organ,212
4112341210,condition_era group during day -365 through 0 days relative to index: Acute respiratory infections,210
4112341212,condition_era group during day -30 through 0 days relative to index: Acute respiratory infections,212
4112586210,"condition_era group during day -365 through 0 days relative to index: Tumor of ear, nose and throat",210
4112586212,"condition_era group during day -30 through 0 days relative to index: Tumor of ear, nose and throat",212
4112603210,"condition_era group during day -365 through 0 days relative to index: Tumor of esophagus, stomach and duodenum",210
4112603212,"condition_era group during day -30 through 0 days relative to index: Tumor of esophagus, stomach and duodenum",212
4112731210,condition_era group during day -365 through 0 days relative to index: Polyp of intestine,210
4112731212,condition_era group during day -30 through 0 days relative to index: Polyp of intestine,212
4112878210,condition_era group during day -365 through 0 days relative to index: Neoplasm of urinary tract proper,210
4112878212,condition_era group during day -30 through 0 days relative to index: Neoplasm of urinary tract proper,212
4113121210,"condition_era group during day -365 through 0 days relative to index: Benign tumor of ear, nose and throat",210
4113121212,"condition_era group during day -30 through 0 days relative to index: Benign tumor of ear, nose and throat",212
4113129210,"condition_era group during day -365 through 0 days relative to index: Benign tumor of soft tissue of head, face and neck",210
4113129212,"condition_era group during day -30 through 0 days relative to index: Benign tumor of soft tissue of head, face and neck",212
4113130210,condition_era group during day -365 through 0 days relative to index: Benign tumor of hypothalamus,210
4113130212,condition_era group during day -30 through 0 days relative to index: Benign tumor of hypothalamus,212
4113545210,condition_era group during day -365 through 0 days relative to index: Lesion of esophagus,210
4113545212,condition_era group during day -30 through 0 days relative to index: Lesion of esophagus,212
4113547210,condition_era group during day -365 through 0 days relative to index: Lesion of stomach,210
4113547212,condition_era group during day -30 through 0 days relative to index: Lesion of stomach,212
4113639210,condition_era group during day -365 through 0 days relative to index: Benign genital neoplasm,210
4113998210,condition_era group during day -365 through 0 days relative to index: Mass of urogenital structure,210
4113998212,condition_era group during day -30 through 0 days relative to index: Mass of urogenital structure,212
4114197210,condition_era group during day -365 through 0 days relative to index: Tumor of hypothalamus,210
4114197212,condition_era group during day -30 through 0 days relative to index: Tumor of hypothalamus,212
4114223210,condition_era group during day -365 through 0 days relative to index: Benign tumor of head and neck,210
4114223212,condition_era group during day -30 through 0 days relative to index: Benign tumor of head and neck,212
4114336210,condition_era group during day -365 through 0 days relative to index: Benign neoplasm of abdomen,210
4114341210,condition_era group during day -365 through 0 days relative to index: Secondary lymphangitic carcinoma,210
4114341212,condition_era group during day -30 through 0 days relative to index: Secondary lymphangitic carcinoma,212
4114506210,condition_era group during day -365 through 0 days relative to index: Infection - suppurative,210
4114585210,"condition_era group during day -365 through 0 days relative to index: Primary gonarthrosis, bilateral",210
4114585212,"condition_era group during day -30 through 0 days relative to index: Primary gonarthrosis, bilateral",212
4115105210,condition_era group during day -365 through 0 days relative to index: Mass of respiratory structure,210
4115105212,condition_era group during day -30 through 0 days relative to index: Mass of respiratory structure,212
4115106210,condition_era group during day -365 through 0 days relative to index: Mass of digestive structure,210
4115106212,condition_era group during day -30 through 0 days relative to index: Mass of digestive structure,212
4115107210,condition_era group during day -365 through 0 days relative to index: Mass of female genital structure,210
4115408210,condition_era group during day -365 through 0 days relative to index: Pain of cardiovascular structure,210
4115408212,condition_era group during day -30 through 0 days relative to index: Pain of cardiovascular structure,212
4116092210,condition_era group during day -365 through 0 days relative to index: Intracranial tumor,210
4116092212,condition_era group during day -30 through 0 days relative to index: Intracranial tumor,212
4116208210,condition_era group during day -365 through 0 days relative to index: Choroidal and/or chorioretinal disorder,210
4116208212,condition_era group during day -30 through 0 days relative to index: Choroidal and/or chorioretinal disorder,212
4116238210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of digestive organ,210
4116238212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of digestive organ,212
4116811210,condition_era group during day -365 through 0 days relative to index: Pain of truncal structure,210
4116811212,condition_era group during day -30 through 0 days relative to index: Pain of truncal structure,212
4116962210,condition_era group during day -365 through 0 days relative to index: Mass of lymphoreticular structure,210
4116962212,condition_era group during day -30 through 0 days relative to index: Mass of lymphoreticular structure,212
4116963210,condition_era group during day -365 through 0 days relative to index: Mass of urinary system structure,210
4116963212,condition_era group during day -30 through 0 days relative to index: Mass of urinary system structure,212
4116964210,condition_era group during day -365 through 0 days relative to index: Mass of musculoskeletal structure,210
4116964212,condition_era group during day -30 through 0 days relative to index: Mass of musculoskeletal structure,212
4116975502,procedure_occurrence during day -365 through 0 days relative to index: Arm venogram,502
4117779210,condition_era group during day -365 through 0 days relative to index: Peripheral nerve disease,210
4117779212,condition_era group during day -30 through 0 days relative to index: Peripheral nerve disease,212
4118291210,condition_era group during day -365 through 0 days relative to index: Tympanic membrane inflamed,210
4119135210,condition_era group during day -365 through 0 days relative to index: Phagocytic cell dysfunction,210
4119135212,condition_era group during day -30 through 0 days relative to index: Phagocytic cell dysfunction,212
4120120502,procedure_occurrence during day -365 through 0 days relative to index: Hemodialysis,502
4120120504,procedure_occurrence during day -30 through 0 days relative to index: Hemodialysis,504
4121123210,condition_era group during day -365 through 0 days relative to index: Hemophagocytic lymphohistiocytosis,210
4121123212,condition_era group during day -30 through 0 days relative to index: Hemophagocytic lymphohistiocytosis,212
4121285210,condition_era group during day -365 through 0 days relative to index: Phagocytic cell defect,210
4121285212,condition_era group during day -30 through 0 days relative to index: Phagocytic cell defect,212
4121560602,device_exposure during day -365 through 0 days relative to index: Y connector,602
4122115210,condition_era group during day -365 through 0 days relative to index: Tooth disorder,210
4123726210,condition_era group during day -365 through 0 days relative to index: Impacted tooth,210
4124141502,procedure_occurrence during day -365 through 0 days relative to index: Continuous suction drainage,502
4124293602,device_exposure during day -365 through 0 days relative to index: Venous cannula,602
4124393602,device_exposure during day -365 through 0 days relative to index: Balloon dilatation catheter,602
4125637210,condition_era group during day -365 through 0 days relative to index: Hemolytic erythrophagocytic syndrome,210
4125637212,condition_era group during day -30 through 0 days relative to index: Hemolytic erythrophagocytic syndrome,212
4125811210,condition_era group during day -365 through 0 days relative to index: Combined phagocytic defect,210
4125811212,condition_era group during day -30 through 0 days relative to index: Combined phagocytic defect,212
4125937210,condition_era group during day -365 through 0 days relative to index: Myalgia/myositis - multiple,210
4126305210,condition_era group during day -365 through 0 days relative to index: Acute renal impairment,210
4126305212,condition_era group during day -30 through 0 days relative to index: Acute renal impairment,212
4127688210,condition_era group during day -365 through 0 days relative to index: Lesion of uterus,210
4128492210,condition_era group during day -365 through 0 days relative to index: Lesion of breast,210
4129540210,condition_era group during day -365 through 0 days relative to index: Pituitary mass,210
4129540212,condition_era group during day -30 through 0 days relative to index: Pituitary mass,212
4129642602,device_exposure during day -365 through 0 days relative to index: Closed-circuit suction catheter,602
4129880210,condition_era group during day -365 through 0 days relative to index: Neoplasm of sigmoid colon,210
4129880212,condition_era group during day -30 through 0 days relative to index: Neoplasm of sigmoid colon,212
4129884210,condition_era group during day -365 through 0 days relative to index: Neoplasm of biliary tract,210
4129884212,condition_era group during day -30 through 0 days relative to index: Neoplasm of biliary tract,212
4129886210,condition_era group during day -365 through 0 days relative to index: Neoplasm of pancreas,210
4129886212,condition_era group during day -30 through 0 days relative to index: Neoplasm of pancreas,212
4129891210,condition_era group during day -365 through 0 days relative to index: Neoplasm of retroperitoneum,210
4129891212,condition_era group during day -30 through 0 days relative to index: Neoplasm of retroperitoneum,212
4129956602,device_exposure during day -365 through 0 days relative to index: Hemoconcentrator,602
4130037210,condition_era group during day -365 through 0 days relative to index: Neoplasm of cerebrum,210
4130037212,condition_era group during day -30 through 0 days relative to index: Neoplasm of cerebrum,212
4130061210,condition_era group during day -365 through 0 days relative to index: Neoplasm of pituitary gland,210
4130061212,condition_era group during day -30 through 0 days relative to index: Neoplasm of pituitary gland,212
4130197210,condition_era group during day -365 through 0 days relative to index: Histiocytic syndrome,210
4130197212,condition_era group during day -30 through 0 days relative to index: Histiocytic syndrome,212
4130200210,condition_era group during day -365 through 0 days relative to index: Immunoproliferative disorder,210
4130200212,condition_era group during day -30 through 0 days relative to index: Immunoproliferative disorder,212
4130373210,condition_era group during day -365 through 0 days relative to index: Neoplasm of gastrointestinal tract,210
4130373212,condition_era group during day -30 through 0 days relative to index: Neoplasm of gastrointestinal tract,212
4130514210,condition_era group during day -365 through 0 days relative to index: Neoplasm of large intestine,210
4130514212,condition_era group during day -30 through 0 days relative to index: Neoplasm of large intestine,212
4130518210,condition_era group during day -365 through 0 days relative to index: Neoplasm of liver,210
4130839210,condition_era group during day -365 through 0 days relative to index: Neoplasm of lymph node,210
4130839212,condition_era group during day -30 through 0 days relative to index: Neoplasm of lymph node,212
4130990210,condition_era group during day -365 through 0 days relative to index: Neoplasm of esophagus,210
4130990212,condition_era group during day -30 through 0 days relative to index: Neoplasm of esophagus,212
4130995210,condition_era group during day -365 through 0 days relative to index: Neoplasm of colon,210
4130995212,condition_era group during day -30 through 0 days relative to index: Neoplasm of colon,212
4131007210,condition_era group during day -365 through 0 days relative to index: Neoplasm of uterus,210
4131101210,condition_era group during day -365 through 0 days relative to index: Excessive cerumen in ear canal,210
4131422210,condition_era group during day -365 through 0 days relative to index: Neoplasm of intra-abdominal lymph nodes,210
4131422212,condition_era group during day -30 through 0 days relative to index: Neoplasm of intra-abdominal lymph nodes,212
4131598210,condition_era group during day -365 through 0 days relative to index: Neoplasm of intestinal tract,210
4131598212,condition_era group during day -30 through 0 days relative to index: Neoplasm of intestinal tract,212
4131619210,condition_era group during day -365 through 0 days relative to index: Neoplasm of extrahepatic bile ducts,210
4131619212,condition_era group during day -30 through 0 days relative to index: Neoplasm of extrahepatic bile ducts,212
4131749210,condition_era group during day -365 through 0 days relative to index: Neoplasm of lateral wall of urinary bladder,210
4131749212,condition_era group during day -30 through 0 days relative to index: Neoplasm of lateral wall of urinary bladder,212
4131756210,condition_era group during day -365 through 0 days relative to index: Neoplasm of female genital organ,210
4131770210,condition_era group during day -365 through 0 days relative to index: Neoplasm of central nervous system,210
4131770212,condition_era group during day -30 through 0 days relative to index: Neoplasm of central nervous system,212
4132088210,condition_era group during day -365 through 0 days relative to index: Acute heart disease,210
4132088212,condition_era group during day -30 through 0 days relative to index: Acute heart disease,212
4132090210,condition_era group during day -365 through 0 days relative to index: Acute metabolic disorder,210
4132090212,condition_era group during day -30 through 0 days relative to index: Acute metabolic disorder,212
4132552210,condition_era group during day -365 through 0 days relative to index: Acute digestive system disorder,210
4132926210,condition_era group during day -365 through 0 days relative to index: Pain finding at anatomical site,210
4132926212,condition_era group during day -30 through 0 days relative to index: Pain finding at anatomical site,212
4133611210,condition_era group during day -365 through 0 days relative to index: Traumatic AND/OR non-traumatic brain injury,210
4133611212,condition_era group during day -30 through 0 days relative to index: Traumatic AND/OR non-traumatic brain injury,212
4133974210,condition_era group during day -365 through 0 days relative to index: Neoplasm of abdomen,210
4133974212,condition_era group during day -30 through 0 days relative to index: Neoplasm of abdomen,212
4134133210,condition_era group during day -365 through 0 days relative to index: Chronic disease of musculoskeletal system,210
4134133212,condition_era group during day -30 through 0 days relative to index: Chronic disease of musculoskeletal system,212
4134146210,condition_era group during day -365 through 0 days relative to index: Chronic peptic ulcer,210
4134294210,condition_era group during day -365 through 0 days relative to index: Acute inflammatory disease,210
4134294212,condition_era group during day -30 through 0 days relative to index: Acute inflammatory disease,212
4134440210,condition_era group during day -365 through 0 days relative to index: Visual system disorder,210
4134440212,condition_era group during day -30 through 0 days relative to index: Visual system disorder,212
4134586210,condition_era group during day -365 through 0 days relative to index: Chronic heart disease,210
4134586212,condition_era group during day -30 through 0 days relative to index: Chronic heart disease,212
4134593210,condition_era group during day -365 through 0 days relative to index: Chronic digestive system disorder,210
4134593212,condition_era group during day -30 through 0 days relative to index: Chronic digestive system disorder,212
4134595210,condition_era group during day -365 through 0 days relative to index: Chronic disease of genitourinary system,210
4134595212,condition_era group during day -30 through 0 days relative to index: Chronic disease of genitourinary system,212
4134597210,condition_era group during day -365 through 0 days relative to index: Chronic disease of ear,210
4134887210,condition_era group during day -365 through 0 days relative to index: Infectious disease of digestive tract,210
4135471502,procedure_occurrence during day -365 through 0 days relative to index: Radiography of kidney-ureter-bladder,502
4137220210,condition_era group during day -365 through 0 days relative to index: Diabetic glomerulonephritis,210
4137220212,condition_era group during day -30 through 0 days relative to index: Diabetic glomerulonephritis,212
4137275210,condition_era group during day -365 through 0 days relative to index: Vasculitis,210
4137275212,condition_era group during day -30 through 0 days relative to index: Vasculitis,212
4137468210,condition_era group during day -365 through 0 days relative to index: Abscess of skin and/or subcutaneous tissue,210
4137859502,procedure_occurrence during day -365 through 0 days relative to index: Transfusion of leucoreduced red blood cells,502
4137859504,procedure_occurrence during day -30 through 0 days relative to index: Transfusion of leucoreduced red blood cells,504
4139745502,procedure_occurrence during day -365 through 0 days relative to index: CT of abdomen with contrast,502
4140920502,procedure_occurrence during day -365 through 0 days relative to index: Fiberoptic endoscopic submucosal resection of lesion of colon,502
4140920504,procedure_occurrence during day -30 through 0 days relative to index: Fiberoptic endoscopic submucosal resection of lesion of colon,504
4142645502,procedure_occurrence during day -365 through 0 days relative to index: Coronary angiography,502
4143250210,condition_era group during day -365 through 0 days relative to index: Mass of colon,210
4143250212,condition_era group during day -30 through 0 days relative to index: Mass of colon,212
4143397210,condition_era group during day -365 through 0 days relative to index: Mass of pancreas,210
4143397212,condition_era group during day -30 through 0 days relative to index: Mass of pancreas,212
4143501502,procedure_occurrence during day -365 through 0 days relative to index: Femoral arteriography,502
4143660502,procedure_occurrence during day -365 through 0 days relative to index: Suture of skin of head or neck,502
4144111210,condition_era group during day -365 through 0 days relative to index: Gastroesophageal reflux disease without esophagitis,210
4144111212,condition_era group during day -30 through 0 days relative to index: Gastroesophageal reflux disease without esophagitis,212
4144452502,procedure_occurrence during day -365 through 0 days relative to index: Optical coherence tomography of eye region,502
4145739502,procedure_occurrence during day -365 through 0 days relative to index: Computerized axial tomography of brain,502
4145786502,procedure_occurrence during day -365 through 0 days relative to index: Endotracheal anesthesia,502
4146103210,condition_era group during day -365 through 0 days relative to index: Degeneration of macula and posterior pole,210
4147498210,"condition_era group during day -365 through 0 days relative to index: Encephalitis, myelitis and encephalomyelitis",210
4147498212,"condition_era group during day -30 through 0 days relative to index: Encephalitis, myelitis and encephalomyelitis",212
4147761210,condition_era group during day -365 through 0 days relative to index: Hyperuricemia,210
4147761212,condition_era group during day -30 through 0 days relative to index: Hyperuricemia,212
4148593210,condition_era group during day -365 through 0 days relative to index: Blood urate raised,210
4148593212,condition_era group during day -30 through 0 days relative to index: Blood urate raised,212
4150129210,condition_era group during day -365 through 0 days relative to index: Musculoskeletal pain,210
4150852210,condition_era group during day -365 through 0 days relative to index: Finding related to orientation,210
4151199210,condition_era group during day -365 through 0 days relative to index: Clavicle injury,210
4151199212,condition_era group during day -30 through 0 days relative to index: Clavicle injury,212
4154162210,condition_era group during day -365 through 0 days relative to index: Head and neck injury,210
4154290210,condition_era group during day -365 through 0 days relative to index: Paroxysmal atrial fibrillation,210
4154290212,condition_era group during day -30 through 0 days relative to index: Paroxysmal atrial fibrillation,212
4154630210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of genitourinary organ,210
4154630212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of genitourinary organ,212
4154739210,condition_era group during day -365 through 0 days relative to index: Bone injury,210
4154739212,condition_era group during day -30 through 0 days relative to index: Bone injury,212
4155151502,procedure_occurrence during day -365 through 0 days relative to index: Oxygen administration by nasal cannula,502
4155902210,condition_era group during day -365 through 0 days relative to index: Wax in ear canal,210
4159136210,condition_era group during day -365 through 0 days relative to index: Renal hematuria,210
4159136212,condition_era group during day -30 through 0 days relative to index: Renal hematuria,212
4159813602,device_exposure during day -365 through 0 days relative to index: Guide wire,602
4159963210,condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of genitourinary system,210
4159963212,condition_era group during day -30 through 0 days relative to index: Inflammatory disorder of genitourinary system,212
4160628602,device_exposure during day -365 through 0 days relative to index: Catheter sheath,602
4161193210,condition_era group during day -365 through 0 days relative to index: Disease due to Gram-positive bacteria,210
4161814602,device_exposure during day -365 through 0 days relative to index: Peripherally inserted central catheter,602
4162282210,condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of the respiratory system,210
4162282212,condition_era group during day -30 through 0 days relative to index: Inflammatory disorder of the respiratory system,212
4162382502,procedure_occurrence during day -365 through 0 days relative to index: Post-anesthesia assessment,502
4162701210,condition_era group during day -365 through 0 days relative to index: Abducens nerve disorder,210
4163872502,procedure_occurrence during day -365 through 0 days relative to index: Plain chest X-ray,502
4163872504,procedure_occurrence during day -30 through 0 days relative to index: Plain chest X-ray,504
4164337210,condition_era group during day -365 through 0 days relative to index: Polyp of large intestine,210
4164337212,condition_era group during day -30 through 0 days relative to index: Polyp of large intestine,212
4164894502,procedure_occurrence during day -365 through 0 days relative to index: Radiography of thoracic spine,502
4165112210,condition_era group during day -365 through 0 days relative to index: Bronchiolitis,210
4165112212,condition_era group during day -30 through 0 days relative to index: Bronchiolitis,212
4167217802,observation during day -365 through 0 days relative to index: Family history of clinical finding,802
4168666210,condition_era group during day -365 through 0 days relative to index: Cerebral degeneration,210
4168666212,condition_era group during day -30 through 0 days relative to index: Cerebral degeneration,212
4169287210,condition_era group during day -365 through 0 days relative to index: Itching of skin,210
4169598210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of urinary system,210
4169598212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of urinary system,212
4169747210,condition_era group during day -365 through 0 days relative to index: Increased uric acid level,210
4169747212,condition_era group during day -30 through 0 days relative to index: Increased uric acid level,212
4170143210,condition_era group during day -365 through 0 days relative to index: Respiratory tract infection,210
4170143212,condition_era group during day -30 through 0 days relative to index: Respiratory tract infection,212
4171710502,procedure_occurrence during day -365 through 0 days relative to index: Diagnostic radiography of skull,502
4172522210,condition_era group during day -365 through 0 days relative to index: Tumor of external ear,210
4172522212,condition_era group during day -30 through 0 days relative to index: Tumor of external ear,212
4172654502,procedure_occurrence during day -365 through 0 days relative to index: Recreational therapy,502
4173027210,condition_era group during day -365 through 0 days relative to index: Acute laryngitis and/or tracheitis,210
4173658210,condition_era group during day -365 through 0 days relative to index: Benign cerebral tumor,210
4173658212,condition_era group during day -30 through 0 days relative to index: Benign cerebral tumor,212
4173938210,condition_era group during day -365 through 0 days relative to index: Mass lesion of brain,210
4173938212,condition_era group during day -30 through 0 days relative to index: Mass lesion of brain,212
4173971210,condition_era group during day -365 through 0 days relative to index: Lymphoreticular tumor,210
4173971212,condition_era group during day -30 through 0 days relative to index: Lymphoreticular tumor,212
4174262210,condition_era group during day -365 through 0 days relative to index: Polyneuropathy,210
4174262212,condition_era group during day -30 through 0 days relative to index: Polyneuropathy,212
4174977210,condition_era group during day -365 through 0 days relative to index: Retinopathy due to diabetes mellitus,210
4174977212,condition_era group during day -30 through 0 days relative to index: Retinopathy due to diabetes mellitus,212
4175198210,condition_era group during day -365 through 0 days relative to index: Benign tumor of external ear,210
4175198212,condition_era group during day -30 through 0 days relative to index: Benign tumor of external ear,212
4175297210,condition_era group during day -365 through 0 days relative to index: Lower respiratory tract infection,210
4175440210,condition_era group during day -365 through 0 days relative to index: Diabetic autonomic neuropathy,210
4176880502,procedure_occurrence during day -365 through 0 days relative to index: Radiography of hand,502
4176880504,procedure_occurrence during day -30 through 0 days relative to index: Radiography of hand,504
4176944210,condition_era group during day -365 through 0 days relative to index: Infective disorder of head,210
4176946210,condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of musculoskeletal system,210
4176946212,condition_era group during day -30 through 0 days relative to index: Inflammatory disorder of musculoskeletal system,212
4177067210,condition_era group during day -365 through 0 days relative to index: Mass of urinary bladder,210
4177067212,condition_era group during day -30 through 0 days relative to index: Mass of urinary bladder,212
4177105210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of extrahepatic bile duct,210
4177105212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of extrahepatic bile duct,212
4177206210,condition_era group during day -365 through 0 days relative to index: Tubulointerstitial nephritis,210
4177206212,condition_era group during day -30 through 0 days relative to index: Tubulointerstitial nephritis,212
4177236210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of pelvis,210
4177236212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of pelvis,212
4177483210,condition_era group during day -365 through 0 days relative to index: Lower limb nerve lesion,210
4177483212,condition_era group during day -30 through 0 days relative to index: Lower limb nerve lesion,212
4178367502,procedure_occurrence during day -365 through 0 days relative to index: Radiographic imaging procedure,502
4178680210,condition_era group during day -365 through 0 days relative to index: Degenerative disorder of musculoskeletal system,210
4178680212,condition_era group during day -30 through 0 days relative to index: Degenerative disorder of musculoskeletal system,212
4178818210,condition_era group during day -365 through 0 days relative to index: Inflammation of specific body systems,210
4178818212,condition_era group during day -30 through 0 days relative to index: Inflammation of specific body systems,212
4178904210,condition_era group during day -365 through 0 days relative to index: Body temperature above reference range,210
4178904212,condition_era group during day -30 through 0 days relative to index: Body temperature above reference range,212
4178956210,condition_era group during day -365 through 0 days relative to index: Vascular disorder of extremity,210
4178956212,condition_era group during day -30 through 0 days relative to index: Vascular disorder of extremity,212
4179141210,condition_era group during day -365 through 0 days relative to index: Lesion of joint,210
4179141212,condition_era group during day -30 through 0 days relative to index: Lesion of joint,212
4179206602,device_exposure during day -365 through 0 days relative to index: Central venous catheter,602
4179206604,device_exposure during day -30 through 0 days relative to index: Central venous catheter,604
4179720210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of gastrointestinal tract,210
4179720212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of gastrointestinal tract,212
4179875210,condition_era group during day -365 through 0 days relative to index: Antibody-mediated activation and inactivation,210
4179922210,condition_era group during day -365 through 0 days relative to index: Cytopenia,210
4179922212,condition_era group during day -30 through 0 days relative to index: Cytopenia,212
4180170210,condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of the respiratory tract,210
4180170212,condition_era group during day -30 through 0 days relative to index: Inflammatory disorder of the respiratory tract,212
4180790210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of colon,210
4180790212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of colon,212
4180793210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of pancreas,210
4180793212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of pancreas,212
4180794210,condition_era group during day -365 through 0 days relative to index: Malignant retroperitoneal tumor,210
4180794212,condition_era group during day -30 through 0 days relative to index: Malignant retroperitoneal tumor,212
4180915210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of urinary tract proper,210
4180915212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of urinary tract proper,212
4181062210,condition_era group during day -365 through 0 days relative to index: Inflammation of skin and/or subcutaneous tissue,210
4181062212,condition_era group during day -30 through 0 days relative to index: Inflammation of skin and/or subcutaneous tissue,212
4181063210,condition_era group during day -365 through 0 days relative to index: Inflammation of specific body organs,210
4181063212,condition_era group during day -30 through 0 days relative to index: Inflammation of specific body organs,212
4181064210,condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of extremity,210
4181064212,condition_era group during day -30 through 0 days relative to index: Inflammatory disorder of extremity,212
4181187210,condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of head,210
4181187212,condition_era group during day -30 through 0 days relative to index: Inflammatory disorder of head,212
4181188210,condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of immune system,210
4181188212,condition_era group during day -30 through 0 days relative to index: Inflammatory disorder of immune system,212
4181200210,condition_era group during day -365 through 0 days relative to index: Neoplasm of ear,210
4181200212,condition_era group during day -30 through 0 days relative to index: Neoplasm of ear,212
4181343210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of esophagus,210
4181343212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of esophagus,212
4181345210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of biliary tract,210
4181345212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of biliary tract,212
4181438502,procedure_occurrence during day -365 through 0 days relative to index: Radiography of foot,502
4181438504,procedure_occurrence during day -30 through 0 days relative to index: Radiography of foot,504
4181583210,condition_era group during day -365 through 0 days relative to index: Upper respiratory infection,210
4181583212,condition_era group during day -30 through 0 days relative to index: Upper respiratory infection,212
4181778502,procedure_occurrence during day -365 through 0 days relative to index: Intravenous injection,502
4181778504,procedure_occurrence during day -30 through 0 days relative to index: Intravenous injection,504
4182007210,condition_era group during day -365 through 0 days relative to index: Inflamed joint,210
4182007212,condition_era group during day -30 through 0 days relative to index: Inflamed joint,212
4182210210,condition_era group during day -365 through 0 days relative to index: Dementia,210
4182210212,condition_era group during day -30 through 0 days relative to index: Dementia,212
4182711210,condition_era group during day -365 through 0 days relative to index: Vasculitis of the skin,210
4182711212,condition_era group during day -30 through 0 days relative to index: Vasculitis of the skin,212
4182861502,procedure_occurrence during day -365 through 0 days relative to index: Measurement of central venous pressure,502
4182861504,procedure_occurrence during day -30 through 0 days relative to index: Measurement of central venous pressure,504
4183452210,condition_era group during day -365 through 0 days relative to index: Otitis,210
4183953210,condition_era group during day -365 through 0 days relative to index: Mass of skin,210
4183953212,condition_era group during day -30 through 0 days relative to index: Mass of skin,212
4184824602,device_exposure during day -365 through 0 days relative to index: Urinary collection bag,602
4184824604,device_exposure during day -30 through 0 days relative to index: Urinary collection bag,604
4185607210,condition_era group during day -365 through 0 days relative to index: Embolism,210
4185607212,condition_era group during day -30 through 0 days relative to index: Embolism,212
4185932210,condition_era group during day -365 through 0 days relative to index: Ischemic heart disease,210
4185932212,condition_era group during day -30 through 0 days relative to index: Ischemic heart disease,212
4186167210,condition_era group during day -365 through 0 days relative to index: Lesion of clavicle,210
4186167212,condition_era group during day -30 through 0 days relative to index: Lesion of clavicle,212
4187078502,procedure_occurrence during day -365 through 0 days relative to index: Electrocardiographic monitoring,502
4187078504,procedure_occurrence during day -30 through 0 days relative to index: Electrocardiographic monitoring,504
4188971210,condition_era group during day -365 through 0 days relative to index: Chronic disease of immune structure,210
4188971212,condition_era group during day -30 through 0 days relative to index: Chronic disease of immune structure,212
4189517502,procedure_occurrence during day -365 through 0 days relative to index: Ultrasonic guidance procedure,502
4189517504,procedure_occurrence during day -30 through 0 days relative to index: Ultrasonic guidance procedure,504
4189531210,condition_era group during day -365 through 0 days relative to index: Acute nephritis,210
4189531212,condition_era group during day -30 through 0 days relative to index: Acute nephritis,212
4189640210,condition_era group during day -365 through 0 days relative to index: Neoplasm of hematopoietic cell type,210
4189640212,condition_era group during day -30 through 0 days relative to index: Neoplasm of hematopoietic cell type,212
4189855210,condition_era group during day -365 through 0 days relative to index: Chronic arthropathy,210
4189855212,condition_era group during day -30 through 0 days relative to index: Chronic arthropathy,212
4190185210,condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of digestive system,210
4190185212,condition_era group during day -30 through 0 days relative to index: Inflammatory disorder of digestive system,212
4190307210,condition_era group during day -365 through 0 days relative to index: Inflammatory disease of the central nervous system,210
4190307212,condition_era group during day -30 through 0 days relative to index: Inflammatory disease of the central nervous system,212
4190642210,condition_era group during day -365 through 0 days relative to index: Plasma cell myeloma/plasmacytoma,210
4190642212,condition_era group during day -30 through 0 days relative to index: Plasma cell myeloma/plasmacytoma,212
4190990502,procedure_occurrence during day -365 through 0 days relative to index: Neurological mental status determination,502
4193166210,condition_era group during day -365 through 0 days relative to index: Bacterial gastrointestinal infectious disease,210
4193169210,condition_era group during day -365 through 0 days relative to index: Viral respiratory infection,210
4193169212,condition_era group during day -30 through 0 days relative to index: Viral respiratory infection,212
4193588210,condition_era group during day -365 through 0 days relative to index: Moderate chronic obstructive pulmonary disease,210
4193588212,condition_era group during day -30 through 0 days relative to index: Moderate chronic obstructive pulmonary disease,212
4193704210,condition_era group during day -365 through 0 days relative to index: Type 2 diabetes mellitus without complication,210
4193704212,condition_era group during day -30 through 0 days relative to index: Type 2 diabetes mellitus without complication,212
4193869210,condition_era group during day -365 through 0 days relative to index: Bacterial intestinal infectious disease,210
4193874210,condition_era group during day -365 through 0 days relative to index: Bacterial infection of the digestive tract,210
4193961602,device_exposure during day -365 through 0 days relative to index: Elastic conforming bandage,602
4193988210,condition_era group during day -365 through 0 days relative to index: Genital infection,210
4193990210,condition_era group during day -365 through 0 days relative to index: Infection of digestive system,210
4193990212,condition_era group during day -30 through 0 days relative to index: Infection of digestive system,212
4194360602,device_exposure during day -365 through 0 days relative to index: Fogarty catheter,602
4194610210,condition_era group during day -365 through 0 days relative to index: Trunk arterial embolus,210
4194610212,condition_era group during day -30 through 0 days relative to index: Trunk arterial embolus,212
4194863502,procedure_occurrence during day -365 through 0 days relative to index: External iliac arteriography,502
4196152502,procedure_occurrence during day -365 through 0 days relative to index: CT of neck with contrast,502
4196378502,procedure_occurrence during day -365 through 0 days relative to index: Flexible fiberoptic sigmoidoscopy,502
4196378504,procedure_occurrence during day -30 through 0 days relative to index: Flexible fiberoptic sigmoidoscopy,504
4197217502,procedure_occurrence during day -365 through 0 days relative to index: Arteriovenous anastomosis for renal dialysis,502
4197217504,procedure_occurrence during day -30 through 0 days relative to index: Arteriovenous anastomosis for renal dialysis,504
4198381210,condition_era group during day -365 through 0 days relative to index: Ulcer of duodenum,210
4198451502,procedure_occurrence during day -365 through 0 days relative to index: Contrast radiography via drain,502
4199409210,condition_era group during day -365 through 0 days relative to index: Edema of trunk,210
4200516210,condition_era group during day -365 through 0 days relative to index: Lesion of brain,210
4200516212,condition_era group during day -30 through 0 days relative to index: Lesion of brain,212
4200726210,condition_era group during day -365 through 0 days relative to index: Qualitative abnormality of granulocyte,210
4200726212,condition_era group during day -30 through 0 days relative to index: Qualitative abnormality of granulocyte,212
4201554210,condition_era group during day -365 through 0 days relative to index: Lesion of eye structure,210
4201554212,condition_era group during day -30 through 0 days relative to index: Lesion of eye structure,212
4201612502,procedure_occurrence during day -365 through 0 days relative to index: Ophthalmoscopy,502
4201612504,procedure_occurrence during day -30 through 0 days relative to index: Ophthalmoscopy,504
4203097210,condition_era group during day -365 through 0 days relative to index: Mass of knee,210
4203097212,condition_era group during day -30 through 0 days relative to index: Mass of knee,212
4204138502,procedure_occurrence during day -365 through 0 days relative to index: Warming subject using infusion of warm intravenous fluid,502
4204187210,condition_era group during day -365 through 0 days relative to index: Renal mass,210
4204187212,condition_era group during day -30 through 0 days relative to index: Renal mass,212
4205144502,procedure_occurrence during day -365 through 0 days relative to index: Portable electroencephalogram,502
4205256210,condition_era group during day -365 through 0 days relative to index: Mass of lower limb,210
4205256212,condition_era group during day -30 through 0 days relative to index: Mass of lower limb,212
4205440210,condition_era group during day -365 through 0 days relative to index: Limbic disorder,210
4205440212,condition_era group during day -30 through 0 days relative to index: Limbic disorder,212
4206115210,condition_era group during day -365 through 0 days relative to index: Glomerulopathy due to diabetes mellitus,210
4206115212,condition_era group during day -30 through 0 days relative to index: Glomerulopathy due to diabetes mellitus,212
4206591210,condition_era group during day -365 through 0 days relative to index: Mass of trunk,210
4206591212,condition_era group during day -30 through 0 days relative to index: Mass of trunk,212
4206920502,procedure_occurrence during day -365 through 0 days relative to index: Nebulizer therapy,502
4206920504,procedure_occurrence during day -30 through 0 days relative to index: Nebulizer therapy,504
4207184210,condition_era group during day -365 through 0 days relative to index: Bacterial respiratory infection,210
4207615210,condition_era group during day -365 through 0 days relative to index: Thrombosis of vein of trunk,210
4207615212,condition_era group during day -30 through 0 days relative to index: Thrombosis of vein of trunk,212
4208466210,condition_era group during day -365 through 0 days relative to index: Thrombosis of blood vessel,210
4208466212,condition_era group during day -30 through 0 days relative to index: Thrombosis of blood vessel,212
4208662210,condition_era group during day -365 through 0 days relative to index: Bacterial lower respiratory infection,210
4208784210,condition_era group during day -365 through 0 days relative to index: Infective otitis media,210
4209746210,condition_era group during day -365 through 0 days relative to index: Duodenal ulcer without hemorrhage AND without perforation,210
4210011502,procedure_occurrence during day -365 through 0 days relative to index: Ocular slit lamp examination,502
4210011504,procedure_occurrence during day -30 through 0 days relative to index: Ocular slit lamp examination,504
4210480502,procedure_occurrence during day -365 through 0 days relative to index: Nerve block,502
4212328210,condition_era group during day -365 through 0 days relative to index: Neoplasm affecting hematopoietic structure,210
4212328212,condition_era group during day -30 through 0 days relative to index: Neoplasm affecting hematopoietic structure,212
4213310210,condition_era group during day -365 through 0 days relative to index: Degenerative disease of the central nervous system,210
4213310212,condition_era group during day -30 through 0 days relative to index: Degenerative disease of the central nervous system,212
4214519210,condition_era group during day -365 through 0 days relative to index: Intestinal infectious disease due to anaerobic bacteria,210
4214956802,observation during day -365 through 0 days relative to index: History of clinical finding in subject,802
4214956804,observation during day -30 through 0 days relative to index: History of clinical finding in subject,804
4217197502,"procedure_occurrence during day -365 through 0 days relative to index: Biofeedback, pulse wave velocity",502
4217197504,"procedure_occurrence during day -30 through 0 days relative to index: Biofeedback, pulse wave velocity",504
4217924502,"procedure_occurrence during day -365 through 0 days relative to index: Extremity testing for strength, dexterity or stamina",502
4218403502,"procedure_occurrence during day -365 through 0 days relative to index: Bone density study, dual photon absorptiometry",502
4218781210,condition_era group during day -365 through 0 days relative to index: Cerebral hemisphere hemorrhage,210
4219809602,device_exposure during day -365 through 0 days relative to index: Collagen dressing,602
4219810602,device_exposure during day -365 through 0 days relative to index: Hemostatic gauze product,602
4219810604,device_exposure during day -30 through 0 days relative to index: Hemostatic gauze product,604
4219814602,device_exposure during day -365 through 0 days relative to index: Nebulizer,602
4219814604,device_exposure during day -30 through 0 days relative to index: Nebulizer,604
4220238210,condition_era group during day -365 through 0 days relative to index: Multiple congenital cysts of kidney,210
4220238212,condition_era group during day -30 through 0 days relative to index: Multiple congenital cysts of kidney,212
4220362802,observation during day -365 through 0 days relative to index: Ex-drinker,802
4222896210,condition_era group during day -365 through 0 days relative to index: Chronic duodenal ulcer without hemorrhage AND without perforation,210
4223595210,condition_era group during day -365 through 0 days relative to index: Atopic IgE-mediated allergic disorder,210
4223595212,condition_era group during day -30 through 0 days relative to index: Atopic IgE-mediated allergic disorder,212
4223759210,condition_era group during day -365 through 0 days relative to index: IgE-mediated allergic disorder,210
4223759212,condition_era group during day -30 through 0 days relative to index: IgE-mediated allergic disorder,212
4223938210,condition_era group during day -365 through 0 days relative to index: Dizziness,210
4224022602,device_exposure during day -365 through 0 days relative to index: Elastic adhesive bandage,602
4224118210,condition_era group during day -365 through 0 days relative to index: Bladder dysfunction,210
4224204602,device_exposure during day -365 through 0 days relative to index: Polyurethane foam dressing,602
4224205602,device_exposure during day -365 through 0 days relative to index: Polyurethane foam sterile film dressing,602
4224205604,device_exposure during day -30 through 0 days relative to index: Polyurethane foam sterile film dressing,604
4224741210,condition_era group during day -365 through 0 days relative to index: Degenerative disorder of macula,210
4225273210,condition_era group during day -365 through 0 days relative to index: Chronic gastritis,210
4226263210,condition_era group during day -365 through 0 days relative to index: Pharyngitis,210
4226263212,condition_era group during day -30 through 0 days relative to index: Pharyngitis,212
4226399210,condition_era group during day -365 through 0 days relative to index: Fibrillation,210
4226399212,condition_era group during day -30 through 0 days relative to index: Fibrillation,212
4226401502,procedure_occurrence during day -365 through 0 days relative to index: Taking arterial blood pressure,502
4226991210,condition_era group during day -365 through 0 days relative to index: Xerostomia,210
4226991212,condition_era group during day -30 through 0 days relative to index: Xerostomia,212
4229392210,condition_era group during day -365 through 0 days relative to index: Giddiness,210
4229828502,procedure_occurrence during day -365 through 0 days relative to index: Measurement of blood flow rate in vascular access,502
4229828504,procedure_occurrence during day -30 through 0 days relative to index: Measurement of blood flow rate in vascular access,504
4229928602,device_exposure during day -365 through 0 days relative to index: Surgical adhesive tape,602
4229930602,device_exposure during day -365 through 0 days relative to index: Wound management dressing,602
4229930604,device_exposure during day -30 through 0 days relative to index: Wound management dressing,604
4230167502,procedure_occurrence during day -365 through 0 days relative to index: Artificial respiration,502
4230167504,procedure_occurrence during day -30 through 0 days relative to index: Artificial respiration,504
4230774210,condition_era group during day -365 through 0 days relative to index: Heart valve regurgitation,210
4230774212,condition_era group during day -30 through 0 days relative to index: Heart valve regurgitation,212
4231363210,condition_era group during day -365 through 0 days relative to index: Thrombosis,210
4231363212,condition_era group during day -30 through 0 days relative to index: Thrombosis,212
4233227502,procedure_occurrence during day -365 through 0 days relative to index: Orthopantogram,502
4233903210,condition_era group during day -365 through 0 days relative to index: Mass of thoracic structure,210
4234533210,condition_era group during day -365 through 0 days relative to index: Tonsillitis,210
4234533212,condition_era group during day -30 through 0 days relative to index: Tonsillitis,212
4235076502,procedure_occurrence during day -365 through 0 days relative to index: Replacement of peritoneal dialysis catheter,502
4236024502,procedure_occurrence during day -365 through 0 days relative to index: Diagnostic radiography of lumbar spine,502
4236024504,procedure_occurrence during day -30 through 0 days relative to index: Diagnostic radiography of lumbar spine,504
4236160210,condition_era group during day -365 through 0 days relative to index: Primary systemic vasculitis,210
4236160212,condition_era group during day -30 through 0 days relative to index: Primary systemic vasculitis,212
4236605602,device_exposure during day -365 through 0 days relative to index: Silicone foam sheet dressing,602
4236605604,device_exposure during day -30 through 0 days relative to index: Silicone foam sheet dressing,604
4236607602,device_exposure during day -365 through 0 days relative to index: Silicone gel sheet dressing,602
4237458210,condition_era group during day -365 through 0 days relative to index: Fracture of clavicle,210
4237458212,condition_era group during day -30 through 0 days relative to index: Fracture of clavicle,212
4239130502,procedure_occurrence during day -365 through 0 days relative to index: Oxygen therapy,502
4239130504,procedure_occurrence during day -30 through 0 days relative to index: Oxygen therapy,504
4239189602,device_exposure during day -365 through 0 days relative to index: Bone screw,602
4239314210,condition_era group during day -365 through 0 days relative to index: Primary immune deficiency disorder,210
4239314212,condition_era group during day -30 through 0 days relative to index: Primary immune deficiency disorder,212
4239871210,condition_era group during day -365 through 0 days relative to index: Benign neoplasm of central nervous system,210
4239871212,condition_era group during day -30 through 0 days relative to index: Benign neoplasm of central nervous system,212
4239897210,condition_era group during day -365 through 0 days relative to index: Benign neoplasm of intra-abdominal organs,210
4239975210,condition_era group during day -365 through 0 days relative to index: Myocardial disease,210
4239975212,condition_era group during day -30 through 0 days relative to index: Myocardial disease,212
4241043210,condition_era group during day -365 through 0 days relative to index: Benign neoplasm of head,210
4241043212,condition_era group during day -30 through 0 days relative to index: Benign neoplasm of head,212
4242411210,condition_era group during day -365 through 0 days relative to index: Acute nephropathy,210
4242411212,condition_era group during day -30 through 0 days relative to index: Acute nephropathy,212
4242498210,condition_era group during day -365 through 0 days relative to index: Benign neoplasm of pelvis,210
4242514210,condition_era group during day -365 through 0 days relative to index: Benign neoplasm of skin of ear,210
4242514212,condition_era group during day -30 through 0 days relative to index: Benign neoplasm of skin of ear,212
4242816210,condition_era group during day -365 through 0 days relative to index: Benign neoplasm of pituitary gland,210
4242816212,condition_era group during day -30 through 0 days relative to index: Benign neoplasm of pituitary gland,212
4242980210,condition_era group during day -365 through 0 days relative to index: Benign neoplasm of trunk,210
4243161210,condition_era group during day -365 through 0 days relative to index: Open wound of head,210
4243411210,condition_era group during day -365 through 0 days relative to index: Benign neoplasm of gastrointestinal tract,210
4243427210,condition_era group during day -365 through 0 days relative to index: Benign neoplasm of liver,210
4243600502,procedure_occurrence during day -365 through 0 days relative to index: In situ perfusion,502
4243954602,device_exposure during day -365 through 0 days relative to index: Carbon dioxide absorber,602
4244369502,procedure_occurrence during day -365 through 0 days relative to index: Infusion chemotherapy for malignant neoplasm,502
4244986502,procedure_occurrence during day -365 through 0 days relative to index: CT of brain without contrast,502
4244986504,procedure_occurrence during day -30 through 0 days relative to index: CT of brain without contrast,504
4245975210,condition_era group during day -365 through 0 days relative to index: Hepatic failure,210
4246125210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of large intestine,210
4246125212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of large intestine,212
4246695210,condition_era group during day -365 through 0 days relative to index: Open wound of head AND/OR neck,210
4247120210,condition_era group during day -365 through 0 days relative to index: Gastrointestinal ulcer,210
4247597210,condition_era group during day -365 through 0 days relative to index: Intraocular hemorrhage,210
4247597212,condition_era group during day -30 through 0 days relative to index: Intraocular hemorrhage,212
4248028210,condition_era group during day -365 through 0 days relative to index: Supraventricular arrhythmia,210
4248028212,condition_era group during day -30 through 0 days relative to index: Supraventricular arrhythmia,212
4248965602,device_exposure during day -365 through 0 days relative to index: Wound drainage bag,602
4249437210,condition_era group during day -365 through 0 days relative to index: Disease due to Alphaherpesvirinae,210
4249437212,condition_era group during day -30 through 0 days relative to index: Disease due to Alphaherpesvirinae,212
4249893502,procedure_occurrence during day -365 through 0 days relative to index: Colonoscopy,502
4249893504,procedure_occurrence during day -30 through 0 days relative to index: Colonoscopy,504
4251589502,procedure_occurrence during day -365 through 0 days relative to index: Physical rehabilitation therapy management,502
4251589504,procedure_occurrence during day -30 through 0 days relative to index: Physical rehabilitation therapy management,504
4252419502,procedure_occurrence during day -365 through 0 days relative to index: Radiologic examination of knee,502
4252419504,procedure_occurrence during day -30 through 0 days relative to index: Radiologic examination of knee,504
4254542210,condition_era group during day -365 through 0 days relative to index: Hypopituitarism,210
4254542212,condition_era group during day -30 through 0 days relative to index: Hypopituitarism,212
4254899502,procedure_occurrence during day -365 through 0 days relative to index: Dietary regime management,502
4256228210,condition_era group during day -365 through 0 days relative to index: Respiratory failure,210
4256228212,condition_era group during day -30 through 0 days relative to index: Respiratory failure,212
4256761210,condition_era group during day -365 through 0 days relative to index: Imaging result abnormal,210
4257833502,procedure_occurrence during day -365 through 0 days relative to index: Patient transfer management,502
4260263502,procedure_occurrence during day -365 through 0 days relative to index: Diffusion weighted magnetic resonance imaging,502
4261026210,condition_era group during day -365 through 0 days relative to index: Still's disease with juvenile onset and/or adult onset,210
4261026212,condition_era group during day -30 through 0 days relative to index: Still's disease with juvenile onset and/or adult onset,212
4261497502,procedure_occurrence during day -365 through 0 days relative to index: Ultrasonography of abdomen,502
4261794502,procedure_occurrence during day -365 through 0 days relative to index: Electrocardiogram with exercise test,502
4261842210,condition_era group during day -365 through 0 days relative to index: Sick sinus syndrome,210
4262010502,procedure_occurrence during day -365 through 0 days relative to index: Tracheostomy care management,502
4262010504,procedure_occurrence during day -30 through 0 days relative to index: Tracheostomy care management,504
4262021502,procedure_occurrence during day -365 through 0 days relative to index: Perineal care management,502
4262178210,condition_era group during day -365 through 0 days relative to index: Neurogenic dysfunction of the urinary bladder,210
4262269602,device_exposure during day -365 through 0 days relative to index: Sterile polypropylene monofilament suture,602
4262378502,procedure_occurrence during day -365 through 0 days relative to index: Injection of anesthetic agent into brachial plexus,502
4262378504,procedure_occurrence during day -30 through 0 days relative to index: Injection of anesthetic agent into brachial plexus,504
4262443210,condition_era group during day -365 through 0 days relative to index: Chronic arthritis,210
4262443212,condition_era group during day -30 through 0 days relative to index: Chronic arthritis,212
4263367210,condition_era group during day -365 through 0 days relative to index: Glomerulonephritis,210
4263367212,condition_era group during day -30 through 0 days relative to index: Glomerulonephritis,212
4264033210,condition_era group during day -365 through 0 days relative to index: Systemic vasculitis,210
4264033212,condition_era group during day -30 through 0 days relative to index: Systemic vasculitis,212
4264073210,condition_era group during day -365 through 0 days relative to index: Fracture of tooth,210
4264477502,procedure_occurrence during day -365 through 0 days relative to index: Diagnostic radiography of abdomen,502
4264477504,procedure_occurrence during day -30 through 0 days relative to index: Diagnostic radiography of abdomen,504
4265034502,procedure_occurrence during day -365 through 0 days relative to index: Giving patient an enema,502
4266367210,condition_era group during day -365 through 0 days relative to index: Influenza,210
4266786210,condition_era group during day -365 through 0 days relative to index: Neoplasm of skin region,210
4266786212,condition_era group during day -30 through 0 days relative to index: Neoplasm of skin region,212
4266866502,procedure_occurrence during day -365 through 0 days relative to index: Superficial fine needle aspiration biopsy,502
4267432210,condition_era group during day -365 through 0 days relative to index: Erythropenia,210
4267432212,condition_era group during day -30 through 0 days relative to index: Erythropenia,212
4267560210,condition_era group during day -365 through 0 days relative to index: Neoplasm of integumentary system,210
4267560212,condition_era group during day -30 through 0 days relative to index: Neoplasm of integumentary system,212
4268911210,condition_era group during day -365 through 0 days relative to index: Disorientated,210
4270024210,condition_era group during day -365 through 0 days relative to index: Acute non-ST segment elevation myocardial infarction,210
4270024212,condition_era group during day -30 through 0 days relative to index: Acute non-ST segment elevation myocardial infarction,212
4271310602,device_exposure during day -365 through 0 days relative to index: Tubular bandage,602
4271310604,device_exposure during day -30 through 0 days relative to index: Tubular bandage,604
4271450210,condition_era group during day -365 through 0 days relative to index: Acute infectious disease,210
4271450212,condition_era group during day -30 through 0 days relative to index: Acute infectious disease,212
4272012502,procedure_occurrence during day -365 through 0 days relative to index: Insertion of cannula for hemodialysis,502
4277737602,device_exposure during day -365 through 0 days relative to index: Electrical battery,602
4277745210,condition_era group during day -365 through 0 days relative to index: Disease due to Orthomyxoviridae,210
4281232210,condition_era group during day -365 through 0 days relative to index: Type B viral hepatitis,210
4281232212,condition_era group during day -30 through 0 days relative to index: Type B viral hepatitis,212
4281749210,condition_era group during day -365 through 0 days relative to index: Heart valve disorder,210
4281749212,condition_era group during day -30 through 0 days relative to index: Heart valve disorder,212
4285898210,condition_era group during day -365 through 0 days relative to index: Polyp of colon,210
4285898212,condition_era group during day -30 through 0 days relative to index: Polyp of colon,212
4287399210,condition_era group during day -365 through 0 days relative to index: Retroperitoneal mass,210
4287399212,condition_era group during day -30 through 0 days relative to index: Retroperitoneal mass,212
4288734210,condition_era group during day -365 through 0 days relative to index: Bronchiolar disease,210
4288734212,condition_era group during day -30 through 0 days relative to index: Bronchiolar disease,212
4289526210,condition_era group during day -365 through 0 days relative to index: Nonulcer dyspepsia,210
4289526212,condition_era group during day -30 through 0 days relative to index: Nonulcer dyspepsia,212
4290930502,procedure_occurrence during day -365 through 0 days relative to index: Insertion of pacemaker pulse generator,502
4291005210,condition_era group during day -365 through 0 days relative to index: Viral hepatitis,210
4291005212,condition_era group during day -30 through 0 days relative to index: Viral hepatitis,212
4291025210,condition_era group during day -365 through 0 days relative to index: Arthritis,210
4291025212,condition_era group during day -30 through 0 days relative to index: Arthritis,212
4291302210,condition_era group during day -365 through 0 days relative to index: Dermatosis of external ear,210
4291302212,condition_era group during day -30 through 0 days relative to index: Dermatosis of external ear,212
4294382502,procedure_occurrence during day -365 through 0 days relative to index: Esophagogastroduodenoscopy,502
4294917502,procedure_occurrence during day -365 through 0 days relative to index: Enema administration management,502
4295073502,procedure_occurrence during day -365 through 0 days relative to index: Emergency treatment management,502
4295073504,procedure_occurrence during day -30 through 0 days relative to index: Emergency treatment management,504
4295203502,procedure_occurrence during day -365 through 0 days relative to index: Cardiac rehabilitation assessment,502
4295465210,condition_era group during day -365 through 0 days relative to index: Drug-induced dermatosis,210
4295465212,condition_era group during day -30 through 0 days relative to index: Drug-induced dermatosis,212
4296155602,device_exposure during day -365 through 0 days relative to index: Stainless steel wire suture,602
4296205210,condition_era group during day -365 through 0 days relative to index: Partial thickness burn,210
4296205212,condition_era group during day -30 through 0 days relative to index: Partial thickness burn,212
4296529502,procedure_occurrence during day -365 through 0 days relative to index: Anesthesia management,502
4296529504,procedure_occurrence during day -30 through 0 days relative to index: Anesthesia management,504
4296871502,procedure_occurrence during day -365 through 0 days relative to index: Repair of arteriovenous fistula,502
4296916602,device_exposure during day -365 through 0 days relative to index: Polyurethane foam film dressing sterile without adhesive border 10cm x 10cm square,602
4296916604,device_exposure during day -30 through 0 days relative to index: Polyurethane foam film dressing sterile without adhesive border 10cm x 10cm square,604
4296953502,procedure_occurrence during day -365 through 0 days relative to index: Cardiac rehabilitation management,502
4296953504,procedure_occurrence during day -30 through 0 days relative to index: Cardiac rehabilitation management,504
4297400210,condition_era group during day -365 through 0 days relative to index: Mild cognitive disorder,210
4297400212,condition_era group during day -30 through 0 days relative to index: Mild cognitive disorder,212
4298809210,condition_era group during day -365 through 0 days relative to index: Nephritic syndrome,210
4298809212,condition_era group during day -30 through 0 days relative to index: Nephritic syndrome,212
4300595210,condition_era group during day -365 through 0 days relative to index: Neoplasm of endocrine system,210
4300595212,condition_era group during day -30 through 0 days relative to index: Neoplasm of endocrine system,212
4300866502,procedure_occurrence during day -365 through 0 days relative to index: Ultrasonography of urinary system,502
4301546502,procedure_occurrence during day -365 through 0 days relative to index: Blood specimen care management,502
4301546504,procedure_occurrence during day -30 through 0 days relative to index: Blood specimen care management,504
4301699210,condition_era group during day -365 through 0 days relative to index: Neuropathy,210
4301699212,condition_era group during day -30 through 0 days relative to index: Neuropathy,212
4302654210,condition_era group during day -365 through 0 days relative to index: Itching,210
4302745502,procedure_occurrence during day -365 through 0 days relative to index: Irrigation of urinary bladder,502
4302836210,condition_era group during day -365 through 0 days relative to index: Neoplasm of endocrine gland,210
4302836212,condition_era group during day -30 through 0 days relative to index: Neoplasm of endocrine gland,212
4303233210,condition_era group during day -365 through 0 days relative to index: Gastric polyp,210
4303233212,condition_era group during day -30 through 0 days relative to index: Gastric polyp,212
4305077502,procedure_occurrence during day -365 through 0 days relative to index: Transurethral resection of bladder neoplasm,502
4305317502,procedure_occurrence during day -365 through 0 days relative to index: Computer assisted image analysis,502
4305317504,procedure_occurrence during day -30 through 0 days relative to index: Computer assisted image analysis,504
4305581502,procedure_occurrence during day -365 through 0 days relative to index: Application of dressing,502
4308811210,condition_era group during day -365 through 0 days relative to index: Neoplasm of soft tissue,210
4308811212,condition_era group during day -30 through 0 days relative to index: Neoplasm of soft tissue,212
4309542210,condition_era group during day -365 through 0 days relative to index: Infection due to anaerobic bacteria,210
4310250802,observation during day -365 through 0 days relative to index: Ex-smoker,802
4311115210,condition_era group during day -365 through 0 days relative to index: Intracranial mass,210
4311115212,condition_era group during day -30 through 0 days relative to index: Intracranial mass,212
4311499210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of respiratory tract,210
4311499212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of respiratory tract,212
4311708210,condition_era group during day -365 through 0 days relative to index: Diabetic peripheral neuropathy,210
4311708212,condition_era group during day -30 through 0 days relative to index: Diabetic peripheral neuropathy,212
4312698210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of trunk,210
4312698212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of trunk,212
4313464502,"procedure_occurrence during day -365 through 0 days relative to index: Occupational therapy education, guidance, counseling",502
4313572602,device_exposure during day -365 through 0 days relative to index: Electrocardiographic monitor and recorder,602
4313938602,device_exposure during day -365 through 0 days relative to index: Elastic bandage,602
4313938604,device_exposure during day -30 through 0 days relative to index: Elastic bandage,604
4314071210,condition_era group during day -365 through 0 days relative to index: Secondary malignant neoplasm of trunk,210
4314071212,condition_era group during day -30 through 0 days relative to index: Secondary malignant neoplasm of trunk,212
4316083210,condition_era group during day -365 through 0 days relative to index: Skin lesion,210
4316083212,condition_era group during day -30 through 0 days relative to index: Skin lesion,212
4318404210,condition_era group during day -365 through 0 days relative to index: Lung consolidation,210
4318404212,condition_era group during day -30 through 0 days relative to index: Lung consolidation,212
4318544210,condition_era group during day -365 through 0 days relative to index: Renal tubular disorder,210
4318544212,condition_era group during day -30 through 0 days relative to index: Renal tubular disorder,212
4318985210,condition_era group during day -365 through 0 days relative to index: Degeneration of retina,210
4319156210,condition_era group during day -365 through 0 days relative to index: Bacterial ear infection,210
4319605210,condition_era group during day -365 through 0 days relative to index: Inflammation of orbit,210
4319605212,condition_era group during day -30 through 0 days relative to index: Inflammation of orbit,212
4320791210,condition_era group during day -365 through 0 days relative to index: Rhinitis,210
4320791212,condition_era group during day -30 through 0 days relative to index: Rhinitis,212
4322024210,condition_era group during day -365 through 0 days relative to index: Pulmonary hypertension,210
4322024212,condition_era group during day -30 through 0 days relative to index: Pulmonary hypertension,212
4323715502,procedure_occurrence during day -365 through 0 days relative to index: Transfusion of packed red blood cells,502
4324693502,procedure_occurrence during day -365 through 0 days relative to index: Mammography,502
4324765210,condition_era group during day -365 through 0 days relative to index: Arthropathy of knee joint,210
4324765212,condition_era group during day -30 through 0 days relative to index: Arthropathy of knee joint,212
4326398602,device_exposure during day -365 through 0 days relative to index: Arterial cannula,602
4327032502,procedure_occurrence during day -365 through 0 days relative to index: CT of thorax with contrast,502
4327032504,procedure_occurrence during day -30 through 0 days relative to index: CT of thorax with contrast,504
4329041210,condition_era group during day -365 through 0 days relative to index: Pain,210
4329041212,condition_era group during day -30 through 0 days relative to index: Pain,212
4329775502,procedure_occurrence during day -365 through 0 days relative to index: Insertion of tunneled central venous catheter using fluoroscopic guidance,502
4329847210,condition_era group during day -365 through 0 days relative to index: Myocardial infarction,210
4329847212,condition_era group during day -30 through 0 days relative to index: Myocardial infarction,212
4330519502,procedure_occurrence during day -365 through 0 days relative to index: Transcranial doppler ultrasonography,502
4331509210,condition_era group during day -365 through 0 days relative to index: Mass of head,210
4331509212,condition_era group during day -30 through 0 days relative to index: Mass of head,212
4332191502,procedure_occurrence during day -365 through 0 days relative to index: Whole body bone imaging,502
4332246210,condition_era group during day -365 through 0 days relative to index: Aneurysm,210
4334868210,condition_era group during day -365 through 0 days relative to index: Cataract in systemic disorders,210
4334868212,condition_era group during day -30 through 0 days relative to index: Cataract in systemic disorders,212
4335824502,procedure_occurrence during day -365 through 0 days relative to index: Exercise stress echocardiography,502
4335824504,procedure_occurrence during day -30 through 0 days relative to index: Exercise stress echocardiography,504
4335825502,procedure_occurrence during day -365 through 0 days relative to index: Transthoracic echocardiography,502
4335825504,procedure_occurrence during day -30 through 0 days relative to index: Transthoracic echocardiography,504
4336678502,procedure_occurrence during day -365 through 0 days relative to index: Visual field study,502
4338120210,condition_era group during day -365 through 0 days relative to index: Altered bowel function,210
4339214210,condition_era group during day -365 through 0 days relative to index: Secondary pulmonary hypertension,210
4339214212,condition_era group during day -30 through 0 days relative to index: Secondary pulmonary hypertension,212
4339468210,"condition_era group during day -365 through 0 days relative to index: Ear, nose and throat disorder",210
4339468212,"condition_era group during day -30 through 0 days relative to index: Ear, nose and throat disorder",212
4341650210,condition_era group during day -365 through 0 days relative to index: Liver disorder due to infection,210
4341650212,condition_era group during day -30 through 0 days relative to index: Liver disorder due to infection,212
4341654210,condition_era group during day -365 through 0 days relative to index: Vascular disorder of liver,210
4341654212,condition_era group during day -30 through 0 days relative to index: Vascular disorder of liver,212
4342655210,condition_era group during day -365 through 0 days relative to index: Ulceration of small intestine,210
4342885210,condition_era group during day -365 through 0 days relative to index: Retroperitoneal cyst,210
4342885212,condition_era group during day -30 through 0 days relative to index: Retroperitoneal cyst,212
4344027210,condition_era group during day -365 through 0 days relative to index: Soft tissue lesion of knee region,210
4344027212,condition_era group during day -30 through 0 days relative to index: Soft tissue lesion of knee region,212
4344166210,condition_era group during day -365 through 0 days relative to index: Adult onset Still's disease,210
4344166212,condition_era group during day -30 through 0 days relative to index: Adult onset Still's disease,212
4344273210,condition_era group during day -365 through 0 days relative to index: Soft tissue lesion of foot region,210
4344273212,condition_era group during day -30 through 0 days relative to index: Soft tissue lesion of foot region,212
4344497210,condition_era group during day -365 through 0 days relative to index: Soft tissue lesion,210
4344497212,condition_era group during day -30 through 0 days relative to index: Soft tissue lesion,212
4347174210,condition_era group during day -365 through 0 days relative to index: Synovial cyst of knee,210
4347174212,condition_era group during day -30 through 0 days relative to index: Synovial cyst of knee,212
4354249210,condition_era group during day -365 through 0 days relative to index: Myocardial necrosis,210
4354249212,condition_era group during day -30 through 0 days relative to index: Myocardial necrosis,212
19000537410,drug_era group during day -365 through 0 days relative to index: Threonine,410
19000729410,drug_era group during day -365 through 0 days relative to index: Aprotinin,410
19000811410,drug_era group during day -365 through 0 days relative to index: Lactobacillus casei rhamnosus,410
19000811412,drug_era group during day -30 through 0 days relative to index: Lactobacillus casei rhamnosus,412
19000811413,drug_era group during day 0 through 0 days relative to index: Lactobacillus casei rhamnosus,413
19002425410,drug_era group during day -365 through 0 days relative to index: Sodium Pertechnetate Tc 99m,410
19003201410,drug_era group during day -365 through 0 days relative to index: iodixanol,410
19003201412,drug_era group during day -30 through 0 days relative to index: iodixanol,412
19003201413,drug_era group during day 0 through 0 days relative to index: iodixanol,413
19003206410,drug_era group during day -365 through 0 days relative to index: iopromide,410
19003953410,drug_era group during day -365 through 0 days relative to index: Rocuronium,410
19004724410,drug_era group during day -365 through 0 days relative to index: Methionine,410
19005046410,drug_era group during day -365 through 0 days relative to index: pyridoxine,410
19005046412,drug_era group during day -30 through 0 days relative to index: pyridoxine,412
19005046413,drug_era group during day 0 through 0 days relative to index: pyridoxine,413
19005512410,drug_era group during day -365 through 0 days relative to index: Trimebutine,410
19005512412,drug_era group during day -30 through 0 days relative to index: Trimebutine,412
19005512413,drug_era group during day 0 through 0 days relative to index: Trimebutine,413
19006186410,drug_era group during day -365 through 0 days relative to index: Tryptophan,410
19006410410,drug_era group during day -365 through 0 days relative to index: Arginine,410
19006692410,drug_era group during day -365 through 0 days relative to index: Tyrosine,410
19007572410,drug_era group during day -365 through 0 days relative to index: Valine,410
19008009410,drug_era group during day -365 through 0 days relative to index: Cosyntropin,410
19008339410,drug_era group during day -365 through 0 days relative to index: Vitamin A,410
19009705410,drug_era group during day -365 through 0 days relative to index: lenograstim,410
19010309410,drug_era group during day -365 through 0 days relative to index: Water,410
19010482410,drug_era group during day -365 through 0 days relative to index: Cyclosporine,410
19010482412,drug_era group during day -30 through 0 days relative to index: Cyclosporine,412
19010482413,drug_era group during day 0 through 0 days relative to index: Cyclosporine,413
19011035410,drug_era group during day -365 through 0 days relative to index: Lactate,410
19011339410,drug_era group during day -365 through 0 days relative to index: mosapride,410
19011339412,drug_era group during day -30 through 0 days relative to index: mosapride,412
19011339413,drug_era group during day 0 through 0 days relative to index: mosapride,413
19011355410,drug_era group during day -365 through 0 days relative to index: etoricoxib,410
19011355412,drug_era group during day -30 through 0 days relative to index: etoricoxib,412
19011355413,drug_era group during day 0 through 0 days relative to index: etoricoxib,413
19011773410,drug_era group during day -365 through 0 days relative to index: Ascorbic Acid,410
19011773412,drug_era group during day -30 through 0 days relative to index: Ascorbic Acid,412
19011773413,drug_era group during day 0 through 0 days relative to index: Ascorbic Acid,413
19012200410,drug_era group during day -365 through 0 days relative to index: 4-aminomethylbenzoic acid,410
19012686410,drug_era group during day -365 through 0 days relative to index: Aspartic Acid,410
19014202410,drug_era group during day -365 through 0 days relative to index: Alfacalcidol,410
19014202412,drug_era group during day -30 through 0 days relative to index: Alfacalcidol,412
19014202413,drug_era group during day 0 through 0 days relative to index: Alfacalcidol,413
19014977410,drug_era group during day -365 through 0 days relative to index: Nicorandil,410
19014977412,drug_era group during day -30 through 0 days relative to index: Nicorandil,412
19014977413,drug_era group during day 0 through 0 days relative to index: Nicorandil,413
19015726410,drug_era group during day -365 through 0 days relative to index: Cisatracurium,410
19016749410,drug_era group during day -365 through 0 days relative to index: remifentanil,410
19016749412,drug_era group during day -30 through 0 days relative to index: remifentanil,412
19016749413,drug_era group during day 0 through 0 days relative to index: remifentanil,413
19017742410,drug_era group during day -365 through 0 days relative to index: febuxostat,410
19017742412,drug_era group during day -30 through 0 days relative to index: febuxostat,412
19017742413,drug_era group during day 0 through 0 days relative to index: febuxostat,413
19018419410,drug_era group during day -365 through 0 days relative to index: Niacinamide,410
19018419412,drug_era group during day -30 through 0 days relative to index: Niacinamide,412
19018419413,drug_era group during day 0 through 0 days relative to index: Niacinamide,413
19018544410,drug_era group during day -365 through 0 days relative to index: Calcium,410
19018544412,drug_era group during day -30 through 0 days relative to index: Calcium,412
19018544413,drug_era group during day 0 through 0 days relative to index: Calcium,413
19024770410,drug_era group during day -365 through 0 days relative to index: Biotin,410
19024770412,drug_era group during day -30 through 0 days relative to index: Biotin,412
19024770413,drug_era group during day 0 through 0 days relative to index: Biotin,413
19025274410,drug_era group during day -365 through 0 days relative to index: Oxygen,410
19025274412,drug_era group during day -30 through 0 days relative to index: Oxygen,412
19025274413,drug_era group during day 0 through 0 days relative to index: Oxygen,413
19026459410,drug_era group during day -365 through 0 days relative to index: tapentadol,410
19026739410,drug_era group during day -365 through 0 days relative to index: Pantothenic Acid,410
19026739412,drug_era group during day -30 through 0 days relative to index: Pantothenic Acid,412
19026739413,drug_era group during day 0 through 0 days relative to index: Pantothenic Acid,413
19028950410,drug_era group during day -365 through 0 days relative to index: Procaterol,410
19029393410,drug_era group during day -365 through 0 days relative to index: aceclofenac,410
19029393412,drug_era group during day -30 through 0 days relative to index: aceclofenac,412
19030059410,drug_era group during day -365 through 0 days relative to index: alginic acid,410
19034009410,drug_era group during day -365 through 0 days relative to index: ambroxol-theophylline-7-acetate,410
19034009412,drug_era group during day -30 through 0 days relative to index: ambroxol-theophylline-7-acetate,412
19034009413,drug_era group during day 0 through 0 days relative to index: ambroxol-theophylline-7-acetate,413
19035577410,drug_era group during day -365 through 0 days relative to index: Phenylalanine,410
19035631410,drug_era group during day -365 through 0 days relative to index: Calcitriol,410
19035631412,drug_era group during day -30 through 0 days relative to index: Calcitriol,412
19036781410,drug_era group during day -365 through 0 days relative to index: Calcium Chloride,410
19037038410,drug_era group during day -365 through 0 days relative to index: Calcium Gluconate,410
19037596410,drug_era group during day -365 through 0 days relative to index: Acetylcarnitine,410
19037706410,drug_era group during day -365 through 0 days relative to index: bismuth oxide,410
19037833410,drug_era group during day -365 through 0 days relative to index: Domperidone,410
19037833412,drug_era group during day -30 through 0 days relative to index: Domperidone,412
19037833413,drug_era group during day 0 through 0 days relative to index: Domperidone,413
19039298410,drug_era group during day -365 through 0 days relative to index: sevoflurane,410
19041222410,drug_era group during day -365 through 0 days relative to index: Phloroglucinol,410
19042778410,drug_era group during day -365 through 0 days relative to index: triflusal,410
19044522410,drug_era group during day -365 through 0 days relative to index: Zinc Sulfate,410
19044522412,drug_era group during day -30 through 0 days relative to index: Zinc Sulfate,412
19044522413,drug_era group during day 0 through 0 days relative to index: Zinc Sulfate,413
19044727410,drug_era group during day -365 through 0 days relative to index: Vitamin K 1,410
19045045410,drug_era group during day -365 through 0 days relative to index: Ergocalciferol,410
19049105410,drug_era group during day -365 through 0 days relative to index: Potassium Chloride,410
19049105412,drug_era group during day -30 through 0 days relative to index: Potassium Chloride,412
19049105413,drug_era group during day 0 through 0 days relative to index: Potassium Chloride,413
19050104410,drug_era group during day -365 through 0 days relative to index: Carnitine,410
19050104412,drug_era group during day -30 through 0 days relative to index: Carnitine,412
19050104413,drug_era group during day 0 through 0 days relative to index: Carnitine,413
19052489410,drug_era group during day -365 through 0 days relative to index: Alanine,410
19052736410,drug_era group during day -365 through 0 days relative to index: Proline,410
19054242410,drug_era group during day -365 through 0 days relative to index: Protamine Sulfate (USP),410
19054702410,drug_era group during day -365 through 0 days relative to index: Fibrinogen,410
19056874410,drug_era group during day -365 through 0 days relative to index: Dexketoprofen,410
19058354410,drug_era group during day -365 through 0 days relative to index: Aconite,410
19058354412,drug_era group during day -30 through 0 days relative to index: Aconite,412
19058354413,drug_era group during day 0 through 0 days relative to index: Aconite,413
19058933410,drug_era group during day -365 through 0 days relative to index: erdosteine,410
19058933412,drug_era group during day -30 through 0 days relative to index: erdosteine,412
19058933413,drug_era group during day 0 through 0 days relative to index: erdosteine,413
19059796410,drug_era group during day -365 through 0 days relative to index: Gliclazide,410
19059796412,drug_era group during day -30 through 0 days relative to index: Gliclazide,412
19059796413,drug_era group during day 0 through 0 days relative to index: Gliclazide,413
19060985410,drug_era group during day -365 through 0 days relative to index: Glutamine,410
19061083410,drug_era group during day -365 through 0 days relative to index: Glutathione,410
19061083412,drug_era group during day -30 through 0 days relative to index: Glutathione,412
19061088410,drug_era group during day -365 through 0 days relative to index: Dexmedetomidine,410
19061088412,drug_era group during day -30 through 0 days relative to index: Dexmedetomidine,412
19061088413,drug_era group during day 0 through 0 days relative to index: Dexmedetomidine,413
19062817410,drug_era group during day -365 through 0 days relative to index: Riboflavin,410
19062817412,drug_era group during day -30 through 0 days relative to index: Riboflavin,412
19062817413,drug_era group during day 0 through 0 days relative to index: Riboflavin,413
19063575410,drug_era group during day -365 through 0 days relative to index: esmolol,410
19063874410,drug_era group during day -365 through 0 days relative to index: Roxithromycin,410
19063874412,drug_era group during day -30 through 0 days relative to index: Roxithromycin,412
19065814410,drug_era group during day -365 through 0 days relative to index: grape extract,410
19065814412,drug_era group during day -30 through 0 days relative to index: grape extract,412
19066774410,drug_era group during day -365 through 0 days relative to index: Serine,410
19069131410,drug_era group during day -365 through 0 days relative to index: ioversol,410
19069131412,drug_era group during day -30 through 0 days relative to index: ioversol,412
19069149410,drug_era group during day -365 through 0 days relative to index: Histidine,410
19070224410,drug_era group during day -365 through 0 days relative to index: Soybean Oil,410
19070224412,drug_era group during day -30 through 0 days relative to index: Soybean Oil,412
19070224413,drug_era group during day 0 through 0 days relative to index: Soybean Oil,413
19071836410,drug_era group during day -365 through 0 days relative to index: Calendula officinalis extract,410
19071836412,drug_era group during day -30 through 0 days relative to index: Calendula officinalis extract,412
19071836413,drug_era group during day 0 through 0 days relative to index: Calendula officinalis extract,413
19071966410,drug_era group during day -365 through 0 days relative to index: Adenine,410
19071966412,drug_era group during day -30 through 0 days relative to index: Adenine,412
19071966413,drug_era group during day 0 through 0 days relative to index: Adenine,413
19071995410,drug_era group during day -365 through 0 days relative to index: manidipine,410
19071995412,drug_era group during day -30 through 0 days relative to index: manidipine,412
19071995413,drug_era group during day 0 through 0 days relative to index: manidipine,413
19073699410,drug_era group during day -365 through 0 days relative to index: Hyaluronidase,410
19077884410,drug_era group during day -365 through 0 days relative to index: Sodium Acetate,410
19077884412,drug_era group during day -30 through 0 days relative to index: Sodium Acetate,412
19077884413,drug_era group during day 0 through 0 days relative to index: Sodium Acetate,413
19078092410,drug_era group during day -365 through 0 days relative to index: Sodium gluconate,410
19078092412,drug_era group during day -30 through 0 days relative to index: Sodium gluconate,412
19078092413,drug_era group during day 0 through 0 days relative to index: Sodium gluconate,413
19080985410,drug_era group during day -365 through 0 days relative to index: Iohexol,410
19080985412,drug_era group during day -30 through 0 days relative to index: Iohexol,412
19080985413,drug_era group during day 0 through 0 days relative to index: Iohexol,413
19081224410,drug_era group during day -365 through 0 days relative to index: Iopamidol,410
19082306410,drug_era group during day -365 through 0 days relative to index: Isoleucine,410
19082891410,drug_era group during day -365 through 0 days relative to index: oxiracetam,410
19088167410,drug_era group during day -365 through 0 days relative to index: Ambroxol,410
19088167412,drug_era group during day -30 through 0 days relative to index: Ambroxol,412
19088167413,drug_era group during day 0 through 0 days relative to index: Ambroxol,413
19088571410,drug_era group during day -365 through 0 days relative to index: Leucine,410
19091101410,drug_era group during day -365 through 0 days relative to index: DOBESILIC ACID,410
19091101412,drug_era group during day -30 through 0 days relative to index: DOBESILIC ACID,412
19091101413,drug_era group during day 0 through 0 days relative to index: DOBESILIC ACID,413
19091701410,drug_era group during day -365 through 0 days relative to index: Liver Extract,410
19091701412,drug_era group during day -30 through 0 days relative to index: Liver Extract,412
19091701413,drug_era group during day 0 through 0 days relative to index: Liver Extract,413
19091809410,drug_era group during day -365 through 0 days relative to index: talniflumate,410
19092377410,drug_era group during day -365 through 0 days relative to index: Lysine,410
19092433410,drug_era group during day -365 through 0 days relative to index: ebastine,410
19092433412,drug_era group during day -30 through 0 days relative to index: ebastine,412
19092433413,drug_era group during day 0 through 0 days relative to index: ebastine,413
19092849410,drug_era group during day -365 through 0 days relative to index: Magnesium Chloride,410
19092849412,drug_era group during day -30 through 0 days relative to index: Magnesium Chloride,412
19092849413,drug_era group during day 0 through 0 days relative to index: Magnesium Chloride,413
19093848410,drug_era group during day -365 through 0 days relative to index: Magnesium Sulfate,410
19095164410,drug_era group during day -365 through 0 days relative to index: Cholecalciferol,410
19095164412,drug_era group during day -30 through 0 days relative to index: Cholecalciferol,412
19095164413,drug_era group during day 0 through 0 days relative to index: Cholecalciferol,413
19098505410,drug_era group during day -365 through 0 days relative to index: Ginkgo Biloba Leaf Extract,410
19110701410,drug_era group during day -365 through 0 days relative to index: Fish Oils,410
19110701412,drug_era group during day -30 through 0 days relative to index: Fish Oils,412
19110701413,drug_era group during day 0 through 0 days relative to index: Fish Oils,413
19111620410,drug_era group during day -365 through 0 days relative to index: Folic Acid,410
19111620412,drug_era group during day -30 through 0 days relative to index: Folic Acid,412
19111620413,drug_era group during day 0 through 0 days relative to index: Folic Acid,413
19112563410,drug_era group during day -365 through 0 days relative to index: Calcium polystyrene sulfonate product,410
19112563412,drug_era group during day -30 through 0 days relative to index: Calcium polystyrene sulfonate product,412
19112563413,drug_era group during day 0 through 0 days relative to index: Calcium polystyrene sulfonate product,413
19137056410,drug_era group during day -365 through 0 days relative to index: Theobromine,410
19137056412,drug_era group during day -30 through 0 days relative to index: Theobromine,412
19137312410,drug_era group during day -365 through 0 days relative to index: Thiamine,410
19137312412,drug_era group during day -30 through 0 days relative to index: Thiamine,412
19137312413,drug_era group during day 0 through 0 days relative to index: Thiamine,413
21490721702,measurement during day -365 through 0 days relative to index: Hemoglobin [Moles/volume] in Arterial blood,702
21490852702,measurement during day -365 through 0 days relative to index: Invasive Mean blood pressure,702
21494757702,measurement during day -365 through 0 days relative to index: Japanese cypress IgE Ab RAST class [Presence] in Serum,702
21600001410,drug_era group during day -365 through 0 days relative to index: ALIMENTARY TRACT AND METABOLISM,410
21600001412,drug_era group during day -30 through 0 days relative to index: ALIMENTARY TRACT AND METABOLISM,412
21600001413,drug_era group during day 0 through 0 days relative to index: ALIMENTARY TRACT AND METABOLISM,413
21600002410,drug_era group during day -365 through 0 days relative to index: STOMATOLOGICAL PREPARATIONS,410
21600002412,drug_era group during day -30 through 0 days relative to index: STOMATOLOGICAL PREPARATIONS,412
21600002413,drug_era group during day 0 through 0 days relative to index: STOMATOLOGICAL PREPARATIONS,413
21600003410,drug_era group during day -365 through 0 days relative to index: STOMATOLOGICAL PREPARATIONS,410
21600003412,drug_era group during day -30 through 0 days relative to index: STOMATOLOGICAL PREPARATIONS,412
21600003413,drug_era group during day 0 through 0 days relative to index: STOMATOLOGICAL PREPARATIONS,413
21600011410,drug_era group during day -365 through 0 days relative to index: Antiinfectives and antiseptics for local oral treatment,410
21600011412,drug_era group during day -30 through 0 days relative to index: Antiinfectives and antiseptics for local oral treatment,412
21600011413,drug_era group during day 0 through 0 days relative to index: Antiinfectives and antiseptics for local oral treatment,413
21600033410,drug_era group during day -365 through 0 days relative to index: Corticosteroids for local oral treatment,410
21600046410,drug_era group during day -365 through 0 days relative to index: DRUGS FOR ACID RELATED DISORDERS,410
21600046412,drug_era group during day -30 through 0 days relative to index: DRUGS FOR ACID RELATED DISORDERS,412
21600046413,drug_era group during day 0 through 0 days relative to index: DRUGS FOR ACID RELATED DISORDERS,413
21600047410,drug_era group during day -365 through 0 days relative to index: ANTACIDS,410
21600047412,drug_era group during day -30 through 0 days relative to index: ANTACIDS,412
21600047413,drug_era group during day 0 through 0 days relative to index: ANTACIDS,413
21600048410,drug_era group during day -365 through 0 days relative to index: Magnesium compounds,410
21600055410,drug_era group during day -365 through 0 days relative to index: Aluminium compounds,410
21600055412,drug_era group during day -30 through 0 days relative to index: Aluminium compounds,412
21600055413,drug_era group during day 0 through 0 days relative to index: Aluminium compounds,413
21600080410,drug_era group during day -365 through 0 days relative to index: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),410
21600080412,drug_era group during day -30 through 0 days relative to index: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),412
21600080413,drug_era group during day 0 through 0 days relative to index: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),413
21600081410,drug_era group during day -365 through 0 days relative to index: H2-receptor antagonists,410
21600081412,drug_era group during day -30 through 0 days relative to index: H2-receptor antagonists,412
21600081413,drug_era group during day 0 through 0 days relative to index: H2-receptor antagonists,413
21600095410,drug_era group during day -365 through 0 days relative to index: Proton pump inhibitors,410
21600095412,drug_era group during day -30 through 0 days relative to index: Proton pump inhibitors,412
21600095413,drug_era group during day 0 through 0 days relative to index: Proton pump inhibitors,413
21600109410,drug_era group during day -365 through 0 days relative to index: Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),410
21600127410,drug_era group during day -365 through 0 days relative to index: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,410
21600127412,drug_era group during day -30 through 0 days relative to index: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,412
21600127413,drug_era group during day 0 through 0 days relative to index: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,413
21600128410,drug_era group during day -365 through 0 days relative to index: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,410
21600128412,drug_era group during day -30 through 0 days relative to index: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,412
21600128413,drug_era group during day 0 through 0 days relative to index: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,413
21600129410,"drug_era group during day -365 through 0 days relative to index: Synthetic anticholinergics, esters with tertiary amino group",410
21600129412,"drug_era group during day -30 through 0 days relative to index: Synthetic anticholinergics, esters with tertiary amino group",412
21600129413,"drug_era group during day 0 through 0 days relative to index: Synthetic anticholinergics, esters with tertiary amino group",413
21600139410,"drug_era group during day -365 through 0 days relative to index: Synthetic anticholinergics, quaternary ammonium compounds",410
21600139412,"drug_era group during day -30 through 0 days relative to index: Synthetic anticholinergics, quaternary ammonium compounds",412
21600139413,"drug_era group during day 0 through 0 days relative to index: Synthetic anticholinergics, quaternary ammonium compounds",413
21600174410,drug_era group during day -365 through 0 days relative to index: Other drugs for functional gastrointestinal disorders,410
21600190410,"drug_era group during day -365 through 0 days relative to index: BELLADONNA AND DERIVATIVES, PLAIN",410
21600190412,"drug_era group during day -30 through 0 days relative to index: BELLADONNA AND DERIVATIVES, PLAIN",412
21600190413,"drug_era group during day 0 through 0 days relative to index: BELLADONNA AND DERIVATIVES, PLAIN",413
21600191410,"drug_era group during day -365 through 0 days relative to index: Belladonna alkaloids, tertiary amines",410
21600191412,"drug_era group during day -30 through 0 days relative to index: Belladonna alkaloids, tertiary amines",412
21600191413,"drug_era group during day 0 through 0 days relative to index: Belladonna alkaloids, tertiary amines",413
21600248410,"drug_era group during day -365 through 0 days relative to index: ANTIARRHYTHMICS, CLASS I AND III",410
21600269410,"drug_era group during day -365 through 0 days relative to index: Antiarrhythmics, class III",410
21600279410,drug_era group during day -365 through 0 days relative to index: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,410
21600279412,drug_era group during day -30 through 0 days relative to index: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,412
21600279413,drug_era group during day 0 through 0 days relative to index: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,413
21600280410,drug_era group during day -365 through 0 days relative to index: Adrenergic and dopaminergic agents,410
21600280412,drug_era group during day -30 through 0 days relative to index: Adrenergic and dopaminergic agents,412
21600280413,drug_era group during day 0 through 0 days relative to index: Adrenergic and dopaminergic agents,413
21600315410,drug_era group during day -365 through 0 days relative to index: VASODILATORS USED IN CARDIAC DISEASES,410
21600315412,drug_era group during day -30 through 0 days relative to index: VASODILATORS USED IN CARDIAC DISEASES,412
21600315413,drug_era group during day 0 through 0 days relative to index: VASODILATORS USED IN CARDIAC DISEASES,413
21600316410,drug_era group during day -365 through 0 days relative to index: Organic nitrates,410
21600316412,drug_era group during day -30 through 0 days relative to index: Organic nitrates,412
21600316413,drug_era group during day 0 through 0 days relative to index: Organic nitrates,413
21600337410,drug_era group during day -365 through 0 days relative to index: Other vasodilators used in cardiac diseases,410
21600337412,drug_era group during day -30 through 0 days relative to index: Other vasodilators used in cardiac diseases,412
21600337413,drug_era group during day 0 through 0 days relative to index: Other vasodilators used in cardiac diseases,413
21600360410,drug_era group during day -365 through 0 days relative to index: OTHER CARDIAC PREPARATIONS,410
21600360412,drug_era group during day -30 through 0 days relative to index: OTHER CARDIAC PREPARATIONS,412
21600361410,drug_era group during day -365 through 0 days relative to index: Prostaglandins,410
21600361412,drug_era group during day -30 through 0 days relative to index: Prostaglandins,412
21600381410,drug_era group during day -365 through 0 days relative to index: ANTIHYPERTENSIVES,410
21600381412,drug_era group during day -30 through 0 days relative to index: ANTIHYPERTENSIVES,412
21600381413,drug_era group during day 0 through 0 days relative to index: ANTIHYPERTENSIVES,413
21600424410,"drug_era group during day -365 through 0 days relative to index: ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON",410
21600424412,"drug_era group during day -30 through 0 days relative to index: ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON",412
21600424413,"drug_era group during day 0 through 0 days relative to index: ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON",413
21600427410,drug_era group during day -365 through 0 days relative to index: Hydrazinophthalazine derivatives,410
21600427412,drug_era group during day -30 through 0 days relative to index: Hydrazinophthalazine derivatives,412
21600427413,drug_era group during day 0 through 0 days relative to index: Hydrazinophthalazine derivatives,413
21600438410,drug_era group during day -365 through 0 days relative to index: OTHER ANTIHYPERTENSIVES,410
21600438412,drug_era group during day -30 through 0 days relative to index: OTHER ANTIHYPERTENSIVES,412
21600438413,drug_era group during day 0 through 0 days relative to index: OTHER ANTIHYPERTENSIVES,413
21600447410,drug_era group during day -365 through 0 days relative to index: Antihypertensives for pulmonary arterial hypertension,410
21600447412,drug_era group during day -30 through 0 days relative to index: Antihypertensives for pulmonary arterial hypertension,412
21600447413,drug_era group during day 0 through 0 days relative to index: Antihypertensives for pulmonary arterial hypertension,413
21600482410,drug_era group during day -365 through 0 days relative to index: PROPULSIVES,410
21600482412,drug_era group during day -30 through 0 days relative to index: PROPULSIVES,412
21600482413,drug_era group during day 0 through 0 days relative to index: PROPULSIVES,413
21600483410,drug_era group during day -365 through 0 days relative to index: Propulsives,410
21600483412,drug_era group during day -30 through 0 days relative to index: Propulsives,412
21600483413,drug_era group during day 0 through 0 days relative to index: Propulsives,413
21600490410,drug_era group during day -365 through 0 days relative to index: ANTIEMETICS AND ANTINAUSEANTS,410
21600490412,drug_era group during day -30 through 0 days relative to index: ANTIEMETICS AND ANTINAUSEANTS,412
21600490413,drug_era group during day 0 through 0 days relative to index: ANTIEMETICS AND ANTINAUSEANTS,413
21600491410,drug_era group during day -365 through 0 days relative to index: ANTIEMETICS AND ANTINAUSEANTS,410
21600491412,drug_era group during day -30 through 0 days relative to index: ANTIEMETICS AND ANTINAUSEANTS,412
21600491413,drug_era group during day 0 through 0 days relative to index: ANTIEMETICS AND ANTINAUSEANTS,413
21600492410,drug_era group during day -365 through 0 days relative to index: Serotonin (5HT3) antagonists,410
21600492412,drug_era group during day -30 through 0 days relative to index: Serotonin (5HT3) antagonists,412
21600492413,drug_era group during day 0 through 0 days relative to index: Serotonin (5HT3) antagonists,413
21600509410,drug_era group during day -365 through 0 days relative to index: BILE AND LIVER THERAPY,410
21600509412,drug_era group during day -30 through 0 days relative to index: BILE AND LIVER THERAPY,412
21600509413,drug_era group during day 0 through 0 days relative to index: BILE AND LIVER THERAPY,413
21600510410,drug_era group during day -365 through 0 days relative to index: BILE THERAPY,410
21600510412,drug_era group during day -30 through 0 days relative to index: BILE THERAPY,412
21600510413,drug_era group during day 0 through 0 days relative to index: BILE THERAPY,413
21600511410,drug_era group during day -365 through 0 days relative to index: Bile acids and derivatives,410
21600511412,drug_era group during day -30 through 0 days relative to index: Bile acids and derivatives,412
21600511413,drug_era group during day 0 through 0 days relative to index: Bile acids and derivatives,413
21600521410,"drug_era group during day -365 through 0 days relative to index: LIVER THERAPY, LIPOTROPICS",410
21600522410,drug_era group during day -365 through 0 days relative to index: Liver therapy,410
21600531410,drug_era group during day -365 through 0 days relative to index: DRUGS FOR CONSTIPATION,410
21600531412,drug_era group during day -30 through 0 days relative to index: DRUGS FOR CONSTIPATION,412
21600531413,drug_era group during day 0 through 0 days relative to index: DRUGS FOR CONSTIPATION,413
21600532410,drug_era group during day -365 through 0 days relative to index: DRUGS FOR CONSTIPATION,410
21600532412,drug_era group during day -30 through 0 days relative to index: DRUGS FOR CONSTIPATION,412
21600532413,drug_era group during day 0 through 0 days relative to index: DRUGS FOR CONSTIPATION,413
21600533410,"drug_era group during day -365 through 0 days relative to index: Softeners, emollients",410
21600533412,"drug_era group during day -30 through 0 days relative to index: Softeners, emollients",412
21600533413,"drug_era group during day 0 through 0 days relative to index: Softeners, emollients",413
21600537410,drug_era group during day -365 through 0 days relative to index: Contact laxatives,410
21600554410,drug_era group during day -365 through 0 days relative to index: Bulk-forming laxatives,410
21600565410,drug_era group during day -365 through 0 days relative to index: Osmotically acting laxatives,410
21600565412,drug_era group during day -30 through 0 days relative to index: Osmotically acting laxatives,412
21600565413,drug_era group during day 0 through 0 days relative to index: Osmotically acting laxatives,413
21600600410,"drug_era group during day -365 through 0 days relative to index: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",410
21600600412,"drug_era group during day -30 through 0 days relative to index: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",412
21600600413,"drug_era group during day 0 through 0 days relative to index: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",413
21600601410,drug_era group during day -365 through 0 days relative to index: INTESTINAL ANTIINFECTIVES,410
21600601412,drug_era group during day -30 through 0 days relative to index: INTESTINAL ANTIINFECTIVES,412
21600601413,drug_era group during day 0 through 0 days relative to index: INTESTINAL ANTIINFECTIVES,413
21600602410,drug_era group during day -365 through 0 days relative to index: Antibiotics,410
21600602412,drug_era group during day -30 through 0 days relative to index: Antibiotics,412
21600602413,drug_era group during day 0 through 0 days relative to index: Antibiotics,413
21600642410,drug_era group during day -365 through 0 days relative to index: ANTIPROPULSIVES,410
21600643410,drug_era group during day -365 through 0 days relative to index: Antipropulsives,410
21600651410,drug_era group during day -365 through 0 days relative to index: INTESTINAL ANTIINFLAMMATORY AGENTS,410
21600651412,drug_era group during day -30 through 0 days relative to index: INTESTINAL ANTIINFLAMMATORY AGENTS,412
21600651413,drug_era group during day 0 through 0 days relative to index: INTESTINAL ANTIINFLAMMATORY AGENTS,413
21600652410,drug_era group during day -365 through 0 days relative to index: Corticosteroids acting locally,410
21600652412,drug_era group during day -30 through 0 days relative to index: Corticosteroids acting locally,412
21600652413,drug_era group during day 0 through 0 days relative to index: Corticosteroids acting locally,413
21600697410,"drug_era group during day -365 through 0 days relative to index: DIGESTIVES, INCL. ENZYMES",410
21600698410,"drug_era group during day -365 through 0 days relative to index: DIGESTIVES, INCL. ENZYMES",410
21600704410,drug_era group during day -365 through 0 days relative to index: Acid preparations,410
21600712410,drug_era group during day -365 through 0 days relative to index: DRUGS USED IN DIABETES,410
21600712412,drug_era group during day -30 through 0 days relative to index: DRUGS USED IN DIABETES,412
21600712413,drug_era group during day 0 through 0 days relative to index: DRUGS USED IN DIABETES,413
21600713410,drug_era group during day -365 through 0 days relative to index: INSULINS AND ANALOGUES,410
21600713412,drug_era group during day -30 through 0 days relative to index: INSULINS AND ANALOGUES,412
21600714410,"drug_era group during day -365 through 0 days relative to index: Insulins and analogues for injection, fast-acting",410
21600722410,"drug_era group during day -365 through 0 days relative to index: Insulins and analogues for injection, intermediate-acting",410
21600728410,"drug_era group during day -365 through 0 days relative to index: Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting",410
21600735410,"drug_era group during day -365 through 0 days relative to index: Insulins and analogues for injection, long-acting",410
21600735412,"drug_era group during day -30 through 0 days relative to index: Insulins and analogues for injection, long-acting",412
21600744410,"drug_era group during day -365 through 0 days relative to index: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",410
21600744412,"drug_era group during day -30 through 0 days relative to index: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",412
21600744413,"drug_era group during day 0 through 0 days relative to index: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",413
21600749410,drug_era group during day -365 through 0 days relative to index: Sulfonylureas,410
21600749412,drug_era group during day -30 through 0 days relative to index: Sulfonylureas,412
21600749413,drug_era group during day 0 through 0 days relative to index: Sulfonylureas,413
21600779410,drug_era group during day -365 through 0 days relative to index: Thiazolidinediones,410
21600779412,drug_era group during day -30 through 0 days relative to index: Thiazolidinediones,412
21600779413,drug_era group during day 0 through 0 days relative to index: Thiazolidinediones,413
21600783410,drug_era group during day -365 through 0 days relative to index: Dipeptidyl peptidase 4 (DPP-4) inhibitors,410
21600783412,drug_era group during day -30 through 0 days relative to index: Dipeptidyl peptidase 4 (DPP-4) inhibitors,412
21600783413,drug_era group during day 0 through 0 days relative to index: Dipeptidyl peptidase 4 (DPP-4) inhibitors,413
21600788410,"drug_era group during day -365 through 0 days relative to index: Other blood glucose lowering drugs, excl. insulins",410
21600800410,drug_era group during day -365 through 0 days relative to index: VITAMINS,410
21600800412,drug_era group during day -30 through 0 days relative to index: VITAMINS,412
21600800413,drug_era group during day 0 through 0 days relative to index: VITAMINS,413
21600810410,"drug_era group during day -365 through 0 days relative to index: VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",410
21600810412,"drug_era group during day -30 through 0 days relative to index: VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",412
21600810413,"drug_era group during day 0 through 0 days relative to index: VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",413
21600811410,"drug_era group during day -365 through 0 days relative to index: Vitamin A, plain",410
21600815410,drug_era group during day -365 through 0 days relative to index: Vitamin D and analogues,410
21600815412,drug_era group during day -30 through 0 days relative to index: Vitamin D and analogues,412
21600815413,drug_era group during day 0 through 0 days relative to index: Vitamin D and analogues,413
21600823410,"drug_era group during day -365 through 0 days relative to index: VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12",410
21600823412,"drug_era group during day -30 through 0 days relative to index: VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12",412
21600823413,"drug_era group during day 0 through 0 days relative to index: VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12",413
21600824410,"drug_era group during day -365 through 0 days relative to index: Vitamin B1, plain",410
21600824412,"drug_era group during day -30 through 0 days relative to index: Vitamin B1, plain",412
21600824413,"drug_era group during day 0 through 0 days relative to index: Vitamin B1, plain",413
21600835410,"drug_era group during day -365 through 0 days relative to index: ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS",410
21600835412,"drug_era group during day -30 through 0 days relative to index: ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS",412
21600835413,"drug_era group during day 0 through 0 days relative to index: ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS",413
21600836410,"drug_era group during day -365 through 0 days relative to index: Ascorbic acid (vitamin C), plain",410
21600836412,"drug_era group during day -30 through 0 days relative to index: Ascorbic acid (vitamin C), plain",412
21600836413,"drug_era group during day 0 through 0 days relative to index: Ascorbic acid (vitamin C), plain",413
21600840410,drug_era group during day -365 through 0 days relative to index: OTHER PLAIN VITAMIN PREPARATIONS,410
21600840412,drug_era group during day -30 through 0 days relative to index: OTHER PLAIN VITAMIN PREPARATIONS,412
21600840413,drug_era group during day 0 through 0 days relative to index: OTHER PLAIN VITAMIN PREPARATIONS,413
21600841410,drug_era group during day -365 through 0 days relative to index: Other plain vitamin preparations,410
21600841412,drug_era group during day -30 through 0 days relative to index: Other plain vitamin preparations,412
21600841413,drug_era group during day 0 through 0 days relative to index: Other plain vitamin preparations,413
21600857410,drug_era group during day -365 through 0 days relative to index: MINERAL SUPPLEMENTS,410
21600857412,drug_era group during day -30 through 0 days relative to index: MINERAL SUPPLEMENTS,412
21600857413,drug_era group during day 0 through 0 days relative to index: MINERAL SUPPLEMENTS,413
21600858410,drug_era group during day -365 through 0 days relative to index: CALCIUM,410
21600858412,drug_era group during day -30 through 0 days relative to index: CALCIUM,412
21600858413,drug_era group during day 0 through 0 days relative to index: CALCIUM,413
21600859410,drug_era group during day -365 through 0 days relative to index: Calcium,410
21600859412,drug_era group during day -30 through 0 days relative to index: Calcium,412
21600859413,drug_era group during day 0 through 0 days relative to index: Calcium,413
21600884410,drug_era group during day -365 through 0 days relative to index: OTHER MINERAL SUPPLEMENTS,410
21600884412,drug_era group during day -30 through 0 days relative to index: OTHER MINERAL SUPPLEMENTS,412
21600884413,drug_era group during day 0 through 0 days relative to index: OTHER MINERAL SUPPLEMENTS,413
21600885410,drug_era group during day -365 through 0 days relative to index: Sodium,410
21600885412,drug_era group during day -30 through 0 days relative to index: Sodium,412
21600885413,drug_era group during day 0 through 0 days relative to index: Sodium,413
21600888410,drug_era group during day -365 through 0 days relative to index: Zinc,410
21600888412,drug_era group during day -30 through 0 days relative to index: Zinc,412
21600888413,drug_era group during day 0 through 0 days relative to index: Zinc,413
21600892410,drug_era group during day -365 through 0 days relative to index: Magnesium,410
21600892412,drug_era group during day -30 through 0 days relative to index: Magnesium,412
21600892413,drug_era group during day 0 through 0 days relative to index: Magnesium,413
21600932410,drug_era group during day -365 through 0 days relative to index: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,410
21600933410,drug_era group during day -365 through 0 days relative to index: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,410
21600934410,drug_era group during day -365 through 0 days relative to index: Amino acids and derivatives,410
21600959410,drug_era group during day -365 through 0 days relative to index: BLOOD AND BLOOD FORMING ORGANS,410
21600959412,drug_era group during day -30 through 0 days relative to index: BLOOD AND BLOOD FORMING ORGANS,412
21600959413,drug_era group during day 0 through 0 days relative to index: BLOOD AND BLOOD FORMING ORGANS,413
21600960410,drug_era group during day -365 through 0 days relative to index: ANTITHROMBOTIC AGENTS,410
21600960412,drug_era group during day -30 through 0 days relative to index: ANTITHROMBOTIC AGENTS,412
21600960413,drug_era group during day 0 through 0 days relative to index: ANTITHROMBOTIC AGENTS,413
21600961410,drug_era group during day -365 through 0 days relative to index: ANTITHROMBOTIC AGENTS,410
21600961412,drug_era group during day -30 through 0 days relative to index: ANTITHROMBOTIC AGENTS,412
21600961413,drug_era group during day 0 through 0 days relative to index: ANTITHROMBOTIC AGENTS,413
21600962410,drug_era group during day -365 through 0 days relative to index: Vitamin K antagonists,410
21600972410,drug_era group during day -365 through 0 days relative to index: Heparin group,410
21600972412,drug_era group during day -30 through 0 days relative to index: Heparin group,412
21600972413,drug_era group during day 0 through 0 days relative to index: Heparin group,413
21600985410,drug_era group during day -365 through 0 days relative to index: Platelet aggregation inhibitors excl. heparin,410
21600985412,drug_era group during day -30 through 0 days relative to index: Platelet aggregation inhibitors excl. heparin,412
21600985413,drug_era group during day 0 through 0 days relative to index: Platelet aggregation inhibitors excl. heparin,413
21601006410,drug_era group during day -365 through 0 days relative to index: Enzymes,410
21601032410,drug_era group during day -365 through 0 days relative to index: ANTIHEMORRHAGICS,410
21601033410,drug_era group during day -365 through 0 days relative to index: ANTIFIBRINOLYTICS,410
21601034410,drug_era group during day -365 through 0 days relative to index: Amino acids,410
21601038410,drug_era group during day -365 through 0 days relative to index: Proteinase inhibitors,410
21601043410,drug_era group during day -365 through 0 days relative to index: VITAMIN K AND OTHER HEMOSTATICS,410
21601044410,drug_era group during day -365 through 0 days relative to index: Vitamin K,410
21601077410,drug_era group during day -365 through 0 days relative to index: ANTIANEMIC PREPARATIONS,410
21601077412,drug_era group during day -30 through 0 days relative to index: ANTIANEMIC PREPARATIONS,412
21601077413,drug_era group during day 0 through 0 days relative to index: ANTIANEMIC PREPARATIONS,413
21601078410,drug_era group during day -365 through 0 days relative to index: IRON PREPARATIONS,410
21601078412,drug_era group during day -30 through 0 days relative to index: IRON PREPARATIONS,412
21601078413,drug_era group during day 0 through 0 days relative to index: IRON PREPARATIONS,413
21601079410,"drug_era group during day -365 through 0 days relative to index: Iron bivalent, oral preparations",410
21601079412,"drug_era group during day -30 through 0 days relative to index: Iron bivalent, oral preparations",412
21601079413,"drug_era group during day 0 through 0 days relative to index: Iron bivalent, oral preparations",413
21601091410,"drug_era group during day -365 through 0 days relative to index: Iron trivalent, oral preparations",410
21601091412,"drug_era group during day -30 through 0 days relative to index: Iron trivalent, oral preparations",412
21601101410,"drug_era group during day -365 through 0 days relative to index: Iron, parenteral preparations",410
21601101412,"drug_era group during day -30 through 0 days relative to index: Iron, parenteral preparations",412
21601119410,drug_era group during day -365 through 0 days relative to index: VITAMIN B12 AND FOLIC ACID,410
21601119412,drug_era group during day -30 through 0 days relative to index: VITAMIN B12 AND FOLIC ACID,412
21601119413,drug_era group during day 0 through 0 days relative to index: VITAMIN B12 AND FOLIC ACID,413
21601128410,drug_era group during day -365 through 0 days relative to index: Folic acid and derivatives,410
21601128412,drug_era group during day -30 through 0 days relative to index: Folic acid and derivatives,412
21601128413,drug_era group during day 0 through 0 days relative to index: Folic acid and derivatives,413
21601131410,drug_era group during day -365 through 0 days relative to index: OTHER ANTIANEMIC PREPARATIONS,410
21601131412,drug_era group during day -30 through 0 days relative to index: OTHER ANTIANEMIC PREPARATIONS,412
21601131413,drug_era group during day 0 through 0 days relative to index: OTHER ANTIANEMIC PREPARATIONS,413
21601132410,drug_era group during day -365 through 0 days relative to index: Other antianemic preparations,410
21601132412,drug_era group during day -30 through 0 days relative to index: Other antianemic preparations,412
21601132413,drug_era group during day 0 through 0 days relative to index: Other antianemic preparations,413
21601136410,drug_era group during day -365 through 0 days relative to index: BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,410
21601136412,drug_era group during day -30 through 0 days relative to index: BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,412
21601136413,drug_era group during day 0 through 0 days relative to index: BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,413
21601137410,drug_era group during day -365 through 0 days relative to index: BLOOD AND RELATED PRODUCTS,410
21601138410,drug_era group during day -365 through 0 days relative to index: Blood substitutes and plasma protein fractions,410
21601153410,drug_era group during day -365 through 0 days relative to index: I.V. SOLUTIONS,410
21601153412,drug_era group during day -30 through 0 days relative to index: I.V. SOLUTIONS,412
21601153413,drug_era group during day 0 through 0 days relative to index: I.V. SOLUTIONS,413
21601154410,drug_era group during day -365 through 0 days relative to index: Solutions for parenteral nutrition,410
21601154412,drug_era group during day -30 through 0 days relative to index: Solutions for parenteral nutrition,412
21601154413,drug_era group during day 0 through 0 days relative to index: Solutions for parenteral nutrition,413
21601160410,drug_era group during day -365 through 0 days relative to index: Solutions affecting the electrolyte balance,410
21601160412,drug_era group during day -30 through 0 days relative to index: Solutions affecting the electrolyte balance,412
21601160413,drug_era group during day 0 through 0 days relative to index: Solutions affecting the electrolyte balance,413
21601167410,drug_era group during day -365 through 0 days relative to index: IRRIGATING SOLUTIONS,410
21601167412,drug_era group during day -30 through 0 days relative to index: IRRIGATING SOLUTIONS,412
21601167413,drug_era group during day 0 through 0 days relative to index: IRRIGATING SOLUTIONS,413
21601179410,drug_era group during day -365 through 0 days relative to index: Salt solutions,410
21601179412,drug_era group during day -30 through 0 days relative to index: Salt solutions,412
21601179413,drug_era group during day 0 through 0 days relative to index: Salt solutions,413
21601194410,drug_era group during day -365 through 0 days relative to index: I.V. SOLUTION ADDITIVES,410
21601194412,drug_era group during day -30 through 0 days relative to index: I.V. SOLUTION ADDITIVES,412
21601194413,drug_era group during day 0 through 0 days relative to index: I.V. SOLUTION ADDITIVES,413
21601195410,drug_era group during day -365 through 0 days relative to index: Electrolyte solutions,410
21601195412,drug_era group during day -30 through 0 days relative to index: Electrolyte solutions,412
21601195413,drug_era group during day 0 through 0 days relative to index: Electrolyte solutions,413
21601215410,drug_era group during day -365 through 0 days relative to index: Amino acids,410
21601225410,drug_era group during day -365 through 0 days relative to index: OTHER HEMATOLOGICAL AGENTS,410
21601226410,drug_era group during day -365 through 0 days relative to index: OTHER HEMATOLOGICAL AGENTS,410
21601227410,drug_era group during day -365 through 0 days relative to index: Enzymes,410
21601237410,drug_era group during day -365 through 0 days relative to index: CARDIOVASCULAR SYSTEM,410
21601237412,drug_era group during day -30 through 0 days relative to index: CARDIOVASCULAR SYSTEM,412
21601237413,drug_era group during day 0 through 0 days relative to index: CARDIOVASCULAR SYSTEM,413
21601238410,drug_era group during day -365 through 0 days relative to index: CARDIAC THERAPY,410
21601238412,drug_era group during day -30 through 0 days relative to index: CARDIAC THERAPY,412
21601238413,drug_era group during day 0 through 0 days relative to index: CARDIAC THERAPY,413
21601239410,drug_era group during day -365 through 0 days relative to index: CARDIAC GLYCOSIDES,410
21601239412,drug_era group during day -30 through 0 days relative to index: CARDIAC GLYCOSIDES,412
21601239413,drug_era group during day 0 through 0 days relative to index: CARDIAC GLYCOSIDES,413
21601240410,drug_era group during day -365 through 0 days relative to index: Digitalis glycosides,410
21601240412,drug_era group during day -30 through 0 days relative to index: Digitalis glycosides,412
21601240413,drug_era group during day 0 through 0 days relative to index: Digitalis glycosides,413
21601245410,drug_era group during day -365 through 0 days relative to index: IMMUNE SERA AND IMMUNOGLOBULINS,410
21601254410,drug_era group during day -365 through 0 days relative to index: IMMUNOGLOBULINS,410
21601258410,drug_era group during day -365 through 0 days relative to index: Specific immunoglobulins,410
21601386410,drug_era group during day -365 through 0 days relative to index: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,410
21601386412,drug_era group during day -30 through 0 days relative to index: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,412
21601386413,drug_era group during day 0 through 0 days relative to index: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,413
21601387410,drug_era group during day -365 through 0 days relative to index: ANTINEOPLASTIC AGENTS,410
21601387412,drug_era group during day -30 through 0 days relative to index: ANTINEOPLASTIC AGENTS,412
21601387413,drug_era group during day 0 through 0 days relative to index: ANTINEOPLASTIC AGENTS,413
21601421410,drug_era group during day -365 through 0 days relative to index: ANTIMETABOLITES,410
21601421412,drug_era group during day -30 through 0 days relative to index: ANTIMETABOLITES,412
21601421413,drug_era group during day 0 through 0 days relative to index: ANTIMETABOLITES,413
21601422410,drug_era group during day -365 through 0 days relative to index: Folic acid analogues,410
21601422412,drug_era group during day -30 through 0 days relative to index: Folic acid analogues,412
21601422413,drug_era group during day 0 through 0 days relative to index: Folic acid analogues,413
21601434410,drug_era group during day -365 through 0 days relative to index: Pyrimidine analogues,410
21601445410,drug_era group during day -365 through 0 days relative to index: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,410
21601452410,drug_era group during day -365 through 0 days relative to index: Podophyllotoxin derivatives,410
21601461410,drug_era group during day -365 through 0 days relative to index: DIURETICS,410
21601461412,drug_era group during day -30 through 0 days relative to index: DIURETICS,412
21601461413,drug_era group during day 0 through 0 days relative to index: DIURETICS,413
21601462410,"drug_era group during day -365 through 0 days relative to index: LOW-CEILING DIURETICS, THIAZIDES",410
21601463410,"drug_era group during day -365 through 0 days relative to index: Thiazides, plain",410
21601516410,drug_era group during day -365 through 0 days relative to index: HIGH-CEILING DIURETICS,410
21601516412,drug_era group during day -30 through 0 days relative to index: HIGH-CEILING DIURETICS,412
21601516413,drug_era group during day 0 through 0 days relative to index: HIGH-CEILING DIURETICS,413
21601517410,"drug_era group during day -365 through 0 days relative to index: Sulfonamides, plain",410
21601517412,"drug_era group during day -30 through 0 days relative to index: Sulfonamides, plain",412
21601517413,"drug_era group during day 0 through 0 days relative to index: Sulfonamides, plain",413
21601605410,drug_era group during day -365 through 0 days relative to index: VASOPROTECTIVES,410
21601605412,drug_era group during day -30 through 0 days relative to index: VASOPROTECTIVES,412
21601605413,drug_era group during day 0 through 0 days relative to index: VASOPROTECTIVES,413
21601606410,drug_era group during day -365 through 0 days relative to index: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,410
21601606412,drug_era group during day -30 through 0 days relative to index: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,412
21601606413,drug_era group during day 0 through 0 days relative to index: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,413
21601625410,drug_era group during day -365 through 0 days relative to index: Muscle relaxants,410
21601625412,drug_era group during day -30 through 0 days relative to index: Muscle relaxants,412
21601625413,drug_era group during day 0 through 0 days relative to index: Muscle relaxants,413
21601664410,drug_era group during day -365 through 0 days relative to index: BETA BLOCKING AGENTS,410
21601664412,drug_era group during day -30 through 0 days relative to index: BETA BLOCKING AGENTS,412
21601664413,drug_era group during day 0 through 0 days relative to index: BETA BLOCKING AGENTS,413
21601665410,drug_era group during day -365 through 0 days relative to index: BETA BLOCKING AGENTS,410
21601665412,drug_era group during day -30 through 0 days relative to index: BETA BLOCKING AGENTS,412
21601665413,drug_era group during day 0 through 0 days relative to index: BETA BLOCKING AGENTS,413
21601666410,"drug_era group during day -365 through 0 days relative to index: Beta blocking agents, non-selective",410
21601666412,"drug_era group during day -30 through 0 days relative to index: Beta blocking agents, non-selective",412
21601682410,"drug_era group during day -365 through 0 days relative to index: Beta blocking agents, selective",410
21601682412,"drug_era group during day -30 through 0 days relative to index: Beta blocking agents, selective",412
21601682413,"drug_era group during day 0 through 0 days relative to index: Beta blocking agents, selective",413
21601698410,drug_era group during day -365 through 0 days relative to index: Alpha and beta blocking agents,410
21601698412,drug_era group during day -30 through 0 days relative to index: Alpha and beta blocking agents,412
21601698413,drug_era group during day 0 through 0 days relative to index: Alpha and beta blocking agents,413
21601744410,drug_era group during day -365 through 0 days relative to index: CALCIUM CHANNEL BLOCKERS,410
21601744412,drug_era group during day -30 through 0 days relative to index: CALCIUM CHANNEL BLOCKERS,412
21601744413,drug_era group during day 0 through 0 days relative to index: CALCIUM CHANNEL BLOCKERS,413
21601745410,drug_era group during day -365 through 0 days relative to index: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,410
21601745412,drug_era group during day -30 through 0 days relative to index: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,412
21601745413,drug_era group during day 0 through 0 days relative to index: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,413
21601746410,drug_era group during day -365 through 0 days relative to index: Dihydropyridine derivatives,410
21601746412,drug_era group during day -30 through 0 days relative to index: Dihydropyridine derivatives,412
21601746413,drug_era group during day 0 through 0 days relative to index: Dihydropyridine derivatives,413
21601765410,drug_era group during day -365 through 0 days relative to index: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS,410
21601765412,drug_era group during day -30 through 0 days relative to index: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS,412
21601765413,drug_era group during day 0 through 0 days relative to index: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS,413
21601766410,drug_era group during day -365 through 0 days relative to index: Phenylalkylamine derivatives,410
21601770410,drug_era group during day -365 through 0 days relative to index: Benzothiazepine derivatives,410
21601770412,drug_era group during day -30 through 0 days relative to index: Benzothiazepine derivatives,412
21601770413,drug_era group during day 0 through 0 days relative to index: Benzothiazepine derivatives,413
21601782410,drug_era group during day -365 through 0 days relative to index: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,410
21601782412,drug_era group during day -30 through 0 days relative to index: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,412
21601782413,drug_era group during day 0 through 0 days relative to index: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,413
21601783410,"drug_era group during day -365 through 0 days relative to index: ACE INHIBITORS, PLAIN",410
21601783412,"drug_era group during day -30 through 0 days relative to index: ACE INHIBITORS, PLAIN",412
21601783413,"drug_era group during day 0 through 0 days relative to index: ACE INHIBITORS, PLAIN",413
21601784410,"drug_era group during day -365 through 0 days relative to index: ACE inhibitors, plain",410
21601784412,"drug_era group during day -30 through 0 days relative to index: ACE inhibitors, plain",412
21601784413,"drug_era group during day 0 through 0 days relative to index: ACE inhibitors, plain",413
21601822410,"drug_era group during day -365 through 0 days relative to index: ANGIOTENSIN II ANTAGONISTS, PLAIN",410
21601822412,"drug_era group during day -30 through 0 days relative to index: ANGIOTENSIN II ANTAGONISTS, PLAIN",412
21601822413,"drug_era group during day 0 through 0 days relative to index: ANGIOTENSIN II ANTAGONISTS, PLAIN",413
21601823410,"drug_era group during day -365 through 0 days relative to index: Angiotensin II antagonists, plain",410
21601823412,"drug_era group during day -30 through 0 days relative to index: Angiotensin II antagonists, plain",412
21601823413,"drug_era group during day 0 through 0 days relative to index: Angiotensin II antagonists, plain",413
21601853410,drug_era group during day -365 through 0 days relative to index: LIPID MODIFYING AGENTS,410
21601853412,drug_era group during day -30 through 0 days relative to index: LIPID MODIFYING AGENTS,412
21601853413,drug_era group during day 0 through 0 days relative to index: LIPID MODIFYING AGENTS,413
21601854410,"drug_era group during day -365 through 0 days relative to index: LIPID MODIFYING AGENTS, PLAIN",410
21601854412,"drug_era group during day -30 through 0 days relative to index: LIPID MODIFYING AGENTS, PLAIN",412
21601854413,"drug_era group during day 0 through 0 days relative to index: LIPID MODIFYING AGENTS, PLAIN",413
21601855410,drug_era group during day -365 through 0 days relative to index: HMG CoA reductase inhibitors,410
21601855412,drug_era group during day -30 through 0 days relative to index: HMG CoA reductase inhibitors,412
21601855413,drug_era group during day 0 through 0 days relative to index: HMG CoA reductase inhibitors,413
21601888410,drug_era group during day -365 through 0 days relative to index: Other lipid modifying agents,410
21601907410,drug_era group during day -365 through 0 days relative to index: DERMATOLOGICALS,410
21601907412,drug_era group during day -30 through 0 days relative to index: DERMATOLOGICALS,412
21601907413,drug_era group during day 0 through 0 days relative to index: DERMATOLOGICALS,413
21602002410,"drug_era group during day -365 through 0 days relative to index: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",410
21602003410,"drug_era group during day -365 through 0 days relative to index: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",410
21602019410,drug_era group during day -365 through 0 days relative to index: Anesthetics for topical use,410
21602028410,drug_era group during day -365 through 0 days relative to index: ANTIPSORIATICS,410
21602028412,drug_era group during day -30 through 0 days relative to index: ANTIPSORIATICS,412
21602029410,drug_era group during day -365 through 0 days relative to index: ANTIPSORIATICS FOR TOPICAL USE,410
21602029412,drug_era group during day -30 through 0 days relative to index: ANTIPSORIATICS FOR TOPICAL USE,412
21602037410,drug_era group during day -365 through 0 days relative to index: Other antipsoriatics for topical use,410
21602037412,drug_era group during day -30 through 0 days relative to index: Other antipsoriatics for topical use,412
21602054410,drug_era group during day -365 through 0 days relative to index: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,410
21602054412,drug_era group during day -30 through 0 days relative to index: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,412
21602055410,drug_era group during day -365 through 0 days relative to index: ANTIBIOTICS FOR TOPICAL USE,410
21602055412,drug_era group during day -30 through 0 days relative to index: ANTIBIOTICS FOR TOPICAL USE,412
21602061410,drug_era group during day -365 through 0 days relative to index: Other antibiotics for topical use,410
21602061412,drug_era group during day -30 through 0 days relative to index: Other antibiotics for topical use,412
21602073410,drug_era group during day -365 through 0 days relative to index: CHEMOTHERAPEUTICS FOR TOPICAL USE,410
21602073412,drug_era group during day -30 through 0 days relative to index: CHEMOTHERAPEUTICS FOR TOPICAL USE,412
21602082410,drug_era group during day -365 through 0 days relative to index: Antivirals,410
21602082412,drug_era group during day -30 through 0 days relative to index: Antivirals,412
21602095410,drug_era group during day -365 through 0 days relative to index: Other chemotherapeutics,410
21602095412,drug_era group during day -30 through 0 days relative to index: Other chemotherapeutics,412
21602098410,"drug_era group during day -365 through 0 days relative to index: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",410
21602099410,"drug_era group during day -365 through 0 days relative to index: CORTICOSTEROIDS, PLAIN",410
21602100410,"drug_era group during day -365 through 0 days relative to index: Corticosteroids, weak (group I)",410
21602104410,"drug_era group during day -365 through 0 days relative to index: Corticosteroids, moderately potent (group II)",410
21602119410,"drug_era group during day -365 through 0 days relative to index: Corticosteroids, potent (group III)",410
21602195410,drug_era group during day -365 through 0 days relative to index: ANTISEPTICS AND DISINFECTANTS,410
21602195412,drug_era group during day -30 through 0 days relative to index: ANTISEPTICS AND DISINFECTANTS,412
21602195413,drug_era group during day 0 through 0 days relative to index: ANTISEPTICS AND DISINFECTANTS,413
21602196410,drug_era group during day -365 through 0 days relative to index: ANTISEPTICS AND DISINFECTANTS,410
21602196412,drug_era group during day -30 through 0 days relative to index: ANTISEPTICS AND DISINFECTANTS,412
21602196413,drug_era group during day 0 through 0 days relative to index: ANTISEPTICS AND DISINFECTANTS,413
21602202410,drug_era group during day -365 through 0 days relative to index: Biguanides and amidines,410
21602202412,drug_era group during day -30 through 0 days relative to index: Biguanides and amidines,412
21602202413,drug_era group during day 0 through 0 days relative to index: Biguanides and amidines,413
21602359410,drug_era group during day -365 through 0 days relative to index: GENITO URINARY SYSTEM AND SEX HORMONES,410
21602359412,drug_era group during day -30 through 0 days relative to index: GENITO URINARY SYSTEM AND SEX HORMONES,412
21602359413,drug_era group during day 0 through 0 days relative to index: GENITO URINARY SYSTEM AND SEX HORMONES,413
21602360410,drug_era group during day -365 through 0 days relative to index: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,410
21602361410,"drug_era group during day -365 through 0 days relative to index: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",410
21602384410,drug_era group during day -365 through 0 days relative to index: Organic acids,410
21602627410,drug_era group during day -365 through 0 days relative to index: UROLOGICALS,410
21602627412,drug_era group during day -30 through 0 days relative to index: UROLOGICALS,412
21602627413,drug_era group during day 0 through 0 days relative to index: UROLOGICALS,413
21602628410,drug_era group during day -365 through 0 days relative to index: UROLOGICALS,410
21602628412,drug_era group during day -30 through 0 days relative to index: UROLOGICALS,412
21602628413,drug_era group during day 0 through 0 days relative to index: UROLOGICALS,413
21602629410,drug_era group during day -365 through 0 days relative to index: Acidifiers,410
21602629412,drug_era group during day -30 through 0 days relative to index: Acidifiers,412
21602629413,drug_era group during day 0 through 0 days relative to index: Acidifiers,413
21602633410,drug_era group during day -365 through 0 days relative to index: Drugs for urinary frequency and incontinence,410
21602645410,drug_era group during day -365 through 0 days relative to index: Drugs used in erectile dysfunction,410
21602645412,drug_era group during day -30 through 0 days relative to index: Drugs used in erectile dysfunction,412
21602666410,drug_era group during day -365 through 0 days relative to index: DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,410
21602666412,drug_era group during day -30 through 0 days relative to index: DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,412
21602667410,drug_era group during day -365 through 0 days relative to index: Alpha-adrenoreceptor antagonists,410
21602667412,drug_era group during day -30 through 0 days relative to index: Alpha-adrenoreceptor antagonists,412
21602674410,drug_era group during day -365 through 0 days relative to index: Testosterone-5-alpha reductase inhibitors,410
21602674412,drug_era group during day -30 through 0 days relative to index: Testosterone-5-alpha reductase inhibitors,412
21602681410,"drug_era group during day -365 through 0 days relative to index: SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",410
21602681412,"drug_era group during day -30 through 0 days relative to index: SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",412
21602681413,"drug_era group during day 0 through 0 days relative to index: SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",413
21602682410,drug_era group during day -365 through 0 days relative to index: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,410
21602683410,drug_era group during day -365 through 0 days relative to index: ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,410
21602684410,drug_era group during day -365 through 0 days relative to index: ACTH,410
21602722410,drug_era group during day -365 through 0 days relative to index: CORTICOSTEROIDS FOR SYSTEMIC USE,410
21602722412,drug_era group during day -30 through 0 days relative to index: CORTICOSTEROIDS FOR SYSTEMIC USE,412
21602722413,drug_era group during day 0 through 0 days relative to index: CORTICOSTEROIDS FOR SYSTEMIC USE,413
21602723410,"drug_era group during day -365 through 0 days relative to index: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",410
21602723412,"drug_era group during day -30 through 0 days relative to index: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",412
21602723413,"drug_era group during day 0 through 0 days relative to index: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",413
21602724410,drug_era group during day -365 through 0 days relative to index: Mineralocorticoids,410
21602724412,drug_era group during day -30 through 0 days relative to index: Mineralocorticoids,412
21602724413,drug_era group during day 0 through 0 days relative to index: Mineralocorticoids,413
21602728410,drug_era group during day -365 through 0 days relative to index: Glucocorticoids,410
21602728412,drug_era group during day -30 through 0 days relative to index: Glucocorticoids,412
21602728413,drug_era group during day 0 through 0 days relative to index: Glucocorticoids,413
21602779410,drug_era group during day -365 through 0 days relative to index: CALCIUM HOMEOSTASIS,410
21602785410,drug_era group during day -365 through 0 days relative to index: ANTI-PARATHYROID AGENTS,410
21602791410,drug_era group during day -365 through 0 days relative to index: Other anti-parathyroid agents,410
21602795410,drug_era group during day -365 through 0 days relative to index: ANTIINFECTIVES FOR SYSTEMIC USE,410
21602795412,drug_era group during day -30 through 0 days relative to index: ANTIINFECTIVES FOR SYSTEMIC USE,412
21602795413,drug_era group during day 0 through 0 days relative to index: ANTIINFECTIVES FOR SYSTEMIC USE,413
21602796410,drug_era group during day -365 through 0 days relative to index: ANTIBACTERIALS FOR SYSTEMIC USE,410
21602796412,drug_era group during day -30 through 0 days relative to index: ANTIBACTERIALS FOR SYSTEMIC USE,412
21602796413,drug_era group during day 0 through 0 days relative to index: ANTIBACTERIALS FOR SYSTEMIC USE,413
21602797410,drug_era group during day -365 through 0 days relative to index: TETRACYCLINES,410
21602798410,drug_era group during day -365 through 0 days relative to index: Tetracyclines,410
21602818410,"drug_era group during day -365 through 0 days relative to index: BETA-LACTAM ANTIBACTERIALS, PENICILLINS",410
21602818412,"drug_era group during day -30 through 0 days relative to index: BETA-LACTAM ANTIBACTERIALS, PENICILLINS",412
21602818413,"drug_era group during day 0 through 0 days relative to index: BETA-LACTAM ANTIBACTERIALS, PENICILLINS",413
21602819410,drug_era group during day -365 through 0 days relative to index: Penicillins with extended spectrum,410
21602819412,drug_era group during day -30 through 0 days relative to index: Penicillins with extended spectrum,412
21602819413,drug_era group during day 0 through 0 days relative to index: Penicillins with extended spectrum,413
21602858410,drug_era group during day -365 through 0 days relative to index: Beta-lactamase inhibitors,410
21602858412,drug_era group during day -30 through 0 days relative to index: Beta-lactamase inhibitors,412
21602858413,drug_era group during day 0 through 0 days relative to index: Beta-lactamase inhibitors,413
21602868410,drug_era group during day -365 through 0 days relative to index: OTHER BETA-LACTAM ANTIBACTERIALS,410
21602868412,drug_era group during day -30 through 0 days relative to index: OTHER BETA-LACTAM ANTIBACTERIALS,412
21602868413,drug_era group during day 0 through 0 days relative to index: OTHER BETA-LACTAM ANTIBACTERIALS,413
21602869410,drug_era group during day -365 through 0 days relative to index: First-generation cephalosporins,410
21602869412,drug_era group during day -30 through 0 days relative to index: First-generation cephalosporins,412
21602869413,drug_era group during day 0 through 0 days relative to index: First-generation cephalosporins,413
21602882410,drug_era group during day -365 through 0 days relative to index: Second-generation cephalosporins,410
21602882412,drug_era group during day -30 through 0 days relative to index: Second-generation cephalosporins,412
21602882413,drug_era group during day 0 through 0 days relative to index: Second-generation cephalosporins,413
21602894410,drug_era group during day -365 through 0 days relative to index: Third-generation cephalosporins,410
21602894412,drug_era group during day -30 through 0 days relative to index: Third-generation cephalosporins,412
21602894413,drug_era group during day 0 through 0 days relative to index: Third-generation cephalosporins,413
21602914410,drug_era group during day -365 through 0 days relative to index: Fourth-generation cephalosporins,410
21602920410,drug_era group during day -365 through 0 days relative to index: Carbapenems,410
21602968410,"drug_era group during day -365 through 0 days relative to index: MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",410
21602968412,"drug_era group during day -30 through 0 days relative to index: MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",412
21602968413,"drug_era group during day 0 through 0 days relative to index: MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",413
21602969410,drug_era group during day -365 through 0 days relative to index: Macrolides,410
21602969412,drug_era group during day -30 through 0 days relative to index: Macrolides,412
21602969413,drug_era group during day 0 through 0 days relative to index: Macrolides,413
21603006410,drug_era group during day -365 through 0 days relative to index: QUINOLONE ANTIBACTERIALS,410
21603006412,drug_era group during day -30 through 0 days relative to index: QUINOLONE ANTIBACTERIALS,412
21603006413,drug_era group during day 0 through 0 days relative to index: QUINOLONE ANTIBACTERIALS,413
21603007410,drug_era group during day -365 through 0 days relative to index: Fluoroquinolones,410
21603007412,drug_era group during day -30 through 0 days relative to index: Fluoroquinolones,412
21603007413,drug_era group during day 0 through 0 days relative to index: Fluoroquinolones,413
21603071410,drug_era group during day -365 through 0 days relative to index: ANTIMYCOTICS FOR SYSTEMIC USE,410
21603072410,drug_era group during day -365 through 0 days relative to index: ANTIMYCOTICS FOR SYSTEMIC USE,410
21603079410,drug_era group during day -365 through 0 days relative to index: Triazole derivatives,410
21603089410,drug_era group during day -365 through 0 days relative to index: ANTIMYCOBACTERIALS,410
21603089412,drug_era group during day -30 through 0 days relative to index: ANTIMYCOBACTERIALS,412
21603089413,drug_era group during day 0 through 0 days relative to index: ANTIMYCOBACTERIALS,413
21603090410,drug_era group during day -365 through 0 days relative to index: DRUGS FOR TREATMENT OF TUBERCULOSIS,410
21603090412,drug_era group during day -30 through 0 days relative to index: DRUGS FOR TREATMENT OF TUBERCULOSIS,412
21603090413,drug_era group during day 0 through 0 days relative to index: DRUGS FOR TREATMENT OF TUBERCULOSIS,413
21603095410,drug_era group during day -365 through 0 days relative to index: Antibiotics,410
21603095412,drug_era group during day -30 through 0 days relative to index: Antibiotics,412
21603095413,drug_era group during day 0 through 0 days relative to index: Antibiotics,413
21603102410,drug_era group during day -365 through 0 days relative to index: Hydrazides,410
21603102412,drug_era group during day -30 through 0 days relative to index: Hydrazides,412
21603102413,drug_era group during day 0 through 0 days relative to index: Hydrazides,413
21603126410,drug_era group during day -365 through 0 days relative to index: ANTIVIRALS FOR SYSTEMIC USE,410
21603126412,drug_era group during day -30 through 0 days relative to index: ANTIVIRALS FOR SYSTEMIC USE,412
21603126413,drug_era group during day 0 through 0 days relative to index: ANTIVIRALS FOR SYSTEMIC USE,413
21603127410,drug_era group during day -365 through 0 days relative to index: DIRECT ACTING ANTIVIRALS,410
21603127412,drug_era group during day -30 through 0 days relative to index: DIRECT ACTING ANTIVIRALS,412
21603127413,drug_era group during day 0 through 0 days relative to index: DIRECT ACTING ANTIVIRALS,413
21603130410,drug_era group during day -365 through 0 days relative to index: Nucleosides and nucleotides excl. reverse transcriptase inhibitors,410
21603130412,drug_era group during day -30 through 0 days relative to index: Nucleosides and nucleotides excl. reverse transcriptase inhibitors,412
21603148410,drug_era group during day -365 through 0 days relative to index: Protease inhibitors,410
21603148412,drug_era group during day -30 through 0 days relative to index: Protease inhibitors,412
21603148413,drug_era group during day 0 through 0 days relative to index: Protease inhibitors,413
21603159410,drug_era group during day -365 through 0 days relative to index: Nucleoside and nucleotide reverse transcriptase inhibitors,410
21603159412,drug_era group during day -30 through 0 days relative to index: Nucleoside and nucleotide reverse transcriptase inhibitors,412
21603159413,drug_era group during day 0 through 0 days relative to index: Nucleoside and nucleotide reverse transcriptase inhibitors,413
21603196410,drug_era group during day -365 through 0 days relative to index: Other nasal preparations,410
21603196412,drug_era group during day -30 through 0 days relative to index: Other nasal preparations,412
21603207410,drug_era group during day -365 through 0 days relative to index: NASAL DECONGESTANTS FOR SYSTEMIC USE,410
21603207412,drug_era group during day -30 through 0 days relative to index: NASAL DECONGESTANTS FOR SYSTEMIC USE,412
21603207413,drug_era group during day 0 through 0 days relative to index: NASAL DECONGESTANTS FOR SYSTEMIC USE,413
21603208410,drug_era group during day -365 through 0 days relative to index: Sympathomimetics,410
21603208412,drug_era group during day -30 through 0 days relative to index: Sympathomimetics,412
21603208413,drug_era group during day 0 through 0 days relative to index: Sympathomimetics,413
21603215410,drug_era group during day -365 through 0 days relative to index: THROAT PREPARATIONS,410
21603215412,drug_era group during day -30 through 0 days relative to index: THROAT PREPARATIONS,412
21603215413,drug_era group during day 0 through 0 days relative to index: THROAT PREPARATIONS,413
21603216410,drug_era group during day -365 through 0 days relative to index: THROAT PREPARATIONS,410
21603216412,drug_era group during day -30 through 0 days relative to index: THROAT PREPARATIONS,412
21603216413,drug_era group during day 0 through 0 days relative to index: THROAT PREPARATIONS,413
21603217410,drug_era group during day -365 through 0 days relative to index: Antiseptics,410
21603217412,drug_era group during day -30 through 0 days relative to index: Antiseptics,412
21603217413,drug_era group during day 0 through 0 days relative to index: Antiseptics,413
21603241410,"drug_era group during day -365 through 0 days relative to index: Anesthetics, local",410
21603248410,drug_era group during day -365 through 0 days relative to index: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,410
21603248412,drug_era group during day -30 through 0 days relative to index: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,412
21603248413,drug_era group during day 0 through 0 days relative to index: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,413
21603249410,"drug_era group during day -365 through 0 days relative to index: ADRENERGICS, INHALANTS",410
21603249412,"drug_era group during day -30 through 0 days relative to index: ADRENERGICS, INHALANTS",412
21603249413,"drug_era group during day 0 through 0 days relative to index: ADRENERGICS, INHALANTS",413
21603255410,drug_era group during day -365 through 0 days relative to index: Selective beta-2-adrenoreceptor agonists,410
21603255412,drug_era group during day -30 through 0 days relative to index: Selective beta-2-adrenoreceptor agonists,412
21603255413,drug_era group during day 0 through 0 days relative to index: Selective beta-2-adrenoreceptor agonists,413
21603282410,"drug_era group during day -365 through 0 days relative to index: OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",410
21603282412,"drug_era group during day -30 through 0 days relative to index: OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",412
21603283410,drug_era group during day -365 through 0 days relative to index: Glucocorticoids,410
21603292410,drug_era group during day -365 through 0 days relative to index: Anticholinergics,410
21603292412,drug_era group during day -30 through 0 days relative to index: Anticholinergics,412
21603302410,drug_era group during day -365 through 0 days relative to index: ADRENERGICS FOR SYSTEMIC USE,410
21603302412,drug_era group during day -30 through 0 days relative to index: ADRENERGICS FOR SYSTEMIC USE,412
21603302413,drug_era group during day 0 through 0 days relative to index: ADRENERGICS FOR SYSTEMIC USE,413
21603303410,drug_era group during day -365 through 0 days relative to index: Alpha- and beta-adrenoreceptor agonists,410
21603311410,drug_era group during day -365 through 0 days relative to index: Selective beta-2-adrenoreceptor agonists,410
21603311412,drug_era group during day -30 through 0 days relative to index: Selective beta-2-adrenoreceptor agonists,412
21603311413,drug_era group during day 0 through 0 days relative to index: Selective beta-2-adrenoreceptor agonists,413
21603327410,drug_era group during day -365 through 0 days relative to index: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,410
21603327412,drug_era group during day -30 through 0 days relative to index: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,412
21603327413,drug_era group during day 0 through 0 days relative to index: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,413
21603353410,drug_era group during day -365 through 0 days relative to index: Leukotriene receptor antagonists,410
21603353412,drug_era group during day -30 through 0 days relative to index: Leukotriene receptor antagonists,412
21603353413,drug_era group during day 0 through 0 days relative to index: Leukotriene receptor antagonists,413
21603365410,drug_era group during day -365 through 0 days relative to index: COUGH AND COLD PREPARATIONS,410
21603365412,drug_era group during day -30 through 0 days relative to index: COUGH AND COLD PREPARATIONS,412
21603365413,drug_era group during day 0 through 0 days relative to index: COUGH AND COLD PREPARATIONS,413
21603366410,"drug_era group during day -365 through 0 days relative to index: EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",410
21603366412,"drug_era group during day -30 through 0 days relative to index: EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",412
21603366413,"drug_era group during day 0 through 0 days relative to index: EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",413
21603379410,drug_era group during day -365 through 0 days relative to index: Mucolytics,410
21603379412,drug_era group during day -30 through 0 days relative to index: Mucolytics,412
21603379413,drug_era group during day 0 through 0 days relative to index: Mucolytics,413
21603395410,"drug_era group during day -365 through 0 days relative to index: COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",410
21603395412,"drug_era group during day -30 through 0 days relative to index: COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",412
21603395413,"drug_era group during day 0 through 0 days relative to index: COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",413
21603396410,drug_era group during day -365 through 0 days relative to index: Opium alkaloids and derivatives,410
21603396412,drug_era group during day -30 through 0 days relative to index: Opium alkaloids and derivatives,412
21603396413,drug_era group during day 0 through 0 days relative to index: Opium alkaloids and derivatives,413
21603444410,drug_era group during day -365 through 0 days relative to index: ANTIHISTAMINES FOR SYSTEMIC USE,410
21603444412,drug_era group during day -30 through 0 days relative to index: ANTIHISTAMINES FOR SYSTEMIC USE,412
21603444413,drug_era group during day 0 through 0 days relative to index: ANTIHISTAMINES FOR SYSTEMIC USE,413
21603445410,drug_era group during day -365 through 0 days relative to index: ANTIHISTAMINES FOR SYSTEMIC USE,410
21603445412,drug_era group during day -30 through 0 days relative to index: ANTIHISTAMINES FOR SYSTEMIC USE,412
21603445413,drug_era group during day 0 through 0 days relative to index: ANTIHISTAMINES FOR SYSTEMIC USE,413
21603458410,drug_era group during day -365 through 0 days relative to index: Substituted alkylamines,410
21603458412,drug_era group during day -30 through 0 days relative to index: Substituted alkylamines,412
21603458413,drug_era group during day 0 through 0 days relative to index: Substituted alkylamines,413
21603491410,drug_era group during day -365 through 0 days relative to index: Piperazine derivatives,410
21603491412,drug_era group during day -30 through 0 days relative to index: Piperazine derivatives,412
21603491413,drug_era group during day 0 through 0 days relative to index: Piperazine derivatives,413
21603503410,drug_era group during day -365 through 0 days relative to index: Other antihistamines for systemic use,410
21603503412,drug_era group during day -30 through 0 days relative to index: Other antihistamines for systemic use,412
21603503413,drug_era group during day 0 through 0 days relative to index: Other antihistamines for systemic use,413
21603550410,drug_era group during day -365 through 0 days relative to index: SENSORY ORGANS,410
21603550412,drug_era group during day -30 through 0 days relative to index: SENSORY ORGANS,412
21603550413,drug_era group during day 0 through 0 days relative to index: SENSORY ORGANS,413
21603551410,drug_era group during day -365 through 0 days relative to index: OPHTHALMOLOGICALS,410
21603551412,drug_era group during day -30 through 0 days relative to index: OPHTHALMOLOGICALS,412
21603551413,drug_era group during day 0 through 0 days relative to index: OPHTHALMOLOGICALS,413
21603552410,drug_era group during day -365 through 0 days relative to index: ANTIINFECTIVES,410
21603552412,drug_era group during day -30 through 0 days relative to index: ANTIINFECTIVES,412
21603552413,drug_era group during day 0 through 0 days relative to index: ANTIINFECTIVES,413
21603585410,drug_era group during day -365 through 0 days relative to index: Antivirals,410
21603585412,drug_era group during day -30 through 0 days relative to index: Antivirals,412
21603594410,drug_era group during day -365 through 0 days relative to index: Other antiinfectives,410
21603594412,drug_era group during day -30 through 0 days relative to index: Other antiinfectives,412
21603594413,drug_era group during day 0 through 0 days relative to index: Other antiinfectives,413
21603616410,drug_era group during day -365 through 0 days relative to index: ANTIINFLAMMATORY AGENTS,410
21603616412,drug_era group during day -30 through 0 days relative to index: ANTIINFLAMMATORY AGENTS,412
21603616413,drug_era group during day 0 through 0 days relative to index: ANTIINFLAMMATORY AGENTS,413
21603617410,"drug_era group during day -365 through 0 days relative to index: Corticosteroids, plain",410
21603617412,"drug_era group during day -30 through 0 days relative to index: Corticosteroids, plain",412
21603617413,"drug_era group during day 0 through 0 days relative to index: Corticosteroids, plain",413
21603638410,"drug_era group during day -365 through 0 days relative to index: Antiinflammatory agents, non-steroids",410
21603638412,"drug_era group during day -30 through 0 days relative to index: Antiinflammatory agents, non-steroids",412
21603671410,drug_era group during day -365 through 0 days relative to index: ANTIGLAUCOMA PREPARATIONS AND MIOTICS,410
21603671412,drug_era group during day -30 through 0 days relative to index: ANTIGLAUCOMA PREPARATIONS AND MIOTICS,412
21603672410,drug_era group during day -365 through 0 days relative to index: Sympathomimetics in glaucoma therapy,410
21603672412,drug_era group during day -30 through 0 days relative to index: Sympathomimetics in glaucoma therapy,412
21603692410,drug_era group during day -365 through 0 days relative to index: Carbonic anhydrase inhibitors,410
21603728410,drug_era group during day -365 through 0 days relative to index: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,410
21603741410,drug_era group during day -365 through 0 days relative to index: Other cytotoxic antibiotics,410
21603746410,drug_era group during day -365 through 0 days relative to index: OTHER ANTINEOPLASTIC AGENTS,410
21603747410,drug_era group during day -365 through 0 days relative to index: Platinum compounds,410
21603771410,drug_era group during day -365 through 0 days relative to index: Protein kinase inhibitors,410
21603812410,drug_era group during day -365 through 0 days relative to index: ENDOCRINE THERAPY,410
21603812412,drug_era group during day -30 through 0 days relative to index: ENDOCRINE THERAPY,412
21603812413,drug_era group during day 0 through 0 days relative to index: ENDOCRINE THERAPY,413
21603813410,drug_era group during day -365 through 0 days relative to index: HORMONES AND RELATED AGENTS,410
21603813412,drug_era group during day -30 through 0 days relative to index: HORMONES AND RELATED AGENTS,412
21603813413,drug_era group during day 0 through 0 days relative to index: HORMONES AND RELATED AGENTS,413
21603819410,drug_era group during day -365 through 0 days relative to index: Progestogens,410
21603819412,drug_era group during day -30 through 0 days relative to index: Progestogens,412
21603819413,drug_era group during day 0 through 0 days relative to index: Progestogens,413
21603848410,drug_era group during day -365 through 0 days relative to index: IMMUNOSTIMULANTS,410
21603849410,drug_era group during day -365 through 0 days relative to index: IMMUNOSTIMULANTS,410
21603850410,drug_era group during day -365 through 0 days relative to index: Colony stimulating factors,410
21603890410,drug_era group during day -365 through 0 days relative to index: IMMUNOSUPPRESSANTS,410
21603890412,drug_era group during day -30 through 0 days relative to index: IMMUNOSUPPRESSANTS,412
21603890413,drug_era group during day 0 through 0 days relative to index: IMMUNOSUPPRESSANTS,413
21603891410,drug_era group during day -365 through 0 days relative to index: IMMUNOSUPPRESSANTS,410
21603891412,drug_era group during day -30 through 0 days relative to index: IMMUNOSUPPRESSANTS,412
21603891413,drug_era group during day 0 through 0 days relative to index: IMMUNOSUPPRESSANTS,413
21603923410,drug_era group during day -365 through 0 days relative to index: Calcineurin inhibitors,410
21603923412,drug_era group during day -30 through 0 days relative to index: Calcineurin inhibitors,412
21603923413,drug_era group during day 0 through 0 days relative to index: Calcineurin inhibitors,413
21603926410,drug_era group during day -365 through 0 days relative to index: Other immunosuppressants,410
21603926412,drug_era group during day -30 through 0 days relative to index: Other immunosuppressants,412
21603926413,drug_era group during day 0 through 0 days relative to index: Other immunosuppressants,413
21603931410,drug_era group during day -365 through 0 days relative to index: MUSCULO-SKELETAL SYSTEM,410
21603931412,drug_era group during day -30 through 0 days relative to index: MUSCULO-SKELETAL SYSTEM,412
21603931413,drug_era group during day 0 through 0 days relative to index: MUSCULO-SKELETAL SYSTEM,413
21603932410,drug_era group during day -365 through 0 days relative to index: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,410
21603932412,drug_era group during day -30 through 0 days relative to index: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,412
21603932413,drug_era group during day 0 through 0 days relative to index: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,413
21603933410,"drug_era group during day -365 through 0 days relative to index: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",410
21603933412,"drug_era group during day -30 through 0 days relative to index: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",412
21603933413,"drug_era group during day 0 through 0 days relative to index: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",413
21603940410,drug_era group during day -365 through 0 days relative to index: Acetic acid derivatives and related substances,410
21603940412,drug_era group during day -30 through 0 days relative to index: Acetic acid derivatives and related substances,412
21603966410,drug_era group during day -365 through 0 days relative to index: Propionic acid derivatives,410
21603966412,drug_era group during day -30 through 0 days relative to index: Propionic acid derivatives,412
21603966413,drug_era group during day 0 through 0 days relative to index: Propionic acid derivatives,413
21603991410,drug_era group during day -365 through 0 days relative to index: Coxibs,410
21603991412,drug_era group during day -30 through 0 days relative to index: Coxibs,412
21603991413,drug_era group during day 0 through 0 days relative to index: Coxibs,413
21604034410,drug_era group during day -365 through 0 days relative to index: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,410
21604034412,drug_era group during day -30 through 0 days relative to index: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,412
21604035410,drug_era group during day -365 through 0 days relative to index: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,410
21604035412,drug_era group during day -30 through 0 days relative to index: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,412
21604036410,"drug_era group during day -365 through 0 days relative to index: Antiinflammatory preparations, non-steroids for topical use",410
21604036412,"drug_era group during day -30 through 0 days relative to index: Antiinflammatory preparations, non-steroids for topical use",412
21604069410,drug_era group during day -365 through 0 days relative to index: MUSCLE RELAXANTS,410
21604070410,"drug_era group during day -365 through 0 days relative to index: MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",410
21604077410,drug_era group during day -365 through 0 days relative to index: Other quaternary ammonium compounds,410
21604128410,drug_era group during day -365 through 0 days relative to index: ANTIGOUT PREPARATIONS,410
21604128412,drug_era group during day -30 through 0 days relative to index: ANTIGOUT PREPARATIONS,412
21604128413,drug_era group during day 0 through 0 days relative to index: ANTIGOUT PREPARATIONS,413
21604129410,drug_era group during day -365 through 0 days relative to index: ANTIGOUT PREPARATIONS,410
21604129412,drug_era group during day -30 through 0 days relative to index: ANTIGOUT PREPARATIONS,412
21604129413,drug_era group during day 0 through 0 days relative to index: ANTIGOUT PREPARATIONS,413
21604130410,drug_era group during day -365 through 0 days relative to index: Preparations inhibiting uric acid production,410
21604130412,drug_era group during day -30 through 0 days relative to index: Preparations inhibiting uric acid production,412
21604130413,drug_era group during day 0 through 0 days relative to index: Preparations inhibiting uric acid production,413
21604140410,drug_era group during day -365 through 0 days relative to index: Preparations with no effect on uric acid metabolism,410
21604140412,drug_era group during day -30 through 0 days relative to index: Preparations with no effect on uric acid metabolism,412
21604140413,drug_era group during day 0 through 0 days relative to index: Preparations with no effect on uric acid metabolism,413
21604146410,drug_era group during day -365 through 0 days relative to index: DRUGS FOR TREATMENT OF BONE DISEASES,410
21604147410,drug_era group during day -365 through 0 days relative to index: DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,410
21604165410,drug_era group during day -365 through 0 days relative to index: Other drugs affecting bone structure and mineralization,410
21604170410,drug_era group during day -365 through 0 days relative to index: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,410
21604170412,drug_era group during day -30 through 0 days relative to index: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,412
21604171410,drug_era group during day -365 through 0 days relative to index: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,410
21604171412,drug_era group during day -30 through 0 days relative to index: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,412
21604178410,drug_era group during day -365 through 0 days relative to index: Other drugs for disorders of the musculo-skeletal system,410
21604178412,drug_era group during day -30 through 0 days relative to index: Other drugs for disorders of the musculo-skeletal system,412
21604180410,drug_era group during day -365 through 0 days relative to index: NERVOUS SYSTEM,410
21604180412,drug_era group during day -30 through 0 days relative to index: NERVOUS SYSTEM,412
21604180413,drug_era group during day 0 through 0 days relative to index: NERVOUS SYSTEM,413
21604181410,drug_era group during day -365 through 0 days relative to index: ANESTHETICS,410
21604181412,drug_era group during day -30 through 0 days relative to index: ANESTHETICS,412
21604181413,drug_era group during day 0 through 0 days relative to index: ANESTHETICS,413
21604182410,"drug_era group during day -365 through 0 days relative to index: ANESTHETICS, GENERAL",410
21604182412,"drug_era group during day -30 through 0 days relative to index: ANESTHETICS, GENERAL",412
21604182413,"drug_era group during day 0 through 0 days relative to index: ANESTHETICS, GENERAL",413
21604186410,drug_era group during day -365 through 0 days relative to index: Halogenated hydrocarbons,410
21604200410,drug_era group during day -365 through 0 days relative to index: Opioid anesthetics,410
21604200412,drug_era group during day -30 through 0 days relative to index: Opioid anesthetics,412
21604200413,drug_era group during day 0 through 0 days relative to index: Opioid anesthetics,413
21604208410,drug_era group during day -365 through 0 days relative to index: Other general anesthetics,410
21604220410,"drug_era group during day -365 through 0 days relative to index: ANESTHETICS, LOCAL",410
21604220412,"drug_era group during day -30 through 0 days relative to index: ANESTHETICS, LOCAL",412
21604228410,drug_era group during day -365 through 0 days relative to index: Amides,410
21604228412,drug_era group during day -30 through 0 days relative to index: Amides,412
21604253410,drug_era group during day -365 through 0 days relative to index: ANALGESICS,410
21604253412,drug_era group during day -30 through 0 days relative to index: ANALGESICS,412
21604253413,drug_era group during day 0 through 0 days relative to index: ANALGESICS,413
21604254410,drug_era group during day -365 through 0 days relative to index: OPIOIDS,410
21604254412,drug_era group during day -30 through 0 days relative to index: OPIOIDS,412
21604254413,drug_era group during day 0 through 0 days relative to index: OPIOIDS,413
21604255410,drug_era group during day -365 through 0 days relative to index: Natural opium alkaloids,410
21604255412,drug_era group during day -30 through 0 days relative to index: Natural opium alkaloids,412
21604255413,drug_era group during day 0 through 0 days relative to index: Natural opium alkaloids,413
21604269410,drug_era group during day -365 through 0 days relative to index: Phenylpiperidine derivatives,410
21604269412,drug_era group during day -30 through 0 days relative to index: Phenylpiperidine derivatives,412
21604269413,drug_era group during day 0 through 0 days relative to index: Phenylpiperidine derivatives,413
21604286410,drug_era group during day -365 through 0 days relative to index: Oripavine derivatives,410
21604296410,drug_era group during day -365 through 0 days relative to index: Other opioids,410
21604296412,drug_era group during day -30 through 0 days relative to index: Other opioids,412
21604296413,drug_era group during day 0 through 0 days relative to index: Other opioids,413
21604303410,drug_era group during day -365 through 0 days relative to index: OTHER ANALGESICS AND ANTIPYRETICS,410
21604303412,drug_era group during day -30 through 0 days relative to index: OTHER ANALGESICS AND ANTIPYRETICS,412
21604303413,drug_era group during day 0 through 0 days relative to index: OTHER ANALGESICS AND ANTIPYRETICS,413
21604304410,drug_era group during day -365 through 0 days relative to index: Salicylic acid and derivatives,410
21604304412,drug_era group during day -30 through 0 days relative to index: Salicylic acid and derivatives,412
21604304413,drug_era group during day 0 through 0 days relative to index: Salicylic acid and derivatives,413
21604343410,drug_era group during day -365 through 0 days relative to index: Anilides,410
21604343412,drug_era group during day -30 through 0 days relative to index: Anilides,412
21604343413,drug_era group during day 0 through 0 days relative to index: Anilides,413
21604389410,drug_era group during day -365 through 0 days relative to index: ANTIEPILEPTICS,410
21604389412,drug_era group during day -30 through 0 days relative to index: ANTIEPILEPTICS,412
21604389413,drug_era group during day 0 through 0 days relative to index: ANTIEPILEPTICS,413
21604390410,drug_era group during day -365 through 0 days relative to index: ANTIEPILEPTICS,410
21604390412,drug_era group during day -30 through 0 days relative to index: ANTIEPILEPTICS,412
21604390413,drug_era group during day 0 through 0 days relative to index: ANTIEPILEPTICS,413
21604428410,drug_era group during day -365 through 0 days relative to index: Other antiepileptics,410
21604428412,drug_era group during day -30 through 0 days relative to index: Other antiepileptics,412
21604428413,drug_era group during day 0 through 0 days relative to index: Other antiepileptics,413
21604443410,drug_era group during day -365 through 0 days relative to index: ANTI-PARKINSON DRUGS,410
21604443412,drug_era group during day -30 through 0 days relative to index: ANTI-PARKINSON DRUGS,412
21604443413,drug_era group during day 0 through 0 days relative to index: ANTI-PARKINSON DRUGS,413
21604462410,drug_era group during day -365 through 0 days relative to index: DOPAMINERGIC AGENTS,410
21604462412,drug_era group during day -30 through 0 days relative to index: DOPAMINERGIC AGENTS,412
21604462413,drug_era group during day 0 through 0 days relative to index: DOPAMINERGIC AGENTS,413
21604472410,drug_era group during day -365 through 0 days relative to index: Dopamine agonists,410
21604472412,drug_era group during day -30 through 0 days relative to index: Dopamine agonists,412
21604472413,drug_era group during day 0 through 0 days relative to index: Dopamine agonists,413
21604489410,drug_era group during day -365 through 0 days relative to index: PSYCHOLEPTICS,410
21604489412,drug_era group during day -30 through 0 days relative to index: PSYCHOLEPTICS,412
21604489413,drug_era group during day 0 through 0 days relative to index: PSYCHOLEPTICS,413
21604490410,drug_era group during day -365 through 0 days relative to index: ANTIPSYCHOTICS,410
21604491410,drug_era group during day -365 through 0 days relative to index: Phenothiazines with aliphatic side-chain,410
21604515410,drug_era group during day -365 through 0 days relative to index: Butyrophenone derivatives,410
21604540410,"drug_era group during day -365 through 0 days relative to index: Diazepines, oxazepines, thiazepines and oxepines",410
21604564410,drug_era group during day -365 through 0 days relative to index: ANXIOLYTICS,410
21604564412,drug_era group during day -30 through 0 days relative to index: ANXIOLYTICS,412
21604565410,drug_era group during day -365 through 0 days relative to index: Benzodiazepine derivatives,410
21604589410,drug_era group during day -365 through 0 days relative to index: Diphenylmethane derivatives,410
21604589412,drug_era group during day -30 through 0 days relative to index: Diphenylmethane derivatives,412
21604606410,drug_era group during day -365 through 0 days relative to index: HYPNOTICS AND SEDATIVES,410
21604606412,drug_era group during day -30 through 0 days relative to index: HYPNOTICS AND SEDATIVES,412
21604606413,drug_era group during day 0 through 0 days relative to index: HYPNOTICS AND SEDATIVES,413
21604635410,drug_era group during day -365 through 0 days relative to index: Benzodiazepine derivatives,410
21604635412,drug_era group during day -30 through 0 days relative to index: Benzodiazepine derivatives,412
21604635413,drug_era group during day 0 through 0 days relative to index: Benzodiazepine derivatives,413
21604653410,drug_era group during day -365 through 0 days relative to index: Benzodiazepine related drugs,410
21604661410,drug_era group during day -365 through 0 days relative to index: Other hypnotics and sedatives,410
21604661412,drug_era group during day -30 through 0 days relative to index: Other hypnotics and sedatives,412
21604661413,drug_era group during day 0 through 0 days relative to index: Other hypnotics and sedatives,413
21604685410,drug_era group during day -365 through 0 days relative to index: PSYCHOANALEPTICS,410
21604685412,drug_era group during day -30 through 0 days relative to index: PSYCHOANALEPTICS,412
21604685413,drug_era group during day 0 through 0 days relative to index: PSYCHOANALEPTICS,413
21604686410,drug_era group during day -365 through 0 days relative to index: ANTIDEPRESSANTS,410
21604686412,drug_era group during day -30 through 0 days relative to index: ANTIDEPRESSANTS,412
21604729410,drug_era group during day -365 through 0 days relative to index: Other antidepressants,410
21604729412,drug_era group during day -30 through 0 days relative to index: Other antidepressants,412
21604752410,"drug_era group during day -365 through 0 days relative to index: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",410
21604768410,drug_era group during day -365 through 0 days relative to index: Other psychostimulants and nootropics,410
21604792410,drug_era group during day -365 through 0 days relative to index: ANTI-DEMENTIA DRUGS,410
21604792412,drug_era group during day -30 through 0 days relative to index: ANTI-DEMENTIA DRUGS,412
21604792413,drug_era group during day 0 through 0 days relative to index: ANTI-DEMENTIA DRUGS,413
21604793410,drug_era group during day -365 through 0 days relative to index: Anticholinesterases,410
21604793412,drug_era group during day -30 through 0 days relative to index: Anticholinesterases,412
21604793413,drug_era group during day 0 through 0 days relative to index: Anticholinesterases,413
21604801410,drug_era group during day -365 through 0 days relative to index: OTHER NERVOUS SYSTEM DRUGS,410
21604802410,drug_era group during day -365 through 0 days relative to index: PARASYMPATHOMIMETICS,410
21604803410,drug_era group during day -365 through 0 days relative to index: Anticholinesterases,410
21604816410,drug_era group during day -365 through 0 days relative to index: DRUGS USED IN ADDICTIVE DISORDERS,410
21604825410,drug_era group during day -365 through 0 days relative to index: Drugs used in opioid dependence,410
21604847410,"drug_era group during day -365 through 0 days relative to index: ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",410
21604847412,"drug_era group during day -30 through 0 days relative to index: ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",412
21604847413,"drug_era group during day 0 through 0 days relative to index: ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",413
21604848410,drug_era group during day -365 through 0 days relative to index: ANTIPROTOZOALS,410
21604848412,drug_era group during day -30 through 0 days relative to index: ANTIPROTOZOALS,412
21604848413,drug_era group during day 0 through 0 days relative to index: ANTIPROTOZOALS,413
21604849410,drug_era group during day -365 through 0 days relative to index: AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES,410
21604849412,drug_era group during day -30 through 0 days relative to index: AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES,412
21604856410,drug_era group during day -365 through 0 days relative to index: Nitroimidazole derivatives,410
21604856412,drug_era group during day -30 through 0 days relative to index: Nitroimidazole derivatives,412
21604886410,drug_era group during day -365 through 0 days relative to index: ANTIMALARIALS,410
21604886412,drug_era group during day -30 through 0 days relative to index: ANTIMALARIALS,412
21604886413,drug_era group during day 0 through 0 days relative to index: ANTIMALARIALS,413
21604887410,drug_era group during day -365 through 0 days relative to index: Aminoquinolines,410
21604887412,drug_era group during day -30 through 0 days relative to index: Aminoquinolines,412
21604887413,drug_era group during day 0 through 0 days relative to index: Aminoquinolines,413
21605007410,drug_era group during day -365 through 0 days relative to index: RESPIRATORY SYSTEM,410
21605007412,drug_era group during day -30 through 0 days relative to index: RESPIRATORY SYSTEM,412
21605007413,drug_era group during day 0 through 0 days relative to index: RESPIRATORY SYSTEM,413
21605008410,drug_era group during day -365 through 0 days relative to index: NASAL PREPARATIONS,410
21605008412,drug_era group during day -30 through 0 days relative to index: NASAL PREPARATIONS,412
21605008413,drug_era group during day 0 through 0 days relative to index: NASAL PREPARATIONS,413
21605009410,drug_era group during day -365 through 0 days relative to index: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,410
21605009412,drug_era group during day -30 through 0 days relative to index: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,412
21605010410,"drug_era group during day -365 through 0 days relative to index: Sympathomimetics, plain",410
21605010412,"drug_era group during day -30 through 0 days relative to index: Sympathomimetics, plain",412
21605032410,"drug_era group during day -365 through 0 days relative to index: Antiallergic agents, excl. corticosteroids",410
21605042410,drug_era group during day -365 through 0 days relative to index: Corticosteroids,410
21605058410,drug_era group during day -365 through 0 days relative to index: MYDRIATICS AND CYCLOPLEGICS,410
21605058412,drug_era group during day -30 through 0 days relative to index: MYDRIATICS AND CYCLOPLEGICS,412
21605058413,drug_era group during day 0 through 0 days relative to index: MYDRIATICS AND CYCLOPLEGICS,413
21605059410,drug_era group during day -365 through 0 days relative to index: Anticholinergics,410
21605059412,drug_era group during day -30 through 0 days relative to index: Anticholinergics,412
21605059413,drug_era group during day 0 through 0 days relative to index: Anticholinergics,413
21605067410,drug_era group during day -365 through 0 days relative to index: Sympathomimetics excl. antiglaucoma preparations,410
21605067412,drug_era group during day -30 through 0 days relative to index: Sympathomimetics excl. antiglaucoma preparations,412
21605071410,drug_era group during day -365 through 0 days relative to index: DECONGESTANTS AND ANTIALLERGICS,410
21605084410,drug_era group during day -365 through 0 days relative to index: Other antiallergics,410
21605125410,drug_era group during day -365 through 0 days relative to index: OTHER OPHTHALMOLOGICALS,410
21605125412,drug_era group during day -30 through 0 days relative to index: OTHER OPHTHALMOLOGICALS,412
21605125413,drug_era group during day 0 through 0 days relative to index: OTHER OPHTHALMOLOGICALS,413
21605126410,drug_era group during day -365 through 0 days relative to index: Other ophthalmologicals,410
21605126412,drug_era group during day -30 through 0 days relative to index: Other ophthalmologicals,412
21605126413,drug_era group during day 0 through 0 days relative to index: Other ophthalmologicals,413
21605187410,drug_era group during day -365 through 0 days relative to index: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS,410
21605187412,drug_era group during day -30 through 0 days relative to index: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS,412
21605187413,drug_era group during day 0 through 0 days relative to index: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS,413
21605199410,drug_era group during day -365 through 0 days relative to index: CORTICOSTEROIDS,410
21605199412,drug_era group during day -30 through 0 days relative to index: CORTICOSTEROIDS,412
21605199413,drug_era group during day 0 through 0 days relative to index: CORTICOSTEROIDS,413
21605200410,drug_era group during day -365 through 0 days relative to index: Corticosteroids,410
21605200412,drug_era group during day -30 through 0 days relative to index: Corticosteroids,412
21605200413,drug_era group during day 0 through 0 days relative to index: Corticosteroids,413
21605212410,drug_era group during day -365 through 0 days relative to index: VARIOUS,410
21605212412,drug_era group during day -30 through 0 days relative to index: VARIOUS,412
21605212413,drug_era group during day 0 through 0 days relative to index: VARIOUS,413
21605227410,drug_era group during day -365 through 0 days relative to index: ALL OTHER THERAPEUTIC PRODUCTS,410
21605227412,drug_era group during day -30 through 0 days relative to index: ALL OTHER THERAPEUTIC PRODUCTS,412
21605227413,drug_era group during day 0 through 0 days relative to index: ALL OTHER THERAPEUTIC PRODUCTS,413
21605228410,drug_era group during day -365 through 0 days relative to index: ALL OTHER THERAPEUTIC PRODUCTS,410
21605228412,drug_era group during day -30 through 0 days relative to index: ALL OTHER THERAPEUTIC PRODUCTS,412
21605228413,drug_era group during day 0 through 0 days relative to index: ALL OTHER THERAPEUTIC PRODUCTS,413
21605229410,drug_era group during day -365 through 0 days relative to index: Antidotes,410
21605229412,drug_era group during day -30 through 0 days relative to index: Antidotes,412
21605229413,drug_era group during day 0 through 0 days relative to index: Antidotes,413
21605263410,drug_era group during day -365 through 0 days relative to index: Drugs for treatment of hyperkalemia and hyperphosphatemia,410
21605263412,drug_era group during day -30 through 0 days relative to index: Drugs for treatment of hyperkalemia and hyperphosphatemia,412
21605263413,drug_era group during day 0 through 0 days relative to index: Drugs for treatment of hyperkalemia and hyperphosphatemia,413
21605285410,drug_era group during day -365 through 0 days relative to index: Medical gases,410
21605285412,drug_era group during day -30 through 0 days relative to index: Medical gases,412
21605285413,drug_era group during day 0 through 0 days relative to index: Medical gases,413
21605342410,drug_era group during day -365 through 0 days relative to index: GENERAL NUTRIENTS,410
21605342412,drug_era group during day -30 through 0 days relative to index: GENERAL NUTRIENTS,412
21605342413,drug_era group during day 0 through 0 days relative to index: GENERAL NUTRIENTS,413
21605348410,drug_era group during day -365 through 0 days relative to index: OTHER NUTRIENTS,410
21605348412,drug_era group during day -30 through 0 days relative to index: OTHER NUTRIENTS,412
21605348413,drug_era group during day 0 through 0 days relative to index: OTHER NUTRIENTS,413
21605351410,drug_era group during day -365 through 0 days relative to index: Carbohydrates,410
21605351412,drug_era group during day -30 through 0 days relative to index: Carbohydrates,412
21605351413,drug_era group during day 0 through 0 days relative to index: Carbohydrates,413
21605372410,drug_era group during day -365 through 0 days relative to index: CONTRAST MEDIA,410
21605372412,drug_era group during day -30 through 0 days relative to index: CONTRAST MEDIA,412
21605372413,drug_era group during day 0 through 0 days relative to index: CONTRAST MEDIA,413
21605373410,"drug_era group during day -365 through 0 days relative to index: X-RAY CONTRAST MEDIA, IODINATED",410
21605373412,"drug_era group during day -30 through 0 days relative to index: X-RAY CONTRAST MEDIA, IODINATED",412
21605373413,"drug_era group during day 0 through 0 days relative to index: X-RAY CONTRAST MEDIA, IODINATED",413
21605385410,"drug_era group during day -365 through 0 days relative to index: Watersoluble, nephrotropic, low osmolar X-ray contrast media",410
21605385412,"drug_era group during day -30 through 0 days relative to index: Watersoluble, nephrotropic, low osmolar X-ray contrast media",412
21605385413,"drug_era group during day 0 through 0 days relative to index: Watersoluble, nephrotropic, low osmolar X-ray contrast media",413
21605444410,drug_era group during day -365 through 0 days relative to index: DIAGNOSTIC RADIOPHARMACEUTICALS,410
21605536410,drug_era group during day -365 through 0 days relative to index: TUMOUR DETECTION,410
21605549410,drug_era group during day -365 through 0 days relative to index: Other diagnostic radiopharmaceuticals for tumour detection,410
30000671710,measurement below normal range during day -365 through 0 days relative to index: Parathyrin.intact [Mass/volume] in Serum or Plasma,710
30000672710,measurement within normal range during day -365 through 0 days relative to index: Parathyrin.intact [Mass/volume] in Serum or Plasma,710
30000673710,measurement above normal range during day -365 through 0 days relative to index: Parathyrin.intact [Mass/volume] in Serum or Plasma,710
30005151710,measurement below normal range during day -365 through 0 days relative to index: Antithrombin actual/normal in Platelet poor plasma by Chromogenic method,710
30005152710,measurement within normal range during day -365 through 0 days relative to index: Antithrombin actual/normal in Platelet poor plasma by Chromogenic method,710
30005932710,measurement within normal range during day -365 through 0 days relative to index: Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,710
30005933710,measurement above normal range during day -365 through 0 days relative to index: Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,710
30006201710,measurement below normal range during day -365 through 0 days relative to index: Complement C3 [Mass/volume] in Serum or Plasma,710
30006202710,measurement within normal range during day -365 through 0 days relative to index: Complement C3 [Mass/volume] in Serum or Plasma,710
30007402710,measurement within normal range during day -365 through 0 days relative to index: Common Reed IgE Ab RAST class [Presence] in Serum,710
30010812710,measurement within normal range during day -365 through 0 days relative to index: Peach IgE Ab RAST class [Presence] in Serum,710
30011232710,measurement within normal range during day -365 through 0 days relative to index: Platelet mean volume [Entitic volume] in Blood,710
30013572710,measurement within normal range during day -365 through 0 days relative to index: Hazelnut IgE Ab RAST class [Presence] in Serum,710
30014202710,measurement within normal range during day -365 through 0 days relative to index: Magnesium [Mass/volume] in Serum or Plasma,710
30014203710,measurement above normal range during day -365 through 0 days relative to index: Magnesium [Mass/volume] in Serum or Plasma,710
30015392710,measurement within normal range during day -365 through 0 days relative to index: Cat dander IgE Ab RAST class [Presence] in Serum,710
30017212710,measurement within normal range during day -365 through 0 days relative to index: Guinea pig epithelium IgE Ab RAST class [Presence] in Serum,710
30018021710,measurement below normal range during day -365 through 0 days relative to index: Microalbumin/Creatinine [Mass Ratio] in Urine,710
30018022710,measurement within normal range during day -365 through 0 days relative to index: Microalbumin/Creatinine [Mass Ratio] in Urine,710
30020301710,measurement below normal range during day -365 through 0 days relative to index: Lymphocytes/100 leukocytes in Blood,710
30020302710,measurement within normal range during day -365 through 0 days relative to index: Lymphocytes/100 leukocytes in Blood,710
30020303710,measurement above normal range during day -365 through 0 days relative to index: Lymphocytes/100 leukocytes in Blood,710
30020582710,measurement within normal range during day -365 through 0 days relative to index: Cow milk IgE Ab RAST class [Presence] in Serum,710
30022372710,measurement within normal range during day -365 through 0 days relative to index: Japanese Cedar IgE Ab RAST class [Presence] in Serum,710
30024001710,measurement below normal range during day -365 through 0 days relative to index: Iron [Mass/volume] in Serum or Plasma,710
30024002710,measurement within normal range during day -365 through 0 days relative to index: Iron [Mass/volume] in Serum or Plasma,710
30024602710,measurement within normal range during day -365 through 0 days relative to index: Hamster epithelium IgE Ab RAST class [Presence] in Serum,710
30027202710,measurement within normal range during day -365 through 0 days relative to index: Acarus siro IgE Ab RAST class [Presence] in Serum,710
30028522710,measurement within normal range during day -365 through 0 days relative to index: Dog epithelium IgE Ab RAST class [Presence] in Serum,710
30031811710,measurement below normal range during day -365 through 0 days relative to index: Sodium [Moles/volume] in Urine,710
30031812710,measurement within normal range during day -365 through 0 days relative to index: Sodium [Moles/volume] in Urine,710
30033381710,measurement below normal range during day -365 through 0 days relative to index: MCHC [Mass/volume],710
30033382710,measurement within normal range during day -365 through 0 days relative to index: MCHC [Mass/volume],710
30033961710,measurement below normal range during day -365 through 0 days relative to index: Base excess in Arterial blood by calculation,710
30033962710,measurement within normal range during day -365 through 0 days relative to index: Base excess in Arterial blood by calculation,710
30033963710,measurement above normal range during day -365 through 0 days relative to index: Base excess in Arterial blood by calculation,710
30035262710,measurement within normal range during day -365 through 0 days relative to index: Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma by Immunoassay,710
30044102710,measurement within normal range during day -365 through 0 days relative to index: Hemoglobin A1c/Hemoglobin.total in Blood,710
30044103710,measurement above normal range during day -365 through 0 days relative to index: Hemoglobin A1c/Hemoglobin.total in Blood,710
30045011710,measurement below normal range during day -365 through 0 days relative to index: Glucose [Mass/volume] in Serum or Plasma,710
30045012710,measurement within normal range during day -365 through 0 days relative to index: Glucose [Mass/volume] in Serum or Plasma,710
30045013710,measurement above normal range during day -365 through 0 days relative to index: Glucose [Mass/volume] in Serum or Plasma,710
30047891710,measurement below normal range during day -365 through 0 days relative to index: Transferrin [Mass/volume] in Serum or Plasma,710
30047892710,measurement within normal range during day -365 through 0 days relative to index: Transferrin [Mass/volume] in Serum or Plasma,710
30048092710,measurement within normal range during day -365 through 0 days relative to index: Band form neutrophils/100 leukocytes in Blood,710
30048093710,measurement above normal range during day -365 through 0 days relative to index: Band form neutrophils/100 leukocytes in Blood,710
30049052710,measurement within normal range during day -365 through 0 days relative to index: Lipase [Enzymatic activity/volume] in Serum or Plasma,710
30049053710,measurement above normal range during day -365 through 0 days relative to index: Lipase [Enzymatic activity/volume] in Serum or Plasma,710
30053222710,measurement within normal range during day -365 through 0 days relative to index: IgE [Units/volume] in Serum or Plasma,710
30053223710,measurement above normal range during day -365 through 0 days relative to index: IgE [Units/volume] in Serum or Plasma,710
30053562710,measurement within normal range during day -365 through 0 days relative to index: Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay,710
30057191710,measurement below normal range during day -365 through 0 days relative to index: IgG [Mass/volume] in Serum or Plasma,710
30057192710,measurement within normal range during day -365 through 0 days relative to index: IgG [Mass/volume] in Serum or Plasma,710
30057193710,measurement above normal range during day -365 through 0 days relative to index: IgG [Mass/volume] in Serum or Plasma,710
30057701710,measurement below normal range during day -365 through 0 days relative to index: Creatinine renal clearance in 24 hour Urine and Serum or Plasma,710
30058952710,measurement within normal range during day -365 through 0 days relative to index: Myoglobin [Mass/volume] in Serum or Plasma,710
30058953710,measurement above normal range during day -365 through 0 days relative to index: Myoglobin [Mass/volume] in Serum or Plasma,710
30065042710,measurement within normal range during day -365 through 0 days relative to index: Eosinophils/100 leukocytes in Blood,710
30065043710,measurement above normal range during day -365 through 0 days relative to index: Eosinophils/100 leukocytes in Blood,710
30065942710,measurement within normal range during day -365 through 0 days relative to index: Cockroach IgE Ab RAST class [Presence] in Serum,710
30066612710,measurement within normal range during day -365 through 0 days relative to index: Calcium [Mass/volume] in Urine,710
30069061710,measurement below normal range during day -365 through 0 days relative to index: Calcium [Mass/volume] in Serum or Plasma,710
30069062710,measurement within normal range during day -365 through 0 days relative to index: Calcium [Mass/volume] in Serum or Plasma,710
30069063710,measurement above normal range during day -365 through 0 days relative to index: Calcium [Mass/volume] in Serum or Plasma,710
30070872710,measurement within normal range during day -365 through 0 days relative to index: Corn IgE Ab RAST class [Presence] in Serum,710
30071242710,measurement within normal range during day -365 through 0 days relative to index: Reticulocytes/100 erythrocytes in Blood by Automated count,710
30071243710,measurement above normal range during day -365 through 0 days relative to index: Reticulocytes/100 erythrocytes in Blood by Automated count,710
30071641710,measurement below normal range during day -365 through 0 days relative to index: IgA [Mass/volume] in Serum or Plasma,710
30071642710,measurement within normal range during day -365 through 0 days relative to index: IgA [Mass/volume] in Serum or Plasma,710
30071643710,measurement above normal range during day -365 through 0 days relative to index: IgA [Mass/volume] in Serum or Plasma,710
30072201710,measurement below normal range during day -365 through 0 days relative to index: Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,710
30072202710,measurement within normal range during day -365 through 0 days relative to index: Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,710
30072203710,measurement above normal range during day -365 through 0 days relative to index: Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,710
30074611710,measurement below normal range during day -365 through 0 days relative to index: Platelets [#/volume] in Blood,710
30074612710,measurement within normal range during day -365 through 0 days relative to index: Platelets [#/volume] in Blood,710
30074613710,measurement above normal range during day -365 through 0 days relative to index: Platelets [#/volume] in Blood,710
30074902710,measurement within normal range during day -365 through 0 days relative to index: White Oak IgE Ab RAST class [Presence] in Serum,710
30077331710,measurement below normal range during day -365 through 0 days relative to index: Chloride [Moles/volume] in Urine,710
30077332710,measurement within normal range during day -365 through 0 days relative to index: Chloride [Moles/volume] in Urine,710
30079802710,measurement within normal range during day -365 through 0 days relative to index: Soybean IgE Ab RAST class [Presence] in Serum,710
30081521710,measurement below normal range during day -365 through 0 days relative to index: Bicarbonate [Moles/volume] in Arterial blood,710
30081522710,measurement within normal range during day -365 through 0 days relative to index: Bicarbonate [Moles/volume] in Arterial blood,710
30081523710,measurement above normal range during day -365 through 0 days relative to index: Bicarbonate [Moles/volume] in Arterial blood,710
30082951710,measurement below normal range during day -365 through 0 days relative to index: Osmolality of Serum or Plasma,710
30082952710,measurement within normal range during day -365 through 0 days relative to index: Osmolality of Serum or Plasma,710
30082953710,measurement above normal range during day -365 through 0 days relative to index: Osmolality of Serum or Plasma,710
30083641710,measurement below normal range during day -365 through 0 days relative to index: Apolipoprotein A-I [Mass/volume] in Serum or Plasma,710
30083642710,measurement within normal range during day -365 through 0 days relative to index: Apolipoprotein A-I [Mass/volume] in Serum or Plasma,710
30088822710,measurement within normal range during day -365 through 0 days relative to index: English plantain IgE Ab RAST class [Presence] in Serum,710
30092011710,measurement below normal range during day -365 through 0 days relative to index: Thyrotropin [Units/volume] in Serum or Plasma,710
30092012710,measurement within normal range during day -365 through 0 days relative to index: Thyrotropin [Units/volume] in Serum or Plasma,710
30092013710,measurement above normal range during day -365 through 0 days relative to index: Thyrotropin [Units/volume] in Serum or Plasma,710
30092682710,measurement within normal range during day -365 through 0 days relative to index: Sheep epithelium IgE Ab RAST class [Presence] in Serum,710
30094711710,measurement below normal range during day -365 through 0 days relative to index: Fatty acids.nonesterified [Moles/volume] in Serum or Plasma,710
30094712710,measurement within normal range during day -365 through 0 days relative to index: Fatty acids.nonesterified [Moles/volume] in Serum or Plasma,710
30094713710,measurement above normal range during day -365 through 0 days relative to index: Fatty acids.nonesterified [Moles/volume] in Serum or Plasma,710
30095372710,measurement within normal range during day -365 through 0 days relative to index: Aspergillus fumigatus IgE Ab RAST class [Presence] in Serum,710
30096091710,"measurement below normal range during day -365 through 0 days relative to index: Carbon dioxide, total [Moles/volume] in Arterial blood",710
30096092710,"measurement within normal range during day -365 through 0 days relative to index: Carbon dioxide, total [Moles/volume] in Arterial blood",710
30096093710,"measurement above normal range during day -365 through 0 days relative to index: Carbon dioxide, total [Moles/volume] in Arterial blood",710
30097452710,measurement within normal range during day -365 through 0 days relative to index: Common Ragweed IgE Ab RAST class [Presence] in Serum,710
30100202710,measurement within normal range during day -365 through 0 days relative to index: Ox-eye daisy IgE Ab RAST class [Presence] in Serum,710
30100842710,measurement within normal range during day -365 through 0 days relative to index: C peptide [Mass/volume] in Serum or Plasma,710
30100843710,measurement above normal range during day -365 through 0 days relative to index: C peptide [Mass/volume] in Serum or Plasma,710
30101012710,measurement within normal range during day -365 through 0 days relative to index: Cocksfoot IgE Ab RAST class [Presence] in Serum,710
30102342710,measurement within normal range during day -365 through 0 days relative to index: Bromelin IgE Ab RAST class [Presence] in Serum,710
30103752710,measurement within normal range during day -365 through 0 days relative to index: cycloSPORINE [Mass/volume] in Blood,710
30107022710,measurement within normal range during day -365 through 0 days relative to index: American house dust mite IgE Ab RAST class [Presence] in Serum,710
30107612710,measurement within normal range during day -365 through 0 days relative to index: Herpes simplex virus IgM Ab [Presence] in Serum,710
30108131710,measurement below normal range during day -365 through 0 days relative to index: Leukocytes [#/volume] in Blood,710
30108132710,measurement within normal range during day -365 through 0 days relative to index: Leukocytes [#/volume] in Blood,710
30108133710,measurement above normal range during day -365 through 0 days relative to index: Leukocytes [#/volume] in Blood,710
30111772710,measurement within normal range during day -365 through 0 days relative to index: Bermuda grass IgE Ab RAST class [Presence] in Serum,710
30119041710,measurement below normal range during day -365 through 0 days relative to index: Phosphate [Mass/volume] in Serum or Plasma,710
30119042710,measurement within normal range during day -365 through 0 days relative to index: Phosphate [Mass/volume] in Serum or Plasma,710
30119043710,measurement above normal range during day -365 through 0 days relative to index: Phosphate [Mass/volume] in Serum or Plasma,710
30119582710,measurement within normal range during day -365 through 0 days relative to index: Ammonia [Moles/volume] in Plasma,710
30125651710,measurement below normal range during day -365 through 0 days relative to index: Volume of 24 hour Urine,710
30125653710,measurement above normal range during day -365 through 0 days relative to index: Volume of 24 hour Urine,710
30130432710,measurement within normal range during day -365 through 0 days relative to index: Timothy IgE Ab RAST class [Presence] in Serum,710
30131153710,measurement above normal range during day -365 through 0 days relative to index: Eosinophils [#/volume] in Blood,710
30132732710,measurement within normal range during day -365 through 0 days relative to index: Insulin-like growth factor-I [Mass/volume] in Serum or Plasma,710
30134982710,measurement within normal range during day -365 through 0 days relative to index: Variant lymphocytes/100 leukocytes in Blood,710
30136501710,measurement below normal range during day -365 through 0 days relative to index: Neutrophils [#/volume] in Blood by Automated count,710
30136502710,measurement within normal range during day -365 through 0 days relative to index: Neutrophils [#/volume] in Blood by Automated count,710
30136503710,measurement above normal range during day -365 through 0 days relative to index: Neutrophils [#/volume] in Blood by Automated count,710
30136821710,measurement below normal range during day -365 through 0 days relative to index: Urea nitrogen [Mass/volume] in Serum or Plasma,710
30136822710,measurement within normal range during day -365 through 0 days relative to index: Urea nitrogen [Mass/volume] in Serum or Plasma,710
30136823710,measurement above normal range during day -365 through 0 days relative to index: Urea nitrogen [Mass/volume] in Serum or Plasma,710
30142181710,measurement below normal range during day -365 through 0 days relative to index: Bicarbonate [Moles/volume] standard in Arterial blood,710
30142182710,measurement within normal range during day -365 through 0 days relative to index: Bicarbonate [Moles/volume] standard in Arterial blood,710
30142183710,measurement above normal range during day -365 through 0 days relative to index: Bicarbonate [Moles/volume] standard in Arterial blood,710
30145761710,measurement below normal range during day -365 through 0 days relative to index: Chloride [Moles/volume] in Serum or Plasma,710
30145762710,measurement within normal range during day -365 through 0 days relative to index: Chloride [Moles/volume] in Serum or Plasma,710
30145763710,measurement above normal range during day -365 through 0 days relative to index: Chloride [Moles/volume] in Serum or Plasma,710
30147911710,measurement below normal range during day -365 through 0 days relative to index: Apolipoprotein B [Mass/volume] in Serum or Plasma,710
30147912710,measurement within normal range during day -365 through 0 days relative to index: Apolipoprotein B [Mass/volume] in Serum or Plasma,710
30147913710,measurement above normal range during day -365 through 0 days relative to index: Apolipoprotein B [Mass/volume] in Serum or Plasma,710
30150562710,measurement within normal range during day -365 through 0 days relative to index: Horse epithelium IgE Ab RAST class [Presence] in Serum,710
30151832710,measurement within normal range during day -365 through 0 days relative to index: Erythrocyte sedimentation rate,710
30151833710,measurement above normal range during day -365 through 0 days relative to index: Erythrocyte sedimentation rate,710
30152422710,measurement within normal range during day -365 through 0 days relative to index: Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,710
30152423710,measurement above normal range during day -365 through 0 days relative to index: Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,710
30156321710,"measurement below normal range during day -365 through 0 days relative to index: Carbon dioxide, total [Moles/volume] in Serum or Plasma",710
30156322710,"measurement within normal range during day -365 through 0 days relative to index: Carbon dioxide, total [Moles/volume] in Serum or Plasma",710
30156323710,"measurement above normal range during day -365 through 0 days relative to index: Carbon dioxide, total [Moles/volume] in Serum or Plasma",710
30157042710,measurement within normal range during day -365 through 0 days relative to index: Mugwort IgE Ab RAST class [Presence] in Serum,710
30159422710,measurement within normal range during day -365 through 0 days relative to index: Alternaria alternata IgE Ab RAST class [Presence] in Serum,710
30160381710,measurement below normal range during day -365 through 0 days relative to index: Potassium [Moles/volume] in Urine,710
30160382710,measurement within normal range during day -365 through 0 days relative to index: Potassium [Moles/volume] in Urine,710
30161352710,measurement within normal range during day -365 through 0 days relative to index: IgD [Mass/volume] in Serum,710
30162442710,measurement within normal range during day -365 through 0 days relative to index: Insulin [Units/volume] in Serum or Plasma,710
30164072710,measurement within normal range during day -365 through 0 days relative to index: Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay,710
30164073710,measurement above normal range during day -365 through 0 days relative to index: Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay,710
30165021710,measurement below normal range during day -365 through 0 days relative to index: Oxygen saturation in Arterial blood,710
30165022710,measurement within normal range during day -365 through 0 days relative to index: Oxygen saturation in Arterial blood,710
30165023710,measurement above normal range during day -365 through 0 days relative to index: Oxygen saturation in Arterial blood,710
30167231710,measurement below normal range during day -365 through 0 days relative to index: Creatinine [Mass/volume] in Serum or Plasma,710
30167232710,measurement within normal range during day -365 through 0 days relative to index: Creatinine [Mass/volume] in Serum or Plasma,710
30167233710,measurement above normal range during day -365 through 0 days relative to index: Creatinine [Mass/volume] in Serum or Plasma,710
30167711710,measurement below normal range during day -365 through 0 days relative to index: Amylase [Enzymatic activity/volume] in Serum or Plasma,710
30167712710,measurement within normal range during day -365 through 0 days relative to index: Amylase [Enzymatic activity/volume] in Serum or Plasma,710
30167713710,measurement above normal range during day -365 through 0 days relative to index: Amylase [Enzymatic activity/volume] in Serum or Plasma,710
30168352710,measurement within normal range during day -365 through 0 days relative to index: Common Pigweed IgE Ab RAST class [Presence] in Serum,710
30169802710,measurement within normal range during day -365 through 0 days relative to index: House dust IgE Ab RAST class [Presence] in Serum,710
30171432710,measurement within normal range during day -365 through 0 days relative to index: Hepatitis C virus Ab [Presence] in Serum,710
30172501710,measurement below normal range during day -365 through 0 days relative to index: Creatinine [Mass/volume] in Urine,710
30172502710,measurement within normal range during day -365 through 0 days relative to index: Creatinine [Mass/volume] in Urine,710
30173541710,measurement below normal range during day -365 through 0 days relative to index: Segmented neutrophils/100 leukocytes in Blood,710
30173542710,measurement within normal range during day -365 through 0 days relative to index: Segmented neutrophils/100 leukocytes in Blood,710
30173543710,measurement above normal range during day -365 through 0 days relative to index: Segmented neutrophils/100 leukocytes in Blood,710
30175042710,measurement within normal range during day -365 through 0 days relative to index: Pine IgE Ab RAST class [Presence] in Serum,710
30177662710,measurement within normal range during day -365 through 0 days relative to index: Complement C4 [Mass/volume] in Serum or Plasma,710
30179251710,measurement below normal range during day -365 through 0 days relative to index: Prealbumin [Mass/volume] in Serum or Plasma by Immunoassay,710
30179252710,measurement within normal range during day -365 through 0 days relative to index: Prealbumin [Mass/volume] in Serum or Plasma by Immunoassay,710
30183392710,measurement within normal range during day -365 through 0 days relative to index: Honey bee IgE Ab RAST class [Presence] in Serum,710
30186452710,measurement within normal range during day -365 through 0 days relative to index: Cladosporium herbarum IgE Ab RAST class [Presence] in Serum,710
30186771710,measurement below normal range during day -365 through 0 days relative to index: aPTT in Platelet poor plasma by Coagulation assay,710
30186772710,measurement within normal range during day -365 through 0 days relative to index: aPTT in Platelet poor plasma by Coagulation assay,710
30186773710,measurement above normal range during day -365 through 0 days relative to index: aPTT in Platelet poor plasma by Coagulation assay,710
30189702710,measurement within normal range during day -365 through 0 days relative to index: Chocolate IgE Ab RAST class [Presence] in Serum,710
30190691710,measurement below normal range during day -365 through 0 days relative to index: Monocytes/100 leukocytes in Blood,710
30190692710,measurement within normal range during day -365 through 0 days relative to index: Monocytes/100 leukocytes in Blood,710
30190693710,measurement above normal range during day -365 through 0 days relative to index: Monocytes/100 leukocytes in Blood,710
30192842710,measurement within normal range during day -365 through 0 days relative to index: Hepatitis B virus surface Ag [Presence] in Serum,710
30195501710,measurement below normal range during day -365 through 0 days relative to index: Sodium [Moles/volume] in Serum or Plasma,710
30195502710,measurement within normal range during day -365 through 0 days relative to index: Sodium [Moles/volume] in Serum or Plasma,710
30198973710,measurement above normal range during day -365 through 0 days relative to index: Erythrocyte distribution width [Ratio] by Automated count,710
30199771710,measurement below normal range during day -365 through 0 days relative to index: pH of Arterial blood,710
30199772710,measurement within normal range during day -365 through 0 days relative to index: pH of Arterial blood,710
30199773710,measurement above normal range during day -365 through 0 days relative to index: pH of Arterial blood,710
30201342710,measurement within normal range during day -365 through 0 days relative to index: Herpes simplex virus IgG Ab [Presence] in Serum,710
30201842710,measurement within normal range during day -365 through 0 days relative to index: Dandelion IgE Ab RAST class [Presence] in Serum,710
30204672710,measurement within normal range during day -365 through 0 days relative to index: Red top grass IgE Ab RAST class [Presence] in Serum,710
30205152710,measurement within normal range during day -365 through 0 days relative to index: Wattle IgE Ab RAST class [Presence] in Serum,710
30206301710,measurement below normal range during day -365 through 0 days relative to index: Protein [Mass/volume] in Serum or Plasma,710
30206302710,measurement within normal range during day -365 through 0 days relative to index: Protein [Mass/volume] in Serum or Plasma,710
30206952710,measurement within normal range during day -365 through 0 days relative to index: Perennial rye grass IgE Ab RAST class [Presence] in Serum,710
30208252710,measurement within normal range during day -365 through 0 days relative to index: European house dust mite IgE Ab RAST class [Presence] in Serum,710
30210441710,measurement below normal range during day -365 through 0 days relative to index: Iron binding capacity [Mass/volume] in Serum or Plasma,710
30210442710,measurement within normal range during day -365 through 0 days relative to index: Iron binding capacity [Mass/volume] in Serum or Plasma,710
30213471710,measurement below normal range during day -365 through 0 days relative to index: Calcium.ionized [Moles/volume] in Serum or Plasma,710
30213472710,measurement within normal range during day -365 through 0 days relative to index: Calcium.ionized [Moles/volume] in Serum or Plasma,710
30213473710,measurement above normal range during day -365 through 0 days relative to index: Calcium.ionized [Moles/volume] in Serum or Plasma,710
30213542710,measurement within normal range during day -365 through 0 days relative to index: Sweet Vernal grass IgE Ab RAST class [Presence] in Serum,710
30216442710,measurement within normal range during day -365 through 0 days relative to index: Mackerel IgE Ab RAST class [Presence] in Serum,710
30217373710,measurement above normal range during day -365 through 0 days relative to index: Glucose [Mass/volume] in Serum or Plasma --2 hours post meal,710
30220962710,measurement within normal range during day -365 through 0 days relative to index: Basophils/100 leukocytes in Blood,710
30220963710,measurement above normal range during day -365 through 0 days relative to index: Basophils/100 leukocytes in Blood,710
30222172710,measurement within normal range during day -365 through 0 days relative to index: INR in Platelet poor plasma by Coagulation assay,710
30222173710,measurement above normal range during day -365 through 0 days relative to index: INR in Platelet poor plasma by Coagulation assay,710
30223792710,measurement within normal range during day -365 through 0 days relative to index: Silver Birch IgG Ab RAST class [Presence] in Serum,710
30231031710,measurement below normal range during day -365 through 0 days relative to index: Potassium [Moles/volume] in Serum or Plasma,710
30231032710,measurement within normal range during day -365 through 0 days relative to index: Potassium [Moles/volume] in Serum or Plasma,710
30231033710,measurement above normal range during day -365 through 0 days relative to index: Potassium [Moles/volume] in Serum or Plasma,710
30232301710,measurement below normal range during day -365 through 0 days relative to index: Hematocrit [Volume Fraction] of Arterial blood,710
30233141710,measurement below normal range during day -365 through 0 days relative to index: Hematocrit [Volume Fraction] of Blood by Automated count,710
30233142710,measurement within normal range during day -365 through 0 days relative to index: Hematocrit [Volume Fraction] of Blood by Automated count,710
30233143710,measurement above normal range during day -365 through 0 days relative to index: Hematocrit [Volume Fraction] of Blood by Automated count,710
30236462710,measurement within normal range during day -365 through 0 days relative to index: Shrimp IgE Ab RAST class [Presence] in Serum,710
30237092710,measurement within normal range during day -365 through 0 days relative to index: Somatotropin [Mass/volume] in Serum or Plasma,710
30238302710,measurement within normal range during day -365 through 0 days relative to index: Crab IgE Ab RAST class [Presence] in Serum,710
30239142710,measurement within normal range during day -365 through 0 days relative to index: Latex IgE Ab RAST class [Presence] in Serum,710
30241722710,measurement within normal range during day -365 through 0 days relative to index: Erythropoietin (EPO) [Units/volume] in Serum or Plasma,710
30243112710,measurement within normal range during day -365 through 0 days relative to index: White Poplar IgE Ab RAST class [Presence] in Serum,710
30245611710,measurement below normal range during day -365 through 0 days relative to index: Albumin [Mass/volume] in Serum or Plasma,710
30245612710,measurement within normal range during day -365 through 0 days relative to index: Albumin [Mass/volume] in Serum or Plasma,710
30245613710,measurement above normal range during day -365 through 0 days relative to index: Albumin [Mass/volume] in Serum or Plasma,710
30247311710,measurement below normal range during day -365 through 0 days relative to index: MCV [Entitic volume],710
30247312710,measurement within normal range during day -365 through 0 days relative to index: MCV [Entitic volume],710
30247313710,measurement above normal range during day -365 through 0 days relative to index: MCV [Entitic volume],710
30249802710,measurement within normal range during day -365 through 0 days relative to index: IgG subclass 4 [Mass/volume] in Serum,710
30250052710,measurement within normal range during day -365 through 0 days relative to index: Willow IgE Ab RAST class [Presence] in Serum,710
30252872710,measurement within normal range during day -365 through 0 days relative to index: Rabbit epithelium IgE Ab RAST class [Presence] in Serum,710
30253131710,measurement below normal range during day -365 through 0 days relative to index: Albumin [Mass/volume] in Body fluid,710
30263611710,measurement below normal range during day -365 through 0 days relative to index: Erythrocytes [#/volume] in Blood,710
30263612710,measurement within normal range during day -365 through 0 days relative to index: Erythrocytes [#/volume] in Blood,710
30263613710,measurement above normal range during day -365 through 0 days relative to index: Erythrocytes [#/volume] in Blood,710
30266921710,measurement below normal range during day -365 through 0 days relative to index: Albumin [Mass/volume] in Peritoneal fluid,710
30267291710,measurement below normal range during day -365 through 0 days relative to index: Phosphate [Mass/volume] in Urine,710
30267802710,measurement within normal range during day -365 through 0 days relative to index: Yellow Jacket IgE Ab RAST class [Presence] in Serum,710
30267821710,measurement below normal range during day -365 through 0 days relative to index: Osmolality of Urine,710
30267822710,measurement within normal range during day -365 through 0 days relative to index: Osmolality of Urine,710
30269101710,measurement below normal range during day -365 through 0 days relative to index: Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,710
30269102710,measurement within normal range during day -365 through 0 days relative to index: Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,710
30269103710,measurement above normal range during day -365 through 0 days relative to index: Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,710
30269251710,measurement below normal range during day -365 through 0 days relative to index: Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,710
30269252710,measurement within normal range during day -365 through 0 days relative to index: Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,710
30271172710,measurement within normal range during day -365 through 0 days relative to index: Goldenrod IgE Ab RAST class [Presence] in Serum,710
30272712710,measurement within normal range during day -365 through 0 days relative to index: Potato IgE Ab RAST class [Presence] in Serum,710
30274841710,measurement below normal range during day -365 through 0 days relative to index: Hemoglobin [Mass/volume] in Blood by calculation,710
30274842710,measurement within normal range during day -365 through 0 days relative to index: Hemoglobin [Mass/volume] in Blood by calculation,710
30274843710,measurement above normal range during day -365 through 0 days relative to index: Hemoglobin [Mass/volume] in Blood by calculation,710
30276582710,measurement within normal range during day -365 through 0 days relative to index: Sesame Seed IgE Ab RAST class [Presence] in Serum,710
30278011710,measurement below normal range during day -365 through 0 days relative to index: Oxygen [Partial pressure] in Arterial blood,710
30278012710,measurement within normal range during day -365 through 0 days relative to index: Oxygen [Partial pressure] in Arterial blood,710
30278013710,measurement above normal range during day -365 through 0 days relative to index: Oxygen [Partial pressure] in Arterial blood,710
30279461710,measurement below normal range during day -365 through 0 days relative to index: Carbon dioxide [Partial pressure] in Arterial blood,710
30279462710,measurement within normal range during day -365 through 0 days relative to index: Carbon dioxide [Partial pressure] in Arterial blood,710
30279463710,measurement above normal range during day -365 through 0 days relative to index: Carbon dioxide [Partial pressure] in Arterial blood,710
30280261710,measurement below normal range during day -365 through 0 days relative to index: IgM [Mass/volume] in Serum or Plasma,710
30280262710,measurement within normal range during day -365 through 0 days relative to index: IgM [Mass/volume] in Serum or Plasma,710
30281641710,measurement below normal range during day -365 through 0 days relative to index: Complement total hemolytic [Units/volume] in Blood,710
30281642710,measurement within normal range during day -365 through 0 days relative to index: Complement total hemolytic [Units/volume] in Blood,710
30281643710,measurement above normal range during day -365 through 0 days relative to index: Complement total hemolytic [Units/volume] in Blood,710
30291873710,measurement above normal range during day -365 through 0 days relative to index: Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma,710
30293052710,measurement within normal range during day -365 through 0 days relative to index: pH of Urine by Automated test strip,710
30294832710,measurement within normal range during day -365 through 0 days relative to index: DNA double strand Ab [Units/volume] in Serum by Immunoassay,710
30303663710,measurement above normal range during day -365 through 0 days relative to index: Cystatin C [Mass/volume] in Serum or Plasma,710
30333352710,measurement within normal range during day -365 through 0 days relative to index: Egg white IgE Ab RAST class [Presence] in Serum,710
30335152710,measurement within normal range during day -365 through 0 days relative to index: Saltwort IgE Ab RAST class [Presence] in Serum,710
30335261710,measurement below normal range during day -365 through 0 days relative to index: Urate [Mass/volume] in Urine,710
30335262710,measurement within normal range during day -365 through 0 days relative to index: Urate [Mass/volume] in Urine,710
30336581710,measurement below normal range during day -365 through 0 days relative to index: Prothrombin time (PT) actual/Normal,710
30336582710,measurement within normal range during day -365 through 0 days relative to index: Prothrombin time (PT) actual/Normal,710
30344262710,measurement within normal range during day -365 through 0 days relative to index: Prothrombin time (PT),710
30344263710,measurement above normal range during day -365 through 0 days relative to index: Prothrombin time (PT),710
30348603710,measurement above normal range during day -365 through 0 days relative to index: Kappa light chains.free [Mass/volume] in Serum,710
30356371710,measurement below normal range during day -365 through 0 days relative to index: Corticotropin [Mass/volume] in Plasma,710
30356372710,measurement within normal range during day -365 through 0 days relative to index: Corticotropin [Mass/volume] in Plasma,710
30357062710,measurement within normal range during day -365 through 0 days relative to index: Apple IgE Ab RAST class [Presence] in Serum,710
30358801710,measurement below normal range during day -365 through 0 days relative to index: pH of Pleural fluid,710
30359411710,measurement below normal range during day -365 through 0 days relative to index: MCH [Entitic mass],710
30359412710,measurement within normal range during day -365 through 0 days relative to index: MCH [Entitic mass],710
30359413710,measurement above normal range during day -365 through 0 days relative to index: MCH [Entitic mass],710
30359951710,measurement below normal range during day -365 through 0 days relative to index: Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,710
30359952710,measurement within normal range during day -365 through 0 days relative to index: Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,710
30359953710,measurement above normal range during day -365 through 0 days relative to index: Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,710
30365742710,measurement within normal range during day -365 through 0 days relative to index: Grey Alder IgE Ab RAST class [Presence] in Serum,710
30366711710,measurement below normal range during day -365 through 0 days relative to index: Fasting glucose [Mass/volume] in Capillary blood,710
30366712710,measurement within normal range during day -365 through 0 days relative to index: Fasting glucose [Mass/volume] in Capillary blood,710
30366713710,measurement above normal range during day -365 through 0 days relative to index: Fasting glucose [Mass/volume] in Capillary blood,710
30368572710,measurement within normal range during day -365 through 0 days relative to index: White Ash IgE Ab RAST class [Presence] in Serum,710
30369872710,measurement within normal range during day -365 through 0 days relative to index: Folate [Mass/volume] in Serum or Plasma,710
30369873710,measurement above normal range during day -365 through 0 days relative to index: Folate [Mass/volume] in Serum or Plasma,710
30371101710,measurement below normal range during day -365 through 0 days relative to index: Fasting glucose [Mass/volume] in Serum or Plasma,710
30371102710,measurement within normal range during day -365 through 0 days relative to index: Fasting glucose [Mass/volume] in Serum or Plasma,710
30371103710,measurement above normal range during day -365 through 0 days relative to index: Fasting glucose [Mass/volume] in Serum or Plasma,710
30372352710,measurement within normal range during day -365 through 0 days relative to index: Penicillium notatum IgE Ab RAST class [Presence] in Serum,710
30375561710,measurement below normal range during day -365 through 0 days relative to index: Urate [Mass/volume] in Serum or Plasma,710
30375562710,measurement within normal range during day -365 through 0 days relative to index: Urate [Mass/volume] in Serum or Plasma,710
30375563710,measurement above normal range during day -365 through 0 days relative to index: Urate [Mass/volume] in Serum or Plasma,710
30380662710,measurement within normal range during day -365 through 0 days relative to index: American Sycamore IgE Ab RAST class [Presence] in Serum,710
30384662710,measurement within normal range during day -365 through 0 days relative to index: Reticulocytes.high light scatter [#/volume] in Blood,710
30384663710,measurement above normal range during day -365 through 0 days relative to index: Reticulocytes.high light scatter [#/volume] in Blood,710
30393122710,measurement within normal range during day -365 through 0 days relative to index: Plateletocrit [Volume Fraction] in Blood,710
30394173710,measurement above normal range during day -365 through 0 days relative to index: Platelet distribution width [Ratio] in Blood,710
30399192710,measurement within normal range during day -365 through 0 days relative to index: Specific gravity of Urine by Automated test strip,710
30399193710,measurement above normal range during day -365 through 0 days relative to index: Specific gravity of Urine by Automated test strip,710
30427023710,measurement above normal range during day -365 through 0 days relative to index: Immunoglobulin light chains [Mass/time] in 24 hour Urine,710
30434091710,measurement below normal range during day -365 through 0 days relative to index: Potassium [Moles/volume] in Arterial blood,710
30434092710,measurement within normal range during day -365 through 0 days relative to index: Potassium [Moles/volume] in Arterial blood,710
30434093710,measurement above normal range during day -365 through 0 days relative to index: Potassium [Moles/volume] in Arterial blood,710
30437061710,measurement below normal range during day -365 through 0 days relative to index: Sodium [Moles/volume] in Arterial blood,710
30437062710,measurement within normal range during day -365 through 0 days relative to index: Sodium [Moles/volume] in Arterial blood,710
30442422710,measurement within normal range during day -365 through 0 days relative to index: Glucose [Moles/volume] in Arterial blood,710
30443311710,measurement below normal range during day -365 through 0 days relative to index: Calcium.ionized [Moles/volume] in Arterial blood,710
30449362710,measurement within normal range during day -365 through 0 days relative to index: Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay,710
30460002710,measurement within normal range during day -365 through 0 days relative to index: Immature reticulocytes/Reticulocytes.total in Blood,710
30460003710,measurement above normal range during day -365 through 0 days relative to index: Immature reticulocytes/Reticulocytes.total in Blood,710
30468062710,measurement within normal range during day -365 through 0 days relative to index: Japanese hop IgE Ab RAST class [Presence] in Serum,710
30471693710,measurement above normal range during day -365 through 0 days relative to index: Lambda light chains.free [Mass/volume] in Serum or Plasma,710
30471811710,measurement below normal range during day -365 through 0 days relative to index: Lactate [Moles/volume] in Blood,710
30471812710,measurement within normal range during day -365 through 0 days relative to index: Lactate [Moles/volume] in Blood,710
30471813710,measurement above normal range during day -365 through 0 days relative to index: Lactate [Moles/volume] in Blood,710
30498581710,measurement below normal range during day -365 through 0 days relative to index: Reticulocyte mean volume [Entitic volume] in Reticulocytes,710
30498582710,measurement within normal range during day -365 through 0 days relative to index: Reticulocyte mean volume [Entitic volume] in Reticulocytes,710
30498583710,measurement above normal range during day -365 through 0 days relative to index: Reticulocyte mean volume [Entitic volume] in Reticulocytes,710
35602717410,drug_era group during day -365 through 0 days relative to index: insulin degludec,410
35602717412,drug_era group during day -30 through 0 days relative to index: insulin degludec,412
35604680410,drug_era group during day -365 through 0 days relative to index: Tetanus immune globulin,410
35604767410,drug_era group during day -365 through 0 days relative to index: methylephedrine,410
35604767412,drug_era group during day -30 through 0 days relative to index: methylephedrine,412
35604767413,drug_era group during day 0 through 0 days relative to index: methylephedrine,413
36203627702,measurement during day -365 through 0 days relative to index: Carbapenem resistance bla OXA-48-like gene [Presence] by Molecular method,702
36203627704,measurement during day -30 through 0 days relative to index: Carbapenem resistance bla OXA-48-like gene [Presence] by Molecular method,704
36303311702,measurement during day -365 through 0 days relative to index: Pneumocystis jiroveci DNA [#/volume] in Lower respiratory specimen by NAA with probe detection,702
36303607702,measurement during day -365 through 0 days relative to index: Human coronavirus 229E RNA [Presence] in Aspirate by NAA with probe detection,702
36303607704,measurement during day -30 through 0 days relative to index: Human coronavirus 229E RNA [Presence] in Aspirate by NAA with probe detection,704
36303621702,measurement during day -365 through 0 days relative to index: Chlamydophila pneumoniae DNA [Presence] in Nasopharynx by NAA with probe detection,702
36303621704,measurement during day -30 through 0 days relative to index: Chlamydophila pneumoniae DNA [Presence] in Nasopharynx by NAA with probe detection,704
36304079702,measurement during day -365 through 0 days relative to index: Mucus [Presence] in Urine sediment,702
36304170702,measurement during day -365 through 0 days relative to index: Clostridioides difficile BI-NAP1-027 strain DNA [Presence] in Stool by NAA with probe detection,702
36304170704,measurement during day -30 through 0 days relative to index: Clostridioides difficile BI-NAP1-027 strain DNA [Presence] in Stool by NAA with probe detection,704
36304372702,measurement during day -365 through 0 days relative to index: Mycobacterium tuberculosis complex rpoB gene rifAMPin resistance mutation [Presence] by Molecular method,702
36304372704,measurement during day -30 through 0 days relative to index: Mycobacterium tuberculosis complex rpoB gene rifAMPin resistance mutation [Presence] by Molecular method,704
36304464702,measurement during day -365 through 0 days relative to index: Human coronavirus OC43 RNA [Presence] in Upper respiratory specimen by NAA with probe detection,702
36304464704,measurement during day -30 through 0 days relative to index: Human coronavirus OC43 RNA [Presence] in Upper respiratory specimen by NAA with probe detection,704
36304548702,measurement during day -365 through 0 days relative to index: Human coronavirus NL63 RNA [Presence] in Upper respiratory specimen by NAA with probe detection,702
36304548704,measurement during day -30 through 0 days relative to index: Human coronavirus NL63 RNA [Presence] in Upper respiratory specimen by NAA with probe detection,704
36304601702,measurement during day -365 through 0 days relative to index: Human coronavirus 229E RNA [Presence] in Upper respiratory specimen by NAA with probe detection,702
36304601704,measurement during day -30 through 0 days relative to index: Human coronavirus 229E RNA [Presence] in Upper respiratory specimen by NAA with probe detection,704
36305584702,measurement during day -365 through 0 days relative to index: Mycoplasma pneumoniae DNA [Presence] in Nasopharynx by NAA with probe detection,702
36305584704,measurement during day -30 through 0 days relative to index: Mycoplasma pneumoniae DNA [Presence] in Nasopharynx by NAA with probe detection,704
36305655702,measurement during day -365 through 0 days relative to index: Human bocavirus DNA [Presence] in Upper respiratory specimen by NAA with probe detection,702
36305655704,measurement during day -30 through 0 days relative to index: Human bocavirus DNA [Presence] in Upper respiratory specimen by NAA with probe detection,704
36305676702,measurement during day -365 through 0 days relative to index: Human coronavirus HKU1 RNA [Presence] in Upper respiratory specimen by NAA with probe detection,702
36305676704,measurement during day -30 through 0 days relative to index: Human coronavirus HKU1 RNA [Presence] in Upper respiratory specimen by NAA with probe detection,704
36683531210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of colon and/or rectum,210
36683531212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of colon and/or rectum,212
36683564210,condition_era group during day -365 through 0 days relative to index: Allergic disorder,210
36683564212,condition_era group during day -30 through 0 days relative to index: Allergic disorder,212
36684203210,condition_era group during day -365 through 0 days relative to index: Immune-mediated neuropathy,210
36684472210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of abdomen,210
36684472212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of abdomen,212
36685860502,procedure_occurrence during day -365 through 0 days relative to index: Management of infusion pump,502
36685860504,procedure_occurrence during day -30 through 0 days relative to index: Management of infusion pump,504
36685990210,condition_era group during day -365 through 0 days relative to index: Mass of skin of head,210
36685990212,condition_era group during day -30 through 0 days relative to index: Mass of skin of head,212
36713048502,procedure_occurrence during day -365 through 0 days relative to index: High resolution computed tomography of chest without contrast,502
36713048504,procedure_occurrence during day -30 through 0 days relative to index: High resolution computed tomography of chest without contrast,504
36713176502,procedure_occurrence during day -365 through 0 days relative to index: CT of head without contrast,502
36713200502,procedure_occurrence during day -365 through 0 days relative to index: CT of chest without contrast,502
36713200504,procedure_occurrence during day -30 through 0 days relative to index: CT of chest without contrast,504
36716270210,condition_era group during day -365 through 0 days relative to index: Cyst of kidney,210
36716270212,condition_era group during day -30 through 0 days relative to index: Cyst of kidney,212
37016195210,condition_era group during day -365 through 0 days relative to index: Leiomyoma,210
37016354210,condition_era group during day -365 through 0 days relative to index: Neuropathy due to type 2 diabetes mellitus,210
37016354212,condition_era group during day -30 through 0 days relative to index: Neuropathy due to type 2 diabetes mellitus,212
37016875502,procedure_occurrence during day -365 through 0 days relative to index: Plain radiography of pelvis,502
37017432210,condition_era group during day -365 through 0 days relative to index: Polyneuropathy due to type 2 diabetes mellitus,210
37017432212,condition_era group during day -30 through 0 days relative to index: Polyneuropathy due to type 2 diabetes mellitus,212
37018424210,condition_era group during day -365 through 0 days relative to index: Lesion of skin and/or skin-associated mucous membrane,210
37018424212,condition_era group during day -30 through 0 days relative to index: Lesion of skin and/or skin-associated mucous membrane,212
37018677210,condition_era group during day -365 through 0 days relative to index: Anomaly of eye,210
37018677212,condition_era group during day -30 through 0 days relative to index: Anomaly of eye,212
37018936602,"device_exposure during day -365 through 0 days relative to index: Peripheral vascular guidewire, powered",602
37020338702,measurement during day -365 through 0 days relative to index: Haemophilus influenzae DNA [Presence] in Respiratory specimen by NAA with probe detection,702
37020338704,measurement during day -30 through 0 days relative to index: Haemophilus influenzae DNA [Presence] in Respiratory specimen by NAA with probe detection,704
37020998702,measurement during day -365 through 0 days relative to index: Streptococcus pneumoniae DNA [Presence] in Respiratory specimen by NAA with probe detection,702
37020998704,measurement during day -30 through 0 days relative to index: Streptococcus pneumoniae DNA [Presence] in Respiratory specimen by NAA with probe detection,704
37109313502,procedure_occurrence during day -365 through 0 days relative to index: CT of abdomen without contrast,502
37110208210,condition_era group during day -365 through 0 days relative to index: Lesion of genitalia,210
37110594210,condition_era group during day -365 through 0 days relative to index: Localized eruption of skin,210
37110594212,condition_era group during day -30 through 0 days relative to index: Localized eruption of skin,212
37311061210,condition_era group during day -365 through 0 days relative to index: Disease caused by severe acute respiratory syndrome coronavirus 2,210
37311061212,condition_era group during day -30 through 0 days relative to index: Disease caused by severe acute respiratory syndrome coronavirus 2,212
37311784210,condition_era group during day -365 through 0 days relative to index: Exogenous dermatitis,210
37395564210,condition_era group during day -365 through 0 days relative to index: Hypoxemic respiratory failure,210
37395564212,condition_era group during day -30 through 0 days relative to index: Hypoxemic respiratory failure,212
37396146210,condition_era group during day -365 through 0 days relative to index: Gastrointestinal infection,210
37399728502,procedure_occurrence during day -365 through 0 days relative to index: Assessment using CDR,502
38003585004,race = Korean,4
40166571410,drug_era group during day -365 through 0 days relative to index: bepotastine,410
40167569410,drug_era group during day -365 through 0 days relative to index: peramivir,410
40222444410,drug_era group during day -365 through 0 days relative to index: denosumab,410
40239216410,drug_era group during day -365 through 0 days relative to index: Linagliptin,410
40239216412,drug_era group during day -30 through 0 days relative to index: Linagliptin,412
40239216413,drug_era group during day 0 through 0 days relative to index: Linagliptin,413
40405599210,condition_era group during day -365 through 0 days relative to index: Fibromyalgia,210
40405599212,condition_era group during day -30 through 0 days relative to index: Fibromyalgia,212
40479379502,procedure_occurrence during day -365 through 0 days relative to index: Insertion of single chamber pacing cardioverter defibrillator pulse generator,502
40479625210,condition_era group during day -365 through 0 days relative to index: Atherosclerosis of artery,210
40479625212,condition_era group during day -30 through 0 days relative to index: Atherosclerosis of artery,212
40479649210,condition_era group during day -365 through 0 days relative to index: Systemic inflammatory response syndrome associated with organ dysfunction,210
40479649212,condition_era group during day -30 through 0 days relative to index: Systemic inflammatory response syndrome associated with organ dysfunction,212
40480052602,"device_exposure during day -365 through 0 days relative to index: Tape for stabilization of intravenous catheter, device",602
40480513210,condition_era group during day -365 through 0 days relative to index: Hemoglobin level outside reference range,210
40480513212,condition_era group during day -30 through 0 days relative to index: Hemoglobin level outside reference range,212
40480615210,condition_era group during day -365 through 0 days relative to index: Cognitive disorder,210
40480615212,condition_era group during day -30 through 0 days relative to index: Cognitive disorder,212
40481517210,condition_era group during day -365 through 0 days relative to index: Mass of soft tissue,210
40481517212,condition_era group during day -30 through 0 days relative to index: Mass of soft tissue,212
40481841210,condition_era group during day -365 through 0 days relative to index: Measurement finding outside reference range,210
40481841212,condition_era group during day -30 through 0 days relative to index: Measurement finding outside reference range,212
40481910210,condition_era group during day -365 through 0 days relative to index: Neoplasm of lymphoid system structure,210
40481910212,condition_era group during day -30 through 0 days relative to index: Neoplasm of lymphoid system structure,212
40481977502,procedure_occurrence during day -365 through 0 days relative to index: Change of drainage collection device,502
40484167210,condition_era group during day -365 through 0 days relative to index: Arteriosclerosis of artery of extremity,210
40484167212,condition_era group during day -30 through 0 days relative to index: Arteriosclerosis of artery of extremity,212
40484533210,condition_era group during day -365 through 0 days relative to index: Measurement finding below reference range,210
40484533212,condition_era group during day -30 through 0 days relative to index: Measurement finding below reference range,212
40484935210,condition_era group during day -365 through 0 days relative to index: Measurement finding above reference range,210
40484935212,condition_era group during day -30 through 0 days relative to index: Measurement finding above reference range,212
40486024210,condition_era group during day -365 through 0 days relative to index: Cyst of abdomen,210
40486024212,condition_era group during day -30 through 0 days relative to index: Cyst of abdomen,212
40486896210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of extrahepatic bile duct,210
40486896212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of extrahepatic bile duct,212
40488919210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of urinary organ,210
40488919212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of urinary organ,212
40489931602,device_exposure during day -365 through 0 days relative to index: Catheter stabilization device,602
40489931604,device_exposure during day -30 through 0 days relative to index: Catheter stabilization device,604
40491001210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of digestive system,210
40491001212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of digestive system,212
40491439210,condition_era group during day -365 through 0 days relative to index: Tumor of respiratory system,210
40491439212,condition_era group during day -30 through 0 days relative to index: Tumor of respiratory system,212
40492037210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of intraabdominal organ,210
40492037212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of intraabdominal organ,212
40492969210,condition_era group during day -365 through 0 days relative to index: Intraparenchymal hemorrhage of brain,210
40493038210,condition_era group during day -365 through 0 days relative to index: Sepsis due to Gram negative bacteria,210
40493428210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of respiratory system,210
40493428212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of respiratory system,212
40758474702,measurement during day -365 through 0 days relative to index: VIM gene methylation [Presence] in Stool by Molecular genetics method,702
40758474704,measurement during day -30 through 0 days relative to index: VIM gene methylation [Presence] in Stool by Molecular genetics method,704
40760844702,measurement during day -365 through 0 days relative to index: Ketones [Presence] in Urine by Automated test strip,702
40760844704,measurement during day -30 through 0 days relative to index: Ketones [Presence] in Urine by Automated test strip,704
40761554702,measurement during day -365 through 0 days relative to index: Hemoglobin.gastrointestinal.lower [Mass/volume] in Stool by Immunoassay,702
40761554704,measurement during day -30 through 0 days relative to index: Hemoglobin.gastrointestinal.lower [Mass/volume] in Stool by Immunoassay,704
40761566702,measurement during day -365 through 0 days relative to index: DNA double strand IgG Ab [Presence] in Serum by Immunoassay,702
40762352702,measurement during day -365 through 0 days relative to index: Hemoglobin A1c/Hemoglobin.total in Blood by IFCC protocol,702
40762352704,measurement during day -30 through 0 days relative to index: Hemoglobin A1c/Hemoglobin.total in Blood by IFCC protocol,704
40763082702,measurement during day -365 through 0 days relative to index: Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction,702
40765038702,"measurement during day -365 through 0 days relative to index: 1,25-Dihydroxyvitamin D [Mass/volume] in Serum or Plasma",702
40765038704,"measurement during day -30 through 0 days relative to index: 1,25-Dihydroxyvitamin D [Mass/volume] in Serum or Plasma",704
40765224702,measurement during day -365 through 0 days relative to index: Urobilinogen [Presence] in Urine by Automated test strip,702
40765224704,measurement during day -30 through 0 days relative to index: Urobilinogen [Presence] in Urine by Automated test strip,704
40765994702,measurement during day -365 through 0 days relative to index: Glomerular basement membrane Ab [Presence] in Serum by Immunoassay,702
40765994704,measurement during day -30 through 0 days relative to index: Glomerular basement membrane Ab [Presence] in Serum by Immunoassay,704
40766042702,measurement during day -365 through 0 days relative to index: Proteinase 3 Ab [Presence] in Serum by Immunoassay,702
40766042704,measurement during day -30 through 0 days relative to index: Proteinase 3 Ab [Presence] in Serum by Immunoassay,704
40766100702,measurement during day -365 through 0 days relative to index: Carbapenem resistance genes [Identifier] by NAA with probe detection,702
40766100704,measurement during day -30 through 0 days relative to index: Carbapenem resistance genes [Identifier] by NAA with probe detection,704
40766945802,observation during day -365 through 0 days relative to index: Current smoker,802
40766945804,observation during day -30 through 0 days relative to index: Current smoker,804
40769783702,measurement during day -365 through 0 days relative to index: Troponin T.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method,702
40769783704,measurement during day -30 through 0 days relative to index: Troponin T.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method,704
40770446702,measurement during day -365 through 0 days relative to index: Leukocyte clumps [Presence] in Urine sediment by Light microscopy,702
40770446704,measurement during day -30 through 0 days relative to index: Leukocyte clumps [Presence] in Urine sediment by Light microscopy,704
40770975702,measurement during day -365 through 0 days relative to index: Lactate dehydrogenase [Enzymatic activity/volume] in Peritoneal fluid by Lactate to pyruvate reaction,702
40771922702,"measurement during day -365 through 0 days relative to index: Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood",702
40771922704,"measurement during day -30 through 0 days relative to index: Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood",704
42529187702,measurement during day -365 through 0 days relative to index: 25-Hydroxyvitamin D2+25-Hydroxyvitamin D3 [Mass/volume] in Serum or Plasma by Immunoassay,702
42529187704,measurement during day -30 through 0 days relative to index: 25-Hydroxyvitamin D2+25-Hydroxyvitamin D3 [Mass/volume] in Serum or Plasma by Immunoassay,704
42529201702,measurement during day -365 through 0 days relative to index: Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay,702
42529201704,measurement during day -30 through 0 days relative to index: Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay,704
42529202702,measurement during day -365 through 0 days relative to index: Carcinoembryonic Ag [Mass/volume] in Serum or Plasma by Immunoassay,702
42529202704,measurement during day -30 through 0 days relative to index: Carcinoembryonic Ag [Mass/volume] in Serum or Plasma by Immunoassay,704
42529233702,measurement during day -365 through 0 days relative to index: Thyroxine (T4) free [Mass/volume] in Serum or Plasma by Immunoassay,702
42529233704,measurement during day -30 through 0 days relative to index: Thyroxine (T4) free [Mass/volume] in Serum or Plasma by Immunoassay,704
42529253702,measurement during day -365 through 0 days relative to index: Triiodothyronine (T3) [Mass/volume] in Serum or Plasma by Immunoassay,702
42535425210,condition_era group during day -365 through 0 days relative to index: Spontaneous hemorrhage of cerebral hemisphere,210
42537705210,condition_era group during day -365 through 0 days relative to index: Autonomic neuropathy due to endocrine disease,210
42537706210,condition_era group during day -365 through 0 days relative to index: Autonomic neuropathy due to metabolic disease,210
42537727210,condition_era group during day -365 through 0 days relative to index: Degeneration of posterior pole of eye,210
42537730210,condition_era group during day -365 through 0 days relative to index: Coronary artery graft present,210
42537730212,condition_era group during day -30 through 0 days relative to index: Coronary artery graft present,212
42538062210,condition_era group during day -365 through 0 days relative to index: Spontaneous intracranial hemorrhage,210
42538830210,condition_era group during day -365 through 0 days relative to index: Abnormal blood cell count,210
42538830212,condition_era group during day -30 through 0 days relative to index: Abnormal blood cell count,212
42538966502,procedure_occurrence during day -365 through 0 days relative to index: Doppler ultrasonography of bilateral carotid arteries,502
42596177210,condition_era group during day -365 through 0 days relative to index: Mass of intestine,210
42596177212,condition_era group during day -30 through 0 days relative to index: Mass of intestine,212
42596178210,condition_era group during day -365 through 0 days relative to index: Large intestinal mass,210
42596178212,condition_era group during day -30 through 0 days relative to index: Large intestinal mass,212
42600414210,condition_era group during day -365 through 0 days relative to index: Tubulonephritis,210
42600414212,condition_era group during day -30 through 0 days relative to index: Tubulonephritis,212
42709318410,drug_era group during day -365 through 0 days relative to index: Tocopherol,410
42709988502,procedure_occurrence during day -365 through 0 days relative to index: Insertion of nontunneled central venous catheter,502
42709988504,procedure_occurrence during day -30 through 0 days relative to index: Insertion of nontunneled central venous catheter,504
42742387502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
42742498502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
42868421702,measurement during day -365 through 0 days relative to index: Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay,702
42868421704,measurement during day -30 through 0 days relative to index: Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay,704
42874054410,drug_era group during day -365 through 0 days relative to index: OXIDRONATE,410
42898363410,drug_era group during day -365 through 0 days relative to index: Artemisia argyi leaf extract,410
42898363412,drug_era group during day -30 through 0 days relative to index: Artemisia argyi leaf extract,412
42898363413,drug_era group during day 0 through 0 days relative to index: Artemisia argyi leaf extract,413
42899139410,drug_era group during day -365 through 0 days relative to index: Hypericum extract,410
42899139412,drug_era group during day -30 through 0 days relative to index: Hypericum extract,412
42899139413,drug_era group during day 0 through 0 days relative to index: Hypericum extract,413
42899367410,drug_era group during day -365 through 0 days relative to index: Matricaria chamomilla whole extract,410
42899367412,drug_era group during day -30 through 0 days relative to index: Matricaria chamomilla whole extract,412
42899367413,drug_era group during day 0 through 0 days relative to index: Matricaria chamomilla whole extract,413
42899398410,drug_era group during day -365 through 0 days relative to index: Medium chain triglycerides,410
42899398412,drug_era group during day -30 through 0 days relative to index: Medium chain triglycerides,412
42899398413,drug_era group during day 0 through 0 days relative to index: Medium chain triglycerides,413
42899476410,drug_era group during day -365 through 0 days relative to index: Lanthanum,410
42899476412,drug_era group during day -30 through 0 days relative to index: Lanthanum,412
42899476413,drug_era group during day 0 through 0 days relative to index: Lanthanum,413
42899536410,drug_era group during day -365 through 0 days relative to index: Oil of garlic,410
42900448410,drug_era group during day -365 through 0 days relative to index: olive oil,410
42900448412,drug_era group during day -30 through 0 days relative to index: olive oil,412
42900448413,drug_era group during day 0 through 0 days relative to index: olive oil,413
42903989410,drug_era group during day -365 through 0 days relative to index: Bellis perennis extract,410
42903989412,drug_era group during day -30 through 0 days relative to index: Bellis perennis extract,412
42903989413,drug_era group during day 0 through 0 days relative to index: Bellis perennis extract,413
42904285410,drug_era group during day -365 through 0 days relative to index: alanylglutamine,410
43008791602,device_exposure during day -365 through 0 days relative to index: AMIRAL Injectable Solution,602
43008791604,device_exposure during day -30 through 0 days relative to index: AMIRAL Injectable Solution,604
43008798602,device_exposure during day -365 through 0 days relative to index: BICART Powder for Hemodialysis Solution,602
43008803602,device_exposure during day -365 through 0 days relative to index: BIOCAPGI Powder for Hemodialysis Solution,602
43008803604,device_exposure during day -30 through 0 days relative to index: BIOCAPGI Powder for Hemodialysis Solution,604
43008808602,device_exposure during day -365 through 0 days relative to index: BORYUNG HEMOSIS AG Hemodialysis Solution,602
43008808604,device_exposure during day -30 through 0 days relative to index: BORYUNG HEMOSIS AG Hemodialysis Solution,604
43008851602,device_exposure during day -365 through 0 days relative to index: DIANEAL PD-2 Peritoneal Dialysis Solution,602
43008852602,device_exposure during day -365 through 0 days relative to index: DIANEAL PD-2 Peritoneal Dialysis Solution,602
43008853602,device_exposure during day -365 through 0 days relative to index: DIANEAL PD-2 Peritoneal Dialysis Solution,602
43008863602,device_exposure during day -365 through 0 days relative to index: EXTRANEAL Peritoneal Dialysis Solution,602
43008885602,device_exposure during day -365 through 0 days relative to index: HD SOL BCGA Hemodialysis Solution,602
43008894602,device_exposure during day -365 through 0 days relative to index: HEMO B DEX Hemodialysis Solution,602
43008894604,device_exposure during day -30 through 0 days relative to index: HEMO B DEX Hemodialysis Solution,604
43008898602,device_exposure during day -365 through 0 days relative to index: HEMOSOL B0 Hemodialysis Solution,602
43008938602,device_exposure during day -365 through 0 days relative to index: NEPHSOL Injectable Solution,602
43008938604,device_exposure during day -30 through 0 days relative to index: NEPHSOL Injectable Solution,604
43008967602,device_exposure during day -365 through 0 days relative to index: SOLCATBI Powder for Hemodialysis Solution,602
43008967604,device_exposure during day -30 through 0 days relative to index: SOLCATBI Powder for Hemodialysis Solution,604
43012202410,drug_era group during day -365 through 0 days relative to index: Fluorodeoxyglucose F18,410
43013884410,drug_era group during day -365 through 0 days relative to index: alogliptin,410
43013884412,drug_era group during day -30 through 0 days relative to index: alogliptin,412
43013884413,drug_era group during day 0 through 0 days relative to index: alogliptin,413
43021974210,condition_era group during day -365 through 0 days relative to index: Complication associated with device,210
43055681702,measurement during day -365 through 0 days relative to index: Creatinine [Mass/time] by Calculated in Urine collected for unspecified duration,702
43055681704,measurement during day -30 through 0 days relative to index: Creatinine [Mass/time] by Calculated in Urine collected for unspecified duration,704
43525846410,drug_era group during day -365 through 0 days relative to index: Achillea millefolium extract,410
43525846412,drug_era group during day -30 through 0 days relative to index: Achillea millefolium extract,412
43525846413,drug_era group during day 0 through 0 days relative to index: Achillea millefolium extract,413
43525922410,drug_era group during day -365 through 0 days relative to index: Coptis chinensis root extract,410
43525922412,drug_era group during day -30 through 0 days relative to index: Coptis chinensis root extract,412
43525922413,drug_era group during day 0 through 0 days relative to index: Coptis chinensis root extract,413
43526404410,drug_era group during day -365 through 0 days relative to index: gadoterate meglumine,410
43530620210,condition_era group during day -365 through 0 days relative to index: Oral lesion,210
43530689210,condition_era group during day -365 through 0 days relative to index: Peripheral neuropathy with type 2 diabetes,210
43530689212,condition_era group during day -30 through 0 days relative to index: Peripheral neuropathy with type 2 diabetes,212
43530727210,condition_era group during day -365 through 0 days relative to index: Spontaneous cerebral hemorrhage,210
43531034210,condition_era group during day -365 through 0 days relative to index: Neuropathy of lower limb,210
43531034212,condition_era group during day -30 through 0 days relative to index: Neuropathy of lower limb,212
43532539410,drug_era group during day -365 through 0 days relative to index: vilanterol,410
43532539412,drug_era group during day -30 through 0 days relative to index: vilanterol,412
44507580410,drug_era group during day -365 through 0 days relative to index: Macitentan,410
44507580412,drug_era group during day -30 through 0 days relative to index: Macitentan,412
44507580413,drug_era group during day 0 through 0 days relative to index: Macitentan,413
44513978502,procedure_occurrence during day -365 through 0 days relative to index: Image controlled percutaneous drainage of abdominal abscess NEC,502
44782730210,condition_era group during day -365 through 0 days relative to index: Nontraumatic intraparenchymal cerebral hemorrhage,210
44783617210,condition_era group during day -365 through 0 days relative to index: Precapillary pulmonary hypertension,210
44783617212,condition_era group during day -30 through 0 days relative to index: Precapillary pulmonary hypertension,212
44784217210,condition_era group during day -365 through 0 days relative to index: Cardiac arrhythmia,210
44784217212,condition_era group during day -30 through 0 days relative to index: Cardiac arrhythmia,212
44785907410,drug_era group during day -365 through 0 days relative to index: umeclidinium,410
44785907412,drug_era group during day -30 through 0 days relative to index: umeclidinium,412
44789813502,procedure_occurrence during day -365 through 0 days relative to index: Percutaneous transhepatic biliary drainage single,502
44793113210,condition_era group during day -365 through 0 days relative to index: Diabetes mellitus with multiple complications,210
44802448502,procedure_occurrence during day -365 through 0 days relative to index: Prompting to change position,502
44802448504,procedure_occurrence during day -30 through 0 days relative to index: Prompting to change position,504
44806352502,procedure_occurrence during day -365 through 0 days relative to index: Continuous intravenous infusion of therapeutic substance,502
44806352504,procedure_occurrence during day -30 through 0 days relative to index: Continuous intravenous infusion of therapeutic substance,504
44807318502,procedure_occurrence during day -365 through 0 days relative to index: Endovascular insertion of metallic stent,502
44808014502,procedure_occurrence during day -365 through 0 days relative to index: Fluoroscopy guided insertion of non-tunnelled central venous catheter,502
44814448410,drug_era group during day -365 through 0 days relative to index: Symphytum officinale whole extract,410
44814448412,drug_era group during day -30 through 0 days relative to index: Symphytum officinale whole extract,412
44814448413,drug_era group during day 0 through 0 days relative to index: Symphytum officinale whole extract,413
44816714702,measurement during day -365 through 0 days relative to index: Clostridioides difficile toxin B tcdB gene [Presence] in Stool by NAA with probe detection,702
44816714704,measurement during day -30 through 0 days relative to index: Clostridioides difficile toxin B tcdB gene [Presence] in Stool by NAA with probe detection,704
44817130702,measurement during day -365 through 0 days relative to index: Procalcitonin [Mass/volume] in Serum or Plasma by Immunoassay,702
44817130704,measurement during day -30 through 0 days relative to index: Procalcitonin [Mass/volume] in Serum or Plasma by Immunoassay,704
45757363210,condition_era group during day -365 through 0 days relative to index: Hypoglycemia due to type 2 diabetes mellitus,210
45757399210,condition_era group during day -365 through 0 days relative to index: Mass of uterus,210
45757697210,condition_era group during day -365 through 0 days relative to index: Ear lesion,210
45757697212,condition_era group during day -30 through 0 days relative to index: Ear lesion,212
45757772210,condition_era group during day -365 through 0 days relative to index: Congenital renal cyst,210
45757772212,condition_era group during day -30 through 0 days relative to index: Congenital renal cyst,212
45757798210,condition_era group during day -365 through 0 days relative to index: Proliferative retinopathy,210
45757798212,condition_era group during day -30 through 0 days relative to index: Proliferative retinopathy,212
45757875602,"device_exposure during day -365 through 0 days relative to index: Hemodialysis catheter, implantable",602
45758028602,device_exposure during day -365 through 0 days relative to index: Arterial blood pressure catheter,602
45758274602,device_exposure during day -365 through 0 days relative to index: Hemodialysis system plasma filtration unit,602
45758369602,"device_exposure during day -365 through 0 days relative to index: Ligation clip, metallic",602
45758369604,"device_exposure during day -30 through 0 days relative to index: Ligation clip, metallic",604
45758378602,device_exposure during day -365 through 0 days relative to index: Peripheral angioplasty balloon catheter,602
45758408602,device_exposure during day -365 through 0 days relative to index: Perfusing coronary angioplasty balloon catheter,602
45758561602,device_exposure during day -365 through 0 days relative to index: Polyglycolic acid suture,602
45758825602,device_exposure during day -365 through 0 days relative to index: Microflow infusion system,602
45758825604,device_exposure during day -30 through 0 days relative to index: Microflow infusion system,604
45758903602,"device_exposure during day -365 through 0 days relative to index: Nylon suture, monofilament",602
45758903604,"device_exposure during day -30 through 0 days relative to index: Nylon suture, monofilament",604
45758967602,device_exposure during day -365 through 0 days relative to index: Polydioxanone suture,602
45758967604,device_exposure during day -30 through 0 days relative to index: Polydioxanone suture,604
45758977602,device_exposure during day -365 through 0 days relative to index: Polyglactin suture,602
45759348602,device_exposure during day -365 through 0 days relative to index: Sterile scar management dressing,602
45759471602,device_exposure during day -365 through 0 days relative to index: Oxygen sensor,602
45759635602,"device_exposure during day -365 through 0 days relative to index: Nasal snare, single-use",602
45759635604,"device_exposure during day -30 through 0 days relative to index: Nasal snare, single-use",604
45759692602,device_exposure during day -365 through 0 days relative to index: Ureteral dilatation/injection catheter,602
45759692604,device_exposure during day -30 through 0 days relative to index: Ureteral dilatation/injection catheter,604
45759886602,device_exposure during day -365 through 0 days relative to index: Skin stapler,602
45760191602,"device_exposure during day -365 through 0 days relative to index: Syringe filter, clinical",602
45760405602,"device_exposure during day -365 through 0 days relative to index: Reinforced endotracheal tube, single-use",602
45760468602,device_exposure during day -365 through 0 days relative to index: Warming/high-flow infusion pump,602
45761144602,device_exposure during day -365 through 0 days relative to index: Blood autotransfusion system tubing,602
45761363602,device_exposure during day -365 through 0 days relative to index: Coronary artery guide catheter,602
45761561602,device_exposure during day -365 through 0 days relative to index: Continuous ambulatory peritoneal dialysis (CAPD) transfer set,602
45761573602,device_exposure during day -365 through 0 days relative to index: Catheter introducer,602
45761660602,device_exposure during day -365 through 0 days relative to index: Cardioplegia cannula,602
45761759602,device_exposure during day -365 through 0 days relative to index: Cardiopulmonary bypass system tubing set,602
45761951602,"device_exposure during day -365 through 0 days relative to index: Endotherapy electrosurgical coagulator/cutter, bipolar, reusable",602
45762091602,device_exposure during day -365 through 0 days relative to index: Endocardial pacing lead,602
45762626602,device_exposure during day -365 through 0 days relative to index: Intermittent venous compression system,602
45762626604,device_exposure during day -30 through 0 days relative to index: Intermittent venous compression system,604
45762899602,device_exposure during day -365 through 0 days relative to index: Intravenous line filter,602
45762899604,device_exposure during day -30 through 0 days relative to index: Intravenous line filter,604
45763065602,device_exposure during day -365 through 0 days relative to index: Anesthesia depth monitor,602
45763459602,"device_exposure during day -365 through 0 days relative to index: Apheresis system column, selective leukocyte adsorption",602
45763613210,condition_era group during day -365 through 0 days relative to index: Colonic lesion,210
45763613212,condition_era group during day -30 through 0 days relative to index: Colonic lesion,212
45763923502,procedure_occurrence during day -365 through 0 days relative to index: Assessment of psychotic and behavioral symptoms of dementia,502
45764319602,device_exposure during day -365 through 0 days relative to index: Temporary cardiac pacing catheter,602
45764330602,"device_exposure during day -365 through 0 days relative to index: Cardiovascular patch, synthetic",602
45765283602,device_exposure during day -365 through 0 days relative to index: Medical image management system,602
45765283604,device_exposure during day -30 through 0 days relative to index: Medical image management system,604
45766332210,condition_era group during day -365 through 0 days relative to index: Bacterial otitis media,210
45766714210,condition_era group during day -365 through 0 days relative to index: Inflammatory dermatosis,210
45766714212,condition_era group during day -30 through 0 days relative to index: Inflammatory dermatosis,212
45767972602,device_exposure during day -365 through 0 days relative to index: Hemostatic agent,602
45768017602,device_exposure during day -365 through 0 days relative to index: Ligation clip,602
45768037602,device_exposure during day -365 through 0 days relative to index: Endotherapy biopsy forceps,602
45768037604,device_exposure during day -30 through 0 days relative to index: Endotherapy biopsy forceps,604
45768093602,device_exposure during day -365 through 0 days relative to index: Coronary angioplasty balloon catheter,602
45768113602,device_exposure during day -365 through 0 days relative to index: Electrocardiograph,602
45768200602,device_exposure during day -365 through 0 days relative to index: Ventilator breathing circuit,602
45768200604,device_exposure during day -30 through 0 days relative to index: Ventilator breathing circuit,604
45769862210,condition_era group during day -365 through 0 days relative to index: Kidney lesion,210
45769862212,condition_era group during day -30 through 0 days relative to index: Kidney lesion,212
45770945602,device_exposure during day -365 through 0 days relative to index: Intravenous administration set,602
45771910602,"device_exposure during day -365 through 0 days relative to index: Angiographic catheter, single-use",602
45772030602,device_exposure during day -365 through 0 days relative to index: Apheresis kit,602
45772169602,device_exposure during day -365 through 0 days relative to index: Insulation bandage,602
45772169604,device_exposure during day -30 through 0 days relative to index: Insulation bandage,604
45772322602,device_exposure during day -365 through 0 days relative to index: Invasive blood pressure monitor,602
45772322604,device_exposure during day -30 through 0 days relative to index: Invasive blood pressure monitor,604
45773259602,device_exposure during day -365 through 0 days relative to index: Heart ventricle cannula,602
45775571410,drug_era group during day -365 through 0 days relative to index: glycopyrronium,410
45775571412,drug_era group during day -30 through 0 days relative to index: glycopyrronium,412
45775571413,drug_era group during day 0 through 0 days relative to index: glycopyrronium,413
46234982702,measurement during day -365 through 0 days relative to index: Respiratory syncytial virus A RNA [Presence] in Nasopharynx by NAA with probe detection,702
46234982704,measurement during day -30 through 0 days relative to index: Respiratory syncytial virus A RNA [Presence] in Nasopharynx by NAA with probe detection,704
46234983702,measurement during day -365 through 0 days relative to index: Respiratory syncytial virus B RNA [Presence] in Nasopharynx by NAA with probe detection,702
46234983704,measurement during day -30 through 0 days relative to index: Respiratory syncytial virus B RNA [Presence] in Nasopharynx by NAA with probe detection,704
46235749702,measurement during day -365 through 0 days relative to index: Adenovirus DNA [Presence] in Nasopharynx by NAA with probe detection,702
46235749704,measurement during day -30 through 0 days relative to index: Adenovirus DNA [Presence] in Nasopharynx by NAA with probe detection,704
46235757702,measurement during day -365 through 0 days relative to index: Influenza virus A RNA [Presence] in Nasopharynx by NAA with probe detection,702
46235757704,measurement during day -30 through 0 days relative to index: Influenza virus A RNA [Presence] in Nasopharynx by NAA with probe detection,704
46235763702,measurement during day -365 through 0 days relative to index: Parainfluenza virus 1 RNA [Presence] in Nasopharynx by NAA with probe detection,702
46235763704,measurement during day -30 through 0 days relative to index: Parainfluenza virus 1 RNA [Presence] in Nasopharynx by NAA with probe detection,704
46235764702,measurement during day -365 through 0 days relative to index: Parainfluenza virus 2 RNA [Presence] in Nasopharynx by NAA with probe detection,702
46235764704,measurement during day -30 through 0 days relative to index: Parainfluenza virus 2 RNA [Presence] in Nasopharynx by NAA with probe detection,704
46235765702,measurement during day -365 through 0 days relative to index: Parainfluenza virus 3 RNA [Presence] in Nasopharynx by NAA with probe detection,702
46235765704,measurement during day -30 through 0 days relative to index: Parainfluenza virus 3 RNA [Presence] in Nasopharynx by NAA with probe detection,704
46235766702,measurement during day -365 through 0 days relative to index: Parainfluenza virus 4 RNA [Presence] in Nasopharynx by NAA with probe detection,702
46235766704,measurement during day -30 through 0 days relative to index: Parainfluenza virus 4 RNA [Presence] in Nasopharynx by NAA with probe detection,704
46235794702,measurement during day -365 through 0 days relative to index: Respiratory syncytial virus RNA [Presence] in Nasopharynx by NAA with probe detection,702
46235794704,measurement during day -30 through 0 days relative to index: Respiratory syncytial virus RNA [Presence] in Nasopharynx by NAA with probe detection,704
46236734702,measurement during day -365 through 0 days relative to index: Human metapneumovirus RNA [Presence] in Nasopharynx by NAA with probe detection,702
46236734704,measurement during day -30 through 0 days relative to index: Human metapneumovirus RNA [Presence] in Nasopharynx by NAA with probe detection,704
46236735702,measurement during day -365 through 0 days relative to index: Rhinovirus RNA [Presence] in Nasopharynx by NAA with probe detection,702
46236735704,measurement during day -30 through 0 days relative to index: Rhinovirus RNA [Presence] in Nasopharynx by NAA with probe detection,704
46236736702,measurement during day -365 through 0 days relative to index: Influenza virus A H1 RNA [Presence] in Nasopharynx by NAA with probe detection,702
46236736704,measurement during day -30 through 0 days relative to index: Influenza virus A H1 RNA [Presence] in Nasopharynx by NAA with probe detection,704
46236737702,measurement during day -365 through 0 days relative to index: Influenza virus A H3 RNA [Presence] in Nasopharynx by NAA with probe detection,702
46236737704,measurement during day -30 through 0 days relative to index: Influenza virus A H3 RNA [Presence] in Nasopharynx by NAA with probe detection,704
46236738702,measurement during day -365 through 0 days relative to index: Influenza virus A H1 2009 pandemic RNA [Presence] in Nasopharynx by NAA with probe detection,702
46236738704,measurement during day -30 through 0 days relative to index: Influenza virus A H1 2009 pandemic RNA [Presence] in Nasopharynx by NAA with probe detection,704
46257455502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
46270317210,condition_era group during day -365 through 0 days relative to index: Fracture of shoulder,210
46270317212,condition_era group during day -30 through 0 days relative to index: Fracture of shoulder,212
46271022210,condition_era group during day -365 through 0 days relative to index: Chronic kidney disease,210
46271022212,condition_era group during day -30 through 0 days relative to index: Chronic kidney disease,212
46271075210,condition_era group during day -365 through 0 days relative to index: Acute hypoxemic respiratory failure,210
46271075212,condition_era group during day -30 through 0 days relative to index: Acute hypoxemic respiratory failure,212
46272059210,condition_era group during day -365 through 0 days relative to index: Peripheral neuropathy due to metabolic disorder,210
46272059212,condition_era group during day -30 through 0 days relative to index: Peripheral neuropathy due to metabolic disorder,212
46273162210,condition_era group during day -365 through 0 days relative to index: Bursitis of elbow,210
46273162212,condition_era group during day -30 through 0 days relative to index: Bursitis of elbow,212
46273620210,condition_era group during day -365 through 0 days relative to index: Bursitis of upper limb,210
46273620212,condition_era group during day -30 through 0 days relative to index: Bursitis of upper limb,212
214907211710,measurement below normal range during day -365 through 0 days relative to index: Hemoglobin [Moles/volume] in Arterial blood,710
214947572710,measurement within normal range during day -365 through 0 days relative to index: Japanese cypress IgE Ab RAST class [Presence] in Serum,710
407650381710,"measurement below normal range during day -365 through 0 days relative to index: 1,25-Dihydroxyvitamin D [Mass/volume] in Serum or Plasma",710
407650382710,"measurement within normal range during day -365 through 0 days relative to index: 1,25-Dihydroxyvitamin D [Mass/volume] in Serum or Plasma",710
407659942710,measurement within normal range during day -365 through 0 days relative to index: Glomerular basement membrane Ab [Presence] in Serum by Immunoassay,710
425291872710,measurement within normal range during day -365 through 0 days relative to index: 25-Hydroxyvitamin D2+25-Hydroxyvitamin D3 [Mass/volume] in Serum or Plasma by Immunoassay,710
425292331710,measurement below normal range during day -365 through 0 days relative to index: Thyroxine (T4) free [Mass/volume] in Serum or Plasma by Immunoassay,710
425292332710,measurement within normal range during day -365 through 0 days relative to index: Thyroxine (T4) free [Mass/volume] in Serum or Plasma by Immunoassay,710
425292531710,measurement below normal range during day -365 through 0 days relative to index: Triiodothyronine (T3) [Mass/volume] in Serum or Plasma by Immunoassay,710
425292532710,measurement within normal range during day -365 through 0 days relative to index: Triiodothyronine (T3) [Mass/volume] in Serum or Plasma by Immunoassay,710
428684212710,measurement within normal range during day -365 through 0 days relative to index: Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay,710
430556811710,measurement below normal range during day -365 through 0 days relative to index: Creatinine [Mass/time] by Calculated in Urine collected for unspecified duration,710
430556812710,measurement within normal range during day -365 through 0 days relative to index: Creatinine [Mass/time] by Calculated in Urine collected for unspecified duration,710
30356210,condition_era group during day -365 through 0 days relative to index: Benign neoplasm of pharynx,210
30356212,condition_era group during day -30 through 0 days relative to index: Benign neoplasm of pharynx,212
132797212,condition_era group during day -30 through 0 days relative to index: Sepsis,212
135333210,condition_era group during day -365 through 0 days relative to index: Pressure ulcer,210
135333212,condition_era group during day -30 through 0 days relative to index: Pressure ulcer,212
137548210,condition_era group during day -365 through 0 days relative to index: Cervical radiculopathy,210
137548212,condition_era group during day -30 through 0 days relative to index: Cervical radiculopathy,212
138994210,condition_era group during day -365 through 0 days relative to index: Myelodysplastic syndrome,210
138994212,condition_era group during day -30 through 0 days relative to index: Myelodysplastic syndrome,212
193250210,condition_era group during day -365 through 0 days relative to index: Gastric hemorrhage,210
193431212,condition_era group during day -30 through 0 days relative to index: Benign tumor of digestive organ,212
196152210,condition_era group during day -365 through 0 days relative to index: Peritonitis,210
196152212,condition_era group during day -30 through 0 days relative to index: Peritonitis,212
201519210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of liver,210
201519212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of liver,212
201965210,condition_era group during day -365 through 0 days relative to index: Shock,210
201965212,condition_era group during day -30 through 0 days relative to index: Shock,212
253954210,condition_era group during day -365 through 0 days relative to index: Pulmonary tuberculosis,210
253954212,condition_era group during day -30 through 0 days relative to index: Pulmonary tuberculosis,212
256622210,condition_era group during day -365 through 0 days relative to index: Pulmonary disease due to Mycobacteria,210
256622212,condition_era group during day -30 through 0 days relative to index: Pulmonary disease due to Mycobacteria,212
257010210,condition_era group during day -365 through 0 days relative to index: Abscess of lung,210
257010212,condition_era group during day -30 through 0 days relative to index: Abscess of lung,212
257315212,condition_era group during day -30 through 0 days relative to index: Bacterial pneumonia,212
261326210,condition_era group during day -365 through 0 days relative to index: Viral pneumonia,210
261326212,condition_era group during day -30 through 0 days relative to index: Viral pneumonia,212
317009212,condition_era group during day -30 through 0 days relative to index: Asthma,212
321596210,condition_era group during day -365 through 0 days relative to index: Peripheral venous insufficiency,210
381316212,condition_era group during day -30 through 0 days relative to index: Cerebrovascular accident,212
381591212,condition_era group during day -30 through 0 days relative to index: Cerebrovascular disease,212
432296210,condition_era group during day -365 through 0 days relative to index: Coagulation factor deficiency syndrome,210
432545212,condition_era group during day -30 through 0 days relative to index: Bacterial infectious disease,212
432571210,condition_era group during day -365 through 0 days relative to index: Malignant lymphoma,210
432571212,condition_era group during day -30 through 0 days relative to index: Malignant lymphoma,212
432574210,"condition_era group during day -365 through 0 days relative to index: Diffuse non-Hodgkin's lymphoma, large cell",210
432574212,"condition_era group during day -30 through 0 days relative to index: Diffuse non-Hodgkin's lymphoma, large cell",212
432585210,condition_era group during day -365 through 0 days relative to index: Blood coagulation disorder,210
432585212,condition_era group during day -30 through 0 days relative to index: Blood coagulation disorder,212
432860210,condition_era group during day -365 through 0 days relative to index: Benign tumor of nasopharynx,210
432860212,condition_era group during day -30 through 0 days relative to index: Benign tumor of nasopharynx,212
432863210,condition_era group during day -365 through 0 days relative to index: Acquired coagulation factor deficiency,210
433125210,condition_era group during day -365 through 0 days relative to index: Infection due to Staphylococcus aureus,210
433125212,condition_era group during day -30 through 0 days relative to index: Infection due to Staphylococcus aureus,212
434557210,condition_era group during day -365 through 0 days relative to index: Tuberculosis,210
434557212,condition_era group during day -30 through 0 days relative to index: Tuberculosis,212
434592210,condition_era group during day -365 through 0 days relative to index: B-cell lymphoma,210
434592212,condition_era group during day -30 through 0 days relative to index: B-cell lymphoma,212
435459210,condition_era group during day -365 through 0 days relative to index: Staphylococcal infectious disease,210
435459212,condition_era group during day -30 through 0 days relative to index: Staphylococcal infectious disease,212
435613210,condition_era group during day -365 through 0 days relative to index: Cellulitis,210
436045210,"condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of lip, oral cavity and pharynx",210
436045212,"condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of lip, oral cavity and pharynx",212
439743210,condition_era group during day -365 through 0 days relative to index: Late effects of respiratory tuberculosis,210
439743212,condition_era group during day -30 through 0 days relative to index: Late effects of respiratory tuberculosis,212
440631210,condition_era group during day -365 through 0 days relative to index: Mycobacteriosis,210
440631212,condition_era group during day -30 through 0 days relative to index: Mycobacteriosis,212
443410212,condition_era group during day -30 through 0 days relative to index: Infective pneumonia,212
744740412,drug_era group during day -30 through 0 days relative to index: zolpidem,412
744740413,drug_era group during day 0 through 0 days relative to index: zolpidem,413
911486412,drug_era group during day -30 through 0 days relative to index: Glutamate,412
911486413,drug_era group during day 0 through 0 days relative to index: Glutamate,413
934075412,drug_era group during day -30 through 0 days relative to index: azelastine,412
989878412,drug_era group during day -30 through 0 days relative to index: Lidocaine,412
1167322410,drug_era group during day -365 through 0 days relative to index: Allopurinol,410
1167322412,drug_era group during day -30 through 0 days relative to index: Allopurinol,412
1167322413,drug_era group during day 0 through 0 days relative to index: Allopurinol,413
1185922410,drug_era group during day -365 through 0 days relative to index: Ketoprofen,410
1307863412,drug_era group during day -30 through 0 days relative to index: Verapamil,412
1314865410,drug_era group during day -365 through 0 days relative to index: Azacitidine,410
1314865412,drug_era group during day -30 through 0 days relative to index: Azacitidine,412
1337860412,drug_era group during day -30 through 0 days relative to index: Dopamine,412
1344143412,"drug_era group during day -30 through 0 days relative to index: Albumin Human, USP",412
1518254412,drug_era group during day -30 through 0 days relative to index: Dexamethasone,412
1518254413,drug_era group during day 0 through 0 days relative to index: Dexamethasone,413
1596977412,"drug_era group during day -30 through 0 days relative to index: Regular Insulin, Human",412
1596977413,"drug_era group during day 0 through 0 days relative to index: Regular Insulin, Human",413
1709170412,drug_era group during day -30 through 0 days relative to index: meropenem,412
1717963410,drug_era group during day -365 through 0 days relative to index: ertapenem,410
1748975412,drug_era group during day -30 through 0 days relative to index: cefepime,412
1748975413,drug_era group during day 0 through 0 days relative to index: cefepime,413
1749301410,drug_era group during day -365 through 0 days relative to index: Ethambutol,410
1749301412,drug_era group during day -30 through 0 days relative to index: Ethambutol,412
1749301413,drug_era group during day 0 through 0 days relative to index: Ethambutol,413
1754994412,drug_era group during day -30 through 0 days relative to index: Fluconazole,412
1754994413,drug_era group during day 0 through 0 days relative to index: Fluconazole,413
1757803410,drug_era group during day -365 through 0 days relative to index: Ganciclovir,410
1757803412,drug_era group during day -30 through 0 days relative to index: Ganciclovir,412
1786055410,drug_era group during day -365 through 0 days relative to index: deferasirox,410
1786055412,drug_era group during day -30 through 0 days relative to index: deferasirox,412
1786055413,drug_era group during day 0 through 0 days relative to index: deferasirox,413
1786621412,drug_era group during day -30 through 0 days relative to index: Cephalexin,412
1790868410,drug_era group during day -365 through 0 days relative to index: Amikacin,410
2212964504,procedure_occurrence during day -30 through 0 days relative to index: Unknown concept,504
2313795502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2313795504,procedure_occurrence during day -30 through 0 days relative to index: Unknown concept,504
2615771604,"device_exposure during day -30 through 0 days relative to index: Closure device, vascular (implantable/insertable)",604
3002022702,measurement during day -365 through 0 days relative to index: Protein C Ag actual/normal in Platelet poor plasma by Immunoassay,702
3006338702,measurement during day -365 through 0 days relative to index: Orientia tsutsugamushi Ab [Titer] in Serum,702
3006441702,measurement during day -365 through 0 days relative to index: Cardiolipin IgM Ab [Presence] in Serum by Immunoassay,702
3013339702,measurement during day -365 through 0 days relative to index: Measles virus IgG Ab [Presence] in Serum,702
3016759702,measurement during day -365 through 0 days relative to index: Leptospira sp Ab [Presence] in Serum,702
3017528702,measurement during day -365 through 0 days relative to index: Coagulation factor IX Ag actual/normal in Platelet poor plasma by Immunoassay,702
3019174702,measurement during day -365 through 0 days relative to index: dRVVT (LA screen),702
3020629702,measurement during day -365 through 0 days relative to index: Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay,702
3023945702,measurement during day -365 through 0 days relative to index: Coagulation factor V Ag actual/normal in Platelet poor plasma by Immunoassay,702
3023945704,measurement during day -30 through 0 days relative to index: Coagulation factor V Ag actual/normal in Platelet poor plasma by Immunoassay,704
3024974702,measurement during day -365 through 0 days relative to index: Cytomegalovirus DNA [#/volume] (viral load) in Blood by NAA with probe detection,702
3024974704,measurement during day -30 through 0 days relative to index: Cytomegalovirus DNA [#/volume] (viral load) in Blood by NAA with probe detection,704
3028333702,measurement during day -365 through 0 days relative to index: Cardiolipin IgG Ab [Presence] in Serum,702
3031391702,measurement during day -365 through 0 days relative to index: Hantavirus Ab [Presence] in Serum,702
3032077702,measurement during day -365 through 0 days relative to index: Neutrophil cytoplasmic Ab [Presence] in Serum by Immunofluorescence,702
3037110704,measurement during day -30 through 0 days relative to index: Fasting glucose [Mass/volume] in Serum or Plasma,704
3037201702,measurement during day -365 through 0 days relative to index: Protein S Ag actual/normal in Platelet poor plasma by Immunoassay,702
3052074702,measurement during day -365 through 0 days relative to index: Coagulation factor VIII Ag actual/normal in Platelet poor plasma by Immunoassay,702
4000938212,condition_era group during day -30 through 0 days relative to index: Bacterial sepsis,212
4001171210,condition_era group during day -365 through 0 days relative to index: Liver cell carcinoma,210
4001171212,condition_era group during day -30 through 0 days relative to index: Liver cell carcinoma,212
4003830210,condition_era group during day -365 through 0 days relative to index: Diffuse non-Hodgkin's lymphoma,210
4003830212,condition_era group during day -30 through 0 days relative to index: Diffuse non-Hodgkin's lymphoma,212
4022171502,procedure_occurrence during day -365 through 0 days relative to index: Transfusion of fresh frozen plasma,502
4025165210,condition_era group during day -365 through 0 days relative to index: Abscess of lung with pneumonia,210
4025165212,condition_era group during day -30 through 0 days relative to index: Abscess of lung with pneumonia,212
4028389212,condition_era group during day -30 through 0 days relative to index: Infectious disease of lung,212
4028913502,procedure_occurrence during day -365 through 0 days relative to index: Ultrasound procedure on female genital system AND/OR pregnancy related structure,502
4029363210,condition_era group during day -365 through 0 days relative to index: Granulomatous disorder,210
4029363212,condition_era group during day -30 through 0 days relative to index: Granulomatous disorder,212
4037672504,procedure_occurrence during day -30 through 0 days relative to index: Ultrasonography,504
4038838210,condition_era group during day -365 through 0 days relative to index: Non-Hodgkin's lymphoma,210
4038838212,condition_era group during day -30 through 0 days relative to index: Non-Hodgkin's lymphoma,212
4041621602,device_exposure during day -365 through 0 days relative to index: Packing material,602
4047288502,procedure_occurrence during day -365 through 0 days relative to index: Nasogastric feeding,502
4047288504,procedure_occurrence during day -30 through 0 days relative to index: Nasogastric feeding,504
4049466210,condition_era group during day -365 through 0 days relative to index: Gastric ulcer with hemorrhage,210
4054511210,condition_era group during day -365 through 0 days relative to index: Neoplasm of upper respiratory tract,210
4054511212,condition_era group during day -30 through 0 days relative to index: Neoplasm of upper respiratory tract,212
4054514210,condition_era group during day -365 through 0 days relative to index: Neoplasm of nasopharynx,210
4054514212,condition_era group during day -30 through 0 days relative to index: Neoplasm of nasopharynx,212
4064161210,condition_era group during day -365 through 0 days relative to index: Cirrhosis of liver,210
4064161212,condition_era group during day -30 through 0 days relative to index: Cirrhosis of liver,212
4075951504,procedure_occurrence during day -30 through 0 days relative to index: Intermittent urethral catheterization,504
4079692210,condition_era group during day -365 through 0 days relative to index: High grade B-cell lymphoma,210
4079692212,condition_era group during day -30 through 0 days relative to index: High grade B-cell lymphoma,212
4079709210,condition_era group during day -365 through 0 days relative to index: Ulcer of skin or mucosa,210
4079709212,condition_era group during day -30 through 0 days relative to index: Ulcer of skin or mucosa,212
4080011212,condition_era group during day -30 through 0 days relative to index: Organ dysfunction syndrome,212
4082488210,condition_era group during day -365 through 0 days relative to index: Diffuse high grade B-cell lymphoma,210
4082488212,condition_era group during day -30 through 0 days relative to index: Diffuse high grade B-cell lymphoma,212
4090205210,condition_era group during day -365 through 0 days relative to index: Sequelae of tuberculosis,210
4090205212,condition_era group during day -30 through 0 days relative to index: Sequelae of tuberculosis,212
4091163210,"condition_era group during day -365 through 0 days relative to index: Respiratory tuberculosis, bacteriologically and histologically confirmed",210
4091163212,"condition_era group during day -30 through 0 days relative to index: Respiratory tuberculosis, bacteriologically and histologically confirmed",212
4095312210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of nasopharynx,210
4095312212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of nasopharynx,212
4101227212,condition_era group during day -30 through 0 days relative to index: Liver mass,212
4103703210,condition_era group during day -365 through 0 days relative to index: Melena,210
4104000212,condition_era group during day -30 through 0 days relative to index: Lesion of liver,212
4105239604,device_exposure during day -30 through 0 days relative to index: Breathing circuit,604
4111261210,condition_era group during day -365 through 0 days relative to index: Gram positive sepsis,210
4111261212,condition_era group during day -30 through 0 days relative to index: Gram positive sepsis,212
4114222210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of head and neck,210
4114222212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of head and neck,212
4114353210,condition_era group during day -365 through 0 days relative to index: Benign neoplasm of respiratory system,210
4114353212,condition_era group during day -30 through 0 days relative to index: Benign neoplasm of respiratory system,212
4116236210,"condition_era group during day -365 through 0 days relative to index: Malignant tumor of ear, nose and throat",210
4116236212,"condition_era group during day -30 through 0 days relative to index: Malignant tumor of ear, nose and throat",212
4116778210,condition_era group during day -365 through 0 days relative to index: Lesion of lung,210
4116778212,condition_era group during day -30 through 0 days relative to index: Lesion of lung,212
4120613210,condition_era group during day -365 through 0 days relative to index: Acquired coagulation disorder,210
4121560604,device_exposure during day -30 through 0 days relative to index: Y connector,604
4130518212,condition_era group during day -30 through 0 days relative to index: Neoplasm of liver,212
4131124210,condition_era group during day -365 through 0 days relative to index: Bone marrow disorder,210
4131124212,condition_era group during day -30 through 0 days relative to index: Bone marrow disorder,212
4131451210,condition_era group during day -365 through 0 days relative to index: Neoplasm of pharynx,210
4131451212,condition_era group during day -30 through 0 days relative to index: Neoplasm of pharynx,212
4142645504,procedure_occurrence during day -30 through 0 days relative to index: Coronary angiography,504
4147164210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of lymphoid hemopoietic and related tissue,210
4147164212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of lymphoid hemopoietic and related tissue,212
4155151504,procedure_occurrence during day -30 through 0 days relative to index: Oxygen administration by nasal cannula,504
4156941210,"condition_era group during day -365 through 0 days relative to index: Benign neoplasm of lip, oral cavity and pharynx",210
4156941212,"condition_era group during day -30 through 0 days relative to index: Benign neoplasm of lip, oral cavity and pharynx",212
4159813604,device_exposure during day -30 through 0 days relative to index: Guide wire,604
4161193212,condition_era group during day -30 through 0 days relative to index: Disease due to Gram-positive bacteria,212
4165998210,condition_era group during day -365 through 0 days relative to index: Generalized enlarged lymph nodes,210
4165998212,condition_era group during day -30 through 0 days relative to index: Generalized enlarged lymph nodes,212
4174044210,condition_era group during day -365 through 0 days relative to index: Chronic peptic ulcer with hemorrhage,210
4175297212,condition_era group during day -30 through 0 days relative to index: Lower respiratory tract infection,212
4175485210,condition_era group during day -365 through 0 days relative to index: Myeloproliferative disorder,210
4175485212,condition_era group during day -30 through 0 days relative to index: Myeloproliferative disorder,212
4176868210,condition_era group during day -365 through 0 days relative to index: Abscess of trunk,210
4176868212,condition_era group during day -30 through 0 days relative to index: Abscess of trunk,212
4177243210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of pharynx,210
4177243212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of pharynx,212
4178949210,condition_era group during day -365 through 0 days relative to index: Sequelae of inflammatory diseases,210
4178949212,condition_era group during day -30 through 0 days relative to index: Sequelae of inflammatory diseases,212
4181960210,condition_era group during day -365 through 0 days relative to index: Mass of nasopharynx,210
4181960212,condition_era group during day -30 through 0 days relative to index: Mass of nasopharynx,212
4186405210,condition_era group during day -365 through 0 days relative to index: Neoplasm of bone marrow,210
4186405212,condition_era group during day -30 through 0 days relative to index: Neoplasm of bone marrow,212
4195847210,condition_era group during day -365 through 0 days relative to index: Acute peritonitis,210
4195847212,condition_era group during day -30 through 0 days relative to index: Acute peritonitis,212
4201705210,condition_era group during day -365 through 0 days relative to index: Sequela of disorder,210
4201705212,condition_era group during day -30 through 0 days relative to index: Sequela of disorder,212
4203096210,condition_era group during day -365 through 0 days relative to index: Lung mass,210
4203096212,condition_era group during day -30 through 0 days relative to index: Lung mass,212
4207184212,condition_era group during day -30 through 0 days relative to index: Bacterial respiratory infection,212
4207187210,condition_era group during day -365 through 0 days relative to index: Viral lower respiratory infection,210
4207187212,condition_era group during day -30 through 0 days relative to index: Viral lower respiratory infection,212
4208662212,condition_era group during day -30 through 0 days relative to index: Bacterial lower respiratory infection,212
4211001210,condition_era group during day -365 through 0 days relative to index: Chronic gastric ulcer with hemorrhage,210
4212540210,condition_era group during day -365 through 0 days relative to index: Chronic liver disease,210
4212540212,condition_era group during day -30 through 0 days relative to index: Chronic liver disease,212
4216397210,condition_era group during day -365 through 0 days relative to index: Nerve root disorder,210
4216397212,condition_era group during day -30 through 0 days relative to index: Nerve root disorder,212
4232106210,condition_era group during day -365 through 0 days relative to index: Neoplasm of upper aerodigestive tract,210
4232106212,condition_era group during day -30 through 0 days relative to index: Neoplasm of upper aerodigestive tract,212
4233903212,condition_era group during day -30 through 0 days relative to index: Mass of thoracic structure,212
4237168210,condition_era group during day -365 through 0 days relative to index: Abscess of thorax,210
4237168212,condition_era group during day -30 through 0 days relative to index: Abscess of thorax,212
4240153210,condition_era group during day -365 through 0 days relative to index: Benign neoplasm of respiratory tract,210
4240153212,condition_era group during day -30 through 0 days relative to index: Benign neoplasm of respiratory tract,212
4240305502,procedure_occurrence during day -365 through 0 days relative to index: Thoracentesis,502
4242982210,condition_era group during day -365 through 0 days relative to index: Benign neoplasm of upper respiratory tract,210
4242982212,condition_era group during day -30 through 0 days relative to index: Benign neoplasm of upper respiratory tract,212
4244369504,procedure_occurrence during day -30 through 0 days relative to index: Infusion chemotherapy for malignant neoplasm,504
4246127210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of liver,210
4246127212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of liver,212
4248801210,condition_era group during day -365 through 0 days relative to index: Disease due to Gram-positive coccus,210
4248801212,condition_era group during day -30 through 0 days relative to index: Disease due to Gram-positive coccus,212
4252535210,condition_era group during day -365 through 0 days relative to index: Adenocarcinoma of liver,210
4252535212,condition_era group during day -30 through 0 days relative to index: Adenocarcinoma of liver,212
4254899504,procedure_occurrence during day -30 through 0 days relative to index: Dietary regime management,504
4260263504,procedure_occurrence during day -30 through 0 days relative to index: Diffusion weighted magnetic resonance imaging,504
4261999502,procedure_occurrence during day -365 through 0 days relative to index: Nutrition care management,502
4262021504,procedure_occurrence during day -30 through 0 days relative to index: Perineal care management,504
4262920210,condition_era group during day -365 through 0 days relative to index: Skin ulcer,210
4262920212,condition_era group during day -30 through 0 days relative to index: Skin ulcer,212
4265600210,condition_era group during day -365 through 0 days relative to index: Gastric ulcer,210
4267417210,condition_era group during day -365 through 0 days relative to index: Hepatic fibrosis,210
4267417212,condition_era group during day -30 through 0 days relative to index: Hepatic fibrosis,212
4271696210,condition_era group during day -365 through 0 days relative to index: Peptic ulcer with hemorrhage,210
4277921210,condition_era group during day -365 through 0 days relative to index: Liver regeneration,210
4277921212,condition_era group during day -30 through 0 days relative to index: Liver regeneration,212
4291649210,condition_era group during day -365 through 0 days relative to index: Upper gastrointestinal bleeding,210
4300704210,condition_era group during day -365 through 0 days relative to index: Diffuse large B-cell lymphoma,210
4300704212,condition_era group during day -30 through 0 days relative to index: Diffuse large B-cell lymphoma,212
4305581504,procedure_occurrence during day -30 through 0 days relative to index: Application of dressing,504
4310250804,observation during day -30 through 0 days relative to index: Ex-smoker,804
4311420210,condition_era group during day -365 through 0 days relative to index: Vascular insufficiency,210
4318377210,condition_era group during day -365 through 0 days relative to index: Mucocutaneous ulcer,210
4318377212,condition_era group during day -30 through 0 days relative to index: Mucocutaneous ulcer,212
4318534210,condition_era group during day -365 through 0 days relative to index: Chronic gastric ulcer,210
4321986502,procedure_occurrence during day -365 through 0 days relative to index: Incisional biopsy,502
4323715504,procedure_occurrence during day -30 through 0 days relative to index: Transfusion of packed red blood cells,504
4329775504,procedure_occurrence during day -30 through 0 days relative to index: Insertion of tunneled central venous catheter using fluoroscopic guidance,504
19000537412,drug_era group during day -30 through 0 days relative to index: Threonine,412
19000537413,drug_era group during day 0 through 0 days relative to index: Threonine,413
19004724412,drug_era group during day -30 through 0 days relative to index: Methionine,412
19004724413,drug_era group during day 0 through 0 days relative to index: Methionine,413
19006186412,drug_era group during day -30 through 0 days relative to index: Tryptophan,412
19006186413,drug_era group during day 0 through 0 days relative to index: Tryptophan,413
19006410412,drug_era group during day -30 through 0 days relative to index: Arginine,412
19006410413,drug_era group during day 0 through 0 days relative to index: Arginine,413
19006692412,drug_era group during day -30 through 0 days relative to index: Tyrosine,412
19006692413,drug_era group during day 0 through 0 days relative to index: Tyrosine,413
19007572412,drug_era group during day -30 through 0 days relative to index: Valine,412
19007572413,drug_era group during day 0 through 0 days relative to index: Valine,413
19012686412,drug_era group during day -30 through 0 days relative to index: Aspartic Acid,412
19012686413,drug_era group during day 0 through 0 days relative to index: Aspartic Acid,413
19019620410,drug_era group during day -365 through 0 days relative to index: Benzydamine,410
19019620412,drug_era group during day -30 through 0 days relative to index: Benzydamine,412
19019620413,drug_era group during day 0 through 0 days relative to index: Benzydamine,413
19030059412,drug_era group during day -30 through 0 days relative to index: alginic acid,412
19030059413,drug_era group during day 0 through 0 days relative to index: alginic acid,413
19035577412,drug_era group during day -30 through 0 days relative to index: Phenylalanine,412
19035577413,drug_era group during day 0 through 0 days relative to index: Phenylalanine,413
19048493410,drug_era group during day -365 through 0 days relative to index: gadobutrol,410
19052489412,drug_era group during day -30 through 0 days relative to index: Alanine,412
19052489413,drug_era group during day 0 through 0 days relative to index: Alanine,413
19052736412,drug_era group during day -30 through 0 days relative to index: Proline,412
19052736413,drug_era group during day 0 through 0 days relative to index: Proline,413
19060985412,drug_era group during day -30 through 0 days relative to index: Glutamine,412
19060985413,drug_era group during day 0 through 0 days relative to index: Glutamine,413
19061083413,drug_era group during day 0 through 0 days relative to index: Glutathione,413
19066774412,drug_era group during day -30 through 0 days relative to index: Serine,412
19066774413,drug_era group during day 0 through 0 days relative to index: Serine,413
19069149412,drug_era group during day -30 through 0 days relative to index: Histidine,412
19069149413,drug_era group during day 0 through 0 days relative to index: Histidine,413
19071936410,drug_era group during day -365 through 0 days relative to index: loxoprofen,410
19082306412,drug_era group during day -30 through 0 days relative to index: Isoleucine,412
19082306413,drug_era group during day 0 through 0 days relative to index: Isoleucine,413
19088571412,drug_era group during day -30 through 0 days relative to index: Leucine,412
19088571413,drug_era group during day 0 through 0 days relative to index: Leucine,413
19092377412,drug_era group during day -30 through 0 days relative to index: Lysine,412
19092377413,drug_era group during day 0 through 0 days relative to index: Lysine,413
21600038410,drug_era group during day -365 through 0 days relative to index: Other agents for local oral treatment,410
21600038412,drug_era group during day -30 through 0 days relative to index: Other agents for local oral treatment,412
21600038413,drug_era group during day 0 through 0 days relative to index: Other agents for local oral treatment,413
21600109412,drug_era group during day -30 through 0 days relative to index: Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),412
21600109413,drug_era group during day 0 through 0 days relative to index: Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),413
21600521412,"drug_era group during day -30 through 0 days relative to index: LIVER THERAPY, LIPOTROPICS",412
21600521413,"drug_era group during day 0 through 0 days relative to index: LIVER THERAPY, LIPOTROPICS",413
21600522412,drug_era group during day -30 through 0 days relative to index: Liver therapy,412
21600522413,drug_era group during day 0 through 0 days relative to index: Liver therapy,413
21600697412,"drug_era group during day -30 through 0 days relative to index: DIGESTIVES, INCL. ENZYMES",412
21600697413,"drug_era group during day 0 through 0 days relative to index: DIGESTIVES, INCL. ENZYMES",413
21600698412,"drug_era group during day -30 through 0 days relative to index: DIGESTIVES, INCL. ENZYMES",412
21600698413,"drug_era group during day 0 through 0 days relative to index: DIGESTIVES, INCL. ENZYMES",413
21600704412,drug_era group during day -30 through 0 days relative to index: Acid preparations,412
21600704413,drug_era group during day 0 through 0 days relative to index: Acid preparations,413
21600713413,drug_era group during day 0 through 0 days relative to index: INSULINS AND ANALOGUES,413
21600714412,"drug_era group during day -30 through 0 days relative to index: Insulins and analogues for injection, fast-acting",412
21600714413,"drug_era group during day 0 through 0 days relative to index: Insulins and analogues for injection, fast-acting",413
21600722412,"drug_era group during day -30 through 0 days relative to index: Insulins and analogues for injection, intermediate-acting",412
21600722413,"drug_era group during day 0 through 0 days relative to index: Insulins and analogues for injection, intermediate-acting",413
21600728412,"drug_era group during day -30 through 0 days relative to index: Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting",412
21600728413,"drug_era group during day 0 through 0 days relative to index: Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting",413
21600932412,drug_era group during day -30 through 0 days relative to index: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,412
21600932413,drug_era group during day 0 through 0 days relative to index: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,413
21600933412,drug_era group during day -30 through 0 days relative to index: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,412
21600933413,drug_era group during day 0 through 0 days relative to index: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,413
21600934412,drug_era group during day -30 through 0 days relative to index: Amino acids and derivatives,412
21600934413,drug_era group during day 0 through 0 days relative to index: Amino acids and derivatives,413
21601137412,drug_era group during day -30 through 0 days relative to index: BLOOD AND RELATED PRODUCTS,412
21601138412,drug_era group during day -30 through 0 days relative to index: Blood substitutes and plasma protein fractions,412
21601215412,drug_era group during day -30 through 0 days relative to index: Amino acids,412
21601215413,drug_era group during day 0 through 0 days relative to index: Amino acids,413
21601434412,drug_era group during day -30 through 0 days relative to index: Pyrimidine analogues,412
21601766412,drug_era group during day -30 through 0 days relative to index: Phenylalkylamine derivatives,412
21602002412,"drug_era group during day -30 through 0 days relative to index: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",412
21602003412,"drug_era group during day -30 through 0 days relative to index: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",412
21602019412,drug_era group during day -30 through 0 days relative to index: Anesthetics for topical use,412
21602914412,drug_era group during day -30 through 0 days relative to index: Fourth-generation cephalosporins,412
21602914413,drug_era group during day 0 through 0 days relative to index: Fourth-generation cephalosporins,413
21602920412,drug_era group during day -30 through 0 days relative to index: Carbapenems,412
21602990410,drug_era group during day -365 through 0 days relative to index: AMINOGLYCOSIDE ANTIBACTERIALS,410
21602994410,drug_era group during day -365 through 0 days relative to index: Other aminoglycosides,410
21603071412,drug_era group during day -30 through 0 days relative to index: ANTIMYCOTICS FOR SYSTEMIC USE,412
21603071413,drug_era group during day 0 through 0 days relative to index: ANTIMYCOTICS FOR SYSTEMIC USE,413
21603072412,drug_era group during day -30 through 0 days relative to index: ANTIMYCOTICS FOR SYSTEMIC USE,412
21603072413,drug_era group during day 0 through 0 days relative to index: ANTIMYCOTICS FOR SYSTEMIC USE,413
21603079412,drug_era group during day -30 through 0 days relative to index: Triazole derivatives,412
21603079413,drug_era group during day 0 through 0 days relative to index: Triazole derivatives,413
21603109410,drug_era group during day -365 through 0 days relative to index: Other drugs for treatment of tuberculosis,410
21603109412,drug_era group during day -30 through 0 days relative to index: Other drugs for treatment of tuberculosis,412
21603109413,drug_era group during day 0 through 0 days relative to index: Other drugs for treatment of tuberculosis,413
21603241412,"drug_era group during day -30 through 0 days relative to index: Anesthetics, local",412
21604653412,drug_era group during day -30 through 0 days relative to index: Benzodiazepine related drugs,412
21604653413,drug_era group during day 0 through 0 days relative to index: Benzodiazepine related drugs,413
21604686413,drug_era group during day 0 through 0 days relative to index: ANTIDEPRESSANTS,413
21604729413,drug_era group during day 0 through 0 days relative to index: Other antidepressants,413
21605071412,drug_era group during day -30 through 0 days relative to index: DECONGESTANTS AND ANTIALLERGICS,412
21605084412,drug_era group during day -30 through 0 days relative to index: Other antiallergics,412
21605259410,drug_era group during day -365 through 0 days relative to index: Iron chelating agents,410
21605259412,drug_era group during day -30 through 0 days relative to index: Iron chelating agents,412
21605259413,drug_era group during day 0 through 0 days relative to index: Iron chelating agents,413
21605418410,drug_era group during day -365 through 0 days relative to index: MAGNETIC RESONANCE IMAGING CONTRAST MEDIA,410
21605419410,drug_era group during day -365 through 0 days relative to index: Paramagnetic contrast media,410
30020221710,measurement below normal range during day -365 through 0 days relative to index: Protein C Ag actual/normal in Platelet poor plasma by Immunoassay,710
30071241710,measurement below normal range during day -365 through 0 days relative to index: Reticulocytes/100 erythrocytes in Blood by Automated count,710
30133392710,measurement within normal range during day -365 through 0 days relative to index: Measles virus IgG Ab [Presence] in Serum,710
30175282710,measurement within normal range during day -365 through 0 days relative to index: Coagulation factor IX Ag actual/normal in Platelet poor plasma by Immunoassay,710
30195503710,measurement above normal range during day -365 through 0 days relative to index: Sodium [Moles/volume] in Serum or Plasma,710
30206292710,measurement within normal range during day -365 through 0 days relative to index: Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay,710
30239452710,measurement within normal range during day -365 through 0 days relative to index: Coagulation factor V Ag actual/normal in Platelet poor plasma by Immunoassay,710
30291872710,measurement within normal range during day -365 through 0 days relative to index: Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma,710
30372011710,measurement below normal range during day -365 through 0 days relative to index: Protein S Ag actual/normal in Platelet poor plasma by Immunoassay,710
30520742710,measurement within normal range during day -365 through 0 days relative to index: Coagulation factor VIII Ag actual/normal in Platelet poor plasma by Immunoassay,710
30520743710,measurement above normal range during day -365 through 0 days relative to index: Coagulation factor VIII Ag actual/normal in Platelet poor plasma by Immunoassay,710
36304079704,measurement during day -30 through 0 days relative to index: Mucus [Presence] in Urine sediment,704
36304283702,measurement during day -365 through 0 days relative to index: Amoeba identified in Stool by Wet preparation,702
36713504210,condition_era group during day -365 through 0 days relative to index: Vascular disorder of the stomach,210
36714927210,condition_era group during day -365 through 0 days relative to index: Sequelae of infectious disease,210
36714927212,condition_era group during day -30 through 0 days relative to index: Sequelae of infectious disease,212
36715956210,condition_era group during day -365 through 0 days relative to index: Infection caused by Actinomycetales,210
36715956212,condition_era group during day -30 through 0 days relative to index: Infection caused by Actinomycetales,212
36716519210,condition_era group during day -365 through 0 days relative to index: Sequela of infection caused by bacterium,210
36716519212,condition_era group during day -30 through 0 days relative to index: Sequela of infection caused by bacterium,212
36716620210,condition_era group during day -365 through 0 days relative to index: Malignant epithelial neoplasm,210
36716620212,condition_era group during day -30 through 0 days relative to index: Malignant epithelial neoplasm,212
36717155210,condition_era group during day -365 through 0 days relative to index: Sequela of infection caused by Mycobacterium,210
36717155212,condition_era group during day -30 through 0 days relative to index: Sequela of infection caused by Mycobacterium,212
40166571412,drug_era group during day -30 through 0 days relative to index: bepotastine,412
40166571413,drug_era group during day 0 through 0 days relative to index: bepotastine,413
40241186410,drug_era group during day -365 through 0 days relative to index: Ticagrelor,410
40241186412,drug_era group during day -30 through 0 days relative to index: Ticagrelor,412
40241186413,drug_era group during day 0 through 0 days relative to index: Ticagrelor,413
40484156210,condition_era group during day -365 through 0 days relative to index: Malignant adenomatous neoplasm,210
40484156212,condition_era group during day -30 through 0 days relative to index: Malignant adenomatous neoplasm,212
40487059210,condition_era group during day -365 through 0 days relative to index: Sepsis due to Staphylococcus,210
40487059212,condition_era group during day -30 through 0 days relative to index: Sepsis due to Staphylococcus,212
40489907210,condition_era group during day -365 through 0 days relative to index: Sepsis due to Staphylococcus aureus,210
40489907212,condition_era group during day -30 through 0 days relative to index: Sepsis due to Staphylococcus aureus,212
40493020210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of upper respiratory tract,210
40493020212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of upper respiratory tract,212
43021257210,condition_era group during day -365 through 0 days relative to index: Infection associated with device,210
43021257212,condition_era group during day -30 through 0 days relative to index: Infection associated with device,212
43021258210,condition_era group during day -365 through 0 days relative to index: Infection associated with implant,210
43021258212,condition_era group during day -30 through 0 days relative to index: Infection associated with implant,212
43021974212,condition_era group during day -30 through 0 days relative to index: Complication associated with device,212
43055120702,measurement during day -365 through 0 days relative to index: Cytomegalovirus DNA [Units/volume] (viral load) in Plasma by NAA with probe detection,702
43055120704,measurement during day -30 through 0 days relative to index: Cytomegalovirus DNA [Units/volume] (viral load) in Plasma by NAA with probe detection,704
43527998502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
43527998504,procedure_occurrence during day -30 through 0 days relative to index: Unknown concept,504
44783160210,condition_era group during day -365 through 0 days relative to index: Lesion of nasopharynx,210
44783160212,condition_era group during day -30 through 0 days relative to index: Lesion of nasopharynx,212
45761363604,device_exposure during day -30 through 0 days relative to index: Coronary artery guide catheter,604
45761573604,device_exposure during day -30 through 0 days relative to index: Catheter introducer,604
45765537502,procedure_occurrence during day -365 through 0 days relative to index: CT of lower limb with contrast,502
45771090210,condition_era group during day -365 through 0 days relative to index: Respiratory tuberculosis,210
45771090212,condition_era group during day -30 through 0 days relative to index: Respiratory tuberculosis,212
45771910604,"device_exposure during day -30 through 0 days relative to index: Angiographic catheter, single-use",604
45772824602,device_exposure during day -365 through 0 days relative to index: Drug-eluting coronary artery stent,602
45772824604,device_exposure during day -30 through 0 days relative to index: Drug-eluting coronary artery stent,604
46271812210,condition_era group during day -365 through 0 days relative to index: Child-Pugh score class B,210
46271812212,condition_era group during day -30 through 0 days relative to index: Child-Pugh score class B,212
1007,index month: 1,7
12007,index month: 12,7
2019006,index year: 2019,6
75860212,condition_era group during day -30 through 0 days relative to index: Constipation,212
79061210,condition_era group during day -365 through 0 days relative to index: Slow transit constipation,210
80767212,condition_era group during day -30 through 0 days relative to index: Breast lump,212
81250210,condition_era group during day -365 through 0 days relative to index: Carcinoma in situ of breast,210
81250212,condition_era group during day -30 through 0 days relative to index: Carcinoma in situ of breast,212
81251210,condition_era group during day -365 through 0 days relative to index: Neoplasm of breast,210
81251212,condition_era group during day -30 through 0 days relative to index: Neoplasm of breast,212
195002212,condition_era group during day -30 through 0 days relative to index: Ulceration of intestine,212
196151210,condition_era group during day -365 through 0 days relative to index: Functional disorder of intestine,210
254061212,condition_era group during day -30 through 0 days relative to index: Pleural effusion,212
255841210,condition_era group during day -365 through 0 days relative to index: Chronic bronchitis,210
255841212,condition_era group during day -30 through 0 days relative to index: Chronic bronchitis,212
258781210,condition_era group during day -365 through 0 days relative to index: Pneumonopathy due to inhalation of dust,210
258781212,condition_era group during day -30 through 0 days relative to index: Pneumonopathy due to inhalation of dust,212
259044210,condition_era group during day -365 through 0 days relative to index: Pneumoconiosis,210
259044212,condition_era group during day -30 through 0 days relative to index: Pneumoconiosis,212
261889210,condition_era group during day -365 through 0 days relative to index: Simple chronic bronchitis,210
261889212,condition_era group during day -30 through 0 days relative to index: Simple chronic bronchitis,212
433435210,condition_era group during day -365 through 0 days relative to index: Carcinoma in situ,210
433435212,condition_era group during day -30 through 0 days relative to index: Carcinoma in situ,212
437677212,condition_era group during day -30 through 0 days relative to index: Abnormal findings on diagnostic imaging of lung,212
441969212,condition_era group during day -30 through 0 days relative to index: Radiology result abnormal,212
442560210,condition_era group during day -365 through 0 days relative to index: Fracture of femur,210
442560212,condition_era group during day -30 through 0 days relative to index: Fracture of femur,212
444206210,condition_era group during day -365 through 0 days relative to index: Arthropathy of pelvis,210
444206212,condition_era group during day -30 through 0 days relative to index: Arthropathy of pelvis,212
781039410,drug_era group during day -365 through 0 days relative to index: Alprazolam,410
924566410,drug_era group during day -365 through 0 days relative to index: tamsulosin,410
940426412,drug_era group during day -30 through 0 days relative to index: calcium polycarbophil,412
970250410,drug_era group during day -365 through 0 days relative to index: Spironolactone,410
970250412,drug_era group during day -30 through 0 days relative to index: Spironolactone,412
970250413,drug_era group during day 0 through 0 days relative to index: Spironolactone,413
992956412,drug_era group during day -30 through 0 days relative to index: Magnesium Hydroxide,412
992956413,drug_era group during day 0 through 0 days relative to index: Magnesium Hydroxide,413
1102527410,drug_era group during day -365 through 0 days relative to index: Meperidine,410
1301025412,drug_era group during day -30 through 0 days relative to index: Enoxaparin,412
1309068410,drug_era group during day -365 through 0 days relative to index: Minoxidil,410
1309068412,drug_era group during day -30 through 0 days relative to index: Minoxidil,412
1309068413,drug_era group during day 0 through 0 days relative to index: Minoxidil,413
1344143413,"drug_era group during day 0 through 0 days relative to index: Albumin Human, USP",413
1347384410,drug_era group during day -365 through 0 days relative to index: irbesartan,410
1347384412,drug_era group during day -30 through 0 days relative to index: irbesartan,412
1347384413,drug_era group during day 0 through 0 days relative to index: irbesartan,413
1436678410,drug_era group during day -365 through 0 days relative to index: Tamoxifen,410
1436678412,drug_era group during day -30 through 0 days relative to index: Tamoxifen,412
1436678413,drug_era group during day 0 through 0 days relative to index: Tamoxifen,413
1503297410,drug_era group during day -365 through 0 days relative to index: Metformin,410
1521987410,drug_era group during day -365 through 0 days relative to index: Teriparatide,410
1521987412,drug_era group during day -30 through 0 days relative to index: Teriparatide,412
1550023412,drug_era group during day -30 through 0 days relative to index: Insulin Lispro,412
1705674410,drug_era group during day -365 through 0 days relative to index: Trimethoprim,410
1716903412,drug_era group during day -30 through 0 days relative to index: moxifloxacin,412
1749008410,drug_era group during day -365 through 0 days relative to index: cefpodoxime,410
1836430410,drug_era group during day -365 through 0 days relative to index: Sulfamethoxazole,410
2000013502,procedure_occurrence during day -365 through 0 days relative to index: Administration of inhaled nitric oxide,502
2314110502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
3008893702,measurement during day -365 through 0 days relative to index: Testosterone [Mass/volume] in Serum or Plasma,702
3011544702,measurement during day -365 through 0 days relative to index: Albumin [Mass/volume] in Pleural fluid,702
3015401702,measurement during day -365 through 0 days relative to index: Amylase [Enzymatic activity/volume] in Pleural fluid,702
3028048702,measurement during day -365 through 0 days relative to index: Mycobacterium tuberculosis DNA [Presence] in Bronchial specimen by NAA with probe detection,702
3033364702,measurement during day -365 through 0 days relative to index: Cholesterol [Mass/volume] in Pleural fluid,702
3034207702,measurement during day -365 through 0 days relative to index: Triglyceride [Mass/volume] in Pleural fluid,702
3048752702,measurement during day -365 through 0 days relative to index: Lipase [Enzymatic activity/volume] in Pleural fluid,702
4015503210,condition_era group during day -365 through 0 days relative to index: Pertrochanteric fracture,210
4015503212,condition_era group during day -30 through 0 days relative to index: Pertrochanteric fracture,212
4027663212,condition_era group during day -30 through 0 days relative to index: Peptic ulcer,212
4028242212,condition_era group during day -30 through 0 days relative to index: Chronic duodenal ulcer,212
4029709502,procedure_occurrence during day -365 through 0 days relative to index: Ocular photography AND/OR evaluation,502
4030520210,condition_era group during day -365 through 0 days relative to index: End stage renal failure on dialysis,210
4032240502,procedure_occurrence during day -365 through 0 days relative to index: Respiratory tract rehabilitation procedure,502
4035793502,procedure_occurrence during day -365 through 0 days relative to index: Pulmonary rehabilitation,502
4053584212,condition_era group during day -30 through 0 days relative to index: Superficial injury,212
4054054210,condition_era group during day -365 through 0 days relative to index: Joint injury,210
4054054212,condition_era group during day -30 through 0 days relative to index: Joint injury,212
4059290212,condition_era group during day -30 through 0 days relative to index: Steatosis of liver,212
4086260502,procedure_occurrence during day -365 through 0 days relative to index: CT of spine,502
4087379210,condition_era group during day -365 through 0 days relative to index: Environmental lung disease,210
4087379212,condition_era group during day -30 through 0 days relative to index: Environmental lung disease,212
4111018210,condition_era group during day -365 through 0 days relative to index: Neoplasm of thorax,210
4111018212,condition_era group during day -30 through 0 days relative to index: Neoplasm of thorax,212
4114336212,condition_era group during day -30 through 0 days relative to index: Benign neoplasm of abdomen,212
4124141504,procedure_occurrence during day -30 through 0 days relative to index: Continuous suction drainage,504
4128492212,condition_era group during day -30 through 0 days relative to index: Lesion of breast,212
4133012210,condition_era group during day -365 through 0 days relative to index: Intertrochanteric fracture,210
4133012212,condition_era group during day -30 through 0 days relative to index: Intertrochanteric fracture,212
4134146212,condition_era group during day -30 through 0 days relative to index: Chronic peptic ulcer,212
4138412210,condition_era group during day -365 through 0 days relative to index: Fracture of proximal end of femur,210
4138412212,condition_era group during day -30 through 0 days relative to index: Fracture of proximal end of femur,212
4145244502,procedure_occurrence during day -365 through 0 days relative to index: Diagnostic bronchoscopy,502
4187096210,condition_era group during day -365 through 0 days relative to index: Fracture of lower limb,210
4187096212,condition_era group during day -30 through 0 days relative to index: Fracture of lower limb,212
4198381212,condition_era group during day -30 through 0 days relative to index: Ulcer of duodenum,212
4209746212,condition_era group during day -30 through 0 days relative to index: Duodenal ulcer without hemorrhage AND without perforation,212
4222896212,condition_era group during day -30 through 0 days relative to index: Chronic duodenal ulcer without hemorrhage AND without perforation,212
4239897212,condition_era group during day -30 through 0 days relative to index: Benign neoplasm of intra-abdominal organs,212
4242272502,procedure_occurrence during day -365 through 0 days relative to index: Physiotherapy training,502
4242980212,condition_era group during day -30 through 0 days relative to index: Benign neoplasm of trunk,212
4243427212,condition_era group during day -30 through 0 days relative to index: Benign neoplasm of liver,212
4247120212,condition_era group during day -30 through 0 days relative to index: Gastrointestinal ulcer,212
4256761212,condition_era group during day -30 through 0 days relative to index: Imaging result abnormal,212
4256910502,procedure_occurrence during day -365 through 0 days relative to index: Radiography of hip,502
4256910504,procedure_occurrence during day -30 through 0 days relative to index: Radiography of hip,504
4265034504,procedure_occurrence during day -30 through 0 days relative to index: Giving patient an enema,504
4266367212,condition_era group during day -30 through 0 days relative to index: Influenza,212
4277745212,condition_era group during day -30 through 0 days relative to index: Disease due to Orthomyxoviridae,212
4338120212,condition_era group during day -30 through 0 days relative to index: Altered bowel function,212
4342655212,condition_era group during day -30 through 0 days relative to index: Ulceration of small intestine,212
19015602410,drug_era group during day -365 through 0 days relative to index: Nefopam,410
19028950412,drug_era group during day -30 through 0 days relative to index: Procaterol,412
19028950413,drug_era group during day 0 through 0 days relative to index: Procaterol,413
19041222412,drug_era group during day -30 through 0 days relative to index: Phloroglucinol,412
19063874413,drug_era group during day 0 through 0 days relative to index: Roxithromycin,413
21600048412,drug_era group during day -30 through 0 days relative to index: Magnesium compounds,412
21600048413,drug_era group during day 0 through 0 days relative to index: Magnesium compounds,413
21600174412,drug_era group during day -30 through 0 days relative to index: Other drugs for functional gastrointestinal disorders,412
21600432410,drug_era group during day -365 through 0 days relative to index: Pyrimidine derivatives,410
21600432412,drug_era group during day -30 through 0 days relative to index: Pyrimidine derivatives,412
21600432413,drug_era group during day 0 through 0 days relative to index: Pyrimidine derivatives,413
21600554412,drug_era group during day -30 through 0 days relative to index: Bulk-forming laxatives,412
21600745410,drug_era group during day -365 through 0 days relative to index: Biguanides,410
21601137413,drug_era group during day 0 through 0 days relative to index: BLOOD AND RELATED PRODUCTS,413
21601138413,drug_era group during day 0 through 0 days relative to index: Blood substitutes and plasma protein fractions,413
21601532410,drug_era group during day -365 through 0 days relative to index: POTASSIUM-SPARING AGENTS,410
21601532412,drug_era group during day -30 through 0 days relative to index: POTASSIUM-SPARING AGENTS,412
21601532413,drug_era group during day 0 through 0 days relative to index: POTASSIUM-SPARING AGENTS,413
21601533410,drug_era group during day -365 through 0 days relative to index: Aldosterone antagonists,410
21601533412,drug_era group during day -30 through 0 days relative to index: Aldosterone antagonists,412
21601533413,drug_era group during day 0 through 0 days relative to index: Aldosterone antagonists,413
21602323410,drug_era group during day -365 through 0 days relative to index: OTHER DERMATOLOGICAL PREPARATIONS,410
21602323412,drug_era group during day -30 through 0 days relative to index: OTHER DERMATOLOGICAL PREPARATIONS,412
21602323413,drug_era group during day 0 through 0 days relative to index: OTHER DERMATOLOGICAL PREPARATIONS,413
21602324410,drug_era group during day -365 through 0 days relative to index: OTHER DERMATOLOGICAL PREPARATIONS,410
21602324412,drug_era group during day -30 through 0 days relative to index: OTHER DERMATOLOGICAL PREPARATIONS,412
21602324413,drug_era group during day 0 through 0 days relative to index: OTHER DERMATOLOGICAL PREPARATIONS,413
21602341410,drug_era group during day -365 through 0 days relative to index: Other dermatologicals,410
21602341412,drug_era group during day -30 through 0 days relative to index: Other dermatologicals,412
21602341413,drug_era group during day 0 through 0 days relative to index: Other dermatologicals,413
21602779412,drug_era group during day -30 through 0 days relative to index: CALCIUM HOMEOSTASIS,412
21602780410,drug_era group during day -365 through 0 days relative to index: PARATHYROID HORMONES AND ANALOGUES,410
21602780412,drug_era group during day -30 through 0 days relative to index: PARATHYROID HORMONES AND ANALOGUES,412
21602781410,drug_era group during day -365 through 0 days relative to index: Parathyroid hormones and analogues,410
21602781412,drug_era group during day -30 through 0 days relative to index: Parathyroid hormones and analogues,412
21602929410,drug_era group during day -365 through 0 days relative to index: SULFONAMIDES AND TRIMETHOPRIM,410
21602930410,drug_era group during day -365 through 0 days relative to index: Trimethoprim and derivatives,410
21602944410,drug_era group during day -365 through 0 days relative to index: Intermediate-acting sulfonamides,410
21603829410,drug_era group during day -365 through 0 days relative to index: HORMONE ANTAGONISTS AND RELATED AGENTS,410
21603829412,drug_era group during day -30 through 0 days relative to index: HORMONE ANTAGONISTS AND RELATED AGENTS,412
21603829413,drug_era group during day 0 through 0 days relative to index: HORMONE ANTAGONISTS AND RELATED AGENTS,413
21603830410,drug_era group during day -365 through 0 days relative to index: Anti-estrogens,410
21603830412,drug_era group during day -30 through 0 days relative to index: Anti-estrogens,412
21603830413,drug_era group during day 0 through 0 days relative to index: Anti-estrogens,413
21604354410,drug_era group during day -365 through 0 days relative to index: Other analgesics and antipyretics,410
30088931710,measurement below normal range during day -365 through 0 days relative to index: Testosterone [Mass/volume] in Serum or Plasma,710
30115441710,measurement below normal range during day -365 through 0 days relative to index: Albumin [Mass/volume] in Pleural fluid,710
30162441710,measurement below normal range during day -365 through 0 days relative to index: Insulin [Units/volume] in Serum or Plasma,710
30206303710,measurement above normal range during day -365 through 0 days relative to index: Protein [Mass/volume] in Serum or Plasma,710
37016875504,procedure_occurrence during day -30 through 0 days relative to index: Plain radiography of pelvis,504
42529190702,measurement during day -365 through 0 days relative to index: Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma by Immunoassay,702
42529190704,measurement during day -30 through 0 days relative to index: Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma by Immunoassay,704
42529215702,measurement during day -365 through 0 days relative to index: Follitropin [Units/volume] in Serum or Plasma by Immunoassay,702
42529220702,measurement during day -365 through 0 days relative to index: Lutropin [Units/volume] in Serum or Plasma by Immunoassay,702
43013024410,drug_era group during day -365 through 0 days relative to index: apixaban,410
43013024412,drug_era group during day -30 through 0 days relative to index: apixaban,412
43013024413,drug_era group during day 0 through 0 days relative to index: apixaban,413
43534760410,drug_era group during day -365 through 0 days relative to index: Direct factor Xa inhibitors,410
43534760412,drug_era group during day -30 through 0 days relative to index: Direct factor Xa inhibitors,412
43534760413,drug_era group during day 0 through 0 days relative to index: Direct factor Xa inhibitors,413
45763653210,condition_era group during day -365 through 0 days relative to index: Fracture of bone of hip region,210
45763653212,condition_era group during day -30 through 0 days relative to index: Fracture of bone of hip region,212
45769906210,condition_era group during day -365 through 0 days relative to index: End stage renal disease on dialysis due to type 2 diabetes mellitus,210
407615542710,measurement within normal range during day -365 through 0 days relative to index: Hemoglobin.gastrointestinal.lower [Mass/volume] in Stool by Immunoassay,710
425292152710,measurement within normal range during day -365 through 0 days relative to index: Follitropin [Units/volume] in Serum or Plasma by Immunoassay,710
425292202710,measurement within normal range during day -365 through 0 days relative to index: Lutropin [Units/volume] in Serum or Plasma by Immunoassay,710
